,bcr_patient_barcode,PID,ACE2,TMPRSS2,X.x,Tinfl_gene160.mean,Tinfl_gene160.median,Tinfl_gene160.centered.scaled.mean,Tinfl_gene160.centered.noscale.mean,Tinfl_gene160.nocenter.scaled.mean,Cancer,patient,Aliquot,sample,barcode,shortLetterCode,definition,RNAseq.legacy.flag,Sampletype.flag,Plate,Aliquot.flag,Exclude.mets.flag,Clinical.flag,Tissue.Type,Use.in.analysis,Sample.type,Sample,X.y,type,age_at_initial_pathologic_diagnosis,gender,race,ajcc_pathologic_tumor_stage,clinical_stage,histological_type,histological_grade,initial_pathologic_dx_year,menopause_status,birth_days_to,vital_status,tumor_status,last_contact_days_to,death_days_to,cause_of_death,new_tumor_event_type,new_tumor_event_site,new_tumor_event_site_other,new_tumor_event_dx_days_to,treatment_outcome_first_course,margin_status,residual_tumor,OS,OS.time,DSS,DSS.time,DFI,DFI.time,PFI,PFI.time,Redaction,age.group,bmi,bmi.group,age_began_smoking_in_years,number_pack_years_smoked,stopped_smoking_year,tobacco_smoking_history,year_of_tobacco_smoking_onset,diabetes
TCGA.2E.A9G8.01A,TCGA-2E-A9G8,TCGA.2E.A9G8,5.985054073,8.030010464,TCGA.2E.A9G8.01A.11R.A40A.07,1.871587,1.767155,-0.7758279,-1.043316,0.415721,UCEC,TCGA-2E-A9G8,TCGA-2E-A9G8-01A-11R-A40A-07,TCGA-2E-A9G8-01A,TCGA-2E-A9G8-01A-11R-A40A-07,TP,Primary solid Tumor,1,1,A40A,1,0,1,Female,1,Tumor,TCGA-2E-A9G8-01A,10476,UCEC,59,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage III,Endometrioid endometrial adenocarcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,1249,NA,[Not Available],Locoregional Recurrence,"Other, specify",abdominal wall,335,Progressive Disease,NA,NA,0,1249,0,1249,NA,NA,1,335,NA,younger,28.80441397,level2,NA,NA,NA,NA,NA,NO
TCGA.2J.AAB1.01A,TCGA-2J-AAB1,TCGA.2J.AAB1,9.407475973,11.18510462,TCGA.2J.AAB1.01A.11R.A41B.07,3.612797,3.323275,0.4650288,0.697894,1.007394,PAAD,TCGA-2J-AAB1,TCGA-2J-AAB1-01A-11R-A41B-07,TCGA-2J-AAB1-01A,TCGA-2J-AAB1-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AAB1-01A,7503,PAAD,65,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2012,[Not Available],-23962,Dead,TUMOR FREE,NA,66,Pancreatic Cancer,NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,66,1,66,0,66,0,66,NA,NA,NA,NA,NA,25,1988,3,1962,NO
TCGA.2J.AAB4.01A,TCGA-2J-AAB4,TCGA.2J.AAB4,8.379231057,11.94531946,TCGA.2J.AAB4.01A.12R.A41B.07,3.477583,3.406208,0.3953195,0.5626795,0.9532163,PAAD,TCGA-2J-AAB4,TCGA-2J-AAB4-01A-12R-A41B-07,TCGA-2J-AAB4-01A,TCGA-2J-AAB4-01A-12R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AAB4-01A,7504,PAAD,48,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2012,[Not Available],-17794,Alive,TUMOR FREE,729,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,729,0,729,0,729,0,729,NA,younger,NA,NA,NA,NA,NA,5,NA,NO
TCGA.2J.AAB6.01A,TCGA-2J-AAB6,TCGA.2J.AAB6,5.568165907,8.57058816,TCGA.2J.AAB6.01A.11R.A41B.07,2.667654,2.638311,-0.1431471,-0.2472489,0.6403622,PAAD,TCGA-2J-AAB6,TCGA-2J-AAB6-01A-11R-A41B-07,TCGA-2J-AAB6-01A,TCGA-2J-AAB6-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AAB6-01A,7505,PAAD,75,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-27600,Dead,WITH TUMOR,NA,293,Pancreatic Cancer,Distant Metastasis,Liver,NA,169,Progressive Disease,NA,NA,1,293,1,293,NA,NA,1,169,NA,older,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.2J.AAB8.01A,TCGA-2J-AAB8,TCGA.2J.AAB8,9.159222987,10.93473026,TCGA.2J.AAB8.01A.12R.A41B.07,2.936325,2.921473,0.02043207,0.02142128,0.780984,PAAD,TCGA-2J-AAB8,TCGA-2J-AAB8-01A-12R-A41B-07,TCGA-2J-AAB8-01A,TCGA-2J-AAB8-01A-12R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AAB8-01A,7506,PAAD,71,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-26028,Alive,TUMOR FREE,80,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,80,0,80,NA,NA,0,80,NA,older,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.2J.AAB9.01A,TCGA-2J-AAB9,TCGA.2J.AAB9,6.305580255,10.50178744,TCGA.2J.AAB9.01A.11R.A41B.07,3.455141,3.321605,0.3856728,0.5402375,0.9512555,PAAD,TCGA-2J-AAB9,TCGA-2J-AAB9-01A-11R-A41B-07,TCGA-2J-AAB9-01A,TCGA-2J-AAB9-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AAB9-01A,7507,PAAD,70,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2012,[Not Available],-25920,Dead,WITH TUMOR,NA,627,Pancreatic Cancer,Distant Metastasis,Liver,NA,521,Complete Remission/Response,NA,NA,1,627,1,627,1,521,1,521,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.2J.AABA.01A,TCGA-2J-AABA,TCGA.2J.AABA,8.991601206,10.51146606,TCGA.2J.AABA.01A.21R.A41B.07,2.832496,2.592565,-0.05858394,-0.08240748,0.7720749,PAAD,TCGA-2J-AABA,TCGA-2J-AABA-01A-21R-A41B-07,TCGA-2J-AABA-01A,TCGA-2J-AABA-01A-21R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABA-01A,7508,PAAD,55,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-20133,Dead,WITH TUMOR,NA,607,Pancreatic Cancer,Distant Metastasis,"Other, specify",subcut nodule,160,Progressive Disease,NA,NA,1,607,1,607,NA,NA,1,160,NA,younger,NA,NA,NA,51,NA,5,NA,NO
TCGA.2J.AABE.01A,TCGA-2J-AABE,TCGA.2J.AABE,4.506640022,11.90650733,TCGA.2J.AABE.01A.12R.A41B.07,3.191284,3.124231,0.2395872,0.2763813,0.8401628,PAAD,TCGA-2J-AABE,TCGA-2J-AABE-01A-12R-A41B-07,TCGA-2J-AABE-01A,TCGA-2J-AABE-01A-12R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABE-01A,7509,PAAD,73,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26943,Alive,TUMOR FREE,676,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,676,0,676,0,676,0,676,NA,older,NA,NA,NA,2.2,1970,3,1960,YES
TCGA.2J.AABF.01A,TCGA-2J-AABF,TCGA.2J.AABF,9.333502003,10.93424373,TCGA.2J.AABF.01A.31R.A41B.07,4.239669,4.179631,0.9320186,1.324766,1.228978,PAAD,TCGA-2J-AABF,TCGA-2J-AABF-01A-31R-A41B-07,TCGA-2J-AABF-01A,TCGA-2J-AABF-01A-31R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABF-01A,7510,PAAD,73,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-26936,Dead,WITH TUMOR,NA,691,Pancreatic Cancer,Distant Metastasis,"Other, specify",Liver/lung,443,Progressive Disease,NA,NA,1,691,1,691,NA,NA,1,443,NA,older,NA,NA,NA,7.5,1965,3,1960,NO
TCGA.2J.AABH.01A,TCGA-2J-AABH,TCGA.2J.AABH,8.494167566,12.02365387,TCGA.2J.AABH.01A.21R.A41B.07,2.853136,2.686245,-0.009455883,-0.06176691,0.7191166,PAAD,TCGA-2J-AABH,TCGA-2J-AABH-01A-21R-A41B-07,TCGA-2J-AABH-01A,TCGA-2J-AABH-01A-21R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABH-01A,7511,PAAD,61,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2011,[Not Available],-22425,Alive,WITH TUMOR,1287,NA,NA,Distant Metastasis,"Other, specify",perigastric mass,1287,Complete Remission/Response,NA,NA,0,1287,0,1287,1,1287,1,1287,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.2J.AABI.01A,TCGA-2J-AABI,TCGA.2J.AABI,4.402053602,10.35531806,TCGA.2J.AABI.01A.12R.A41B.07,3.305426,3.215687,0.2777214,0.3905224,0.9023433,PAAD,TCGA-2J-AABI,TCGA-2J-AABI-01A-12R-A41B-07,TCGA-2J-AABI-01A,TCGA-2J-AABI-01A-12R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABI-01A,7512,PAAD,55,FEMALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2011,[Not Available],-20316,Alive,WITH TUMOR,969,NA,NA,Distant Metastasis,Liver,NA,728,Progressive Disease,NA,NA,0,969,0,969,NA,NA,1,728,NA,younger,NA,NA,NA,42,2004,4,1973,NO
TCGA.2J.AABK.01A,TCGA-2J-AABK,TCGA.2J.AABK,9.128638813,10.52276786,TCGA.2J.AABK.01A.31R.A41B.07,2.663088,2.457256,-0.1919262,-0.2518155,0.685022,PAAD,TCGA-2J-AABK,TCGA-2J-AABK-01A-31R-A41B-07,TCGA-2J-AABK-01A,TCGA-2J-AABK-01A-31R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABK-01A,7513,PAAD,71,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26188,Alive,TUMOR FREE,484,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,484,0,484,0,484,0,484,NA,older,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.2J.AABO.01A,TCGA-2J-AABO,TCGA.2J.AABO,8.014628674,9.348812235,TCGA.2J.AABO.01A.21R.A41B.07,2.737158,2.657386,-0.1199821,-0.1777448,0.7214149,PAAD,TCGA-2J-AABO,TCGA-2J-AABO-01A-21R-A41B-07,TCGA-2J-AABO-01A,TCGA-2J-AABO-01A-21R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABO-01A,7514,PAAD,43,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-15869,Alive,WITH TUMOR,440,NA,NA,Distant Metastasis,Liver,NA,439,Progressive Disease,NA,NA,0,440,0,440,NA,NA,1,439,NA,younger,NA,NA,NA,7.5,2003,4,1993,NO
TCGA.2J.AABP.01A,TCGA-2J-AABP,TCGA.2J.AABP,1.818032475,1.584962501,TCGA.2J.AABP.01A.11R.A41B.07,4.756525,4.655243,1.295156,1.841622,1.4026,PAAD,TCGA-2J-AABP,TCGA-2J-AABP-01A-11R-A41B-07,TCGA-2J-AABP-01A,TCGA-2J-AABP-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABP-01A,7515,PAAD,58,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Undifferentiated Carcinoma,G4,2013,[Not Available],-21484,Alive,TUMOR FREE,463,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,463,0,463,0,463,0,463,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.2J.AABR.01A,TCGA-2J-AABR,TCGA.2J.AABR,9.596527091,10.05475353,TCGA.2J.AABR.01A.11R.A41B.07,4.263641,4.126618,0.9324227,1.348737,1.271979,PAAD,TCGA-2J-AABR,TCGA-2J-AABR-01A-11R-A41B-07,TCGA-2J-AABR-01A,TCGA-2J-AABR-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABR-01A,7516,PAAD,60,FEMALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-22131,Alive,WITH TUMOR,438,NA,NA,Distant Metastasis,Liver,NA,327,Progressive Disease,NA,NA,0,438,0,438,NA,NA,1,327,NA,younger,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.2J.AABT.01A,TCGA-2J-AABT,TCGA.2J.AABT,6.731373343,10.65285393,TCGA.2J.AABT.01A.11R.A41B.07,3.841392,3.666989,0.6713587,0.9264886,1.093015,PAAD,TCGA-2J-AABT,TCGA-2J-AABT-01A-11R-A41B-07,TCGA-2J-AABT-01A,TCGA-2J-AABT-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABT-01A,7517,PAAD,72,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26379,Alive,NA,319,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,319,0,319,NA,NA,0,319,NA,older,NA,NA,NA,NA,NA,1,NA,YES
TCGA.2J.AABU.01A,TCGA-2J-AABU,TCGA.2J.AABU,5.901315845,8.358989585,TCGA.2J.AABU.01A.11R.A41B.07,2.864357,2.826702,-0.03134189,-0.05054628,0.7475959,PAAD,TCGA-2J-AABU,TCGA-2J-AABU-01A-11R-A41B-07,TCGA-2J-AABU-01A,TCGA-2J-AABU-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABU-01A,7518,PAAD,56,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-20641,Dead,WITH TUMOR,NA,277,Pancreatic Cancer,Distant Metastasis,Liver,NA,154,Progressive Disease,NA,NA,1,277,1,277,NA,NA,1,154,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.2J.AABV.01A,TCGA-2J-AABV,TCGA.2J.AABV,8.699044901,12.03341612,TCGA.2J.AABV.01A.12R.A41B.07,2.828344,2.757,-0.04152946,-0.08655969,0.7085413,PAAD,TCGA-2J-AABV,TCGA-2J-AABV-01A-12R-A41B-07,TCGA-2J-AABV-01A,TCGA-2J-AABV-01A-12R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-2J-AABV-01A,7519,PAAD,74,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G4,2012,[Not Available],-27082,Dead,WITH TUMOR,NA,652,Pancreatic Cancer,Distant Metastasis,Liver,NA,126,Progressive Disease,NA,NA,1,652,1,652,NA,NA,1,126,NA,older,NA,NA,NA,30,NA,5,NA,NO
TCGA.2L.AAQA.01A,TCGA-2L-AAQA,TCGA.2L.AAQA,7.821487009,12.7681533,TCGA.2L.AAQA.01A.21R.A38C.07,1.673655,1.552656,-0.864311,-1.241248,0.319835,PAAD,TCGA-2L-AAQA,TCGA-2L-AAQA-01A-21R-A38C-07,TCGA-2L-AAQA-01A,TCGA-2L-AAQA-01A-21R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-2L-AAQA-01A,7520,PAAD,76,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-28074,Dead,WITH TUMOR,NA,143,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,143,1,143,NA,NA,1,143,NA,older,NA,NA,NA,30,NA,2,NA,NO
TCGA.2L.AAQE.01A,TCGA-2L-AAQE,TCGA.2L.AAQE,3.911519023,11.10355665,TCGA.2L.AAQE.01A.11R.A39D.07,2.624047,2.424971,-0.2211549,-0.2908567,0.7127138,PAAD,TCGA-2L-AAQE,TCGA-2L-AAQE-01A-11R-A39D-07,TCGA-2L-AAQE-01A,TCGA-2L-AAQE-01A-11R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-2L-AAQE-01A,7521,PAAD,56,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-20618,Dead,WITH TUMOR,NA,684,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,684,1,684,NA,NA,1,684,NA,younger,NA,NA,NA,30,NA,2,NA,YES
TCGA.2L.AAQI.01A,TCGA-2L-AAQI,TCGA.2L.AAQI,10.63462049,11.73690924,TCGA.2L.AAQI.01A.12R.A39D.07,2.436814,2.420747,-0.3089553,-0.478089,0.5917751,PAAD,TCGA-2L-AAQI,TCGA-2L-AAQI-01A-12R-A39D-07,TCGA-2L-AAQI-01A,TCGA-2L-AAQI-01A-12R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-2L-AAQI-01A,7522,PAAD,66,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-24381,Dead,WITH TUMOR,NA,103,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,103,1,103,NA,NA,1,103,NA,older,NA,NA,NA,NA,NA,1,NA,NA
TCGA.2L.AAQJ.01A,TCGA-2L-AAQJ,TCGA.2L.AAQJ,7.675851208,12.14583983,TCGA.2L.AAQJ.01A.12R.A39D.07,3.109096,2.952578,0.1289611,0.1941925,0.8475842,PAAD,TCGA-2L-AAQJ,TCGA-2L-AAQJ-01A-12R-A39D-07,TCGA-2L-AAQJ-01A,TCGA-2L-AAQJ-01A-12R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-2L-AAQJ-01A,7523,PAAD,49,FEMALE,WHITE,Stage III,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-18103,Dead,WITH TUMOR,NA,394,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,394,1,394,NA,NA,1,394,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.2L.AAQL.01A,TCGA-2L-AAQL,TCGA.2L.AAQL,8.471199656,11.18231986,TCGA.2L.AAQL.01A.11R.A38C.07,2.864279,2.865359,-0.02554255,-0.05062396,0.713605,PAAD,TCGA-2L-AAQL,TCGA-2L-AAQL-01A-11R-A38C-07,TCGA-2L-AAQL-01A,TCGA-2L-AAQL-01A-11R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-2L-AAQL-01A,7524,PAAD,82,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-30092,Dead,WITH TUMOR,NA,292,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,292,1,292,NA,NA,1,292,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.2L.AAQM.01A,TCGA-2L-AAQM,TCGA.2L.AAQM,3.339379715,5.588081959,TCGA.2L.AAQM.01A.11R.A39D.07,1.609465,1.609811,-0.9030472,-1.305438,0.3141482,PAAD,TCGA-2L-AAQM,TCGA-2L-AAQM-01A-11R-A39D-07,TCGA-2L-AAQM-01A,TCGA-2L-AAQM-01A-11R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-2L-AAQM-01A,7525,PAAD,52,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2010,[Not Available],-19315,Alive,TUMOR FREE,1383,NA,NA,NA,NA,NA,NA,Stable Disease,NA,NA,0,1383,0,1383,NA,NA,0,1383,NA,younger,NA,NA,NA,NA,NA,1,NA,NA
TCGA.3A.A9I5.01A,TCGA-3A-A9I5,TCGA.3A.A9I5,7.718930098,9.969242604,TCGA.3A.A9I5.01A.11R.A38C.07,1.67316,1.488163,-0.8632894,-1.241743,0.3418703,PAAD,TCGA-3A-A9I5,TCGA-3A-A9I5-01A-11R-A38C-07,TCGA-3A-A9I5-01A,TCGA-3A-A9I5-01A-11R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9I5-01A,7526,PAAD,57,MALE,WHITE,[Discrepancy],[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2009,[Not Available],-21175,Alive,TUMOR FREE,1794,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1794,0,1794,0,1794,0,1794,NA,younger,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.3A.A9I7.01A,TCGA-3A-A9I7,TCGA.3A.A9I7,11.91159422,10.7827198,TCGA.3A.A9I7.01A.21R.A38C.07,3.018852,2.854339,0.05776546,0.1039492,0.8263425,PAAD,TCGA-3A-A9I7,TCGA-3A-A9I7-01A-21R-A38C-07,TCGA-3A-A9I7-01A,TCGA-3A-A9I7-01A-21R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9I7-01A,7527,PAAD,45,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-16766,Alive,WITH TUMOR,1323,NA,NA,Locoregional Recurrence,Peritoneal Surfaces,NA,1309,[Unknown],NA,NA,0,1323,0,1323,NA,NA,1,1309,NA,younger,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.3A.A9I9.01A,TCGA-3A-A9I9,TCGA.3A.A9I9,7.058662839,11.07450276,TCGA.3A.A9I9.01A.11R.A38C.07,2.7812,2.819663,-0.06952952,-0.1337037,0.7059343,PAAD,TCGA-3A-A9I9,TCGA-3A-A9I9-01A-11R-A38C-07,TCGA-3A-A9I9-01A,TCGA-3A-A9I9-01A-11R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9I9-01A,7528,PAAD,67,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-24731,Dead,WITH TUMOR,NA,634,Pancreatic Cancer,Locoregional Recurrence,Liver,NA,513,Stable Disease,NA,NA,1,634,1,634,NA,NA,1,513,NA,older,NA,NA,NA,75,2007,4,NA,NO
TCGA.3A.A9IB.01A,TCGA-3A-A9IB,TCGA.3A.A9IB,5.515037466,10.14375309,TCGA.3A.A9IB.01A.21R.A39D.07,3.058862,2.90207,0.1304544,0.1439588,0.7948055,PAAD,TCGA-3A-A9IB,TCGA-3A-A9IB-01A-21R-A39D-07,TCGA-3A-A9IB-01A,TCGA-3A-A9IB-01A-21R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IB-01A,7529,PAAD,69,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-25312,Dead,NA,NA,224,NA,NA,NA,NA,NA,[Unknown],NA,NA,1,224,NA,224,NA,NA,0,224,NA,older,NA,NA,NA,5,1982,3,1962,YES
TCGA.3A.A9IC.01A,TCGA-3A-A9IC,TCGA.3A.A9IC,5.597891654,11.49952204,TCGA.3A.A9IC.01A.11R.A38C.07,2.345876,2.1513,-0.3752338,-0.5690271,0.5405167,PAAD,TCGA-3A-A9IC,TCGA-3A-A9IC-01A-11R-A38C-07,TCGA-3A-A9IC-01A,TCGA-3A-A9IC-01A-11R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IC-01A,7530,PAAD,61,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-22400,Dead,WITH TUMOR,NA,738,Pancreatic Cancer,NA,NA,NA,NA,Stable Disease,NA,NA,1,738,1,738,NA,NA,1,738,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.3A.A9IH.01A,TCGA-3A-A9IH,TCGA.3A.A9IH,6.329783783,11.0932723,TCGA.3A.A9IH.01A.12R.A39D.07,2.438846,2.309776,-0.3252081,-0.4760567,0.5867596,PAAD,TCGA-3A-A9IH,TCGA-3A-A9IH-01A-12R-A39D-07,TCGA-3A-A9IH-01A,TCGA-3A-A9IH-01A-12R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IH-01A,7531,PAAD,66,FEMALE,WHITE,Stage IA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-24174,Alive,WITH TUMOR,1021,NA,NA,Distant Metastasis,Lung,NA,763,Stable Disease,NA,NA,0,1021,0,1021,NA,NA,1,763,NA,older,NA,NA,NA,NA,2002,4,NA,NO
TCGA.3A.A9IJ.01A,TCGA-3A-A9IJ,TCGA.3A.A9IJ,7.892427457,5.698849103,TCGA.3A.A9IJ.01A.11R.A39D.07,0.6161066,0.4433514,-1.54411,-2.298797,-0.07454694,PAAD,TCGA-3A-A9IJ,TCGA-3A-A9IJ-01A-11R-A39D-07,TCGA-3A-A9IJ-01A,TCGA-3A-A9IJ-01A-11R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IJ-01A,7532,PAAD,65,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2009,[Not Available],-23791,Alive,TUMOR FREE,1854,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1854,0,1854,0,1854,0,1854,NA,NA,NA,NA,NA,25,1984,3,1954,NO
TCGA.3A.A9IL.01A,TCGA-3A-A9IL,TCGA.3A.A9IL,8.241897372,6.540407055,TCGA.3A.A9IL.01A.11R.A38C.07,1.509037,1.357103,-0.9513196,-1.405866,0.2707598,PAAD,TCGA-3A-A9IL,TCGA-3A-A9IL-01A-11R-A38C-07,TCGA-3A-A9IL-01A,TCGA-3A-A9IL-01A-11R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IL-01A,7533,PAAD,39,FEMALE,WHITE,Stage I,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2007,[Not Available],-14599,Alive,TUMOR FREE,2741,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,2741,0,2741,NA,NA,0,2741,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.3A.A9IN.01A,TCGA-3A-A9IN,TCGA.3A.A9IN,4.536544079,6.338862933,TCGA.3A.A9IN.01A.11R.A39D.07,2.350646,2.24566,-0.3745441,-0.5642577,0.5702715,PAAD,TCGA-3A-A9IN,TCGA-3A-A9IN-01A-11R-A39D-07,TCGA-3A-A9IN-01A,TCGA-3A-A9IN-01A-11R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IN-01A,7534,PAAD,62,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2008,[Not Available],-22799,Alive,TUMOR FREE,2084,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2084,0,2084,0,2084,0,2084,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.3A.A9IO.01A,TCGA-3A-A9IO,TCGA.3A.A9IO,6.960662292,9.880120714,TCGA.3A.A9IO.01A.11R.A38C.07,0.5204113,0.4625504,-1.670735,-2.394492,-0.03277947,PAAD,TCGA-3A-A9IO,TCGA-3A-A9IO-01A-11R-A38C-07,TCGA-3A-A9IO-01A,TCGA-3A-A9IO-01A-11R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IO-01A,7535,PAAD,55,MALE,WHITE,[Not Available],[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2009,[Not Available],-20451,Alive,TUMOR FREE,1942,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,1942,0,1942,NA,NA,0,1942,NA,younger,NA,NA,NA,NA,NA,1,NA,YES
TCGA.3A.A9IR.01A,TCGA-3A-A9IR,TCGA.3A.A9IR,2.340733161,9.196919276,TCGA.3A.A9IR.01A.11R.A38C.07,0.7721153,0.6599517,-1.513433,-2.142788,0.03768802,PAAD,TCGA-3A-A9IR,TCGA-3A-A9IR-01A-11R-A38C-07,TCGA-3A-A9IR-01A,TCGA-3A-A9IR-01A-11R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IR-01A,7536,PAAD,64,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2010,[Not Available],-23406,Alive,TUMOR FREE,1542,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1542,0,1542,0,1542,0,1542,NA,younger,NA,NA,NA,NA,2004,4,1989,NO
TCGA.3A.A9IS.01A,TCGA-3A-A9IS,TCGA.3A.A9IS,3.797438458,10.18636189,TCGA.3A.A9IS.01A.21R.A39D.07,0.1382899,0.06268204,-1.921403,-2.776613,-0.1838034,PAAD,TCGA-3A-A9IS,TCGA-3A-A9IS-01A-21R-A39D-07,TCGA-3A-A9IS-01A,TCGA-3A-A9IS-01A-21R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IS-01A,7537,PAAD,67,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2010,[Not Available],-24621,Alive,TUMOR FREE,998,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,998,0,998,0,998,0,998,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.3A.A9IU.01A,TCGA-3A-A9IU,TCGA.3A.A9IU,5.114133776,10.75191222,TCGA.3A.A9IU.01A.11R.A39D.07,2.335403,2.174885,-0.3862911,-0.5795001,0.5633484,PAAD,TCGA-3A-A9IU,TCGA-3A-A9IU-01A-11R-A39D-07,TCGA-3A-A9IU-01A,TCGA-3A-A9IU-01A-11R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IU-01A,7538,PAAD,65,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-23998,Dead,WITH TUMOR,NA,458,Pancreatic Cancer,Distant Metastasis,Liver,NA,371,[Unknown],NA,NA,1,458,1,458,NA,NA,1,371,NA,NA,NA,NA,NA,NA,NA,1,NA,NO
TCGA.3A.A9IV.01A,TCGA-3A-A9IV,TCGA.3A.A9IV,1.832363461,3.44060676,TCGA.3A.A9IV.01A.11R.A41B.07,1.310533,1.248101,-1.065088,-1.60437,0.1474474,PAAD,TCGA-3A-A9IV,TCGA-3A-A9IV-01A-11R-A41B-07,TCGA-3A-A9IV-01A,TCGA-3A-A9IV-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IV-01A,7539,PAAD,59,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2011,[Not Available],-21732,Alive,TUMOR FREE,1103,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1103,0,1103,0,1103,0,1103,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.3A.A9IX.01A,TCGA-3A-A9IX,TCGA.3A.A9IX,8.226306215,9.813434903,TCGA.3A.A9IX.01A.11R.A41B.07,4.357835,4.164026,1.002319,1.442932,1.314403,PAAD,TCGA-3A-A9IX,TCGA-3A-A9IX-01A-11R-A41B-07,TCGA-3A-A9IX-01A,TCGA-3A-A9IX-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IX-01A,7540,PAAD,40,MALE,WHITE,Stage IA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-14729,Alive,TUMOR FREE,1037,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1037,0,1037,0,1037,0,1037,NA,younger,NA,NA,NA,2.3,2010,4,1988,YES
TCGA.3A.A9IZ.01A,TCGA-3A-A9IZ,TCGA.3A.A9IZ,5.639235058,10.59755911,TCGA.3A.A9IZ.01A.12R.A41B.07,1.653661,1.559398,-0.8706935,-1.261242,0.3090186,PAAD,TCGA-3A-A9IZ,TCGA-3A-A9IZ-01A-12R-A41B-07,TCGA-3A-A9IZ-01A,TCGA-3A-A9IZ-01A-12R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9IZ-01A,7541,PAAD,47,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-17294,Dead,WITH TUMOR,NA,308,Pancreatic Cancer,Locoregional Recurrence,Tumor Bed,NA,109,Progressive Disease,NA,NA,1,308,1,308,NA,NA,1,109,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.3A.A9J0.01A,TCGA-3A-A9J0,TCGA.3A.A9J0,2.954773273,9.676699354,TCGA.3A.A9J0.01A.11R.A41B.07,2.902904,2.726284,0.01643994,-0.01199916,0.7664782,PAAD,TCGA-3A-A9J0,TCGA-3A-A9J0-01A-11R-A41B-07,TCGA-3A-A9J0-01A,TCGA-3A-A9J0-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-3A-A9J0-01A,7542,PAAD,75,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-27453,Alive,WITH TUMOR,743,NA,NA,Distant Metastasis,Lung,NA,363,Progressive Disease,NA,NA,0,743,0,743,NA,NA,1,363,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.3E.AAAY.01A,TCGA-3E-AAAY,TCGA.3E.AAAY,7.604471687,11.26464198,TCGA.3E.AAAY.01A.11R.A38C.07,3.413822,3.360417,0.3620909,0.4989189,0.9541544,PAAD,TCGA-3E-AAAY,TCGA-3E-AAAY-01A-11R-A38C-07,TCGA-3E-AAAY-01A,TCGA-3E-AAAY-01A-11R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-3E-AAAY-01A,7543,PAAD,67,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2008,[Not Available],-24760,Alive,[Discrepancy],2285,NA,NA,Distant Metastasis,Lung,NA,987,Complete Remission/Response,NA,NA,0,2285,0,2285,1,987,1,987,NA,older,NA,NA,NA,NA,NA,5,NA,NO
TCGA.3E.AAAZ.01A,TCGA-3E-AAAZ,TCGA.3E.AAAZ,4.136265226,11.53592658,TCGA.3E.AAAZ.01A.11R.A38C.07,1.718923,1.588687,-0.8242777,-1.19598,0.3479467,PAAD,TCGA-3E-AAAZ,TCGA-3E-AAAZ-01A-11R-A38C-07,TCGA-3E-AAAZ-01A,TCGA-3E-AAAZ-01A-11R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-3E-AAAZ-01A,7544,PAAD,71,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-26234,Dead,WITH TUMOR,NA,2182,"Other, specify",New Primary Tumor,Lung,NA,1600,[Unknown],NA,NA,1,2182,0,2182,NA,NA,1,1600,NA,older,NA,NA,NA,NA,NA,5,NA,NA
TCGA.4E.A92E.01A,TCGA-4E-A92E,TCGA.4E.A92E,6.43184523,10.00249157,TCGA.4E.A92E.01A.11R.A37O.07,3.34254,3.017361,0.2919618,0.427637,0.9215484,UCEC,TCGA-4E-A92E,TCGA-4E-A92E-01A-11R-A37O-07,TCGA-4E-A92E-01A,TCGA-4E-A92E-01A-11R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-4E-A92E-01A,10477,UCEC,54,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G1,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19818,Alive,TUMOR FREE,13,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,13,0,13,0,13,0,13,NA,younger,28.95900015,level2,NA,NA,NA,NA,NA,NO
TCGA.5B.A90C.01A,TCGA-5B-A90C,TCGA.5B.A90C,5.442641659,8.379109732,TCGA.5B.A90C.01A.11R.A37O.07,1.14058,1.026168,-1.250305,-1.774324,0.1327172,UCEC,TCGA-5B-A90C,TCGA-5B-A90C-01A-11R-A37O-07,TCGA-5B-A90C-01A,TCGA-5B-A90C-01A-11R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-5B-A90C-01A,10478,UCEC,69,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25518,Alive,TUMOR FREE,1202,NA,[Not Available],Locoregional Recurrence,"Other, specify",right pelvic mass,517,[Not Available],NA,NA,0,1202,0,1202,NA,NA,1,517,NA,older,39.2565294,level4,NA,NA,NA,NA,NA,NO
TCGA.5S.A9Q8.01A,TCGA-5S-A9Q8,TCGA.5S.A9Q8,4.564012265,9.313769623,TCGA.5S.A9Q8.01A.11R.A40A.07,1.025081,1.034807,-1.342442,-1.889822,0.07381869,UCEC,TCGA-5S-A9Q8,TCGA-5S-A9Q8-01A-11R-A40A-07,TCGA-5S-A9Q8-01A,TCGA-5S-A9Q8-01A-11R-A40A-07,TP,Primary solid Tumor,1,1,A40A,1,0,1,Female,1,Tumor,TCGA-5S-A9Q8-01A,10479,UCEC,51,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2013,[Unknown],-18785,Alive,NA,313,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,313,0,313,0,313,0,313,NA,younger,32.76939491,level3,NA,NA,NA,NA,NA,YES
TCGA.A5.A0G1.01A,TCGA-A5-A0G1,TCGA.A5.A0G1,9.131293677,5.072900478,TCGA.A5.A0G1.01A.11R.A118.07,5.350111,5.379092,1.671995,2.435208,1.634777,UCEC,TCGA-A5-A0G1,TCGA-A5-A0G1-01A-11R-A118-07,TCGA-A5-A0G1-01A,TCGA-A5-A0G1-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-A5-A0G1-01A,10480,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,1996,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24477,Dead,TUMOR FREE,NA,3251,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,3251,0,3251,0,3251,0,3251,NA,older,20.90419501,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0G2.01A,TCGA-A5-A0G2,TCGA.A5.A0G2,2.535809893,2.413651723,TCGA.A5.A0G2.01A.11R.A16W.07,3.887001,3.663434,0.6471191,0.9720976,1.113573,UCEC,TCGA-A5-A0G2,TCGA-A5-A0G2-01A-11R-A16W-07,TCGA-A5-A0G2-01A,TCGA-A5-A0G2-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-A5-A0G2-01A,10481,UCEC,57,FEMALE,ASIAN,[Not Applicable],Stage IIIB,Serous endometrial adenocarcinoma,G3,1997,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20953,Alive,WITH TUMOR,4549,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,4549,0,4549,0,4549,0,4549,NA,younger,25.96952909,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A0G3.01A,TCGA-A5-A0G3,TCGA.A5.A0G3,3.413771678,6.113197348,TCGA.A5.A0G3.01A.11R.A040.07,1.435016,1.373862,-0.9902917,-1.479887,0.2230125,UCEC,TCGA-A5-A0G3,TCGA-A5-A0G3-01A-11R-A040-07,TCGA-A5-A0G3-01A,TCGA-A5-A0G3-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0G3-01A,10482,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22421,Alive,WITH TUMOR,1428,NA,[Not Available],NA,NA,NA,795,Complete Remission/Response,NA,NA,0,1428,0,1428,1,795,1,795,NA,younger,23.50780533,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0G5.01A,TCGA-A5-A0G5,TCGA.A5.A0G5,3.773806125,2.781154774,TCGA.A5.A0G5.01A.11R.A040.07,5.81662,5.612189,2.006608,2.901717,1.814029,UCEC,TCGA-A5-A0G5,TCGA-A5-A0G5-01A-11R-A040-07,TCGA-A5-A0G5-01A,TCGA-A5-A0G5-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0G5-01A,10483,UCEC,73,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26827,Alive,TUMOR FREE,1126,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1126,0,1126,0,1126,0,1126,NA,older,18.75,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0G9.01A,TCGA-A5-A0G9,TCGA.A5.A0G9,4.506635459,9.497974153,TCGA.A5.A0G9.01A.11R.A040.07,3.025648,2.960429,0.1142149,0.1107449,0.7743571,UCEC,TCGA-A5-A0G9,TCGA-A5-A0G9-01A-11R-A040-07,TCGA-A5-A0G9-01A,TCGA-A5-A0G9-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0G9-01A,10484,UCEC,79,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29122,Alive,TUMOR FREE,2540,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2540,0,2540,0,2540,0,2540,NA,older,27.71768524,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GA.01A,TCGA-A5-A0GA,TCGA.A5.A0GA,6.54978967,5.926146745,TCGA.A5.A0GA.01A.11R.A040.07,2.547871,2.268834,-0.2774658,-0.3670325,0.6553491,UCEC,TCGA-A5-A0GA,TCGA-A5-A0GA-01A-11R-A040-07,TCGA-A5-A0GA-01A,TCGA-A5-A0GA-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0GA-01A,10485,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24659,Dead,WITH TUMOR,NA,543,[Not Available],NA,NA,NA,NA,Partial Remission/Response,NA,NA,1,543,1,543,NA,NA,1,543,NA,older,31.14186851,level3,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GB.01A,TCGA-A5-A0GB,TCGA.A5.A0GB,2.963693422,9.758992641,TCGA.A5.A0GB.01A.11R.A040.07,2.148789,2.071821,-0.5918276,-0.7661137,0.5427878,UCEC,TCGA-A5-A0GB,TCGA-A5-A0GB-01A-11R-A040-07,TCGA-A5-A0GB-01A,TCGA-A5-A0GB-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0GB-01A,10486,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23883,Alive,TUMOR FREE,997,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,997,0,997,0,997,0,997,NA,NA,44.8117539,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GD.01A,TCGA-A5-A0GD,TCGA.A5.A0GD,5.322346644,9.853913285,TCGA.A5.A0GD.01A.11R.A16W.07,3.651166,3.661413,0.544067,0.7362632,0.9851931,UCEC,TCGA-A5-A0GD,TCGA-A5-A0GD-01A-11R-A16W-07,TCGA-A5-A0GD-01A,TCGA-A5-A0GD-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-A5-A0GD-01A,10487,UCEC,75,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,1999,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27399,Dead,TUMOR FREE,NA,3423,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,3423,0,3423,0,3423,0,3423,NA,older,27.85200798,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GE.01A,TCGA-A5-A0GE,TCGA.A5.A0GE,3.972650176,9.637201332,TCGA.A5.A0GE.01A.11R.A16W.07,2.887019,2.589579,-0.0291873,-0.02788392,0.777864,UCEC,TCGA-A5-A0GE,TCGA-A5-A0GE-01A-11R-A16W-07,TCGA-A5-A0GE-01A,TCGA-A5-A0GE-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-A5-A0GE-01A,10488,UCEC,38,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2002,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14170,Alive,TUMOR FREE,3205,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,3205,0,3205,0,3205,0,3205,NA,younger,23.72528616,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GG.01A,TCGA-A5-A0GG,TCGA.A5.A0GG,2.892325451,9.317926469,TCGA.A5.A0GG.01A.11R.A118.07,2.854888,2.834898,-0.04579527,-0.06001565,0.7408142,UCEC,TCGA-A5-A0GG,TCGA-A5-A0GG-01A-11R-A118-07,TCGA-A5-A0GG-01A,TCGA-A5-A0GG-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-A5-A0GG-01A,10489,UCEC,76,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27809,Alive,TUMOR FREE,3762,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,3762,0,3762,0,3762,0,3762,NA,older,25,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GH.01A,TCGA-A5-A0GH,TCGA.A5.A0GH,7.910904833,9.676205863,TCGA.A5.A0GH.01A.21R.A16W.07,1.711857,1.669875,-0.8814203,-1.203046,0.3747738,UCEC,TCGA-A5-A0GH,TCGA-A5-A0GH-01A-21R-A16W-07,TCGA-A5-A0GH-01A,TCGA-A5-A0GH-01A-21R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-A5-A0GH-01A,10490,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21090,Alive,TUMOR FREE,2254,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2254,0,2254,0,2254,0,2254,NA,younger,20.70081674,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GI.01A,TCGA-A5-A0GI,TCGA.A5.A0GI,4.681151224,9.819774289,TCGA.A5.A0GI.01A.11R.A040.07,2.741652,2.611423,-0.1279142,-0.1732515,0.726824,UCEC,TCGA-A5-A0GI,TCGA-A5-A0GI-01A-11R-A040-07,TCGA-A5-A0GI-01A,TCGA-A5-A0GI-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0GI-01A,10491,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23195,Alive,TUMOR FREE,2682,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2682,0,2682,0,2682,0,2682,NA,younger,23.38435374,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GJ.01A,TCGA-A5-A0GJ,TCGA.A5.A0GJ,5.446026319,9.264177499,TCGA.A5.A0GJ.01A.11R.A040.07,3.607818,3.538842,0.4732631,0.692915,1.030788,UCEC,TCGA-A5-A0GJ,TCGA-A5-A0GJ-01A-11R-A040-07,TCGA-A5-A0GJ-01A,TCGA-A5-A0GJ-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0GJ-01A,10492,UCEC,44,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16421,Alive,TUMOR FREE,2000,NA,[Not Available],NA,NA,NA,12,Complete Remission/Response,NA,NA,0,2000,0,2000,1,12,1,12,NA,younger,43.28352591,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GM.01A,TCGA-A5-A0GM,TCGA.A5.A0GM,4.122451243,8.554583054,TCGA.A5.A0GM.01A.11R.A040.07,2.093814,1.81285,-0.5611217,-0.8210897,0.4816523,UCEC,TCGA-A5-A0GM,TCGA-A5-A0GM-01A-11R-A040-07,TCGA-A5-A0GM-01A,TCGA-A5-A0GM-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0GM-01A,10493,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19452,Alive,TUMOR FREE,1841,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1841,0,1841,0,1841,0,1841,NA,younger,37.890625,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GN.01A,TCGA-A5-A0GN,TCGA.A5.A0GN,5.833266986,9.739954187,TCGA.A5.A0GN.01A.11R.A040.07,3.953121,3.916202,0.7233676,1.038217,1.167243,UCEC,TCGA-A5-A0GN,TCGA-A5-A0GN-01A-11R-A040-07,TCGA-A5-A0GN-01A,TCGA-A5-A0GN-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0GN-01A,10494,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24020,Alive,TUMOR FREE,1841,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1841,0,1841,0,1841,0,1841,NA,NA,25.2825699,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GP.01A,TCGA-A5-A0GP,TCGA.A5.A0GP,6.316186806,9.595747424,TCGA.A5.A0GP.01A.11R.A040.07,2.183609,2.234379,-0.5206428,-0.731294,0.4973943,UCEC,TCGA-A5-A0GP,TCGA-A5-A0GP-01A-11R-A040-07,TCGA-A5-A0GP-01A,TCGA-A5-A0GP-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0GP-01A,10495,UCEC,58,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21365,Alive,TUMOR FREE,1416,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1416,0,1416,0,1416,0,1416,NA,younger,23.4375,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GQ.01A,TCGA-A5-A0GQ,TCGA.A5.A0GQ,6.058119658,10.39945949,TCGA.A5.A0GQ.01A.11R.A118.07,3.563873,3.596887,0.4778346,0.6489695,0.9857175,UCEC,TCGA-A5-A0GQ,TCGA-A5-A0GQ-01A-11R-A118-07,TCGA-A5-A0GQ-01A,TCGA-A5-A0GQ-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-A5-A0GQ-01A,10496,UCEC,76,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28078,Alive,TUMOR FREE,2247,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2247,0,2247,0,2247,0,2247,NA,older,25.33333333,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GR.01A,TCGA-A5-A0GR,TCGA.A5.A0GR,6.394532593,7.654652275,TCGA.A5.A0GR.01A.11R.A118.07,4.077472,4.011684,0.8051972,1.162569,1.228156,UCEC,TCGA-A5-A0GR,TCGA-A5-A0GR-01A-11R-A118-07,TCGA-A5-A0GR-01A,TCGA-A5-A0GR-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-A5-A0GR-01A,10497,UCEC,69,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25353,Alive,TUMOR FREE,1120,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1120,0,1120,0,1120,0,1120,NA,older,28.08899103,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GU.01A,TCGA-A5-A0GU,TCGA.A5.A0GU,5.75498288,10.19088223,TCGA.A5.A0GU.01A.11R.A16W.07,3.546826,3.45351,0.4326256,0.6319231,0.9733279,UCEC,TCGA-A5-A0GU,TCGA-A5-A0GU-01A-11R-A16W-07,TCGA-A5-A0GU-01A,TCGA-A5-A0GU-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-A5-A0GU-01A,10498,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21192,Alive,TUMOR FREE,860,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,860,0,860,0,860,0,860,NA,younger,37.109375,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GV.01A,TCGA-A5-A0GV,TCGA.A5.A0GV,5.153004457,9.503914661,TCGA.A5.A0GV.01A.31R.A16W.07,1.452543,1.063793,-1.010959,-1.46236,0.2553781,UCEC,TCGA-A5-A0GV,TCGA-A5-A0GV-01A-31R-A16W-07,TCGA-A5-A0GV-01A,TCGA-A5-A0GV-01A-31R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-A5-A0GV-01A,10499,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24540,Alive,TUMOR FREE,1643,NA,[Not Available],NA,NA,NA,304,Complete Remission/Response,NA,NA,0,1643,0,1643,1,304,1,304,NA,older,25.23634033,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GW.01A,TCGA-A5-A0GW,TCGA.A5.A0GW,4.648291815,8.895425912,TCGA.A5.A0GW.01A.11R.A16W.07,4.764919,4.725777,1.254165,1.850016,1.456571,UCEC,TCGA-A5-A0GW,TCGA-A5-A0GW-01A-11R-A16W-07,TCGA-A5-A0GW-01A,TCGA-A5-A0GW-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-A5-A0GW-01A,10500,UCEC,46,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17092,Alive,TUMOR FREE,706,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,706,0,706,0,706,0,706,NA,younger,24.30073398,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0GX.01A,TCGA-A5-A0GX,TCGA.A5.A0GX,4.089481009,10.07632964,TCGA.A5.A0GX.01A.11R.A040.07,3.45678,3.388549,0.3681872,0.5418767,0.9563687,UCEC,TCGA-A5-A0GX,TCGA-A5-A0GX-01A-11R-A040-07,TCGA-A5-A0GX-01A,TCGA-A5-A0GX-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-A5-A0GX-01A,10501,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19625,Alive,TUMOR FREE,2088,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2088,0,2088,0,2088,0,2088,NA,younger,40.15466984,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A0R6.01A,TCGA-A5-A0R6,TCGA.A5.A0R6,5.016121773,7.821200819,TCGA.A5.A0R6.01A.11R.A104.07,2.467815,2.436749,-0.3266893,-0.4470885,0.6333567,UCEC,TCGA-A5-A0R6,TCGA-A5-A0R6-01A-11R-A104-07,TCGA-A5-A0R6-01A,TCGA-A5-A0R6-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-A5-A0R6-01A,10502,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23449,Alive,TUMOR FREE,1153,NA,[Not Available],New Primary Tumor,"Other, specify",Rectum,961,Complete Remission/Response,NA,NA,0,1153,0,1153,0,1153,1,961,NA,younger,27.58732606,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A0R7.01A,TCGA-A5-A0R7,TCGA.A5.A0R7,5.470059158,9.589304549,TCGA.A5.A0R7.01A.31R.A16W.07,3.903602,3.814804,0.668411,0.988699,1.150697,UCEC,TCGA-A5-A0R7,TCGA-A5-A0R7-01A-31R-A16W-07,TCGA-A5-A0R7-01A,TCGA-A5-A0R7-01A-31R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-A5-A0R7-01A,10503,UCEC,55,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20250,Alive,TUMOR FREE,535,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,535,0,535,0,535,0,535,NA,younger,49.95408632,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A0R8.01A,TCGA-A5-A0R8,TCGA.A5.A0R8,6.776924429,9.736229084,TCGA.A5.A0R8.01A.11R.A104.07,3.815984,3.86576,0.6386316,0.9010812,1.085625,UCEC,TCGA-A5-A0R8,TCGA-A5-A0R8-01A-11R-A104-07,TCGA-A5-A0R8-01A,TCGA-A5-A0R8-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-A5-A0R8-01A,10504,UCEC,81,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29777,Alive,TUMOR FREE,596,NA,[Not Available],NA,NA,NA,42,Complete Remission/Response,NA,NA,0,596,0,596,1,42,1,42,NA,older,24.21875,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0R9.01A,TCGA-A5-A0R9,TCGA.A5.A0R9,3.832317442,9.933153165,TCGA.A5.A0R9.01A.11R.A104.07,3.329587,3.301544,0.2882336,0.414684,0.9235,UCEC,TCGA-A5-A0R9,TCGA-A5-A0R9-01A-11R-A104-07,TCGA-A5-A0R9-01A,TCGA-A5-A0R9-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-A5-A0R9-01A,10505,UCEC,51,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18982,Alive,TUMOR FREE,749,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,749,0,749,0,749,0,749,NA,younger,54.5748805,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A0RA.01A,TCGA-A5-A0RA,TCGA.A5.A0RA,7.25510468,9.726623776,TCGA.A5.A0RA.01A.21R.A104.07,2.49935,2.400513,-0.2887338,-0.4155529,0.5813019,UCEC,TCGA-A5-A0RA,TCGA-A5-A0RA-01A-21R-A104-07,TCGA-A5-A0RA-01A,TCGA-A5-A0RA-01A-21R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-A5-A0RA-01A,10506,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25060,Alive,TUMOR FREE,884,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,884,0,884,0,884,0,884,NA,older,47.03433923,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A0VO.01A,TCGA-A5-A0VO,TCGA.A5.A0VO,4.558278472,10.362811,TCGA.A5.A0VO.01A.21R.A109.07,2.552842,2.632974,-0.2577895,-0.3620613,0.6295591,UCEC,TCGA-A5-A0VO,TCGA-A5-A0VO-01A-21R-A109-07,TCGA-A5-A0VO-01A,TCGA-A5-A0VO-01A-21R-A109-07,TP,Primary solid Tumor,1,1,A109,1,0,1,Female,1,Tumor,TCGA-A5-A0VO-01A,10507,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23547,Dead,TUMOR FREE,NA,875,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,875,0,875,0,875,0,875,NA,younger,32.36854981,level3,NA,NA,NA,NA,NA,NA
TCGA.A5.A0VP.01A,TCGA-A5-A0VP,TCGA.A5.A0VP,7.023784556,11.825704,TCGA.A5.A0VP.01A.21R.A104.07,2.688124,2.603127,-0.1724684,-0.2267792,0.714477,UCEC,TCGA-A5-A0VP,TCGA-A5-A0VP-01A-21R-A104-07,TCGA-A5-A0VP-01A,TCGA-A5-A0VP-01A-21R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-A5-A0VP-01A,10508,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27335,Alive,TUMOR FREE,1288,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1288,0,1288,0,1288,0,1288,NA,older,21.8299522,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A0VQ.01A,TCGA-A5-A0VQ,TCGA.A5.A0VQ,5.762769137,9.978405822,TCGA.A5.A0VQ.01A.11R.A104.07,2.847643,2.681498,-0.04096639,-0.06725975,0.7630854,UCEC,TCGA-A5-A0VQ,TCGA-A5-A0VQ-01A-11R-A104-07,TCGA-A5-A0VQ-01A,TCGA-A5-A0VQ-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-A5-A0VQ-01A,10509,UCEC,62,FEMALE,[Not Available],[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22995,Alive,TUMOR FREE,485,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,485,0,485,0,485,0,485,NA,younger,35.65133793,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A1OF.01A,TCGA-A5-A1OF,TCGA.A5.A1OF,6.023126084,4.247772923,TCGA.A5.A1OF.01A.11R.A14D.07,4.605675,4.315865,1.154825,1.690772,1.353829,UCEC,TCGA-A5-A1OF,TCGA-A5-A1OF-01A-11R-A14D-07,TCGA-A5-A1OF-01A,TCGA-A5-A1OF-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-A5-A1OF-01A,10510,UCEC,47,FEMALE,[Not Available],[Not Applicable],Stage IA,Mixed serous and endometrioid,High Grade,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17308,Alive,TUMOR FREE,973,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,973,0,973,0,973,0,973,NA,younger,29.13631634,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A1OG.01A,TCGA-A5-A1OG,TCGA.A5.A1OG,4.949004203,7.377249383,TCGA.A5.A1OG.01A.11R.A14D.07,3.232446,3.373861,0.1972124,0.3175425,0.9014813,UCEC,TCGA-A5-A1OG,TCGA-A5-A1OG-01A-11R-A14D-07,TCGA-A5-A1OG-01A,TCGA-A5-A1OG-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-A5-A1OG-01A,10511,UCEC,65,FEMALE,ASIAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23956,Dead,WITH TUMOR,NA,973,[Not Available],Metastatic,Lung,NA,337,Complete Remission/Response,NA,NA,1,973,1,973,1,337,1,337,NA,NA,25.63691716,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A1OH.01A,TCGA-A5-A1OH,TCGA.A5.A1OH,2.664369059,6.185049844,TCGA.A5.A1OH.01A.21R.A22K.07,0.9426982,0.9715785,-1.351788,-1.972205,0.08024868,UCEC,TCGA-A5-A1OH,TCGA-A5-A1OH-01A-21R-A22K-07,TCGA-A5-A1OH-01A,TCGA-A5-A1OH-01A-21R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-A5-A1OH-01A,10512,UCEC,86,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31451,Alive,TUMOR FREE,1105,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1105,0,1105,0,1105,0,1105,NA,older,24.55775234,level1,NA,NA,NA,NA,NA,NO
TCGA.A5.A1OJ.01A,TCGA-A5-A1OJ,TCGA.A5.A1OJ,5.349559528,8.400605155,TCGA.A5.A1OJ.01A.11R.A14D.07,3.241278,3.098583,0.2146807,0.3263752,0.9284423,UCEC,TCGA-A5-A1OJ,TCGA-A5-A1OJ-01A-11R-A14D-07,TCGA-A5-A1OJ-01A,TCGA-A5-A1OJ-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-A5-A1OJ-01A,10513,UCEC,31,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-11635,Alive,TUMOR FREE,1006,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1006,0,1006,0,1006,0,1006,NA,younger,39.12591051,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A1OK.01A,TCGA-A5-A1OK,TCGA.A5.A1OK,4.396198134,10.2208771,TCGA.A5.A1OK.01A.11R.A14M.07,2.345162,2.218954,-0.3830811,-0.5697413,0.5335382,UCEC,TCGA-A5-A1OK,TCGA-A5-A1OK-01A-11R-A14M-07,TCGA-A5-A1OK-01A,TCGA-A5-A1OK-01A-11R-A14M-07,TP,Primary solid Tumor,1,1,A14M,1,0,1,Female,1,Tumor,TCGA-A5-A1OK-01A,10514,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23179,Alive,TUMOR FREE,917,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,917,0,917,0,917,0,917,NA,younger,31.95592287,level3,NA,NA,NA,NA,NA,NA
TCGA.A5.A2K2.01A,TCGA-A5-A2K2,TCGA.A5.A2K2,4.370715302,5.821944863,TCGA.A5.A2K2.01A.11R.A18M.07,0.8518303,0.6090033,-1.438866,-2.063073,0.02205945,UCEC,TCGA-A5-A2K2,TCGA-A5-A2K2-01A-11R-A18M-07,TCGA-A5-A2K2-01A,TCGA-A5-A2K2-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-A5-A2K2-01A,10515,UCEC,77,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28456,Alive,TUMOR FREE,3595,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,3595,0,3595,0,3595,0,3595,NA,older,20.81165453,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A2K3.01A,TCGA-A5-A2K3,TCGA.A5.A2K3,8.649992608,3.81770511,TCGA.A5.A2K3.01A.11R.A32Y.07,6.791256,6.758457,2.700514,3.876353,2.158319,UCEC,TCGA-A5-A2K3,TCGA-A5-A2K3-01A-11R-A32Y-07,TCGA-A5-A2K3-01A,TCGA-A5-A2K3-01A-11R-A32Y-07,TP,Primary solid Tumor,1,1,A32Y,1,0,1,Female,1,Tumor,TCGA-A5-A2K3-01A,10516,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24907,Alive,TUMOR FREE,2012,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2012,0,2012,0,2012,0,2012,NA,older,31.25,level3,NA,NA,NA,NA,NA,NA
TCGA.A5.A2K4.01A,TCGA-A5-A2K4,TCGA.A5.A2K4,6.081614453,5.38663853,TCGA.A5.A2K4.01A.11R.A18M.07,2.259923,2.117869,-0.4625342,-0.6549801,0.5713793,UCEC,TCGA-A5-A2K4,TCGA-A5-A2K4-01A-11R-A18M-07,TCGA-A5-A2K4-01A,TCGA-A5-A2K4-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-A5-A2K4-01A,10517,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25270,Dead,WITH TUMOR,NA,871,[Not Available],Metastatic,"Other, specify",Bowel,528,Complete Remission/Response,NA,NA,1,871,1,871,1,528,1,528,NA,older,18.06972789,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A2K5.01A,TCGA-A5-A2K5,TCGA.A5.A2K5,2.224102032,9.158766193,TCGA.A5.A2K5.01A.11R.A180.07,3.227695,3.371514,0.2172269,0.3127913,0.8475545,UCEC,TCGA-A5-A2K5,TCGA-A5-A2K5-01A-11R-A180-07,TCGA-A5-A2K5-01A,TCGA-A5-A2K5-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-A5-A2K5-01A,10518,UCEC,76,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28057,Alive,TUMOR FREE,752,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,752,0,752,0,752,0,752,NA,older,47.80006775,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A2K7.01A,TCGA-A5-A2K7,TCGA.A5.A2K7,6.034226722,7.445221817,TCGA.A5.A2K7.01A.11R.A180.07,2.500658,2.05399,-0.2580804,-0.414245,0.5662921,UCEC,TCGA-A5-A2K7,TCGA-A5-A2K7-01A-11R-A180-07,TCGA-A5-A2K7-01A,TCGA-A5-A2K7-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-A5-A2K7-01A,10519,UCEC,41,FEMALE,[Not Available],[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14980,Alive,TUMOR FREE,1063,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1063,0,1063,0,1063,0,1063,NA,younger,29.21010994,level2,NA,NA,NA,NA,NA,NA
TCGA.A5.A3LO.01A,TCGA-A5-A3LO,TCGA.A5.A3LO,8.265343124,11.05995278,TCGA.A5.A3LO.01A.11R.A22K.07,1.84439,1.708287,-0.7613585,-1.070513,0.4197707,UCEC,TCGA-A5-A3LO,TCGA-A5-A3LO-01A-11R-A22K-07,TCGA-A5-A3LO-01A,TCGA-A5-A3LO-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-A5-A3LO-01A,10520,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23401,Alive,TUMOR FREE,776,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,776,0,776,0,776,0,776,NA,younger,36.49376417,level4,NA,NA,NA,NA,NA,NA
TCGA.A5.A3LP.01A,TCGA-A5-A3LP,TCGA.A5.A3LP,5.759094566,6.412817084,TCGA.A5.A3LP.01A.11R.A22K.07,3.173687,2.936548,0.1615161,0.2587837,0.8269406,UCEC,TCGA-A5-A3LP,TCGA-A5-A3LP-01A-11R-A22K-07,TCGA-A5-A3LP-01A,TCGA-A5-A3LP-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-A5-A3LP-01A,10521,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27131,Alive,TUMOR FREE,455,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,455,0,455,0,455,0,455,NA,older,18.19548277,level1,NA,NA,NA,NA,NA,NA
TCGA.A5.A7WJ.01A,TCGA-A5-A7WJ,TCGA.A5.A7WJ,5.150096575,9.852918025,TCGA.A5.A7WJ.01A.12R.A34R.07,1.070562,0.7956233,-1.313237,-1.844342,0.1366934,UCEC,TCGA-A5-A7WJ,TCGA-A5-A7WJ-01A-12R-A34R-07,TCGA-A5-A7WJ-01A,TCGA-A5-A7WJ-01A-12R-A34R-07,TP,Primary solid Tumor,1,1,A34R,1,0,1,Female,1,Tumor,TCGA-A5-A7WJ-01A,10522,UCEC,64,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23723,Alive,TUMOR FREE,341,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,341,0,341,0,341,0,341,NA,younger,22.14532872,level1,NA,NA,NA,NA,NA,NO
TCGA.A5.A7WK.01A,TCGA-A5-A7WK,TCGA.A5.A7WK,3.898875844,8.854061121,TCGA.A5.A7WK.01A.11R.A34R.07,2.083143,1.904088,-0.5836641,-0.8317603,0.4616107,UCEC,TCGA-A5-A7WK,TCGA-A5-A7WK-01A-11R-A34R-07,TCGA-A5-A7WK-01A,TCGA-A5-A7WK-01A-11R-A34R-07,TP,Primary solid Tumor,1,1,A34R,1,0,1,Female,1,Tumor,TCGA-A5-A7WK-01A,10523,UCEC,71,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Mixed serous and endometrioid,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26044,Alive,WITH TUMOR,560,NA,[Not Available],Locoregional Recurrence,"Other, specify",Paraaortic lymph node,350,Complete Remission/Response,NA,NA,0,560,0,560,1,350,1,350,NA,older,34.36791383,level3,NA,NA,NA,NA,NA,YES
TCGA.A5.AB3J.01A,TCGA-A5-AB3J,TCGA.A5.AB3J,4.413485768,9.721864776,TCGA.A5.AB3J.01A.11R.A40A.07,2.169512,2.126245,-0.5540292,-0.745391,0.5494064,UCEC,TCGA-A5-AB3J,TCGA-A5-AB3J-01A-11R-A40A-07,TCGA-A5-AB3J-01A,TCGA-A5-AB3J-01A-11R-A40A-07,TP,Primary solid Tumor,1,1,A40A,1,0,1,Female,1,Tumor,TCGA-A5-AB3J-01A,10524,UCEC,52,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2013,Peri (6-12 months since last menstrual period),-19020,Alive,TUMOR FREE,512,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,512,0,512,0,512,0,512,NA,younger,23.046875,level1,NA,NA,NA,NA,NA,YES
TCGA.AJ.A23M.01A,TCGA-AJ-A23M,TCGA.AJ.A23M,3.445307538,8.465320386,TCGA.AJ.A23M.01A.11R.A157.07,2.14933,2.06334,-0.5370074,-0.7655734,0.4897878,UCEC,TCGA-AJ-A23M,TCGA-AJ-A23M-01A-11R-A157-07,TCGA-AJ-A23M-01A,TCGA-AJ-A23M-01A-11R-A157-07,TP,Primary solid Tumor,1,1,A157,1,0,1,Female,1,Tumor,TCGA-AJ-A23M-01A,10525,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22430,Dead,WITH TUMOR,NA,616,[Not Available],Locoregional Recurrence,"Other, specify",Abdominal Fluid,516,Stable Disease,NA,NA,1,616,1,616,NA,NA,1,516,NA,younger,61.02839335,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A23N.01A,TCGA-AJ-A23N,TCGA.AJ.A23N,3.173447286,10.81408573,TCGA.AJ.A23N.01A.11R.A22K.07,3.313574,3.269616,0.2935601,0.398671,0.8831437,UCEC,TCGA-AJ-A23N,TCGA-AJ-A23N-01A-11R-A22K-07,TCGA-AJ-A23N-01A,TCGA-AJ-A23N-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A23N-01A,10526,UCEC,70,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25772,Dead,WITH TUMOR,NA,439,[Not Available],NA,NA,NA,NA,Progressive Disease,NA,NA,1,439,1,439,NA,NA,1,439,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.AJ.A23O.01A,TCGA-AJ-A23O,TCGA.AJ.A23O,4.706738986,9.032686368,TCGA.AJ.A23O.01A.11R.A157.07,3.83,3.71945,0.604662,0.9150972,1.116978,UCEC,TCGA-AJ-A23O,TCGA-AJ-A23O-01A-11R-A157-07,TCGA-AJ-A23O-01A,TCGA-AJ-A23O-01A-11R-A157-07,TP,Primary solid Tumor,1,1,A157,1,0,1,Female,1,Tumor,TCGA-AJ-A23O-01A,10527,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25433,Dead,TUMOR FREE,NA,312,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,1,312,0,312,NA,NA,0,312,NA,older,24.34175829,level1,NA,NA,NA,NA,NA,NA
TCGA.AJ.A2QK.01A,TCGA-AJ-A2QK,TCGA.AJ.A2QK,4.134363687,9.578691091,TCGA.AJ.A2QK.01A.11R.A18M.07,3.844346,3.67233,0.6382942,0.9294432,1.120191,UCEC,TCGA-AJ-A2QK,TCGA-AJ-A2QK-01A-11R-A18M-07,TCGA-AJ-A2QK-01A,TCGA-AJ-A2QK-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-AJ-A2QK-01A,10528,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23945,Alive,WITH TUMOR,643,NA,[Not Available],Distant Metastasis,Liver,NA,606,Complete Remission/Response,NA,NA,0,643,0,643,1,606,1,606,NA,NA,49.53173777,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A2QL.01A,TCGA-AJ-A2QL,TCGA.AJ.A2QL,5.288014691,10.56858052,TCGA.AJ.A2QL.01A.11R.A18M.07,3.391662,3.549943,0.3578641,0.4767593,0.8962044,UCEC,TCGA-AJ-A2QL,TCGA-AJ-A2QL-01A-11R-A18M-07,TCGA-AJ-A2QL-01A,TCGA-AJ-A2QL-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-AJ-A2QL-01A,10529,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22057,Alive,TUMOR FREE,602,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,602,0,602,0,602,0,602,NA,younger,42.15439046,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A2QM.01A,TCGA-AJ-A2QM,TCGA.AJ.A2QM,5.315602457,11.43977895,TCGA.AJ.A2QM.01A.11R.A18M.07,0.6370341,0.4682244,-1.561296,-2.277869,-0.07381671,UCEC,TCGA-AJ-A2QM,TCGA-AJ-A2QM-01A-11R-A18M-07,TCGA-AJ-A2QM-01A,TCGA-AJ-A2QM-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-AJ-A2QM-01A,10530,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24776,Alive,TUMOR FREE,894,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,894,0,894,0,894,0,894,NA,older,25.60553633,level2,NA,NA,NA,NA,NA,NA
TCGA.AJ.A2QN.01A,TCGA-AJ-A2QN,TCGA.AJ.A2QN,4.916613789,10.43943834,TCGA.AJ.A2QN.01A.11R.A18M.07,1.575251,1.408265,-0.9033798,-1.339652,0.2938744,UCEC,TCGA-AJ-A2QN,TCGA-AJ-A2QN-01A-11R-A18M-07,TCGA-AJ-A2QN-01A,TCGA-AJ-A2QN-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-AJ-A2QN-01A,10531,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21915,Alive,TUMOR FREE,1069,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1069,0,1069,0,1069,0,1069,NA,younger,45.67474048,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A2QO.01A,TCGA-AJ-A2QO,TCGA.AJ.A2QO,6.416344913,9.589647402,TCGA.AJ.A2QO.01A.11R.A32Y.07,2.511531,2.545286,-0.2910998,-0.4033725,0.642886,UCEC,TCGA-AJ-A2QO,TCGA-AJ-A2QO-01A-11R-A32Y-07,TCGA-AJ-A2QO-01A,TCGA-AJ-A2QO-01A-11R-A32Y-07,TP,Primary solid Tumor,1,1,A32Y,1,0,1,Female,1,Tumor,TCGA-AJ-A2QO-01A,10532,UCEC,85,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31222,Dead,TUMOR FREE,NA,1045,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,1045,0,1045,0,1045,0,1045,NA,older,24.6097337,level1,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3BD.01A,TCGA-AJ-A3BD,TCGA.AJ.A3BD,5.855324489,8.710121077,TCGA.AJ.A3BD.01A.11R.A19W.07,3.184028,3.058092,0.1862557,0.2691251,0.8439754,UCEC,TCGA-AJ-A3BD,TCGA-AJ-A3BD-01A-11R-A19W-07,TCGA-AJ-A3BD-01A,TCGA-AJ-A3BD-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-AJ-A3BD-01A,10533,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20998,Alive,TUMOR FREE,1039,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1039,0,1039,0,1039,0,1039,NA,younger,36.7901662,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3BF.01A,TCGA-AJ-A3BF,TCGA.AJ.A3BF,5.212981701,7.265858796,TCGA.AJ.A3BF.01A.11R.A213.07,1.734623,1.691835,-0.8364007,-1.18028,0.3710559,UCEC,TCGA-AJ-A3BF,TCGA-AJ-A3BF-01A-11R-A213-07,TCGA-AJ-A3BF-01A,TCGA-AJ-A3BF-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AJ-A3BF-01A,10534,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23906,Alive,TUMOR FREE,551,NA,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneal LNs,384,Complete Remission/Response,NA,NA,0,551,0,551,1,384,1,384,NA,NA,39.10034602,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3BG.01A,TCGA-AJ-A3BG,TCGA.AJ.A3BG,4.051276383,9.449520107,TCGA.AJ.A3BG.01A.11R.A19W.07,1.954878,1.790817,-0.6426475,-0.9600254,0.388302,UCEC,TCGA-AJ-A3BG,TCGA-AJ-A3BG-01A-11R-A19W-07,TCGA-AJ-A3BG-01A,TCGA-AJ-A3BG-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-AJ-A3BG-01A,10535,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IA,Mixed serous and endometrioid,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23861,Alive,WITH TUMOR,550,NA,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,480,Complete Remission/Response,NA,NA,0,550,0,550,1,480,1,480,NA,NA,24.84098009,level1,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3BH.01A,TCGA-AJ-A3BH,TCGA.AJ.A3BH,2.779322765,4.248937047,TCGA.AJ.A3BH.01A.11R.A19W.07,2.983006,2.828657,0.01178828,0.06810294,0.8252813,UCEC,TCGA-AJ-A3BH,TCGA-AJ-A3BH-01A-11R-A19W-07,TCGA-AJ-A3BH-01A,TCGA-AJ-A3BH-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-AJ-A3BH-01A,10536,UCEC,NA,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,NA,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,NA,0,NA,NA,NA,0,NA,NA,NA,28.80441397,level2,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3BI.01A,TCGA-AJ-A3BI,TCGA.AJ.A3BI,5.742647625,8.712551074,TCGA.AJ.A3BI.01A.11R.A213.07,3.075583,2.975641,0.09174499,0.1606801,0.7824076,UCEC,TCGA-AJ-A3BI,TCGA-AJ-A3BI-01A-11R-A213-07,TCGA-AJ-A3BI-01A,TCGA-AJ-A3BI-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AJ-A3BI-01A,10537,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24623,Alive,TUMOR FREE,575,NA,[Not Available],Locoregional Recurrence,"Other, specify",Anterior Abd. Mass,373,[Not Available],NA,NA,0,575,0,575,NA,NA,1,373,NA,older,40.56959714,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3BK.01A,TCGA-AJ-A3BK,TCGA.AJ.A3BK,4.320231932,7.798523643,TCGA.AJ.A3BK.01A.11R.A19W.07,3.70245,3.59716,0.5564506,0.7875469,1.034259,UCEC,TCGA-AJ-A3BK,TCGA-AJ-A3BK-01A-11R-A19W-07,TCGA-AJ-A3BK-01A,TCGA-AJ-A3BK-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-AJ-A3BK-01A,10538,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24943,Alive,TUMOR FREE,1031,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1031,0,1031,0,1031,0,1031,NA,older,34.62682073,level3,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3EJ.01A,TCGA-AJ-A3EJ,TCGA.AJ.A3EJ,4.77850823,8.462011407,TCGA.AJ.A3EJ.01A.11R.A19W.07,2.819514,2.746037,-0.04115531,-0.09538956,0.7206542,UCEC,TCGA-AJ-A3EJ,TCGA-AJ-A3EJ-01A-11R-A19W-07,TCGA-AJ-A3EJ-01A,TCGA-AJ-A3EJ-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-AJ-A3EJ-01A,10539,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27317,Dead,WITH TUMOR,NA,50,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,1,50,1,50,NA,NA,1,50,NA,older,25.86451247,level2,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3EK.01A,TCGA-AJ-A3EK,TCGA.AJ.A3EK,4.66448284,10.56835518,TCGA.AJ.A3EK.01A.11R.A19W.07,3.722659,3.578191,0.5375058,0.807756,1.078811,UCEC,TCGA-AJ-A3EK,TCGA-AJ-A3EK-01A-11R-A19W-07,TCGA-AJ-A3EK-01A,TCGA-AJ-A3EK-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-AJ-A3EK-01A,10540,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Peri (6-12 months since last menstrual period),-19609,Alive,TUMOR FREE,446,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,446,0,446,0,446,0,446,NA,younger,24.34175829,level1,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3EL.01A,TCGA-AJ-A3EL,TCGA.AJ.A3EL,4.039927974,8.942329758,TCGA.AJ.A3EL.01A.11R.A213.07,3.476316,3.425372,0.3498665,0.5614128,0.9808434,UCEC,TCGA-AJ-A3EL,TCGA-AJ-A3EL-01A-11R-A213-07,TCGA-AJ-A3EL-01A,TCGA-AJ-A3EL-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AJ-A3EL-01A,10541,UCEC,47,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17442,Alive,TUMOR FREE,684,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,684,0,684,0,684,0,684,NA,younger,23.72528616,level1,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3EM.01A,TCGA-AJ-A3EM,TCGA.AJ.A3EM,3.356650919,6.983255859,TCGA.AJ.A3EM.01A.11R.A213.07,-0.1779025,-0.3219953,-2.16076,-3.092806,-0.3131918,UCEC,TCGA-AJ-A3EM,TCGA-AJ-A3EM-01A-11R-A213-07,TCGA-AJ-A3EM-01A,TCGA-AJ-A3EM-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AJ-A3EM-01A,10542,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25557,Alive,TUMOR FREE,677,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,677,0,677,0,677,0,677,NA,older,30.11937557,level3,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3I9.01A,TCGA-AJ-A3I9,TCGA.AJ.A3I9,3.401043331,11.19730271,TCGA.AJ.A3I9.01A.11R.A22K.07,1.602477,1.607524,-0.891592,-1.312427,0.2911727,UCEC,TCGA-AJ-A3I9,TCGA-AJ-A3I9-01A-11R-A22K-07,TCGA-AJ-A3I9-01A,TCGA-AJ-A3I9-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3I9-01A,10543,UCEC,52,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19139,Dead,WITH TUMOR,NA,519,[Not Available],Distant Metastasis,Bone,NA,370,Complete Remission/Response,NA,NA,1,519,1,519,1,370,1,370,NA,younger,28.125,level2,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3IA.01A,TCGA-AJ-A3IA,TCGA.AJ.A3IA,3.491596594,8.705494158,TCGA.AJ.A3IA.01A.11R.A213.07,3.279207,3.193117,0.2402379,0.3643041,0.9062,UCEC,TCGA-AJ-A3IA,TCGA-AJ-A3IA-01A-11R-A213-07,TCGA-AJ-A3IA-01A,TCGA-AJ-A3IA-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AJ-A3IA-01A,10544,UCEC,77,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28470,Alive,TUMOR FREE,633,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,633,0,633,0,633,0,633,NA,older,23.53036634,level1,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3NC.01A,TCGA-AJ-A3NC,TCGA.AJ.A3NC,5.021897196,9.893397101,TCGA.AJ.A3NC.01A.11R.A22K.07,2.511168,2.398798,-0.2679874,-0.4037351,0.6481884,UCEC,TCGA-AJ-A3NC,TCGA-AJ-A3NC-01A-11R-A22K-07,TCGA-AJ-A3NC-01A,TCGA-AJ-A3NC-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3NC-01A,10545,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23353,Alive,TUMOR FREE,1125,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1125,0,1125,0,1125,0,1125,NA,younger,38.9739229,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3NE.01A,TCGA-AJ-A3NE,TCGA.AJ.A3NE,9.041623563,7.587139927,TCGA.AJ.A3NE.01A.11R.A22K.07,3.307182,3.108283,0.232675,0.3922792,0.8959123,UCEC,TCGA-AJ-A3NE,TCGA-AJ-A3NE-01A-11R-A22K-07,TCGA-AJ-A3NE-01A,TCGA-AJ-A3NE-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3NE-01A,10546,UCEC,46,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16957,Alive,TUMOR FREE,628,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,628,0,628,0,628,0,628,NA,younger,31.25,level3,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3NF.01A,TCGA-AJ-A3NF,TCGA.AJ.A3NF,3.30113399,9.215319431,TCGA.AJ.A3NF.01A.11R.A22K.07,3.80494,3.724383,0.5874279,0.8900371,1.09395,UCEC,TCGA-AJ-A3NF,TCGA-AJ-A3NF-01A-11R-A22K-07,TCGA-AJ-A3NF-01A,TCGA-AJ-A3NF-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3NF-01A,10547,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22210,Alive,TUMOR FREE,645,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,645,0,645,0,645,0,645,NA,younger,45.703125,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3NG.01A,TCGA-AJ-A3NG,TCGA.AJ.A3NG,6.399921305,8.743137927,TCGA.AJ.A3NG.01A.11R.A22K.07,1.274699,1.188974,-1.154658,-1.640205,0.1982079,UCEC,TCGA-AJ-A3NG,TCGA-AJ-A3NG-01A-11R-A22K-07,TCGA-AJ-A3NG-01A,TCGA-AJ-A3NG-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3NG-01A,10548,UCEC,83,FEMALE,WHITE,[Not Applicable],Stage II,Mixed serous and endometrioid,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30351,Alive,TUMOR FREE,475,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,475,0,475,0,475,0,475,NA,older,38.70967742,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3NH.01A,TCGA-AJ-A3NH,TCGA.AJ.A3NH,4.589877316,12.62498732,TCGA.AJ.A3NH.01A.11R.A22K.07,1.355086,1.251629,-1.08853,-1.559817,0.2280795,UCEC,TCGA-AJ-A3NH,TCGA-AJ-A3NH-01A-11R-A22K-07,TCGA-AJ-A3NH-01A,TCGA-AJ-A3NH-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3NH-01A,10549,UCEC,90,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871,Dead,TUMOR FREE,NA,310,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,310,0,310,0,310,0,310,NA,older,24.76756592,level1,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3OJ.01A,TCGA-AJ-A3OJ,TCGA.AJ.A3OJ,5.98779835,6.258535884,TCGA.AJ.A3OJ.01A.11R.A22K.07,3.50753,3.334996,0.4133968,0.5926264,0.9718113,UCEC,TCGA-AJ-A3OJ,TCGA-AJ-A3OJ-01A-11R-A22K-07,TCGA-AJ-A3OJ-01A,TCGA-AJ-A3OJ-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3OJ-01A,10550,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2011,Indeterminate (neither Pre or Postmenopausal),-19826,Alive,TUMOR FREE,467,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,467,0,467,0,467,0,467,NA,younger,42.19238103,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3OK.01A,TCGA-AJ-A3OK,TCGA.AJ.A3OK,4.05315479,9.662865943,TCGA.AJ.A3OK.01A.12R.A22K.07,4.179459,4.124293,0.8771484,1.264556,1.231923,UCEC,TCGA-AJ-A3OK,TCGA-AJ-A3OK-01A-12R-A22K-07,TCGA-AJ-A3OK-01A,TCGA-AJ-A3OK-01A-12R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3OK-01A,10551,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26851,Alive,TUMOR FREE,485,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,485,0,485,0,485,0,485,NA,older,29.296875,level2,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3OL.01A,TCGA-AJ-A3OL,TCGA.AJ.A3OL,3.49705025,12.17714231,TCGA.AJ.A3OL.01A.11R.A22K.07,-0.1363389,-0.06250321,-2.098123,-3.051242,-0.2987091,UCEC,TCGA-AJ-A3OL,TCGA-AJ-A3OL-01A-11R-A22K-07,TCGA-AJ-A3OL-01A,TCGA-AJ-A3OL-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3OL-01A,10552,UCEC,55,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20115,Dead,WITH TUMOR,NA,449,[Not Available],Distant Metastasis,"Other, specify","Lung, Liver, and Brain",424,Complete Remission/Response,NA,NA,1,449,1,449,1,424,1,424,NA,younger,25,level1,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3QS.01A,TCGA-AJ-A3QS,TCGA.AJ.A3QS,5.919053994,8.679300631,TCGA.AJ.A3QS.01A.11R.A22K.07,3.893568,3.66098,0.6423896,0.9786653,1.136496,UCEC,TCGA-AJ-A3QS,TCGA-AJ-A3QS-01A-11R-A22K-07,TCGA-AJ-A3QS-01A,TCGA-AJ-A3QS-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3QS-01A,10553,UCEC,57,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21162,Alive,TUMOR FREE,513,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,513,0,513,0,513,0,513,NA,younger,26.07897153,level2,NA,NA,NA,NA,NA,YES
TCGA.AJ.A3TW.01A,TCGA-AJ-A3TW,TCGA.AJ.A3TW,1.584962501,9.981196215,TCGA.AJ.A3TW.01A.11R.A22K.07,4.461191,4.626135,1.093495,1.546288,1.277671,UCEC,TCGA-AJ-A3TW,TCGA-AJ-A3TW-01A-11R-A22K-07,TCGA-AJ-A3TW-01A,TCGA-AJ-A3TW-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AJ-A3TW-01A,10554,UCEC,78,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28559,Alive,TUMOR FREE,513,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,513,0,513,0,513,0,513,NA,older,21.484375,level1,NA,NA,NA,NA,NA,NA
TCGA.AJ.A5DV.01A,TCGA-AJ-A5DV,TCGA.AJ.A5DV,5.694490223,10.2136146,TCGA.AJ.A5DV.01A.11R.A27V.07,3.146634,3.099172,0.1971447,0.2317306,0.8222196,UCEC,TCGA-AJ-A5DV,TCGA-AJ-A5DV-01A-11R-A27V-07,TCGA-AJ-A5DV-01A,TCGA-AJ-A5DV-01A-11R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-AJ-A5DV-01A,10556,UCEC,65,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23892,Alive,TUMOR FREE,679,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,679,0,679,0,679,0,679,NA,NA,57.421875,level4,NA,NA,NA,NA,NA,YES
TCGA.AJ.A5DW.01A,TCGA-AJ-A5DW,TCGA.AJ.A5DW,4.469801339,9.093039839,TCGA.AJ.A5DW.01A.11R.A27V.07,2.506885,2.320269,-0.3230335,-0.4080179,0.6446617,UCEC,TCGA-AJ-A5DW,TCGA-AJ-A5DW-01A-11R-A27V-07,TCGA-AJ-A5DW-01A,TCGA-AJ-A5DW-01A-11R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-AJ-A5DW-01A,10557,UCEC,56,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20711,Alive,TUMOR FREE,390,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,390,0,390,0,390,0,390,NA,younger,39.08350963,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A8CT.01A,TCGA-AJ-A8CT,TCGA.AJ.A8CT,5.145669304,11.02684846,TCGA.AJ.A8CT.01A.11R.A37O.07,4.1117,3.990563,0.8266597,1.196796,1.210907,UCEC,TCGA-AJ-A8CT,TCGA-AJ-A8CT-01A-11R-A37O-07,TCGA-AJ-A8CT-01A,TCGA-AJ-A8CT-01A-11R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-AJ-A8CT-01A,10559,UCEC,58,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21515,Alive,TUMOR FREE,82,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,82,0,82,0,82,0,82,NA,younger,42.2405877,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A8CV.01A,TCGA-AJ-A8CV,TCGA.AJ.A8CV,6.395818576,9.783507402,TCGA.AJ.A8CV.01A.11R.A37O.07,3.172796,3.052402,0.1977632,0.2578932,0.8441688,UCEC,TCGA-AJ-A8CV,TCGA-AJ-A8CV-01A-11R-A37O-07,TCGA-AJ-A8CV-01A,TCGA-AJ-A8CV-01A-11R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-AJ-A8CV-01A,10560,UCEC,58,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21336,Alive,TUMOR FREE,1068,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1068,0,1068,0,1068,0,1068,NA,younger,35.33859303,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A8CW.01A,TCGA-AJ-A8CW,TCGA.AJ.A8CW,6.317671281,6.981864067,TCGA.AJ.A8CW.01A.11R.A37O.07,2.477931,2.370069,-0.3177149,-0.4369724,0.60374,UCEC,TCGA-AJ-A8CW,TCGA-AJ-A8CW-01A-11R-A37O-07,TCGA-AJ-A8CW-01A,TCGA-AJ-A8CW-01A-11R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-AJ-A8CW-01A,10561,UCEC,64,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23554,Alive,TUMOR FREE,4,NA,[Not Available],NA,NA,NA,NA,[Unknown],NA,NA,0,4,0,4,NA,NA,0,4,NA,younger,47.47732426,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A051.01A,TCGA-AP-A051,TCGA.AP.A051,4.711397126,10.1937837,TCGA.AP.A051.01A.21R.A00V.07,3.636831,3.492949,0.4838316,0.7219277,1.048225,UCEC,TCGA-AP-A051,TCGA-AP-A051-01A-21R-A00V-07,TCGA-AP-A051-01A,TCGA-AP-A051-01A-21R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AP-A051-01A,10562,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25269,Alive,TUMOR FREE,3948,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,3948,0,3948,0,3948,0,3948,NA,older,38.36873541,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A052.01A,TCGA-AP-A052,TCGA.AP.A052,6.098615217,8.130055367,TCGA.AP.A052.01A.11R.A00V.07,3.114086,3.094343,0.1580563,0.1991827,0.8208792,UCEC,TCGA-AP-A052,TCGA-AP-A052-01A-11R-A00V-07,TCGA-AP-A052-01A,TCGA-AP-A052-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AP-A052-01A,10563,UCEC,59,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21721,Dead,WITH TUMOR,NA,669,[Not Available],NA,NA,NA,394,Complete Remission/Response,NA,NA,1,669,1,669,NA,NA,1,394,NA,younger,46.28099174,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A054.01A,TCGA-AP-A054,TCGA.AP.A054,3.234878686,4.897413044,TCGA.AP.A054.01A.11R.A16W.07,1.680054,1.709207,-0.9054737,-1.234849,0.3752725,UCEC,TCGA-AP-A054,TCGA-AP-A054-01A-11R-A16W-07,TCGA-AP-A054-01A,TCGA-AP-A054-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-AP-A054-01A,10565,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23404,Dead,WITH TUMOR,NA,709,[Not Available],NA,NA,NA,566,Complete Remission/Response,NA,NA,1,709,1,709,1,566,1,566,NA,younger,26.89232314,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A056.01A,TCGA-AP-A056,TCGA.AP.A056,5.390590945,7.513359732,TCGA.AP.A056.01A.11R.A00V.07,3.941346,3.853354,0.7032609,1.026442,1.152804,UCEC,TCGA-AP-A056,TCGA-AP-A056-01A-11R-A00V-07,TCGA-AP-A056-01A,TCGA-AP-A056-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AP-A056-01A,10566,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23707,Alive,TUMOR FREE,2618,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2618,0,2618,0,2618,0,2618,NA,younger,24.5603263,level1,NA,NA,NA,NA,NA,NA
TCGA.AP.A059.01A,TCGA-AP-A059,TCGA.AP.A059,7.497396829,6.377510981,TCGA.AP.A059.01A.21R.A118.07,4.779954,4.574608,1.264527,1.865051,1.453457,UCEC,TCGA-AP-A059,TCGA-AP-A059-01A-21R-A118-07,TCGA-AP-A059-01A,TCGA-AP-A059-01A-21R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-AP-A059-01A,10567,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25311,Alive,TUMOR FREE,1461,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1461,0,1461,0,1461,0,1461,NA,older,38.671875,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A05A.01A,TCGA-AP-A05A,TCGA.AP.A05A,6.247300243,8.538981127,TCGA.AP.A05A.01A.11R.A00V.07,1.107366,1.09693,-1.245251,-1.807538,0.135436,UCEC,TCGA-AP-A05A,TCGA-AP-A05A-01A-11R-A00V-07,TCGA-AP-A05A-01A,TCGA-AP-A05A-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AP-A05A-01A,10568,UCEC,81,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29914,Dead,TUMOR FREE,NA,1944,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,1944,0,1944,0,1944,0,1944,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.AP.A05D.01A,TCGA-AP-A05D,TCGA.AP.A05D,4.980458536,9.596451932,TCGA.AP.A05D.01A.11R.A00V.07,4.360229,4.270924,1.025042,1.445325,1.223103,UCEC,TCGA-AP-A05D,TCGA-AP-A05D-01A-11R-A00V-07,TCGA-AP-A05D-01A,TCGA-AP-A05D-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AP-A05D-01A,10569,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24597,Alive,TUMOR FREE,1758,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1758,0,1758,0,1758,0,1758,NA,older,37.80718336,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A05H.01A,TCGA-AP-A05H,TCGA.AP.A05H,2.172502167,7.171324558,TCGA.AP.A05H.01A.11R.A00V.07,0.949771,0.7798208,-1.351508,-1.965132,0.05819038,UCEC,TCGA-AP-A05H,TCGA-AP-A05H-01A-11R-A00V-07,TCGA-AP-A05H-01A,TCGA-AP-A05H-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AP-A05H-01A,10570,UCEC,75,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27744,Alive,TUMOR FREE,1385,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1385,0,1385,0,1385,0,1385,NA,older,38.01956512,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A05J.01A,TCGA-AP-A05J,TCGA.AP.A05J,3.576248255,10.96964672,TCGA.AP.A05J.01A.11R.A00V.07,1.494395,1.41219,-0.9740465,-1.420508,0.2454825,UCEC,TCGA-AP-A05J,TCGA-AP-A05J-01A-11R-A00V-07,TCGA-AP-A05J-01A,TCGA-AP-A05J-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AP-A05J-01A,10571,UCEC,66,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24119,Alive,TUMOR FREE,1122,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1122,0,1122,0,1122,0,1122,NA,older,27.99036281,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A05N.01A,TCGA-AP-A05N,TCGA.AP.A05N,6.775644406,8.727894755,TCGA.AP.A05N.01A.11R.A00V.07,1.978963,1.81968,-0.6561742,-0.93594,0.4613781,UCEC,TCGA-AP-A05N,TCGA-AP-A05N-01A-11R-A00V-07,TCGA-AP-A05N-01A,TCGA-AP-A05N-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AP-A05N-01A,10572,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-21254,Dead,TUMOR FREE,NA,726,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,726,0,726,0,726,0,726,NA,younger,46.86785551,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A05O.01A,TCGA-AP-A05O,TCGA.AP.A05O,5.595399846,9.419145351,TCGA.AP.A05O.01A.12R.A118.07,3.11528,2.939978,0.1548653,0.2003767,0.7940063,UCEC,TCGA-AP-A05O,TCGA-AP-A05O-01A-12R-A118-07,TCGA-AP-A05O-01A,TCGA-AP-A05O-01A-12R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-AP-A05O-01A,10573,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24978,Alive,TUMOR FREE,384,NA,[Not Available],NA,NA,NA,340,Complete Remission/Response,NA,NA,0,384,0,384,1,340,1,340,NA,older,41.25941356,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A05P.01A,TCGA-AP-A05P,TCGA.AP.A05P,3.190227616,8.769143454,TCGA.AP.A05P.01A.11R.A16W.07,2.870651,2.661811,-0.04382117,-0.04425219,0.7376807,UCEC,TCGA-AP-A05P,TCGA-AP-A05P-01A-11R-A16W-07,TCGA-AP-A05P-01A,TCGA-AP-A05P-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-AP-A05P-01A,10574,UCEC,54,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20017,Alive,TUMOR FREE,636,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,636,0,636,0,636,0,636,NA,younger,28.54828132,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A0L8.01A,TCGA-AP-A0L8,TCGA.AP.A0L8,2.912172004,10.16777194,TCGA.AP.A0L8.01A.11R.A040.07,1.346634,1.250893,-1.080942,-1.56827,0.2134116,UCEC,TCGA-AP-A0L8,TCGA-AP-A0L8-01A-11R-A040-07,TCGA-AP-A0L8-01A,TCGA-AP-A0L8-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AP-A0L8-01A,10575,UCEC,70,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2000,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25733,Dead,WITH TUMOR,NA,1484,[Not Available],NA,NA,NA,1453,Complete Remission/Response,NA,NA,1,1484,1,1484,1,1453,1,1453,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.AP.A0L9.01A,TCGA-AP-A0L9,TCGA.AP.A0L9,6.109896764,8.842630154,TCGA.AP.A0L9.01A.11R.A040.07,1.780853,1.827759,-0.7771074,-1.13405,0.351158,UCEC,TCGA-AP-A0L9,TCGA-AP-A0L9-01A-11R-A040-07,TCGA-AP-A0L9-01A,TCGA-AP-A0L9-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AP-A0L9-01A,10576,UCEC,71,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26185,Alive,TUMOR FREE,3815,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,3815,0,3815,0,3815,0,3815,NA,older,25.96952909,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LD.01A,TCGA-AP-A0LD,TCGA.AP.A0LD,2.162201969,8.999342044,TCGA.AP.A0LD.01A.11R.A040.07,1.370578,1.329767,-1.087151,-1.544326,0.2389922,UCEC,TCGA-AP-A0LD,TCGA-AP-A0LD-01A-11R-A040-07,TCGA-AP-A0LD-01A,TCGA-AP-A0LD-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AP-A0LD-01A,10577,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23216,Alive,TUMOR FREE,3589,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,3589,0,3589,0,3589,0,3589,NA,younger,27.23922448,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LE.01A,TCGA-AP-A0LE,TCGA.AP.A0LE,3.981809751,7.757769904,TCGA.AP.A0LE.01A.11R.A104.07,2.290756,2.290899,-0.4299338,-0.6241474,0.5578436,UCEC,TCGA-AP-A0LE,TCGA-AP-A0LE-01A-11R-A104-07,TCGA-AP-A0LE-01A,TCGA-AP-A0LE-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-AP-A0LE-01A,10578,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20967,Alive,TUMOR FREE,3357,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,3357,0,3357,0,3357,0,3357,NA,younger,29.296875,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LF.01A,TCGA-AP-A0LF,TCGA.AP.A0LF,4.841913681,5.736324024,TCGA.AP.A0LF.01A.11R.A118.07,4.298458,4.404311,0.9369092,1.383555,1.295058,UCEC,TCGA-AP-A0LF,TCGA-AP-A0LF-01A-11R-A118-07,TCGA-AP-A0LF-01A,TCGA-AP-A0LF-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-AP-A0LF-01A,10579,UCEC,82,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30027,Alive,WITH TUMOR,2859,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],NA,NA,0,2859,0,2859,NA,NA,0,2859,NA,older,27.77670615,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LG.01A,TCGA-AP-A0LG,TCGA.AP.A0LG,5.981629464,8.969881537,TCGA.AP.A0LG.01A.11R.A16W.07,1.754201,1.367602,-0.825252,-1.160702,0.3343302,UCEC,TCGA-AP-A0LG,TCGA-AP-A0LG-01A-11R-A16W-07,TCGA-AP-A0LG-01A,TCGA-AP-A0LG-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-AP-A0LG-01A,10580,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20047,Alive,TUMOR FREE,2015,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2015,0,2015,0,2015,0,2015,NA,younger,28.60476495,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LH.01A,TCGA-AP-A0LH,TCGA.AP.A0LH,8.478740283,9.731827778,TCGA.AP.A0LH.01A.11R.A16W.07,2.511326,2.313606,-0.2899336,-0.4035775,0.5878512,UCEC,TCGA-AP-A0LH,TCGA-AP-A0LH-01A-11R-A16W-07,TCGA-AP-A0LH-01A,TCGA-AP-A0LH-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-AP-A0LH-01A,10581,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IA,Mixed serous and endometrioid,G3,2002,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22169,Dead,WITH TUMOR,NA,1106,[Not Available],NA,NA,NA,302,Complete Remission/Response,NA,NA,1,1106,1,1106,1,302,1,302,NA,younger,30.85960738,level3,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LI.01A,TCGA-AP-A0LI,TCGA.AP.A0LI,3.759133867,7.717550612,TCGA.AP.A0LI.01A.11R.A040.07,4.695405,4.76934,1.214696,1.780502,1.428177,UCEC,TCGA-AP-A0LI,TCGA-AP-A0LI-01A-11R-A040-07,TCGA-AP-A0LI-01A,TCGA-AP-A0LI-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AP-A0LI-01A,10582,UCEC,67,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24573,Alive,TUMOR FREE,2972,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2972,0,2972,0,2972,0,2972,NA,older,33.17773234,level3,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LJ.01A,TCGA-AP-A0LJ,TCGA.AP.A0LJ,5.035852169,10.28003998,TCGA.AP.A0LJ.01A.11R.A040.07,3.462434,3.329424,0.4019107,0.5475309,0.9225539,UCEC,TCGA-AP-A0LJ,TCGA-AP-A0LJ-01A-11R-A040-07,TCGA-AP-A0LJ-01A,TCGA-AP-A0LJ-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AP-A0LJ-01A,10583,UCEC,42,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15577,Alive,TUMOR FREE,1421,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1421,0,1421,0,1421,0,1421,NA,younger,34.62603878,level3,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LL.01A,TCGA-AP-A0LL,TCGA.AP.A0LL,2.233205274,10.54864586,TCGA.AP.A0LL.01A.12R.A104.07,2.643735,2.680008,-0.2076507,-0.2711687,0.7069931,UCEC,TCGA-AP-A0LL,TCGA-AP-A0LL-01A-12R-A104-07,TCGA-AP-A0LL-01A,TCGA-AP-A0LL-01A-12R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-AP-A0LL-01A,10584,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20700,Alive,TUMOR FREE,2554,NA,[Not Available],NA,NA,NA,790,Complete Remission/Response,NA,NA,0,2554,0,2554,1,790,1,790,NA,younger,27.77670615,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LM.01A,TCGA-AP-A0LM,TCGA.AP.A0LM,4.289431246,6.985778889,TCGA.AP.A0LM.01A.11R.A118.07,3.670752,3.711466,0.5060511,0.755849,1.061895,UCEC,TCGA-AP-A0LM,TCGA-AP-A0LM-01A-11R-A118-07,TCGA-AP-A0LM-01A,TCGA-AP-A0LM-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-AP-A0LM-01A,10585,UCEC,33,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2004,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12309,Alive,TUMOR FREE,825,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,825,0,825,0,825,0,825,NA,younger,36.28973726,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LN.01A,TCGA-AP-A0LN,TCGA.AP.A0LN,3.77418449,9.931912469,TCGA.AP.A0LN.01A.11R.A040.07,2.837436,2.722165,-0.03773413,-0.07746694,0.7239889,UCEC,TCGA-AP-A0LN,TCGA-AP-A0LN-01A-11R-A040-07,TCGA-AP-A0LN-01A,TCGA-AP-A0LN-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AP-A0LN-01A,10586,UCEC,56,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20704,Alive,TUMOR FREE,2510,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2510,0,2510,0,2510,0,2510,NA,younger,43.18478734,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LO.01A,TCGA-AP-A0LO,TCGA.AP.A0LO,3.707728124,8.486373921,TCGA.AP.A0LO.01A.11R.A040.07,2.142462,2.023211,-0.5456814,-0.7724413,0.5077999,UCEC,TCGA-AP-A0LO,TCGA-AP-A0LO-01A-11R-A040-07,TCGA-AP-A0LO-01A,TCGA-AP-A0LO-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AP-A0LO-01A,10587,UCEC,45,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16493,Dead,WITH TUMOR,NA,1016,[Not Available],NA,NA,NA,516,Complete Remission/Response,NA,NA,1,1016,1,1016,1,516,1,516,NA,younger,26.171875,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LP.01A,TCGA-AP-A0LP,TCGA.AP.A0LP,5.699244072,10.11849981,TCGA.AP.A0LP.01A.12R.A104.07,3.590533,3.498221,0.4834557,0.6756299,0.9817226,UCEC,TCGA-AP-A0LP,TCGA-AP-A0LP-01A-12R-A104-07,TCGA-AP-A0LP-01A,TCGA-AP-A0LP-01A-12R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-AP-A0LP-01A,10588,UCEC,76,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27898,Alive,TUMOR FREE,1875,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1875,0,1875,0,1875,0,1875,NA,older,21.51385851,level1,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LS.01A,TCGA-AP-A0LS,TCGA.AP.A0LS,5.180614731,8.132785756,TCGA.AP.A0LS.01A.11R.A14D.07,2.346549,2.376824,-0.4508787,-0.5683547,0.6072169,UCEC,TCGA-AP-A0LS,TCGA-AP-A0LS-01A-11R-A14D-07,TCGA-AP-A0LS-01A,TCGA-AP-A0LS-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-AP-A0LS-01A,10590,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23126,Alive,TUMOR FREE,2904,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2904,0,2904,0,2904,0,2904,NA,younger,28.36035153,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LT.01A,TCGA-AP-A0LT,TCGA.AP.A0LT,5.711764557,9.930082807,TCGA.AP.A0LT.01A.11R.A040.07,2.093391,2.028478,-0.5918347,-0.8215127,0.5087447,UCEC,TCGA-AP-A0LT,TCGA-AP-A0LT-01A-11R-A040-07,TCGA-AP-A0LT-01A,TCGA-AP-A0LT-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AP-A0LT-01A,10591,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21107,Alive,TUMOR FREE,1497,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1497,0,1497,0,1497,0,1497,NA,younger,33.4251607,level3,NA,NA,NA,NA,NA,NA
TCGA.AP.A0LV.01A,TCGA-AP-A0LV,TCGA.AP.A0LV,3.939229167,9.310271988,TCGA.AP.A0LV.01A.11R.A040.07,2.721023,2.602015,-0.1120054,-0.1938803,0.6845736,UCEC,TCGA-AP-A0LV,TCGA-AP-A0LV-01A-11R-A040-07,TCGA-AP-A0LV-01A,TCGA-AP-A0LV-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AP-A0LV-01A,10592,UCEC,39,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14556,Alive,TUMOR FREE,763,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,763,0,763,0,763,0,763,NA,younger,32.89473684,level3,NA,NA,NA,NA,NA,NA
TCGA.AP.A1DH.01A,TCGA-AP-A1DH,TCGA.AP.A1DH,6.131912325,9.983164626,TCGA.AP.A1DH.01A.31R.A137.07,4.007995,4.199243,0.7285949,1.093092,1.179071,UCEC,TCGA-AP-A1DH,TCGA-AP-A1DH-01A-31R-A137-07,TCGA-AP-A1DH-01A,TCGA-AP-A1DH-01A-31R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1DH-01A,10593,UCEC,62,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22652,Alive,TUMOR FREE,2180,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2180,0,2180,0,2180,0,2180,NA,younger,44.99716553,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A1DK.01A,TCGA-AP-A1DK,TCGA.AP.A1DK,4.091922512,9.124880653,TCGA.AP.A1DK.01A.11R.A137.07,3.670405,3.735124,0.5008559,0.7555017,1.07562,UCEC,TCGA-AP-A1DK,TCGA-AP-A1DK-01A-11R-A137-07,TCGA-AP-A1DK-01A,TCGA-AP-A1DK-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1DK-01A,10594,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19509,Alive,TUMOR FREE,2767,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2767,0,2767,0,2767,0,2767,NA,younger,21.875,level1,NA,NA,NA,NA,NA,NA
TCGA.AP.A1DM.01A,TCGA-AP-A1DM,TCGA.AP.A1DM,4.519648736,9.561443639,TCGA.AP.A1DM.01A.21R.A137.07,1.94636,2.13828,-0.6981443,-0.9685429,0.4580203,UCEC,TCGA-AP-A1DM,TCGA-AP-A1DM-01A-21R-A137-07,TCGA-AP-A1DM-01A,TCGA-AP-A1DM-01A-21R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1DM-01A,10595,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22239,Alive,TUMOR FREE,1700,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1700,0,1700,0,1700,0,1700,NA,younger,36.39096555,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A1DO.01A,TCGA-AP-A1DO,TCGA.AP.A1DO,4.029798194,10.04408101,TCGA.AP.A1DO.01A.11R.A137.07,1.408116,1.370448,-1.093445,-1.506787,0.25266,UCEC,TCGA-AP-A1DO,TCGA-AP-A1DO-01A-11R-A137-07,TCGA-AP-A1DO-01A,TCGA-AP-A1DO-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1DO-01A,10596,UCEC,62,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22787,Alive,TUMOR FREE,952,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,952,0,952,0,952,0,952,NA,younger,32.8731098,level3,NA,NA,NA,NA,NA,NA
TCGA.AP.A1DP.01A,TCGA-AP-A1DP,TCGA.AP.A1DP,5.791778096,10.77279085,TCGA.AP.A1DP.01A.11R.A137.07,2.289941,2.155931,-0.4077763,-0.6249618,0.5813506,UCEC,TCGA-AP-A1DP,TCGA-AP-A1DP-01A-11R-A137-07,TCGA-AP-A1DP-01A,TCGA-AP-A1DP-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1DP-01A,10597,UCEC,70,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25601,Dead,WITH TUMOR,NA,1081,[Not Available],Metastatic,"Other, specify","Lung, liver, lymph nodes",831,Complete Remission/Response,NA,NA,1,1081,1,1081,1,831,1,831,NA,older,33.24787694,level3,NA,NA,NA,NA,NA,NA
TCGA.AP.A1DQ.01A,TCGA-AP-A1DQ,TCGA.AP.A1DQ,4.857101035,9.612795657,TCGA.AP.A1DQ.01A.11R.A137.07,2.560664,2.623305,-0.2783418,-0.3542394,0.6661705,UCEC,TCGA-AP-A1DQ,TCGA-AP-A1DQ-01A-11R-A137-07,TCGA-AP-A1DQ-01A,TCGA-AP-A1DQ-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1DQ-01A,10598,UCEC,76,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,High Grade,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27815,Dead,WITH TUMOR,NA,1423,[Not Available],Metastatic,"Other, specify","Lymph nodes, lung, bone",905,Complete Remission/Response,NA,NA,1,1423,1,1423,1,905,1,905,NA,older,22.58270917,level1,NA,NA,NA,NA,NA,NA
TCGA.AP.A1DR.01A,TCGA-AP-A1DR,TCGA.AP.A1DR,6.48194574,8.564655563,TCGA.AP.A1DR.01A.11R.A137.07,2.162046,2.181258,-0.535069,-0.7528576,0.4894478,UCEC,TCGA-AP-A1DR,TCGA-AP-A1DR-01A-11R-A137-07,TCGA-AP-A1DR-01A,TCGA-AP-A1DR-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1DR-01A,10599,UCEC,59,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21904,Alive,TUMOR FREE,1495,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1495,0,1495,0,1495,0,1495,NA,younger,42.578125,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A1DV.01A,TCGA-AP-A1DV,TCGA.AP.A1DV,5.42129002,10.23661119,TCGA.AP.A1DV.01A.21R.A137.07,2.160467,2.238559,-0.5451961,-0.7544361,0.5167501,UCEC,TCGA-AP-A1DV,TCGA-AP-A1DV-01A-21R-A137-07,TCGA-AP-A1DV-01A,TCGA-AP-A1DV-01A-21R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1DV-01A,10600,UCEC,59,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21901,Alive,TUMOR FREE,204,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,204,0,204,0,204,0,204,NA,younger,21.28742654,level1,NA,NA,NA,NA,NA,NA
TCGA.AP.A1E0.01A,TCGA-AP-A1E0,TCGA.AP.A1E0,4.062910596,9.249796417,TCGA.AP.A1E0.01A.11R.A137.07,2.320897,2.191021,-0.4483927,-0.5940065,0.5463278,UCEC,TCGA-AP-A1E0,TCGA-AP-A1E0-01A-11R-A137-07,TCGA-AP-A1E0-01A,TCGA-AP-A1E0-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1E0-01A,10601,UCEC,40,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G2,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14653,Alive,TUMOR FREE,1832,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1832,0,1832,0,1832,0,1832,NA,younger,23.63403301,level1,NA,NA,NA,NA,NA,NA
TCGA.AP.A1E1.01A,TCGA-AP-A1E1,TCGA.AP.A1E1,5.048449797,9.796153989,TCGA.AP.A1E1.01A.11R.A137.07,2.926209,2.720467,-0.01502063,0.01130566,0.7564025,UCEC,TCGA-AP-A1E1,TCGA-AP-A1E1-01A-11R-A137-07,TCGA-AP-A1E1-01A,TCGA-AP-A1E1-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1E1-01A,10602,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27072,Alive,TUMOR FREE,1395,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1395,0,1395,0,1395,0,1395,NA,older,28.515625,level2,NA,NA,NA,NA,NA,NA
TCGA.AP.A1E3.01A,TCGA-AP-A1E3,TCGA.AP.A1E3,3.59674593,7.350317797,TCGA.AP.A1E3.01A.11R.A137.07,2.10371,2.119843,-0.5719718,-0.8111936,0.5079456,UCEC,TCGA-AP-A1E3,TCGA-AP-A1E3-01A-11R-A137-07,TCGA-AP-A1E3-01A,TCGA-AP-A1E3-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1E3-01A,10603,UCEC,45,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16544,Alive,WITH TUMOR,847,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,NA,NA,0,847,0,847,NA,NA,0,847,NA,younger,48.92920321,level4,NA,NA,NA,NA,NA,NA
TCGA.AP.A1E4.01A,TCGA-AP-A1E4,TCGA.AP.A1E4,2.52389241,5.238485228,TCGA.AP.A1E4.01A.12R.A137.07,0.2928317,0.2150346,-1.798166,-2.622072,-0.1676213,UCEC,TCGA-AP-A1E4,TCGA-AP-A1E4-01A-12R-A137-07,TCGA-AP-A1E4-01A,TCGA-AP-A1E4-01A-12R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AP-A1E4-01A,10604,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19814,Alive,WITH TUMOR,1555,NA,[Not Available],Metastatic,"Other, specify","Bone, lymph nodes",158,Progressive Disease,NA,NA,0,1555,0,1555,NA,NA,1,158,NA,younger,20.32443826,level1,NA,NA,NA,NA,NA,NA
TCGA.AP.A3K1.01A,TCGA-AP-A3K1,TCGA.AP.A3K1,1.823830866,5.847122509,TCGA.AP.A3K1.01A.11R.A213.07,1.255271,1.37492,-1.138033,-1.659632,0.1558853,UCEC,TCGA-AP-A3K1,TCGA-AP-A3K1-01A-11R-A213-07,TCGA-AP-A3K1-01A,TCGA-AP-A3K1-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AP-A3K1-01A,10605,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,High Grade,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20594,Dead,WITH TUMOR,NA,666,[Not Available],Locoregional Recurrence,"Other, specify",Paracolic gutter,198,Progressive Disease,NA,NA,1,666,1,666,NA,NA,1,198,NA,younger,24.34175829,level1,NA,NA,NA,NA,NA,NA
TCGA.AP.A5FX.01A,TCGA-AP-A5FX,TCGA.AP.A5FX,7.36790394,10.68552848,TCGA.AP.A5FX.01A.11R.A27V.07,3.219918,3.117916,0.2109516,0.3050152,0.8883349,UCEC,TCGA-AP-A5FX,TCGA-AP-A5FX-01A-11R-A27V-07,TCGA-AP-A5FX-01A,TCGA-AP-A5FX-01A-11R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-AP-A5FX-01A,10606,UCEC,68,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25063,Dead,WITH TUMOR,NA,1099,[Not Available],Locoregional Recurrence,"Other, specify",Retroperitoneal LN; vulvar mass,407,Complete Remission/Response,NA,NA,1,1099,1,1099,1,407,1,407,NA,older,28.3446712,level2,NA,NA,NA,NA,NA,YES
TCGA.AW.A1PO.01A,TCGA-AW-A1PO,TCGA.AW.A1PO,6.717966802,10.24473504,TCGA.AW.A1PO.01A.12R.A157.07,0.8929101,1.01861,-1.399863,-2.021993,0.03263302,UCEC,TCGA-AW-A1PO,TCGA-AW-A1PO-01A-12R-A157-07,TCGA-AW-A1PO-01A,TCGA-AW-A1PO-01A-12R-A157-07,TP,Primary solid Tumor,1,1,A157,1,0,1,Female,1,Tumor,TCGA-AW-A1PO-01A,10607,UCEC,66,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24225,Alive,TUMOR FREE,17,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,17,0,17,NA,NA,0,17,NA,older,22.10028959,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A05S.01A,TCGA-AX-A05S,TCGA.AX.A05S,6.055572533,8.986078239,TCGA.AX.A05S.01A.11R.A00V.07,3.695407,3.556326,0.5621817,0.7805034,1.04552,UCEC,TCGA-AX-A05S,TCGA-AX-A05S-01A-11R-A00V-07,TCGA-AX-A05S-01A,TCGA-AX-A05S-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A05S-01A,10608,UCEC,81,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29928,Dead,WITH TUMOR,NA,413,[Not Available],NA,NA,NA,338,Progressive Disease,NA,NA,1,413,1,413,NA,NA,1,338,NA,older,20.77562327,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A05T.01A,TCGA-AX-A05T,TCGA.AX.A05T,5.904990501,10.04405634,TCGA.AX.A05T.01A.11R.A00V.07,3.004206,2.672434,0.07847326,0.08930299,0.7824007,UCEC,TCGA-AX-A05T,TCGA-AX-A05T-01A-11R-A00V-07,TCGA-AX-A05T-01A,TCGA-AX-A05T-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A05T-01A,10609,UCEC,82,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30137,Alive,TUMOR FREE,1010,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1010,0,1010,0,1010,0,1010,NA,older,23.53304271,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A05U.01A,TCGA-AX-A05U,TCGA.AX.A05U,4.640807619,10.01797463,TCGA.AX.A05U.01A.11R.A00V.07,1.917826,1.932189,-0.6634153,-0.9970768,0.3993332,UCEC,TCGA-AX-A05U,TCGA-AX-A05U-01A-11R-A00V-07,TCGA-AX-A05U-01A,TCGA-AX-A05U-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A05U-01A,10610,UCEC,56,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20533,Alive,TUMOR FREE,903,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,903,0,903,0,903,0,903,NA,younger,25.80645161,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A05W.01A,TCGA-AX-A05W,TCGA.AX.A05W,6.334271497,9.094901094,TCGA.AX.A05W.01A.21R.A466.07,3.381715,3.333606,0.3525822,0.4668118,0.8985595,UCEC,TCGA-AX-A05W,TCGA-AX-A05W-01A-21R-A466-07,TCGA-AX-A05W-01A,TCGA-AX-A05W-01A-21R-A466-07,TP,Primary solid Tumor,1,1,A466,1,0,1,Female,1,Tumor,TCGA-AX-A05W-01A,10611,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22200,Alive,TUMOR FREE,2450,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2450,0,2450,0,2450,0,2450,NA,younger,28.54828132,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A05Y.01A,TCGA-AX-A05Y,TCGA.AX.A05Y,4.04863028,10.09275661,TCGA.AX.A05Y.01A.11R.A00V.07,1.453001,1.347125,-0.9932886,-1.461902,0.2249862,UCEC,TCGA-AX-A05Y,TCGA-AX-A05Y-01A-11R-A00V-07,TCGA-AX-A05Y-01A,TCGA-AX-A05Y-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A05Y-01A,10612,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20904,Alive,TUMOR FREE,2684,NA,[Not Available],NA,NA,NA,194,Complete Remission/Response,NA,NA,0,2684,0,2684,1,194,1,194,NA,younger,33.38655828,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A05Z.01A,TCGA-AX-A05Z,TCGA.AX.A05Z,6.098605882,8.763729123,TCGA.AX.A05Z.01A.11R.A00V.07,5.479095,5.326067,1.748984,2.564191,1.659017,UCEC,TCGA-AX-A05Z,TCGA-AX-A05Z-01A-11R-A00V-07,TCGA-AX-A05Z-01A,TCGA-AX-A05Z-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A05Z-01A,10613,UCEC,37,FEMALE,[Not Available],[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2006,Indeterminate (neither Pre or Postmenopausal),-13529,Alive,TUMOR FREE,2175,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2175,0,2175,0,2175,0,2175,NA,younger,29.33333333,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A060.01A,TCGA-AX-A060,TCGA.AX.A060,2.983993738,10.95152082,TCGA.AX.A060.01A.11R.A00V.07,1.170001,0.934552,-1.205967,-1.744902,0.1166784,UCEC,TCGA-AX-A060,TCGA-AX-A060-01A-11R-A00V-07,TCGA-AX-A060-01A,TCGA-AX-A060-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A060-01A,10614,UCEC,77,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28472,Alive,TUMOR FREE,1075,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1075,0,1075,0,1075,0,1075,NA,older,32.7449283,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A062.01A,TCGA-AX-A062,TCGA.AX.A062,7.136908555,9.578612418,TCGA.AX.A062.01A.11R.A00V.07,1.84426,1.753772,-0.742238,-1.070643,0.4222852,UCEC,TCGA-AX-A062,TCGA-AX-A062-01A-11R-A00V-07,TCGA-AX-A062-01A,TCGA-AX-A062-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A062-01A,10615,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2005,Indeterminate (neither Pre or Postmenopausal),-19643,Alive,TUMOR FREE,1399,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1399,0,1399,0,1399,0,1399,NA,younger,40.76313943,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A063.01A,TCGA-AX-A063,TCGA.AX.A063,5.584228644,10.1628322,TCGA.AX.A063.01A.11R.A00V.07,4.948892,4.915221,1.387219,2.033988,1.535585,UCEC,TCGA-AX-A063,TCGA-AX-A063-01A-11R-A00V-07,TCGA-AX-A063-01A,TCGA-AX-A063-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A063-01A,10616,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23045,Alive,TUMOR FREE,2417,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2417,0,2417,0,2417,0,2417,NA,younger,34.375,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A064.01A,TCGA-AX-A064,TCGA.AX.A064,6.975118724,10.62262734,TCGA.AX.A064.01A.11R.A00V.07,2.699996,2.474909,-0.126409,-0.2149069,0.6935506,UCEC,TCGA-AX-A064,TCGA-AX-A064-01A-11R-A00V-07,TCGA-AX-A064-01A,TCGA-AX-A064-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A064-01A,10617,UCEC,81,FEMALE,WHITE,[Not Applicable],Stage IIA,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29625,Alive,TUMOR FREE,1517,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1517,0,1517,0,1517,0,1517,NA,older,20.23950076,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A06B.01A,TCGA-AX-A06B,TCGA.AX.A06B,5.237064088,8.902896526,TCGA.AX.A06B.01A.11R.A00V.07,3.609906,3.595855,0.4606751,0.695003,1.057315,UCEC,TCGA-AX-A06B,TCGA-AX-A06B-01A-11R-A00V-07,TCGA-AX-A06B-01A,TCGA-AX-A06B-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A06B-01A,10618,UCEC,72,FEMALE,WHITE,[Not Applicable],Stage IIA,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26348,Alive,TUMOR FREE,2058,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2058,0,2058,0,2058,0,2058,NA,older,40.78768475,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A06F.01A,TCGA-AX-A06F,TCGA.AX.A06F,5.305780329,11.58550063,TCGA.AX.A06F.01A.11R.A00V.07,4.605105,4.537993,1.15717,1.690201,1.36877,UCEC,TCGA-AX-A06F,TCGA-AX-A06F-01A-11R-A00V-07,TCGA-AX-A06F-01A,TCGA-AX-A06F-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A06F-01A,10620,UCEC,59,FEMALE,WHITE,[Not Applicable],Stage IVA,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21624,Alive,TUMOR FREE,1748,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1748,0,1748,NA,NA,0,1748,NA,younger,30.85399449,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A06H.01A,TCGA-AX-A06H,TCGA.AX.A06H,6.77357067,9.484749218,TCGA.AX.A06H.01A.11R.A118.07,4.443528,4.416834,1.025909,1.528625,1.342343,UCEC,TCGA-AX-A06H,TCGA-AX-A06H-01A-11R-A118-07,TCGA-AX-A06H-01A,TCGA-AX-A06H-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-AX-A06H-01A,10621,UCEC,60,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22270,Alive,WITH TUMOR,833,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,833,0,833,0,833,0,833,NA,younger,38.28125,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A06J.01A,TCGA-AX-A06J,TCGA.AX.A06J,6.148221088,10.56307247,TCGA.AX.A06J.01A.11R.A00V.07,3.3295,3.194455,0.2824971,0.4145971,0.8998303,UCEC,TCGA-AX-A06J,TCGA-AX-A06J-01A-11R-A00V-07,TCGA-AX-A06J-01A,TCGA-AX-A06J-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-AX-A06J-01A,10622,UCEC,71,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26000,Alive,TUMOR FREE,913,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,913,0,913,0,913,0,913,NA,older,45.90872266,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A06L.01A,TCGA-AX-A06L,TCGA.AX.A06L,5.682879779,8.676660975,TCGA.AX.A06L.01A.11R.A118.07,3.425763,3.320813,0.3586599,0.5108593,0.9837413,UCEC,TCGA-AX-A06L,TCGA-AX-A06L-01A-11R-A118-07,TCGA-AX-A06L-01A,TCGA-AX-A06L-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-AX-A06L-01A,10623,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23294,Alive,TUMOR FREE,1845,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1845,0,1845,0,1845,0,1845,NA,younger,43.20820956,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A0IS.01A,TCGA-AX-A0IS,TCGA.AX.A0IS,5.230481703,10.0824069,TCGA.AX.A0IS.01A.12R.A10J.07,1.908348,1.606409,-0.7190145,-1.006555,0.3993307,UCEC,TCGA-AX-A0IS,TCGA-AX-A0IS-01A-12R-A10J-07,TCGA-AX-A0IS-01A,TCGA-AX-A0IS-01A-12R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-AX-A0IS-01A,10624,UCEC,52,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19173,Dead,WITH TUMOR,NA,1858,[Not Available],NA,NA,NA,448,Complete Remission/Response,NA,NA,1,1858,1,1858,1,448,1,448,NA,younger,46.76870748,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A0IU.01A,TCGA-AX-A0IU,TCGA.AX.A0IU,5.169877862,9.29628849,TCGA.AX.A0IU.01A.11R.A16W.07,1.89251,1.709977,-0.7314465,-1.022393,0.4186487,UCEC,TCGA-AX-A0IU,TCGA-AX-A0IU-01A-11R-A16W-07,TCGA-AX-A0IU-01A,TCGA-AX-A0IU-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-AX-A0IU-01A,10625,UCEC,79,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29063,Alive,TUMOR FREE,1087,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1087,0,1087,0,1087,0,1087,NA,older,30.44383913,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A0IW.01A,TCGA-AX-A0IW,TCGA.AX.A0IW,4.143388758,7.718156875,TCGA.AX.A0IW.01A.11R.A040.07,2.250061,2.186663,-0.4713997,-0.6648419,0.5257953,UCEC,TCGA-AX-A0IW,TCGA-AX-A0IW-01A-11R-A040-07,TCGA-AX-A0IW-01A,TCGA-AX-A0IW-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AX-A0IW-01A,10626,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24488,Alive,TUMOR FREE,1149,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1149,0,1149,0,1149,0,1149,NA,older,22.95908766,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A0IZ.01A,TCGA-AX-A0IZ,TCGA.AX.A0IZ,7.551137403,4.953436805,TCGA.AX.A0IZ.01A.11R.A118.07,3.569288,3.463335,0.4125657,0.6543843,1.006902,UCEC,TCGA-AX-A0IZ,TCGA-AX-A0IZ-01A-11R-A118-07,TCGA-AX-A0IZ-01A,TCGA-AX-A0IZ-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-AX-A0IZ-01A,10627,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19364,Alive,TUMOR FREE,1333,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1333,0,1333,0,1333,0,1333,NA,younger,23.4375,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A0J0.01A,TCGA-AX-A0J0,TCGA.AX.A0J0,2.333429668,9.610828966,TCGA.AX.A0J0.01A.11R.A109.07,1.985596,1.993225,-0.6758371,-0.929307,0.4459695,UCEC,TCGA-AX-A0J0,TCGA-AX-A0J0-01A-11R-A109-07,TCGA-AX-A0J0-01A,TCGA-AX-A0J0-01A-11R-A109-07,TP,Primary solid Tumor,1,1,A109,1,0,1,Female,1,Tumor,TCGA-AX-A0J0-01A,10628,UCEC,47,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17466,Alive,TUMOR FREE,1220,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1220,0,1220,0,1220,0,1220,NA,younger,19.94805977,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A0J1.01A,TCGA-AX-A0J1,TCGA.AX.A0J1,4.249517982,10.12187944,TCGA.AX.A0J1.01A.11R.A040.07,3.1921,3.068749,0.154193,0.2771963,0.8963686,UCEC,TCGA-AX-A0J1,TCGA-AX-A0J1-01A-11R-A040-07,TCGA-AX-A0J1-01A,TCGA-AX-A0J1-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-AX-A0J1-01A,10629,UCEC,80,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29501,Alive,TUMOR FREE,2354,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2354,0,2354,0,2354,0,2354,NA,older,22.265625,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A1C4.01A,TCGA-AX-A1C4,TCGA.AX.A1C4,4.648944119,10.16410276,TCGA.AX.A1C4.01A.11R.A137.07,0.2605383,0.08665422,-1.861142,-2.654365,-0.1598933,UCEC,TCGA-AX-A1C4,TCGA-AX-A1C4-01A-11R-A137-07,TCGA-AX-A1C4-01A,TCGA-AX-A1C4-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1C4-01A,10630,UCEC,52,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Indeterminate (neither Pre or Postmenopausal),-19209,Alive,TUMOR FREE,404,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],NA,NA,0,404,0,404,NA,NA,0,404,NA,younger,36.29592223,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A1C5.01A,TCGA-AX-A1C5,TCGA.AX.A1C5,6.676916386,7.000160708,TCGA.AX.A1C5.01A.11R.A137.07,1.366739,1.131377,-1.084704,-1.548164,0.1936176,UCEC,TCGA-AX-A1C5,TCGA-AX-A1C5-01A-11R-A137-07,TCGA-AX-A1C5-01A,TCGA-AX-A1C5-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1C5-01A,10631,UCEC,47,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2009,Indeterminate (neither Pre or Postmenopausal),-17383,Alive,WITH TUMOR,1001,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1001,0,1001,0,1001,0,1001,NA,younger,41.796875,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A1C7.01A,TCGA-AX-A1C7,TCGA.AX.A1C7,4.345651848,8.657475664,TCGA.AX.A1C7.01A.11R.A137.07,1.46813,1.381806,-0.9752582,-1.446773,0.1834451,UCEC,TCGA-AX-A1C7,TCGA-AX-A1C7-01A-11R-A137-07,TCGA-AX-A1C7-01A,TCGA-AX-A1C7-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1C7-01A,10632,UCEC,77,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28198,Alive,NA,1054,NA,[Not Available],NA,NA,NA,390,[Not Applicable],NA,NA,0,1054,0,1054,NA,NA,1,390,NA,older,25.96952909,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A1C8.01A,TCGA-AX-A1C8,TCGA.AX.A1C8,3.081861871,8.655817316,TCGA.AX.A1C8.01A.11R.A137.07,1.632501,1.738037,-0.8779805,-1.282402,0.2998868,UCEC,TCGA-AX-A1C8,TCGA-AX-A1C8-01A-11R-A137-07,TCGA-AX-A1C8-01A,TCGA-AX-A1C8-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1C8-01A,10633,UCEC,77,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28452,Alive,NA,776,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],NA,NA,0,776,0,776,NA,NA,0,776,NA,older,27.12031558,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A1C9.01A,TCGA-AX-A1C9,TCGA.AX.A1C9,5.590904557,9.266415146,TCGA.AX.A1C9.01A.11R.A137.07,3.475292,3.426855,0.3720206,0.5603887,0.9489244,UCEC,TCGA-AX-A1C9,TCGA-AX-A1C9-01A-11R-A137-07,TCGA-AX-A1C9-01A,TCGA-AX-A1C9-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1C9-01A,10634,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26903,Alive,TUMOR FREE,802,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],NA,NA,0,802,0,802,NA,NA,0,802,NA,older,31.59626039,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CA.01A,TCGA-AX-A1CA,TCGA.AX.A1CA,3.729984135,8.429624179,TCGA.AX.A1CA.01A.12R.A137.07,2.810702,2.776316,-0.09692474,-0.1042009,0.7174663,UCEC,TCGA-AX-A1CA,TCGA-AX-A1CA-01A-12R-A137-07,TCGA-AX-A1CA-01A,TCGA-AX-A1CA-01A-12R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1CA-01A,10635,UCEC,70,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2009,[Not Available],-25817,Alive,TUMOR FREE,974,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],NA,NA,0,974,0,974,NA,NA,0,974,NA,older,31.2385898,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CC.01A,TCGA-AX-A1CC,TCGA.AX.A1CC,3.776943526,6.937673195,TCGA.AX.A1CC.01A.11R.A137.07,4.302089,4.281172,0.942686,1.387185,1.270408,UCEC,TCGA-AX-A1CC,TCGA-AX-A1CC-01A-11R-A137-07,TCGA-AX-A1CC-01A,TCGA-AX-A1CC-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1CC-01A,10636,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IC,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23795,Alive,TUMOR FREE,788,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],NA,NA,0,788,0,788,NA,NA,0,788,NA,NA,40.68047337,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CE.01A,TCGA-AX-A1CE,TCGA.AX.A1CE,4.684536351,9.92393559,TCGA.AX.A1CE.01A.11R.A137.07,2.014384,2.123874,-0.6563846,-0.9005189,0.4457795,UCEC,TCGA-AX-A1CE,TCGA-AX-A1CE-01A-11R-A137-07,TCGA-AX-A1CE-01A,TCGA-AX-A1CE-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1CE-01A,10637,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21969,Alive,TUMOR FREE,1037,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],NA,NA,0,1037,0,1037,NA,NA,0,1037,NA,younger,22.65625,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CF.01A,TCGA-AX-A1CF,TCGA.AX.A1CF,1.87046592,9.00088746,TCGA.AX.A1CF.01A.11R.A137.07,2.12838,2.024178,-0.5600174,-0.7865229,0.4591988,UCEC,TCGA-AX-A1CF,TCGA-AX-A1CF-01A-11R-A137-07,TCGA-AX-A1CF-01A,TCGA-AX-A1CF-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1CF-01A,10638,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2004,[Not Available],-25300,Alive,WITH TUMOR,2337,NA,[Not Available],NA,NA,NA,875,Progressive Disease,NA,NA,0,2337,0,2337,NA,NA,1,875,NA,older,35.11111111,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CI.01A,TCGA-AX-A1CI,TCGA.AX.A1CI,5.078197118,9.305792466,TCGA.AX.A1CI.01A.11R.A137.07,2.234721,2.094093,-0.4572701,-0.6801823,0.5273842,UCEC,TCGA-AX-A1CI,TCGA-AX-A1CI-01A-11R-A137-07,TCGA-AX-A1CI-01A,TCGA-AX-A1CI-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1CI-01A,10639,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22582,Alive,TUMOR FREE,2600,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,2600,0,2600,NA,NA,0,2600,NA,younger,27.51338489,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CJ.01A,TCGA-AX-A1CJ,TCGA.AX.A1CJ,4.582955849,9.621672891,TCGA.AX.A1CJ.01A.11R.A137.07,3.591759,3.601224,0.4960364,0.6768562,0.9832316,UCEC,TCGA-AX-A1CJ,TCGA-AX-A1CJ-01A-11R-A137-07,TCGA-AX-A1CJ-01A,TCGA-AX-A1CJ-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1CJ-01A,10640,UCEC,59,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2006,Indeterminate (neither Pre or Postmenopausal),-21655,Alive,TUMOR FREE,2233,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,2233,0,2233,NA,NA,0,2233,NA,younger,43.28352591,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CK.01A,TCGA-AX-A1CK,TCGA.AX.A1CK,5.510424802,9.569126165,TCGA.AX.A1CK.01A.11R.A137.07,0.9938973,0.6605663,-1.342754,-1.921006,0.145801,UCEC,TCGA-AX-A1CK,TCGA-AX-A1CK-01A-11R-A137-07,TCGA-AX-A1CK-01A,TCGA-AX-A1CK-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1CK-01A,10641,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21200,Alive,WITH TUMOR,2441,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,2441,0,2441,NA,NA,0,2441,NA,younger,27.09925101,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CN.01A,TCGA-AX-A1CN,TCGA.AX.A1CN,5.388631086,7.306978757,TCGA.AX.A1CN.01A.11R.A137.07,1.171457,1.019799,-1.200866,-1.743447,0.1658975,UCEC,TCGA-AX-A1CN,TCGA-AX-A1CN-01A-11R-A137-07,TCGA-AX-A1CN-01A,TCGA-AX-A1CN-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-AX-A1CN-01A,10642,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19860,Alive,WITH TUMOR,1143,NA,[Not Available],New Primary Tumor,Lung,NA,1105,[Not Available],NA,NA,0,1143,0,1143,NA,NA,1,1105,NA,younger,47.67346939,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A2H2.01A,TCGA-AX-A2H2,TCGA.AX.A2H2,5.424099872,9.103421394,TCGA.AX.A2H2.01A.11R.A180.07,3.438718,3.419239,0.3318686,0.523815,0.9558216,UCEC,TCGA-AX-A2H2,TCGA-AX-A2H2-01A-11R-A180-07,TCGA-AX-A2H2-01A,TCGA-AX-A2H2-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-AX-A2H2-01A,10645,UCEC,86,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIA,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31524,Dead,TUMOR FREE,NA,145,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,145,0,145,0,145,0,145,NA,older,24.76756592,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A2H4.01A,TCGA-AX-A2H4,TCGA.AX.A2H4,4.608690984,5.925396588,TCGA.AX.A2H4.01A.21R.A18M.07,4.944985,4.765201,1.402101,2.030082,1.511396,UCEC,TCGA-AX-A2H4,TCGA-AX-A2H4-01A-21R-A18M-07,TCGA-AX-A2H4-01A,TCGA-AX-A2H4-01A-21R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-AX-A2H4-01A,10646,UCEC,66,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24234,Dead,WITH TUMOR,NA,916,[Not Available],Locoregional Disease,"Other, specify","Vaginal cuff, iliac",520,Complete Remission/Response,NA,NA,1,916,1,916,1,520,1,520,NA,older,34.0784616,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A2H5.01A,TCGA-AX-A2H5,TCGA.AX.A2H5,4.83640532,9.853955578,TCGA.AX.A2H5.01A.11R.A17B.07,2.248388,2.225062,-0.4842246,-0.6665155,0.5175924,UCEC,TCGA-AX-A2H5,TCGA-AX-A2H5-01A-11R-A17B-07,TCGA-AX-A2H5-01A,TCGA-AX-A2H5-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-AX-A2H5-01A,10647,UCEC,67,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2005,[Not Available],-24757,Alive,TUMOR FREE,2167,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2167,0,2167,0,2167,0,2167,NA,older,33.56351993,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A2H7.01A,TCGA-AX-A2H7,TCGA.AX.A2H7,3.552408323,6.822910093,TCGA.AX.A2H7.01A.12R.A18M.07,1.694385,1.645417,-0.8341187,-1.220518,0.3552133,UCEC,TCGA-AX-A2H7,TCGA-AX-A2H7-01A-12R-A18M-07,TCGA-AX-A2H7-01A,TCGA-AX-A2H7-01A-12R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-AX-A2H7-01A,10648,UCEC,87,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2008,[Not Available],-32100,Dead,WITH TUMOR,NA,1241,[Not Available],Metastatic,Lung,NA,684,Complete Remission/Response,NA,NA,1,1241,1,1241,1,684,1,684,NA,older,26.31463532,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A2HA.01A,TCGA-AX-A2HA,TCGA.AX.A2HA,3.100669037,9.997206164,TCGA.AX.A2HA.01A.12R.A18M.07,2.582948,2.373481,-0.2543667,-0.331955,0.6482733,UCEC,TCGA-AX-A2HA,TCGA-AX-A2HA-01A-12R-A18M-07,TCGA-AX-A2HA-01A,TCGA-AX-A2HA-01A-12R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-AX-A2HA-01A,10650,UCEC,35,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2005,[Not Available],-13142,Alive,TUMOR FREE,2475,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2475,0,2475,0,2475,0,2475,NA,younger,21.51385851,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A2HC.01A,TCGA-AX-A2HC,TCGA.AX.A2HC,2.536461581,2.282880466,TCGA.AX.A2HC.01A.11R.A17B.07,0.9079065,1.022781,-1.358498,-2.006997,0.0447299,UCEC,TCGA-AX-A2HC,TCGA-AX-A2HC-01A-11R-A17B-07,TCGA-AX-A2HC-01A,TCGA-AX-A2HC-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-AX-A2HC-01A,10651,UCEC,53,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2006,[Not Available],-19485,Alive,WITH TUMOR,1044,NA,[Not Available],Metastatic,"Other, specify",Abdomen,756,Complete Remission/Response,NA,NA,0,1044,0,1044,1,756,1,756,NA,younger,47.26806602,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A2HD.01A,TCGA-AX-A2HD,TCGA.AX.A2HD,6.547607403,10.83866883,TCGA.AX.A2HD.01A.21R.A17B.07,2.496083,2.274158,-0.2907037,-0.4188203,0.6088329,UCEC,TCGA-AX-A2HD,TCGA-AX-A2HD-01A-21R-A17B-07,TCGA-AX-A2HD-01A,TCGA-AX-A2HD-01A-21R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-AX-A2HD-01A,10652,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2008,[Not Available],-25499,Alive,WITH TUMOR,1414,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,NA,NA,0,1414,0,1414,NA,NA,0,1414,NA,older,22.9719382,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A2HG.01A,TCGA-AX-A2HG,TCGA.AX.A2HG,4.433493106,8.690082878,TCGA.AX.A2HG.01A.11R.A17B.07,3.270095,3.425348,0.2168589,0.3551916,0.9072531,UCEC,TCGA-AX-A2HG,TCGA-AX-A2HG-01A-11R-A17B-07,TCGA-AX-A2HG-01A,TCGA-AX-A2HG-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-AX-A2HG-01A,10654,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20771,Alive,TUMOR FREE,1163,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1163,0,1163,0,1163,0,1163,NA,younger,46.65503672,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A2HH.01A,TCGA-AX-A2HH,TCGA.AX.A2HH,5.694579368,8.009156789,TCGA.AX.A2HH.01A.11R.A32Y.07,-0.3264187,-0.5702831,-2.216692,-3.241322,-0.374326,UCEC,TCGA-AX-A2HH,TCGA-AX-A2HH-01A-11R-A32Y-07,TCGA-AX-A2HH-01A,TCGA-AX-A2HH-01A-11R-A32Y-07,TP,Primary solid Tumor,1,1,A32Y,1,0,1,Female,1,Tumor,TCGA-AX-A2HH-01A,10655,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,[Not Available],-21924,Alive,WITH TUMOR,540,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,NA,NA,0,540,0,540,NA,NA,0,540,NA,younger,27.05515088,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A2HJ.01A,TCGA-AX-A2HJ,TCGA.AX.A2HJ,3.848832035,9.142755056,TCGA.AX.A2HJ.01A.11R.A17B.07,2.921668,2.870095,-0.009888897,0.006765066,0.7606158,UCEC,TCGA-AX-A2HJ,TCGA-AX-A2HJ-01A-11R-A17B-07,TCGA-AX-A2HJ-01A,TCGA-AX-A2HJ-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-AX-A2HJ-01A,10656,UCEC,35,FEMALE,ASIAN,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009,[Not Available],-13112,Alive,TUMOR FREE,935,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,935,0,935,0,935,0,935,NA,younger,24.23822715,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A2HK.01A,TCGA-AX-A2HK,TCGA.AX.A2HK,5.364271814,8.314051128,TCGA.AX.A2HK.01A.11R.A17B.07,1.623864,1.581536,-0.8836726,-1.29104,0.3071328,UCEC,TCGA-AX-A2HK,TCGA-AX-A2HK-01A-11R-A17B-07,TCGA-AX-A2HK-01A,TCGA-AX-A2HK-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-AX-A2HK-01A,10657,UCEC,77,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28316,Dead,WITH TUMOR,NA,90,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,90,1,90,NA,NA,1,90,NA,older,30.7809074,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A2IN.01A,TCGA-AX-A2IN,TCGA.AX.A2IN,1.78257631,4.835044854,TCGA.AX.A2IN.01A.12R.A180.07,3.373132,3.371911,0.3163669,0.4582285,0.9371033,UCEC,TCGA-AX-A2IN,TCGA-AX-A2IN-01A-12R-A180-07,TCGA-AX-A2IN-01A,TCGA-AX-A2IN-01A-12R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-AX-A2IN-01A,10658,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23275,Dead,WITH TUMOR,NA,947,[Not Available],New Primary Tumor,"Other, specify",Right Breast,257,[Not Available],NA,NA,1,947,1,947,NA,NA,1,257,NA,younger,40.56959714,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A2IO.01A,TCGA-AX-A2IO,TCGA.AX.A2IO,4.972638969,9.053329029,TCGA.AX.A2IO.01A.11R.A180.07,2.295176,2.31415,-0.4458832,-0.6197277,0.5430473,UCEC,TCGA-AX-A2IO,TCGA-AX-A2IO-01A-11R-A180-07,TCGA-AX-A2IO-01A,TCGA-AX-A2IO-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-AX-A2IO-01A,10659,UCEC,83,FEMALE,WHITE,[Not Applicable],Stage IIA,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30539,Alive,TUMOR FREE,1975,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,1975,0,1975,NA,NA,0,1975,NA,older,24.38652644,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A3FS.01A,TCGA-AX-A3FS,TCGA.AX.A3FS,3.617745141,5.528821331,TCGA.AX.A3FS.01A.11R.A22K.07,2.39043,2.268799,-0.3978442,-0.5244729,0.6273916,UCEC,TCGA-AX-A3FS,TCGA-AX-A3FS-01A-11R-A22K-07,TCGA-AX-A3FS-01A,TCGA-AX-A3FS-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AX-A3FS-01A,10660,UCEC,82,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30102,Alive,NA,7,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,7,0,7,NA,NA,0,7,NA,older,50.72201232,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A3FT.01A,TCGA-AX-A3FT,TCGA.AX.A3FT,2.84402403,4.041733611,TCGA.AX.A3FT.01A.11R.A22K.07,4.915435,5.027022,1.348735,2.000532,1.504822,UCEC,TCGA-AX-A3FT,TCGA-AX-A3FT-01A-11R-A22K-07,TCGA-AX-A3FT-01A,TCGA-AX-A3FT-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AX-A3FT-01A,10661,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23543,Alive,NA,6,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,6,0,6,NA,NA,0,6,NA,younger,31.634582,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A3FV.01A,TCGA-AX-A3FV,TCGA.AX.A3FV,4.87757249,5.231728075,TCGA.AX.A3FV.01A.11R.A22K.07,1.354761,1.103485,-1.061694,-1.560142,0.2245164,UCEC,TCGA-AX-A3FV,TCGA-AX-A3FV-01A-11R-A22K-07,TCGA-AX-A3FV-01A,TCGA-AX-A3FV-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AX-A3FV-01A,10662,UCEC,62,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009,[Not Available],-22752,Alive,NA,-6,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,0,0,0,NA,NA,0,0,NA,younger,48.90927978,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A3FW.01A,TCGA-AX-A3FW,TCGA.AX.A3FW,4.59776356,11.16408355,TCGA.AX.A3FW.01A.11R.A22K.07,1.568144,1.337705,-0.9578019,-1.346759,0.2849976,UCEC,TCGA-AX-A3FW,TCGA-AX-A3FW-01A-11R-A22K-07,TCGA-AX-A3FW-01A,TCGA-AX-A3FW-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AX-A3FW-01A,10663,UCEC,66,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24419,Alive,NA,17,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,17,0,17,NA,NA,0,17,NA,older,30.11940191,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A3FX.01A,TCGA-AX-A3FX,TCGA.AX.A3FX,2.661453188,9.652361007,TCGA.AX.A3FX.01A.11R.A22K.07,2.851918,2.853929,-0.04322788,-0.06298488,0.7689522,UCEC,TCGA-AX-A3FX,TCGA-AX-A3FX-01A-11R-A22K-07,TCGA-AX-A3FX-01A,TCGA-AX-A3FX-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AX-A3FX-01A,10664,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25260,Dead,NA,NA,1333,[Not Available],Locoregional Recurrence,"Other, specify",Chest,938,[Not Available],NA,NA,1,1333,NA,1333,NA,NA,1,938,NA,older,38.28656367,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A3FZ.01A,TCGA-AX-A3FZ,TCGA.AX.A3FZ,1.87282876,1.584962501,TCGA.AX.A3FZ.01A.11R.A22K.07,0.4380063,0.3870588,-1.704896,-2.476897,-0.09699375,UCEC,TCGA-AX-A3FZ,TCGA-AX-A3FZ-01A-11R-A22K-07,TCGA-AX-A3FZ-01A,TCGA-AX-A3FZ-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AX-A3FZ-01A,10665,UCEC,33,FEMALE,WHITE,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2010,[Not Available],-12331,Alive,NA,6,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,6,0,6,NA,NA,0,6,NA,younger,48.90927978,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A3G1.01A,TCGA-AX-A3G1,TCGA.AX.A3G1,5.456980234,9.646268882,TCGA.AX.A3G1.01A.11R.A22K.07,3.816256,3.810042,0.5868694,0.9013532,1.126872,UCEC,TCGA-AX-A3G1,TCGA-AX-A3G1-01A-11R-A22K-07,TCGA-AX-A3G1-01A,TCGA-AX-A3G1-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AX-A3G1-01A,10666,UCEC,84,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31037,Dead,NA,NA,624,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,1,624,NA,624,NA,NA,0,624,NA,older,23.828125,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A3G3.01A,TCGA-AX-A3G3,TCGA.AX.A3G3,4.328692877,6.377266068,TCGA.AX.A3G3.01A.11R.A213.07,4.416393,4.394415,1.044448,1.50149,1.269335,UCEC,TCGA-AX-A3G3,TCGA-AX-A3G3-01A-11R-A213-07,TCGA-AX-A3G3-01A,TCGA-AX-A3G3-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AX-A3G3-01A,10667,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21308,Alive,NA,42,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,42,0,42,NA,NA,0,42,NA,younger,19.72103697,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A3G4.01A,TCGA-AX-A3G4,TCGA.AX.A3G4,4.074522562,6.619699115,TCGA.AX.A3G4.01A.11R.A213.07,1.253123,1.223748,-1.159845,-1.66178,0.1977348,UCEC,TCGA-AX-A3G4,TCGA-AX-A3G4-01A-11R-A213-07,TCGA-AX-A3G4-01A,TCGA-AX-A3G4-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AX-A3G4-01A,10668,UCEC,60,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22099,Alive,NA,9,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,9,0,9,NA,NA,0,9,NA,younger,38.36638101,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A3G6.01A,TCGA-AX-A3G6,TCGA.AX.A3G6,4.568506437,7.541685192,TCGA.AX.A3G6.01A.11R.A213.07,2.281148,2.483771,-0.4059619,-0.633755,0.5197136,UCEC,TCGA-AX-A3G6,TCGA-AX-A3G6-01A-11R-A213-07,TCGA-AX-A3G6-01A,TCGA-AX-A3G6-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AX-A3G6-01A,10669,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G2,2010,[Not Available],-24681,Alive,NA,8,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,8,0,8,NA,NA,0,8,NA,older,21.51385851,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A3G7.01A,TCGA-AX-A3G7,TCGA.AX.A3G7,5.713984435,8.650463009,TCGA.AX.A3G7.01A.12R.A213.07,3.056168,2.979509,0.1117827,0.1412645,0.7559318,UCEC,TCGA-AX-A3G7,TCGA-AX-A3G7-01A-12R-A213-07,TCGA-AX-A3G7-01A,TCGA-AX-A3G7-01A-12R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AX-A3G7-01A,10670,UCEC,71,FEMALE,WHITE,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2010,[Not Available],-26187,Alive,NA,9,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,9,0,9,NA,NA,0,9,NA,older,31.20256367,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A3G8.01A,TCGA-AX-A3G8,TCGA.AX.A3G8,5.312523598,8.926693311,TCGA.AX.A3G8.01A.11R.A22K.07,0.9667742,0.8048216,-1.358585,-1.948129,0.05565962,UCEC,TCGA-AX-A3G8,TCGA-AX-A3G8-01A-11R-A22K-07,TCGA-AX-A3G8-01A,TCGA-AX-A3G8-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AX-A3G8-01A,10671,UCEC,76,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27899,Alive,NA,36,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,36,0,36,NA,NA,0,36,NA,older,25.15315023,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A3G9.01A,TCGA-AX-A3G9,TCGA.AX.A3G9,5.501948616,8.953547533,TCGA.AX.A3G9.01A.11R.A22K.07,0.5212933,0.4942516,-1.702887,-2.39361,-0.04330222,UCEC,TCGA-AX-A3G9,TCGA-AX-A3G9-01A-11R-A22K-07,TCGA-AX-A3G9-01A,TCGA-AX-A3G9-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AX-A3G9-01A,10672,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010,[Not Available],-23361,Alive,NA,558,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,558,0,558,NA,NA,0,558,NA,younger,25.29937595,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A3GB.01A,TCGA-AX-A3GB,TCGA.AX.A3GB,3.810155153,9.900305315,TCGA.AX.A3GB.01A.11R.A22K.07,3.373617,3.34833,0.3015578,0.4587142,0.943035,UCEC,TCGA-AX-A3GB,TCGA-AX-A3GB-01A-11R-A22K-07,TCGA-AX-A3GB-01A,TCGA-AX-A3GB-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-AX-A3GB-01A,10673,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26724,Alive,NA,440,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,440,0,440,NA,NA,0,440,NA,older,34.85018427,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A3GI.01A,TCGA-AX-A3GI,TCGA.AX.A3GI,5.808207406,7.540042773,TCGA.AX.A3GI.01A.11R.A213.07,0.5449367,0.1720594,-1.673924,-2.369967,-0.0876998,UCEC,TCGA-AX-A3GI,TCGA-AX-A3GI-01A-11R-A213-07,TCGA-AX-A3GI-01A,TCGA-AX-A3GI-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-AX-A3GI-01A,10674,UCEC,66,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2011,[Not Available],-24388,Alive,NA,12,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,12,0,12,NA,NA,0,12,NA,older,31.19509484,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A0JN.01A,TCGA-B5-A0JN,TCGA.B5.A0JN,3.465334575,9.399361247,TCGA.B5.A0JN.01A.11R.A104.07,1.274479,1.023039,-1.140612,-1.640424,0.2082621,UCEC,TCGA-B5-A0JN,TCGA-B5-A0JN-01A-11R-A104-07,TCGA-B5-A0JN-01A,TCGA-B5-A0JN-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-B5-A0JN-01A,10675,UCEC,84,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30933,Alive,TUMOR FREE,2445,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2445,0,2445,NA,NA,0,2445,NA,older,24.45606342,level1,NA,NA,NA,NA,NA,NA
TCGA.B5.A0JR.01A,TCGA-B5-A0JR,TCGA.B5.A0JR,2.661886385,9.521231377,TCGA.B5.A0JR.01A.13R.A466.07,3.268094,3.2035,0.2019213,0.3531909,0.9374521,UCEC,TCGA-B5-A0JR,TCGA-B5-A0JR-01A-13R-A466-07,TCGA-B5-A0JR-01A,TCGA-B5-A0JR-01A-13R-A466-07,TP,Primary solid Tumor,1,1,A466,1,0,1,Female,1,Tumor,TCGA-B5-A0JR-01A,10676,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26814,Alive,TUMOR FREE,1731,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1731,0,1731,0,1731,0,1731,NA,older,40.50769646,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A0JS.01A,TCGA-B5-A0JS,TCGA.B5.A0JS,4.676317964,9.84500388,TCGA.B5.A0JS.01A.11R.A104.07,3.626673,3.619851,0.4814947,0.7117698,1.011659,UCEC,TCGA-B5-A0JS,TCGA-B5-A0JS-01A-11R-A104-07,TCGA-B5-A0JS-01A,TCGA-B5-A0JS-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-B5-A0JS-01A,10677,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19995,Alive,TUMOR FREE,2627,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2627,0,2627,0,2627,0,2627,NA,younger,38.06228374,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A0JT.01A,TCGA-B5-A0JT,TCGA.B5.A0JT,5.035632642,9.062290166,TCGA.B5.A0JT.01A.21R.A118.07,2.214404,2.197955,-0.4447653,-0.7004996,0.5143416,UCEC,TCGA-B5-A0JT,TCGA-B5-A0JT-01A-21R-A118-07,TCGA-B5-A0JT-01A,TCGA-B5-A0JT-01A-21R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A0JT-01A,10678,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23041,Alive,TUMOR FREE,1682,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1682,0,1682,0,1682,0,1682,NA,younger,42.16269841,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A0JU.01B,TCGA-B5-A0JU,TCGA.B5.A0JU,6.328282251,9.541689034,TCGA.B5.A0JU.01B.11R.A14D.07,0.9101891,0.4876031,-1.418162,-2.004714,0.0498795,UCEC,TCGA-B5-A0JU,TCGA-B5-A0JU-01B-11R-A14D-07,TCGA-B5-A0JU-01B,TCGA-B5-A0JU-01B-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-B5-A0JU-01B,10679,UCEC,57,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21159,Alive,TUMOR FREE,1802,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,1802,0,1802,NA,NA,0,1802,NA,younger,54.8790258,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A0JV.01A,TCGA-B5-A0JV,TCGA.B5.A0JV,3.851961736,9.415684494,TCGA.B5.A0JV.01A.11R.A104.07,1.829596,1.603622,-0.7783404,-1.085308,0.3867916,UCEC,TCGA-B5-A0JV,TCGA-B5-A0JV-01A-11R-A104-07,TCGA-B5-A0JV-01A,TCGA-B5-A0JV-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-B5-A0JV-01A,10680,UCEC,63,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23295,Alive,TUMOR FREE,2616,NA,[Not Available],Locoregional Disease,"Other, specify",vaginal wall,698,Complete Remission/Response,NA,NA,0,2616,0,2616,1,698,1,698,NA,younger,34.11235303,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A0JX.01A,TCGA-B5-A0JX,TCGA.B5.A0JX,5.306066017,8.646292313,TCGA.B5.A0JX.01A.21R.A14M.07,3.319854,3.407393,0.2696271,0.4049508,0.9152967,UCEC,TCGA-B5-A0JX,TCGA-B5-A0JX-01A-21R-A14M-07,TCGA-B5-A0JX-01A,TCGA-B5-A0JX-01A-21R-A14M-07,TP,Primary solid Tumor,1,1,A14M,1,0,1,Female,1,Tumor,TCGA-B5-A0JX-01A,10681,UCEC,62,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22834,Alive,TUMOR FREE,1787,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1787,0,1787,0,1787,0,1787,NA,younger,40.03684807,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A0JY.01A,TCGA-B5-A0JY,TCGA.B5.A0JY,2.231203434,8.28920652,TCGA.B5.A0JY.01A.11R.A104.07,3.094296,3.085422,0.1245308,0.1793926,0.8422629,UCEC,TCGA-B5-A0JY,TCGA-B5-A0JY-01A-11R-A104-07,TCGA-B5-A0JY-01A,TCGA-B5-A0JY-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-B5-A0JY-01A,10682,UCEC,50,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18475,Alive,TUMOR FREE,2107,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2107,0,2107,0,2107,0,2107,NA,younger,23.73866213,level1,NA,NA,NA,NA,NA,NA
TCGA.B5.A0JZ.01A,TCGA-B5-A0JZ,TCGA.B5.A0JZ,4.797006003,9.718833105,TCGA.B5.A0JZ.01A.11R.A040.07,4.793914,4.649216,1.280595,1.879011,1.474124,UCEC,TCGA-B5-A0JZ,TCGA-B5-A0JZ-01A-11R-A040-07,TCGA-B5-A0JZ-01A,TCGA-B5-A0JZ-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-B5-A0JZ-01A,10683,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22106,Alive,TUMOR FREE,2173,NA,[Not Available],Metastatic,"Other, specify",inguinal lymph node,356,Progressive Disease,NA,NA,0,2173,0,2173,NA,NA,1,356,NA,younger,33.15043439,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A0K0.01A,TCGA-B5-A0K0,TCGA.B5.A0K0,7.036398513,9.476673717,TCGA.B5.A0K0.01A.11R.A16W.07,4.385887,4.256622,1.001477,1.470984,1.309808,UCEC,TCGA-B5-A0K0,TCGA-B5-A0K0-01A-11R-A16W-07,TCGA-B5-A0K0-01A,TCGA-B5-A0K0-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-B5-A0K0-01A,10684,UCEC,48,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008,Indeterminate (neither Pre or Postmenopausal),-17810,Alive,TUMOR FREE,1478,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1478,0,1478,0,1478,0,1478,NA,younger,49.6031746,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A0K1.01A,TCGA-B5-A0K1,TCGA.B5.A0K1,4.776836089,10.01023926,TCGA.B5.A0K1.01A.11R.A16W.07,1.874826,1.647159,-0.6956323,-1.040077,0.3721148,UCEC,TCGA-B5-A0K1,TCGA-B5-A0K1-01A-11R-A16W-07,TCGA-B5-A0K1-01A,TCGA-B5-A0K1-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-B5-A0K1-01A,10685,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25291,Alive,TUMOR FREE,1110,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1110,0,1110,0,1110,0,1110,NA,older,38.64447087,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A0K2.01A,TCGA-B5-A0K2,TCGA.B5.A0K2,6.714970073,9.094353305,TCGA.B5.A0K2.01A.12R.A104.07,4.605192,4.452202,1.177437,1.690289,1.362007,UCEC,TCGA-B5-A0K2,TCGA-B5-A0K2-01A-12R-A104-07,TCGA-B5-A0K2-01A,TCGA-B5-A0K2-01A-12R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-B5-A0K2-01A,10686,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008,Indeterminate (neither Pre or Postmenopausal),-20080,Alive,TUMOR FREE,2209,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2209,0,2209,0,2209,0,2209,NA,younger,33.22653376,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A0K3.01A,TCGA-B5-A0K3,TCGA.B5.A0K3,3.214776911,7.362105311,TCGA.B5.A0K3.01A.11R.A040.07,2.63369,2.641104,-0.1724935,-0.2812135,0.6305308,UCEC,TCGA-B5-A0K3,TCGA-B5-A0K3-01A-11R-A040-07,TCGA-B5-A0K3-01A,TCGA-B5-A0K3-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-B5-A0K3-01A,10687,UCEC,62,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22664,Dead,WITH TUMOR,NA,830,[Not Available],Locoregional Disease,"Other, specify",vaginal cuff,256,[Not Available],NA,NA,1,830,1,830,NA,NA,1,256,NA,younger,32.71861987,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A0K4.01A,TCGA-B5-A0K4,TCGA.B5.A0K4,3.48367914,8.658981477,TCGA.B5.A0K4.01A.11R.A040.07,1.381956,1.281854,-1.04713,-1.532947,0.205179,UCEC,TCGA-B5-A0K4,TCGA-B5-A0K4-01A-11R-A040-07,TCGA-B5-A0K4-01A,TCGA-B5-A0K4-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-B5-A0K4-01A,10688,UCEC,51,FEMALE,[Not Available],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18631,Alive,TUMOR FREE,1757,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1757,0,1757,0,1757,0,1757,NA,younger,28.57796068,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A0K6.01A,TCGA-B5-A0K6,TCGA.B5.A0K6,5.168524273,9.66392902,TCGA.B5.A0K6.01A.11R.A040.07,3.613847,3.469676,0.5177517,0.6989436,0.9924214,UCEC,TCGA-B5-A0K6,TCGA-B5-A0K6-01A-11R-A040-07,TCGA-B5-A0K6-01A,TCGA-B5-A0K6-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-B5-A0K6-01A,10689,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21515,Alive,TUMOR FREE,1953,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1953,0,1953,0,1953,0,1953,NA,younger,47.33048872,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A0K7.01A,TCGA-B5-A0K7,TCGA.B5.A0K7,4.323855555,10.1148774,TCGA.B5.A0K7.01A.11R.A104.07,4.036378,3.948414,0.7564289,1.121475,1.1759,UCEC,TCGA-B5-A0K7,TCGA-B5-A0K7-01A-11R-A104-07,TCGA-B5-A0K7-01A,TCGA-B5-A0K7-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-B5-A0K7-01A,10690,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23429,Alive,TUMOR FREE,1933,NA,[Not Available],Metastatic,"Other, specify",vagina,322,Complete Remission/Response,NA,NA,0,1933,0,1933,1,322,1,322,NA,younger,21.61281179,level1,NA,NA,NA,NA,NA,NA
TCGA.B5.A0K8.01A,TCGA-B5-A0K8,TCGA.B5.A0K8,7.085360048,8.173272517,TCGA.B5.A0K8.01A.11R.A14M.07,2.594879,2.582512,-0.2530936,-0.3200243,0.6796291,UCEC,TCGA-B5-A0K8,TCGA-B5-A0K8-01A-11R-A14M-07,TCGA-B5-A0K8-01A,TCGA-B5-A0K8-01A-11R-A14M-07,TP,Primary solid Tumor,1,1,A14M,1,0,1,Female,1,Tumor,TCGA-B5-A0K8-01A,10691,UCEC,71,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25992,Alive,TUMOR FREE,847,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,847,0,847,0,847,0,847,NA,older,23.828125,level1,NA,NA,NA,NA,NA,NA
TCGA.B5.A0K9.01A,TCGA-B5-A0K9,TCGA.B5.A0K9,3.521553331,9.574589743,TCGA.B5.A0K9.01A.21R.A104.07,3.073178,3.091275,0.09037059,0.1582746,0.8299386,UCEC,TCGA-B5-A0K9,TCGA-B5-A0K9-01A-21R-A104-07,TCGA-B5-A0K9-01A,TCGA-B5-A0K9-01A-21R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-B5-A0K9-01A,10692,UCEC,88,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32289,Dead,TUMOR FREE,NA,409,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,409,0,409,0,409,0,409,NA,older,25.390625,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A11E.01A,TCGA-B5-A11E,TCGA.B5.A11E,4.984750519,9.67524729,TCGA.B5.A11E.01A.11R.A10J.07,2.188097,2.228706,-0.5465714,-0.7268065,0.5400429,UCEC,TCGA-B5-A11E,TCGA-B5-A11E-01A-11R-A10J-07,TCGA-B5-A11E-01A,TCGA-B5-A11E-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-B5-A11E-01A,10694,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Peri (6-12 months since last menstrual period),-19458,Alive,TUMOR FREE,1820,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1820,0,1820,0,1820,0,1820,NA,younger,19.10009183,level1,NA,NA,NA,NA,NA,NA
TCGA.B5.A11F.01A,TCGA-B5-A11F,TCGA.B5.A11F,3.430233922,10.31800683,TCGA.B5.A11F.01A.11R.A10J.07,1.831566,1.849457,-0.7510962,-1.083337,0.3964033,UCEC,TCGA-B5-A11F,TCGA-B5-A11F-01A-11R-A10J-07,TCGA-B5-A11F-01A,TCGA-B5-A11F-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-B5-A11F-01A,10695,UCEC,55,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20171,Alive,TUMOR FREE,5651,NA,[Not Available],Metastatic,Bone,NA,1610,Complete Remission/Response,NA,NA,0,5651,0,5651,1,1610,1,1610,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.B5.A11G.01A,TCGA-B5-A11G,TCGA.B5.A11G,4.166867315,9.886098717,TCGA.B5.A11G.01A.13R.A118.07,2.693818,2.819924,-0.1707948,-0.2210855,0.6990523,UCEC,TCGA-B5-A11G,TCGA-B5-A11G-01A-13R-A118-07,TCGA-B5-A11G-01A,TCGA-B5-A11G-01A-13R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11G-01A,10696,UCEC,71,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2001,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25995,Alive,TUMOR FREE,3448,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,3448,0,3448,0,3448,0,3448,NA,older,30.078125,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A11H.01A,TCGA-B5-A11H,TCGA.B5.A11H,5.26766395,9.893028383,TCGA.B5.A11H.01A.11R.A118.07,3.560563,3.512135,0.4409296,0.6456597,1.011855,UCEC,TCGA-B5-A11H,TCGA-B5-A11H-01A-11R-A118-07,TCGA-B5-A11H-01A,TCGA-B5-A11H-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11H-01A,10697,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24556,Alive,TUMOR FREE,2687,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2687,0,2687,0,2687,0,2687,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.B5.A11I.01A,TCGA-B5-A11I,TCGA.B5.A11I,4.395591539,4.728158023,TCGA.B5.A11I.01A.11R.A10J.07,4.34876,4.170058,0.9895529,1.433856,1.242002,UCEC,TCGA-B5-A11I,TCGA-B5-A11I-01A-11R-A10J-07,TCGA-B5-A11I-01A,TCGA-B5-A11I-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-B5-A11I-01A,10698,UCEC,65,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23857,Alive,TUMOR FREE,2303,NA,[Not Available],Metastatic,Lung,NA,705,Complete Remission/Response,NA,NA,0,2303,0,2303,NA,NA,1,705,NA,NA,49.04869269,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A11J.01A,TCGA-B5-A11J,TCGA.B5.A11J,5.83961396,8.633605317,TCGA.B5.A11J.01A.11R.A118.07,2.428698,2.197606,-0.3439757,-0.4862056,0.5861856,UCEC,TCGA-B5-A11J,TCGA-B5-A11J-01A-11R-A118-07,TCGA-B5-A11J-01A,TCGA-B5-A11J-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11J-01A,10699,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23485,Alive,TUMOR FREE,1656,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1656,0,1656,0,1656,0,1656,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.B5.A11L.01B,TCGA-B5-A11L,TCGA.B5.A11L,5.437157921,9.753182194,TCGA.B5.A11L.01B.21R.A13S.07,4.287548,4.110719,0.9599271,1.372645,1.261034,UCEC,TCGA-B5-A11L,TCGA-B5-A11L-01B-21R-A13S-07,TCGA-B5-A11L-01B,TCGA-B5-A11L-01B-21R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-B5-A11L-01B,10700,UCEC,71,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26120,Dead,TUMOR FREE,NA,2240,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal Apex,131,Complete Remission/Response,NA,NA,1,2240,0,2240,1,131,1,131,NA,older,34.62682073,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A11M.01A,TCGA-B5-A11M,TCGA.B5.A11M,4.224516819,9.605629322,TCGA.B5.A11M.01A.11R.A118.07,2.1669,2.050116,-0.5234184,-0.7480031,0.5157187,UCEC,TCGA-B5-A11M,TCGA-B5-A11M-01A-11R-A118-07,TCGA-B5-A11M-01A,TCGA-B5-A11M-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11M-01A,10701,UCEC,43,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16063,Alive,TUMOR FREE,1362,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1362,0,1362,0,1362,0,1362,NA,younger,59.37887137,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A11N.01A,TCGA-B5-A11N,TCGA.B5.A11N,9.110507324,10.76522654,TCGA.B5.A11N.01A.11R.A118.07,4.782277,4.497561,1.270818,1.867374,1.416607,UCEC,TCGA-B5-A11N,TCGA-B5-A11N-01A-11R-A118-07,TCGA-B5-A11N-01A,TCGA-B5-A11N-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11N-01A,10702,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25442,Alive,TUMOR FREE,1876,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1876,0,1876,0,1876,0,1876,NA,older,29.72651605,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A11O.01A,TCGA-B5-A11O,TCGA.B5.A11O,6.993936285,9.507863679,TCGA.B5.A11O.01A.11R.A118.07,2.880108,2.648866,-4.82E-05,-0.03479545,0.7546247,UCEC,TCGA-B5-A11O,TCGA-B5-A11O-01A-11R-A118-07,TCGA-B5-A11O-01A,TCGA-B5-A11O-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11O-01A,10703,UCEC,62,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22720,Alive,TUMOR FREE,2609,NA,[Not Available],New Primary Tumor,"Other, specify",Right Breast,1924,Complete Remission/Response,NA,NA,0,2609,0,2609,0,2609,1,1924,NA,younger,36.38801111,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A11P.01B,TCGA-B5-A11P,TCGA.B5.A11P,4.827973713,9.631983565,TCGA.B5.A11P.01B.11R.A14D.07,1.052767,1.009862,-1.269287,-1.862137,0.06701865,UCEC,TCGA-B5-A11P,TCGA-B5-A11P-01B-11R-A14D-07,TCGA-B5-A11P-01B,TCGA-B5-A11P-01B-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-B5-A11P-01B,10704,UCEC,87,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32047,Alive,TUMOR FREE,1583,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,1583,0,1583,NA,NA,0,1583,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.B5.A11Q.01A,TCGA-B5-A11Q,TCGA.B5.A11Q,2.889765933,9.875487864,TCGA.B5.A11Q.01A.11R.A118.07,0.7579908,0.7909568,-1.478695,-2.156912,0.04490703,UCEC,TCGA-B5-A11Q,TCGA-B5-A11Q-01A-11R-A118-07,TCGA-B5-A11Q-01A,TCGA-B5-A11Q-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11Q-01A,10705,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23538,Alive,TUMOR FREE,976,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,976,0,976,0,976,0,976,NA,younger,33.94930751,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A11R.01A,TCGA-B5-A11R,TCGA.B5.A11R,5.026082959,9.133298935,TCGA.B5.A11R.01A.11R.A118.07,2.210116,2.070625,-0.5278246,-0.7047871,0.5152577,UCEC,TCGA-B5-A11R,TCGA-B5-A11R-01A-11R-A118-07,TCGA-B5-A11R-01A,TCGA-B5-A11R-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11R-01A,10706,UCEC,51,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18878,Alive,TUMOR FREE,2349,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2349,0,2349,0,2349,0,2349,NA,younger,31.53344671,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A11S.01A,TCGA-B5-A11S,TCGA.B5.A11S,3.666154158,9.686406572,TCGA.B5.A11S.01A.11R.A118.07,2.149219,2.056816,-0.5221352,-0.7656838,0.4831746,UCEC,TCGA-B5-A11S,TCGA-B5-A11S-01A-11R-A118-07,TCGA-B5-A11S-01A,TCGA-B5-A11S-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11S-01A,10707,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23085,Alive,TUMOR FREE,2229,NA,[Not Available],New Primary Tumor,"Other, specify",Breast,41,Complete Remission/Response,NA,NA,0,2229,0,2229,0,2229,1,41,NA,younger,47.87212463,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A11U.01A,TCGA-B5-A11U,TCGA.B5.A11U,2.690813065,8.31883015,TCGA.B5.A11U.01A.11R.A118.07,2.21247,2.102463,-0.4872736,-0.7024335,0.5188327,UCEC,TCGA-B5-A11U,TCGA-B5-A11U-01A-11R-A118-07,TCGA-B5-A11U-01A,TCGA-B5-A11U-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11U-01A,10708,UCEC,74,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27160,Alive,TUMOR FREE,509,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,509,0,509,NA,NA,0,509,NA,older,26.40235457,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A11V.01A,TCGA-B5-A11V,TCGA.B5.A11V,4.636737511,10.68718651,TCGA.B5.A11V.01A.11R.A10J.07,1.855137,1.832651,-0.7279835,-1.059766,0.4063679,UCEC,TCGA-B5-A11V,TCGA-B5-A11V-01A-11R-A10J-07,TCGA-B5-A11V-01A,TCGA-B5-A11V-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-B5-A11V-01A,10709,UCEC,64,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23630,Alive,TUMOR FREE,595,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,595,0,595,0,595,0,595,NA,younger,28.80441397,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A11W.01A,TCGA-B5-A11W,TCGA.B5.A11W,5.151819206,10.25189623,TCGA.B5.A11W.01A.12R.A118.07,2.069204,1.804903,-0.5716072,-0.845699,0.4678329,UCEC,TCGA-B5-A11W,TCGA-B5-A11W-01A-12R-A118-07,TCGA-B5-A11W-01A,TCGA-B5-A11W-01A-12R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A11W-01A,10710,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22365,Alive,TUMOR FREE,593,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,593,0,593,0,593,0,593,NA,younger,38.39060559,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A11X.01A,TCGA-B5-A11X,TCGA.B5.A11X,3.638005104,4.749914034,TCGA.B5.A11X.01A.11R.A10J.07,3.893317,3.907996,0.6626072,0.9784142,1.131877,UCEC,TCGA-B5-A11X,TCGA-B5-A11X-01A-11R-A10J-07,TCGA-B5-A11X-01A,TCGA-B5-A11X-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-B5-A11X-01A,10711,UCEC,66,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24217,Alive,TUMOR FREE,596,NA,[Not Available],Metastatic,"Other, specify",lymph nodes,397,[Not Available],NA,NA,0,596,0,596,NA,NA,1,397,NA,older,27.734375,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A11Y.01A,TCGA-B5-A11Y,TCGA.B5.A11Y,7.62131553,9.526814918,TCGA.B5.A11Y.01A.21R.A10J.07,4.460806,4.219665,1.063711,1.545903,1.304932,UCEC,TCGA-B5-A11Y,TCGA-B5-A11Y-01A-21R-A10J-07,TCGA-B5-A11Y-01A,TCGA-B5-A11Y-01A-21R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-B5-A11Y-01A,10712,UCEC,59,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21860,Alive,TUMOR FREE,560,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,560,0,560,0,560,0,560,NA,younger,24.00548697,level1,NA,NA,NA,NA,NA,NA
TCGA.B5.A11Z.01A,TCGA-B5-A11Z,TCGA.B5.A11Z,5.023593565,10.15060197,TCGA.B5.A11Z.01A.11R.A10J.07,1.67496,1.46281,-0.8792522,-1.239943,0.3521006,UCEC,TCGA-B5-A11Z,TCGA-B5-A11Z-01A-11R-A10J-07,TCGA-B5-A11Z-01A,TCGA-B5-A11Z-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-B5-A11Z-01A,10713,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22505,Alive,TUMOR FREE,528,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,528,0,528,0,528,0,528,NA,younger,28.39372634,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A121.01A,TCGA-B5-A121,TCGA.B5.A121,5.695085739,9.685584947,TCGA.B5.A121.01A.31R.A118.07,1.992582,1.974605,-0.639787,-0.9223208,0.4402969,UCEC,TCGA-B5-A121,TCGA-B5-A121-01A-31R-A118-07,TCGA-B5-A121-01A,TCGA-B5-A121-01A-31R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-B5-A121-01A,10714,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21018,Alive,TUMOR FREE,504,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,504,0,504,0,504,0,504,NA,younger,29.38475666,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A1MR.01A,TCGA-B5-A1MR,TCGA.B5.A1MR,1.544851633,9.128777053,TCGA.B5.A1MR.01A.31R.A14D.07,5.492424,5.516739,1.776445,2.577521,1.700415,UCEC,TCGA-B5-A1MR,TCGA-B5-A1MR-01A-31R-A14D-07,TCGA-B5-A1MR-01A,TCGA-B5-A1MR-01A-31R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-B5-A1MR-01A,10715,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,1995,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24017,Alive,TUMOR FREE,6859,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,6859,0,6859,0,6859,0,6859,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.B5.A1MS.01B,TCGA-B5-A1MS,TCGA.B5.A1MS,6.158575356,8.43702378,TCGA.B5.A1MS.01B.11R.A22K.07,1.678456,1.464857,-0.8641379,-1.236448,0.3171621,UCEC,TCGA-B5-A1MS,TCGA-B5-A1MS-01B-11R-A22K-07,TCGA-B5-A1MS-01B,TCGA-B5-A1MS-01B-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-B5-A1MS-01B,10716,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IC,Serous endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22068,Dead,WITH TUMOR,NA,3112,[Not Available],Locoregional Recurrence,"Other, specify",Supraclavicular Fossa,2706,Partial Remission/Response,NA,NA,1,3112,1,3112,NA,NA,1,2706,NA,younger,26.85440557,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A1MU.01A,TCGA-B5-A1MU,TCGA.B5.A1MU,2.870973367,6.926753854,TCGA.B5.A1MU.01A.11R.A13S.07,4.566982,4.546552,1.135723,1.652079,1.338488,UCEC,TCGA-B5-A1MU,TCGA-B5-A1MU-01A-11R-A13S-07,TCGA-B5-A1MU-01A,TCGA-B5-A1MU-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-B5-A1MU-01A,10717,UCEC,79,FEMALE,WHITE,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29027,Dead,WITH TUMOR,NA,1548,[Not Available],New Primary Tumor,"Other, specify",Breast,1365,Complete Remission/Response,NA,NA,1,1548,1,1548,NA,NA,1,1365,NA,older,20.36188625,level1,NA,NA,NA,NA,NA,NA
TCGA.B5.A1MV.01A,TCGA-B5-A1MV,TCGA.B5.A1MV,5.51585528,9.228046205,TCGA.B5.A1MV.01A.31R.A14D.07,2.615947,2.494909,-0.1830894,-0.298956,0.657828,UCEC,TCGA-B5-A1MV,TCGA-B5-A1MV-01A-31R-A14D-07,TCGA-B5-A1MV-01A,TCGA-B5-A1MV-01A-31R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-B5-A1MV-01A,10718,UCEC,84,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30926,Alive,TUMOR FREE,1565,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1565,0,1565,0,1565,0,1565,NA,older,31.57756239,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A1MW.01A,TCGA-B5-A1MW,TCGA.B5.A1MW,4.615716435,8.004664304,TCGA.B5.A1MW.01A.11R.A32Y.07,1.07966,0.9727913,-1.281874,-1.835243,0.1202407,UCEC,TCGA-B5-A1MW,TCGA-B5-A1MW-01A-11R-A32Y-07,TCGA-B5-A1MW-01A,TCGA-B5-A1MW-01A-11R-A32Y-07,TP,Primary solid Tumor,1,1,A32Y,1,0,1,Female,1,Tumor,TCGA-B5-A1MW-01A,10719,UCEC,55,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20183,Alive,TUMOR FREE,447,NA,[Not Available],Locoregional Disease,"Other, specify",vaginal cuff,311,Complete Remission/Response,NA,NA,0,447,0,447,1,311,1,311,NA,younger,23.33546614,level1,NA,NA,NA,NA,NA,NA
TCGA.B5.A1MX.01A,TCGA-B5-A1MX,TCGA.B5.A1MX,4.276469814,10.55018591,TCGA.B5.A1MX.01A.11R.A144.07,2.812597,2.872649,-0.09032364,-0.1023064,0.7529636,UCEC,TCGA-B5-A1MX,TCGA-B5-A1MX-01A-11R-A144-07,TCGA-B5-A1MX-01A,TCGA-B5-A1MX-01A-11R-A144-07,TP,Primary solid Tumor,1,1,A144,1,0,1,Female,1,Tumor,TCGA-B5-A1MX-01A,10720,UCEC,47,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17320,Alive,TUMOR FREE,1473,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1473,0,1473,0,1473,0,1473,NA,younger,25.10387812,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A1MY.01A,TCGA-B5-A1MY,TCGA.B5.A1MY,6.316778616,10.82096052,TCGA.B5.A1MY.01A.11R.A144.07,1.623489,1.729366,-0.8921542,-1.291414,0.3015524,UCEC,TCGA-B5-A1MY,TCGA-B5-A1MY-01A-11R-A144-07,TCGA-B5-A1MY-01A,TCGA-B5-A1MY-01A-11R-A144-07,TP,Primary solid Tumor,1,1,A144,1,0,1,Female,1,Tumor,TCGA-B5-A1MY-01A,10721,UCEC,62,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22805,Dead,WITH TUMOR,NA,361,[Not Available],Locoregional Disease,"Other, specify",peritoneum,333,[Not Available],NA,NA,1,361,1,361,NA,NA,1,333,NA,younger,31.43178833,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A1MZ.01A,TCGA-B5-A1MZ,TCGA.B5.A1MZ,3.902590477,10.12236994,TCGA.B5.A1MZ.01A.11R.A144.07,2.871312,2.636698,-0.04161736,-0.04359117,0.7343296,UCEC,TCGA-B5-A1MZ,TCGA-B5-A1MZ-01A-11R-A144-07,TCGA-B5-A1MZ-01A,TCGA-B5-A1MZ-01A-11R-A144-07,TP,Primary solid Tumor,1,1,A144,1,0,1,Female,1,Tumor,TCGA-B5-A1MZ-01A,10722,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Indeterminate (neither Pre or Postmenopausal),-19955,Alive,TUMOR FREE,1598,NA,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,613,Complete Remission/Response,NA,NA,0,1598,0,1598,1,613,1,613,NA,younger,41.37030048,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A1N2.01A,TCGA-B5-A1N2,TCGA.B5.A1N2,4.673095123,7.03021627,TCGA.B5.A1N2.01A.21R.A144.07,2.220539,2.332024,-0.5067209,-0.6943646,0.5290872,UCEC,TCGA-B5-A1N2,TCGA-B5-A1N2-01A-21R-A144-07,TCGA-B5-A1N2-01A,TCGA-B5-A1N2-01A-21R-A144-07,TP,Primary solid Tumor,1,1,A144,1,0,1,Female,1,Tumor,TCGA-B5-A1N2-01A,10723,UCEC,70,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25612,Dead,WITH TUMOR,NA,954,[Not Available],Distant Metastasis,Brain,NA,804,Complete Remission/Response,NA,NA,1,954,1,954,1,804,1,804,NA,older,40.39115646,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A3F9.01A,TCGA-B5-A3F9,TCGA.B5.A3F9,3.693721115,10.21226534,TCGA.B5.A3F9.01A.21R.A22K.07,3.017356,2.835929,0.07065167,0.1024525,0.7982139,UCEC,TCGA-B5-A3F9,TCGA-B5-A3F9-01A-21R-A22K-07,TCGA-B5-A3F9-01A,TCGA-B5-A3F9-01A-21R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-B5-A3F9-01A,10724,UCEC,56,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20523,Alive,TUMOR FREE,4155,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,4155,0,4155,NA,NA,0,4155,NA,younger,56.24909276,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A3FA.01A,TCGA-B5-A3FA,TCGA.B5.A3FA,5.238003404,10.48409784,TCGA.B5.A3FA.01A.11R.A19W.07,2.258527,2.365703,-0.4673858,-0.6563759,0.5325102,UCEC,TCGA-B5-A3FA,TCGA-B5-A3FA-01A-11R-A19W-07,TCGA-B5-A3FA-01A,TCGA-B5-A3FA-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-B5-A3FA-01A,10725,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26850,Alive,TUMOR FREE,2929,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,2929,0,2929,NA,NA,0,2929,NA,older,29.64268547,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A3FB.01A,TCGA-B5-A3FB,TCGA.B5.A3FB,4.82321946,10.16066561,TCGA.B5.A3FB.01A.11R.A19W.07,2.38232,2.198619,-0.3762406,-0.5325834,0.563713,UCEC,TCGA-B5-A3FB,TCGA-B5-A3FB-01A-11R-A19W-07,TCGA-B5-A3FB-01A,TCGA-B5-A3FB-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-B5-A3FB-01A,10726,UCEC,73,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26779,Alive,TUMOR FREE,2844,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,2844,0,2844,NA,NA,0,2844,NA,older,39.79238754,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A3FC.01A,TCGA-B5-A3FC,TCGA.B5.A3FC,4.187648995,6.504969902,TCGA.B5.A3FC.01A.11R.A22K.07,4.205075,4.179575,0.8817461,1.290171,1.241223,UCEC,TCGA-B5-A3FC,TCGA-B5-A3FC-01A-11R-A22K-07,TCGA-B5-A3FC-01A,TCGA-B5-A3FC-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-B5-A3FC-01A,10727,UCEC,53,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19422,Alive,TUMOR FREE,2185,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,2185,0,2185,NA,NA,0,2185,NA,younger,26.60971255,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A3FD.01A,TCGA-B5-A3FD,TCGA.B5.A3FD,3.761221436,8.049706995,TCGA.B5.A3FD.01A.11R.A19W.07,1.90017,1.855542,-0.6856069,-1.014733,0.4107749,UCEC,TCGA-B5-A3FD,TCGA-B5-A3FD-01A-11R-A19W-07,TCGA-B5-A3FD-01A,TCGA-B5-A3FD-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-B5-A3FD-01A,10728,UCEC,70,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009,Indeterminate (neither Pre or Postmenopausal),-25813,Dead,TUMOR FREE,NA,1197,[Not Available],Locoregional Recurrence,"Other, specify",endometrium,562,[Not Available],NA,NA,1,1197,0,1197,NA,NA,1,562,NA,older,37.98388162,level4,NA,NA,NA,NA,NA,NA
TCGA.B5.A3FH.01A,TCGA-B5-A3FH,TCGA.B5.A3FH,6.685666885,10.23227701,TCGA.B5.A3FH.01A.11R.A19W.07,2.390246,2.317861,-0.3717356,-0.5246569,0.598529,UCEC,TCGA-B5-A3FH,TCGA-B5-A3FH-01A-11R-A19W-07,TCGA-B5-A3FH-01A,TCGA-B5-A3FH-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-B5-A3FH-01A,10729,UCEC,74,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27221,Alive,TUMOR FREE,841,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,841,0,841,0,841,0,841,NA,older,33.203125,level3,NA,NA,NA,NA,NA,NA
TCGA.B5.A3S1.01A,TCGA-B5-A3S1,TCGA.B5.A3S1,3.771843332,9.22062984,TCGA.B5.A3S1.01A.11R.A22K.07,2.899154,2.790795,-0.02965051,-0.0157495,0.7669731,UCEC,TCGA-B5-A3S1,TCGA-B5-A3S1-01A-11R-A22K-07,TCGA-B5-A3S1-01A,TCGA-B5-A3S1-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-B5-A3S1-01A,10730,UCEC,71,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26031,Alive,WITH TUMOR,902,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,902,0,902,0,902,0,902,NA,older,28.30385016,level2,NA,NA,NA,NA,NA,NA
TCGA.B5.A5OC.01A,TCGA-B5-A5OC,TCGA.B5.A5OC,6.674457827,8.568890958,TCGA.B5.A5OC.01A.21R.A27V.07,4.648785,4.390919,1.169202,1.733882,1.389561,UCEC,TCGA-B5-A5OC,TCGA-B5-A5OC-01A-21R-A27V-07,TCGA-B5-A5OC-01A,TCGA-B5-A5OC-01A-21R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-B5-A5OC-01A,10731,UCEC,71,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2011,[Not Available],-26109,Alive,TUMOR FREE,1249,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,1249,0,1249,NA,NA,0,1249,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.B5.A5OD.01A,TCGA-B5-A5OD,TCGA.B5.A5OD,2.312374747,11.58322383,TCGA.B5.A5OD.01A.11R.A31O.07,2.425966,2.407995,-0.3414218,-0.4889367,0.6002001,UCEC,TCGA-B5-A5OD,TCGA-B5-A5OD-01A-11R-A31O-07,TCGA-B5-A5OD-01A,TCGA-B5-A5OD-01A-11R-A31O-07,TP,Primary solid Tumor,1,1,A31O,1,0,1,Female,1,Tumor,TCGA-B5-A5OD-01A,10732,UCEC,67,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2011,[Not Available],-24775,Alive,TUMOR FREE,1038,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,1038,0,1038,NA,NA,0,1038,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.B5.A5OE.01A,TCGA-B5-A5OE,TCGA.B5.A5OE,6.102368388,7.076890402,TCGA.B5.A5OE.01A.11R.A31O.07,0.4217095,0.385146,-1.735928,-2.493194,-0.1172449,UCEC,TCGA-B5-A5OE,TCGA-B5-A5OE-01A-11R-A31O-07,TCGA-B5-A5OE-01A,TCGA-B5-A5OE-01A-11R-A31O-07,TP,Primary solid Tumor,1,1,A31O,1,0,1,Female,1,Tumor,TCGA-B5-A5OE-01A,10733,UCEC,68,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2011,[Not Available],-24905,Alive,TUMOR FREE,1063,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,1063,0,1063,NA,NA,0,1063,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.BG.A0LW.01A,TCGA-BG-A0LW,TCGA.BG.A0LW,5.268957075,10.74184369,TCGA.BG.A0LW.01A.11R.A16W.07,2.818296,2.76171,-0.05541667,-0.09660745,0.6925929,UCEC,TCGA-BG-A0LW,TCGA-BG-A0LW-01A-11R-A16W-07,TCGA-BG-A0LW-01A,TCGA-BG-A0LW-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-BG-A0LW-01A,10734,UCEC,47,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010,Indeterminate (neither Pre or Postmenopausal),-17369,Alive,TUMOR FREE,566,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,566,0,566,0,566,0,566,NA,younger,57.20313197,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0LX.01A,TCGA-BG-A0LX,TCGA.BG.A0LX,4.776178421,4.178569805,TCGA.BG.A0LX.01A.11R.A16W.07,3.508155,3.413451,0.3821724,0.5932519,1.019183,UCEC,TCGA-BG-A0LX,TCGA-BG-A0LX-01A-11R-A16W-07,TCGA-BG-A0LX-01A,TCGA-BG-A0LX-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-BG-A0LX-01A,10735,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20928,Alive,TUMOR FREE,614,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,614,0,614,0,614,0,614,NA,younger,33.21799308,level3,NA,NA,NA,NA,NA,NA
TCGA.BG.A0M0.01A,TCGA-BG-A0M0,TCGA.BG.A0M0,2.227777113,9.07468577,TCGA.BG.A0M0.01A.11R.A104.07,0.6438697,0.5341329,-1.554034,-2.271033,-0.02573076,UCEC,TCGA-BG-A0M0,TCGA-BG-A0M0-01A-11R-A104-07,TCGA-BG-A0M0-01A,TCGA-BG-A0M0-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0M0-01A,10736,UCEC,66,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24427,Alive,TUMOR FREE,588,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,588,0,588,0,588,0,588,NA,older,42.97520661,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0M2.01A,TCGA-BG-A0M2,TCGA.BG.A0M2,5.888963822,10.7244893,TCGA.BG.A0M2.01A.11R.A104.07,2.685487,2.629807,-0.1770804,-0.2294163,0.7389584,UCEC,TCGA-BG-A0M2,TCGA-BG-A0M2-01A-11R-A104-07,TCGA-BG-A0M2-01A,TCGA-BG-A0M2-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0M2-01A,10737,UCEC,62,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22822,Alive,TUMOR FREE,637,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,637,0,637,0,637,0,637,NA,younger,26.92743764,level2,NA,NA,NA,NA,NA,NA
TCGA.BG.A0M3.01A,TCGA-BG-A0M3,TCGA.BG.A0M3,5.418261547,10.42075442,TCGA.BG.A0M3.01A.11R.A104.07,2.248174,2.303951,-0.4492256,-0.6667288,0.516461,UCEC,TCGA-BG-A0M3,TCGA-BG-A0M3-01A-11R-A104-07,TCGA-BG-A0M3-01A,TCGA-BG-A0M3-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0M3-01A,10738,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27183,Alive,TUMOR FREE,1071,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1071,0,1071,0,1071,0,1071,NA,older,29.296875,level2,NA,NA,NA,NA,NA,NA
TCGA.BG.A0M4.01A,TCGA-BG-A0M4,TCGA.BG.A0M4,2.652243086,8.663397578,TCGA.BG.A0M4.01A.11R.A104.07,2.968229,2.70234,0.1089144,0.05332593,0.7140536,UCEC,TCGA-BG-A0M4,TCGA-BG-A0M4-01A-11R-A104-07,TCGA-BG-A0M4-01A,TCGA-BG-A0M4-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0M4-01A,10739,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22090,Alive,TUMOR FREE,2167,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2167,0,2167,0,2167,0,2167,NA,younger,30.61482136,level3,NA,NA,NA,NA,NA,NA
TCGA.BG.A0M6.01A,TCGA-BG-A0M6,TCGA.BG.A0M6,2.442323485,11.09061364,TCGA.BG.A0M6.01A.31R.A104.07,0.5091707,0.2603157,-1.672417,-2.405733,-0.08009357,UCEC,TCGA-BG-A0M6,TCGA-BG-A0M6-01A-31R-A104-07,TCGA-BG-A0M6-01A,TCGA-BG-A0M6-01A-31R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0M6-01A,10740,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26666,Dead,TUMOR FREE,NA,671,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,671,0,671,0,671,0,671,NA,older,23.80540166,level1,NA,NA,NA,NA,NA,NA
TCGA.BG.A0M7.01A,TCGA-BG-A0M7,TCGA.BG.A0M7,5.566160751,10.26778886,TCGA.BG.A0M7.01A.11R.A040.07,3.51712,3.297316,0.4268365,0.6022168,0.9683607,UCEC,TCGA-BG-A0M7,TCGA-BG-A0M7-01A-11R-A040-07,TCGA-BG-A0M7-01A,TCGA-BG-A0M7-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-BG-A0M7-01A,10741,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22096,Alive,TUMOR FREE,1937,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1937,0,1937,0,1937,0,1937,NA,younger,39.84375,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0M9.01A,TCGA-BG-A0M9,TCGA.BG.A0M9,5.164624221,10.13909697,TCGA.BG.A0M9.01A.21R.A104.07,1.784493,1.735306,-0.7607467,-1.13041,0.3510875,UCEC,TCGA-BG-A0M9,TCGA-BG-A0M9-01A-21R-A104-07,TCGA-BG-A0M9-01A,TCGA-BG-A0M9-01A-21R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0M9-01A,10743,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26708,Alive,TUMOR FREE,2270,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2270,0,2270,0,2270,0,2270,NA,older,36.328125,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0MA.01A,TCGA-BG-A0MA,TCGA.BG.A0MA,4.964368637,8.877128984,TCGA.BG.A0MA.01A.11R.A17B.07,2.446714,2.438605,-0.3244663,-0.4681895,0.6032318,UCEC,TCGA-BG-A0MA,TCGA-BG-A0MA-01A-11R-A17B-07,TCGA-BG-A0MA-01A,TCGA-BG-A0MA-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-BG-A0MA-01A,10744,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22036,Dead,WITH TUMOR,NA,326,[Not Available],Metastatic,Bone,NA,70,Progressive Disease,NA,NA,1,326,1,326,NA,NA,1,70,NA,younger,38.4083045,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0MC.01A,TCGA-BG-A0MC,TCGA.BG.A0MC,5.705229329,11.03743681,TCGA.BG.A0MC.01A.21R.A040.07,3.840853,3.703782,0.662392,0.9259494,1.095243,UCEC,TCGA-BG-A0MC,TCGA-BG-A0MC-01A-21R-A040-07,TCGA-BG-A0MC-01A,TCGA-BG-A0MC-01A-21R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-BG-A0MC-01A,10745,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27136,Alive,TUMOR FREE,1263,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1263,0,1263,0,1263,0,1263,NA,older,56.19146722,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0MG.01A,TCGA-BG-A0MG,TCGA.BG.A0MG,3.9685356,9.107269707,TCGA.BG.A0MG.01A.21R.A104.07,2.603049,2.587849,-0.1835714,-0.311854,0.6234369,UCEC,TCGA-BG-A0MG,TCGA-BG-A0MG-01A-21R-A104-07,TCGA-BG-A0MG-01A,TCGA-BG-A0MG-01A-21R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0MG-01A,10746,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26957,Alive,TUMOR FREE,1477,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1477,0,1477,0,1477,0,1477,NA,older,23.828125,level1,NA,NA,NA,NA,NA,NA
TCGA.BG.A0MH.01A,TCGA-BG-A0MH,TCGA.BG.A0MH,6.701327015,9.13635373,TCGA.BG.A0MH.01A.11R.A118.07,3.8142,3.673674,0.6153554,0.8992963,1.096684,UCEC,TCGA-BG-A0MH,TCGA-BG-A0MH-01A-11R-A118-07,TCGA-BG-A0MH-01A,TCGA-BG-A0MH-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BG-A0MH-01A,10747,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22475,Alive,TUMOR FREE,1930,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1930,0,1930,0,1930,0,1930,NA,younger,57.34525215,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0MI.01A,TCGA-BG-A0MI,TCGA.BG.A0MI,5.828058142,9.18034878,TCGA.BG.A0MI.01A.11R.A040.07,3.135022,3.051107,0.1928453,0.220119,0.8052609,UCEC,TCGA-BG-A0MI,TCGA-BG-A0MI-01A-11R-A040-07,TCGA-BG-A0MI-01A,TCGA-BG-A0MI-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-BG-A0MI-01A,10748,UCEC,83,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30334,Dead,TUMOR FREE,NA,714,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,1,714,0,714,NA,NA,0,714,NA,older,37.09825528,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0MK.01A,TCGA-BG-A0MK,TCGA.BG.A0MK,6.260586511,11.06912749,TCGA.BG.A0MK.01A.51R.A19W.07,2.228201,2.067934,-0.4682405,-0.686702,0.5260772,UCEC,TCGA-BG-A0MK,TCGA-BG-A0MK-01A-51R-A19W-07,TCGA-BG-A0MK-01A,TCGA-BG-A0MK-01A-51R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-BG-A0MK-01A,10749,UCEC,52,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19034,Dead,WITH TUMOR,NA,1317,[Not Available],NA,NA,NA,NA,Progressive Disease,NA,NA,1,1317,1,1317,NA,NA,1,1317,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.BG.A0MO.01A,TCGA-BG-A0MO,TCGA.BG.A0MO,4.622193731,10.53173464,TCGA.BG.A0MO.01A.11R.A040.07,3.531589,3.174902,0.3883307,0.6166862,0.9712369,UCEC,TCGA-BG-A0MO,TCGA-BG-A0MO-01A-11R-A040-07,TCGA-BG-A0MO-01A,TCGA-BG-A0MO-01A-11R-A040-07,TP,Primary solid Tumor,1,1,A040,1,0,1,Female,1,Tumor,TCGA-BG-A0MO-01A,10750,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23287,Alive,TUMOR FREE,1309,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1309,0,1309,0,1309,0,1309,NA,younger,32.421875,level3,NA,NA,NA,NA,NA,NA
TCGA.BG.A0MQ.01A,TCGA-BG-A0MQ,TCGA.BG.A0MQ,2.988700767,10.25989121,TCGA.BG.A0MQ.01A.11R.A104.07,1.63228,1.688754,-0.8531822,-1.282623,0.2990273,UCEC,TCGA-BG-A0MQ,TCGA-BG-A0MQ-01A-11R-A104-07,TCGA-BG-A0MQ-01A,TCGA-BG-A0MQ-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0MQ-01A,10751,UCEC,71,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26284,Alive,WITH TUMOR,1817,NA,[Not Available],NA,NA,NA,NA,Stable Disease,NA,NA,0,1817,0,1817,NA,NA,0,1817,NA,older,37.09825528,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0MT.01A,TCGA-BG-A0MT,TCGA.BG.A0MT,4.923672215,9.187039992,TCGA.BG.A0MT.01A.11R.A104.07,3.29282,3.303608,0.3008314,0.3779167,0.8803197,UCEC,TCGA-BG-A0MT,TCGA-BG-A0MT-01A-11R-A104-07,TCGA-BG-A0MT-01A,TCGA-BG-A0MT-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0MT-01A,10753,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23574,Alive,TUMOR FREE,644,NA,[Not Available],Locoregional Disease,"Other, specify",locally in the endometrium,565,Partial Remission/Response,NA,NA,0,644,0,644,NA,NA,1,565,NA,younger,25.86451247,level2,NA,NA,NA,NA,NA,NA
TCGA.BG.A0MU.01A,TCGA-BG-A0MU,TCGA.BG.A0MU,5.294901402,10.49318154,TCGA.BG.A0MU.01A.11R.A104.07,3.593981,3.347069,0.4569059,0.6790775,0.987524,UCEC,TCGA-BG-A0MU,TCGA-BG-A0MU-01A-11R-A104-07,TCGA-BG-A0MU-01A,TCGA-BG-A0MU-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0MU-01A,10754,UCEC,78,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28621,Alive,TUMOR FREE,617,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,617,0,617,0,617,0,617,NA,older,29.43213296,level2,NA,NA,NA,NA,NA,NA
TCGA.BG.A0RY.01A,TCGA-BG-A0RY,TCGA.BG.A0RY,7.183500171,7.582792036,TCGA.BG.A0RY.01A.11R.A104.07,2.88248,3.13438,0.03223406,-0.03242353,0.7006828,UCEC,TCGA-BG-A0RY,TCGA-BG-A0RY-01A-11R-A104-07,TCGA-BG-A0RY-01A,TCGA-BG-A0RY-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BG-A0RY-01A,10755,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24952,Alive,TUMOR FREE,469,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,469,0,469,0,469,0,469,NA,older,40.83044983,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0VT.01A,TCGA-BG-A0VT,TCGA.BG.A0VT,4.112434263,9.806804878,TCGA.BG.A0VT.01A.11R.A10J.07,2.347821,2.1312,-0.395115,-0.5670826,0.5657704,UCEC,TCGA-BG-A0VT,TCGA-BG-A0VT-01A-11R-A10J-07,TCGA-BG-A0VT-01A,TCGA-BG-A0VT-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-BG-A0VT-01A,10756,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20602,Alive,TUMOR FREE,1568,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1568,0,1568,0,1568,0,1568,NA,younger,49.82698962,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0VV.01A,TCGA-BG-A0VV,TCGA.BG.A0VV,5.440631491,10.35332093,TCGA.BG.A0VV.01A.21R.A118.07,2.551289,2.395935,-0.2406106,-0.3636145,0.6103144,UCEC,TCGA-BG-A0VV,TCGA-BG-A0VV-01A-21R-A118-07,TCGA-BG-A0VV-01A,TCGA-BG-A0VV-01A-21R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BG-A0VV-01A,10757,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19581,Alive,TUMOR FREE,1553,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1553,0,1553,0,1553,0,1553,NA,younger,56.01280293,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0VW.01A,TCGA-BG-A0VW,TCGA.BG.A0VW,6.235425449,10.1021437,TCGA.BG.A0VW.01A.11R.A118.07,3.338509,3.158654,0.2907108,0.4236059,0.8986109,UCEC,TCGA-BG-A0VW,TCGA-BG-A0VW-01A-11R-A118-07,TCGA-BG-A0VW-01A,TCGA-BG-A0VW-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BG-A0VW-01A,10758,UCEC,77,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28383,Alive,TUMOR FREE,1582,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1582,0,1582,0,1582,0,1582,NA,older,37.72972534,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0VX.01A,TCGA-BG-A0VX,TCGA.BG.A0VX,4.112269955,9.422286735,TCGA.BG.A0VX.01A.11R.A118.07,3.519791,3.371954,0.4107293,0.6048882,0.9774168,UCEC,TCGA-BG-A0VX,TCGA-BG-A0VX-01A-11R-A118-07,TCGA-BG-A0VX-01A,TCGA-BG-A0VX-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BG-A0VX-01A,10759,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21425,Alive,TUMOR FREE,1043,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1043,0,1043,0,1043,0,1043,NA,younger,67.95360111,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0VZ.01A,TCGA-BG-A0VZ,TCGA.BG.A0VZ,6.052108877,9.205125348,TCGA.BG.A0VZ.01A.11R.A109.07,3.265013,3.264319,0.2170458,0.3501095,0.914887,UCEC,TCGA-BG-A0VZ,TCGA-BG-A0VZ-01A-11R-A109-07,TCGA-BG-A0VZ-01A,TCGA-BG-A0VZ-01A-11R-A109-07,TP,Primary solid Tumor,1,1,A109,1,0,1,Female,1,Tumor,TCGA-BG-A0VZ-01A,10760,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21414,Alive,TUMOR FREE,1601,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1601,0,1601,0,1601,0,1601,NA,younger,40.03673095,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0W1.01A,TCGA-BG-A0W1,TCGA.BG.A0W1,3.432228914,9.96093729,TCGA.BG.A0W1.01A.12R.A109.07,2.319671,2.14073,-0.3842623,-0.5952321,0.5307815,UCEC,TCGA-BG-A0W1,TCGA-BG-A0W1-01A-12R-A109-07,TCGA-BG-A0W1-01A,TCGA-BG-A0W1-01A-12R-A109-07,TP,Primary solid Tumor,1,1,A109,1,0,1,Female,1,Tumor,TCGA-BG-A0W1-01A,10761,UCEC,89,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32750,Alive,TUMOR FREE,1607,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1607,0,1607,0,1607,0,1607,NA,older,33.13609467,level3,NA,NA,NA,NA,NA,NA
TCGA.BG.A0W2.01A,TCGA-BG-A0W2,TCGA.BG.A0W2,3.608919984,10.53172588,TCGA.BG.A0W2.01A.11R.A109.07,2.768362,2.636933,-0.09188439,-0.1465413,0.7046116,UCEC,TCGA-BG-A0W2,TCGA-BG-A0W2-01A-11R-A109-07,TCGA-BG-A0W2-01A,TCGA-BG-A0W2-01A-11R-A109-07,TP,Primary solid Tumor,1,1,A109,1,0,1,Female,1,Tumor,TCGA-BG-A0W2-01A,10762,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20998,Alive,TUMOR FREE,1721,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1721,0,1721,0,1721,0,1721,NA,younger,44.44444444,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0YU.01A,TCGA-BG-A0YU,TCGA.BG.A0YU,4.393579972,10.23608305,TCGA.BG.A0YU.01A.21R.A10J.07,1.917849,1.782066,-0.6993822,-0.9970546,0.4338269,UCEC,TCGA-BG-A0YU,TCGA-BG-A0YU-01A-21R-A10J-07,TCGA-BG-A0YU-01A,TCGA-BG-A0YU-01A-21R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-BG-A0YU-01A,10763,UCEC,37,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13644,Alive,TUMOR FREE,451,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,451,0,451,0,451,0,451,NA,younger,43.40946894,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A0YV.01A,TCGA-BG-A0YV,TCGA.BG.A0YV,3.839934747,8.213438746,TCGA.BG.A0YV.01A.11R.A10J.07,1.562636,1.434909,-0.9086944,-1.352267,0.2525583,UCEC,TCGA-BG-A0YV,TCGA-BG-A0YV-01A-11R-A10J-07,TCGA-BG-A0YV-01A,TCGA-BG-A0YV-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-BG-A0YV-01A,10764,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24567,Alive,TUMOR FREE,382,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,382,0,382,0,382,0,382,NA,older,22.47658689,level1,NA,NA,NA,NA,NA,NA
TCGA.BG.A186.01A,TCGA-BG-A186,TCGA.BG.A186,5.042461394,9.615031411,TCGA.BG.A186.01A.11R.A12I.07,3.400225,3.346122,0.341937,0.4853216,0.9669421,UCEC,TCGA-BG-A186,TCGA-BG-A186-01A-11R-A12I-07,TCGA-BG-A186-01A,TCGA-BG-A186-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-BG-A186-01A,10765,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2010,[Not Available],-22370,Alive,TUMOR FREE,419,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,419,0,419,0,419,0,419,NA,younger,28.57796068,level2,NA,NA,NA,NA,NA,NA
TCGA.BG.A187.01A,TCGA-BG-A187,TCGA.BG.A187,3.538560505,9.963028145,TCGA.BG.A187.01A.11R.A12I.07,2.816627,2.59593,-0.05754396,-0.09827639,0.6921944,UCEC,TCGA-BG-A187,TCGA-BG-A187-01A-11R-A12I-07,TCGA-BG-A187-01A,TCGA-BG-A187-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-BG-A187-01A,10766,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,[Not Available],-24099,Alive,TUMOR FREE,448,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,448,0,448,0,448,0,448,NA,NA,23.828125,level1,NA,NA,NA,NA,NA,NA
TCGA.BG.A18A.01A,TCGA-BG-A18A,TCGA.BG.A18A,5.287705653,9.304930519,TCGA.BG.A18A.01A.21R.A12I.07,3.022184,2.81651,0.07878323,0.1072806,0.7753697,UCEC,TCGA-BG-A18A,TCGA-BG-A18A-01A-21R-A12I-07,TCGA-BG-A18A-01A,TCGA-BG-A18A-01A-21R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-BG-A18A-01A,10767,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27086,Alive,TUMOR FREE,426,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,426,0,426,0,426,0,426,NA,older,32.00731596,level3,NA,NA,NA,NA,NA,NA
TCGA.BG.A18B.01A,TCGA-BG-A18B,TCGA.BG.A18B,4.421957435,10.10761663,TCGA.BG.A18B.01A.11R.A12I.07,3.614055,3.583854,0.4570677,0.6991522,1.044065,UCEC,TCGA-BG-A18B,TCGA-BG-A18B-01A-11R-A12I-07,TCGA-BG-A18B-01A,TCGA-BG-A18B-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-BG-A18B-01A,10768,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2010,Peri (6-12 months since last menstrual period),-19550,Alive,TUMOR FREE,470,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,470,0,470,0,470,0,470,NA,younger,43.6599044,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A18C.01A,TCGA-BG-A18C,TCGA.BG.A18C,5.767018317,8.083171517,TCGA.BG.A18C.01A.11R.A12I.07,2.683061,2.654919,-0.1632681,-0.2318421,0.7100267,UCEC,TCGA-BG-A18C,TCGA-BG-A18C-01A-11R-A12I-07,TCGA-BG-A18C-01A,TCGA-BG-A18C-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-BG-A18C-01A,10769,UCEC,72,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010,[Not Available],-26602,Alive,TUMOR FREE,470,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,470,0,470,0,470,0,470,NA,older,36.13233468,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A222.01A,TCGA-BG-A222,TCGA.BG.A222,4.553708726,8.783334405,TCGA.BG.A222.01A.11R.A157.07,2.496321,2.40844,-0.2958361,-0.4185819,0.6135826,UCEC,TCGA-BG-A222,TCGA-BG-A222-01A-11R-A157-07,TCGA-BG-A222-01A,TCGA-BG-A222-01A-11R-A157-07,TP,Primary solid Tumor,1,1,A157,1,0,1,Female,1,Tumor,TCGA-BG-A222-01A,10772,UCEC,49,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,[Not Available],-18220,Alive,TUMOR FREE,291,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,291,0,291,0,291,0,291,NA,younger,47.33048872,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A2AD.01A,TCGA-BG-A2AD,TCGA.BG.A2AD,5.299418784,10.18425677,TCGA.BG.A2AD.01A.21R.A16F.07,0.08459224,0.005491506,-1.9651,-2.830311,-0.231976,UCEC,TCGA-BG-A2AD,TCGA-BG-A2AD-01A-21R-A16F-07,TCGA-BG-A2AD-01A,TCGA-BG-A2AD-01A-21R-A16F-07,TP,Primary solid Tumor,1,1,A16F,1,0,1,Female,1,Tumor,TCGA-BG-A2AD-01A,10773,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23064,Alive,TUMOR FREE,609,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,609,0,609,0,609,0,609,NA,younger,31.25,level3,NA,NA,NA,NA,NA,NA
TCGA.BG.A2AE.01A,TCGA-BG-A2AE,TCGA.BG.A2AE,3.105883193,11.12291989,TCGA.BG.A2AE.01A.11R.A16F.07,3.414376,3.238565,0.3277397,0.4994728,0.9403037,UCEC,TCGA-BG-A2AE,TCGA-BG-A2AE-01A-11R-A16F-07,TCGA-BG-A2AE-01A,TCGA-BG-A2AE-01A-11R-A16F-07,TP,Primary solid Tumor,1,1,A16F,1,0,1,Female,1,Tumor,TCGA-BG-A2AE-01A,10774,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011,Peri (6-12 months since last menstrual period),-21069,Alive,TUMOR FREE,721,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,721,0,721,0,721,0,721,NA,younger,42.13351643,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A2L7.01A,TCGA-BG-A2L7,TCGA.BG.A2L7,4.714309377,9.904952362,TCGA.BG.A2L7.01A.11R.A18M.07,3.730512,3.435015,0.5525342,0.815609,1.066143,UCEC,TCGA-BG-A2L7,TCGA-BG-A2L7-01A-11R-A18M-07,TCGA-BG-A2L7-01A,TCGA-BG-A2L7-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-BG-A2L7-01A,10775,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,[Not Available],-25091,Alive,TUMOR FREE,612,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,612,0,612,0,612,0,612,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.BG.A3EW.01A,TCGA-BG-A3EW,TCGA.BG.A3EW,5.282258159,10.57180004,TCGA.BG.A3EW.01A.11R.A22K.07,1.683929,1.582989,-0.8517392,-1.230974,0.3095776,UCEC,TCGA-BG-A3EW,TCGA-BG-A3EW-01A-11R-A22K-07,TCGA-BG-A3EW-01A,TCGA-BG-A3EW-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-BG-A3EW-01A,10776,UCEC,62,FEMALE,WHITE,[Not Applicable],Stage III,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22705,Alive,TUMOR FREE,344,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,344,0,344,0,344,0,344,NA,younger,45.72506895,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A3PP.01A,TCGA-BG-A3PP,TCGA.BG.A3PP,3.768639562,8.490293341,TCGA.BG.A3PP.01A.11R.A22K.07,2.171122,2.012189,-0.518212,-0.7437816,0.5006065,UCEC,TCGA-BG-A3PP,TCGA-BG-A3PP-01A-11R-A22K-07,TCGA-BG-A3PP-01A,TCGA-BG-A3PP-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-BG-A3PP-01A,10777,UCEC,82,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30227,Alive,WITH TUMOR,681,NA,[Not Available],Locoregional Recurrence,"Other, specify",Vagina apex,665,Progressive Disease,NA,NA,0,681,0,681,NA,NA,1,665,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.BK.A0C9.01A,TCGA-BK-A0C9,TCGA.BK.A0C9,4.101933021,9.674831707,TCGA.BK.A0C9.01A.11R.A00V.07,3.819914,3.678643,0.6058396,0.9050108,1.090021,UCEC,TCGA-BK-A0C9,TCGA-BK-A0C9-01A-11R-A00V-07,TCGA-BK-A0C9-01A,TCGA-BK-A0C9-01A-11R-A00V-07,TP,Primary solid Tumor,1,1,A00V,1,0,1,Female,1,Tumor,TCGA-BK-A0C9-01A,10778,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20876,Alive,TUMOR FREE,1092,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1092,0,1092,0,1092,0,1092,NA,younger,44.99716553,level4,NA,NA,NA,NA,NA,NA
TCGA.BK.A0CA.01A,TCGA-BK-A0CA,TCGA.BK.A0CA,5.519442755,9.397169352,TCGA.BK.A0CA.01A.21R.A118.07,2.185089,2.182849,-0.4730201,-0.7298141,0.4795371,UCEC,TCGA-BK-A0CA,TCGA-BK-A0CA-01A-21R-A118-07,TCGA-BK-A0CA-01A,TCGA-BK-A0CA-01A-21R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BK-A0CA-01A,10779,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IIIC,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22378,Alive,TUMOR FREE,1064,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1064,0,1064,0,1064,0,1064,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.BK.A0CB.01A,TCGA-BK-A0CB,TCGA.BK.A0CB,6.003657604,9.026240972,TCGA.BK.A0CB.01A.32R.A104.07,3.205212,3.194417,0.2411696,0.2903084,0.8418356,UCEC,TCGA-BK-A0CB,TCGA-BK-A0CB-01A-32R-A104-07,TCGA-BK-A0CB-01A,TCGA-BK-A0CB-01A-32R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BK-A0CB-01A,10780,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21930,Alive,TUMOR FREE,1092,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1092,0,1092,0,1092,0,1092,NA,younger,46.80384551,level4,NA,NA,NA,NA,NA,NA
TCGA.BK.A0CC.01A,TCGA-BK-A0CC,TCGA.BK.A0CC,1.966967432,9.120924041,TCGA.BK.A0CC.01A.21R.A16W.07,2.155248,2.252917,-0.5012036,-0.7596556,0.4934438,UCEC,TCGA-BK-A0CC,TCGA-BK-A0CC-01A-21R-A16W-07,TCGA-BK-A0CC-01A,TCGA-BK-A0CC-01A-21R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-BK-A0CC-01A,10781,UCEC,69,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25479,Alive,WITH TUMOR,1067,NA,[Not Available],Locoregional Recurrence,"Other, specify",Right Pelvic Mass,1010,Complete Remission/Response,NA,NA,0,1067,0,1067,1,1010,1,1010,NA,older,31.1634349,level3,NA,NA,NA,NA,NA,NA
TCGA.BK.A139.01A,TCGA-BK-A139,TCGA.BK.A139,6.717736506,7.57742165,TCGA.BK.A139.01A.11R.A118.07,3.595612,3.422463,0.4789959,0.680709,1.000426,UCEC,TCGA-BK-A139,TCGA-BK-A139-01A-11R-A118-07,TCGA-BK-A139-01A,TCGA-BK-A139-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BK-A139-01A,10782,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27077,Dead,WITH TUMOR,NA,943,[Not Available],Locoregional Recurrence,"Other, specify",Paravaginal mass involving the bladder and rectal walls,684,[Discrepancy],NA,NA,1,943,1,943,NA,NA,1,684,NA,older,24.87771968,level1,NA,NA,NA,NA,NA,NA
TCGA.BK.A13B.01A,TCGA-BK-A13B,TCGA.BK.A13B,5.329130774,10.81563146,TCGA.BK.A13B.01A.51R.A22K.07,2.984875,2.668971,0.05878143,0.06997161,0.7755007,UCEC,TCGA-BK-A13B,TCGA-BK-A13B-01A-51R-A22K-07,TCGA-BK-A13B-01A,TCGA-BK-A13B-01A-51R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-BK-A13B-01A,10783,UCEC,58,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21493,Alive,WITH TUMOR,966,NA,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal,760,Complete Remission/Response,NA,NA,0,966,0,966,1,760,1,760,NA,younger,45.32871972,level4,NA,NA,NA,NA,NA,NA
TCGA.BK.A13C.01A,TCGA-BK-A13C,TCGA.BK.A13C,5.75312355,10.25740822,TCGA.BK.A13C.01A.11R.A118.07,1.234431,1.066347,-1.129274,-1.680473,0.1250088,UCEC,TCGA-BK-A13C,TCGA-BK-A13C-01A-11R-A118-07,TCGA-BK-A13C-01A,TCGA-BK-A13C-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BK-A13C-01A,10784,UCEC,47,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,Peri (6-12 months since last menstrual period),-17317,Alive,TUMOR FREE,760,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,760,0,760,0,760,0,760,NA,younger,33.74945565,level3,NA,NA,NA,NA,NA,NA
TCGA.BK.A26L.01A,TCGA-BK-A26L,TCGA.BK.A26L,4.243608355,8.984602309,TCGA.BK.A26L.01A.11R.A16F.07,2.46931,2.219382,-0.2761303,-0.4455935,0.5924215,UCEC,TCGA-BK-A26L,TCGA-BK-A26L-01A-11R-A16F-07,TCGA-BK-A26L-01A,TCGA-BK-A26L-01A-11R-A16F-07,TP,Primary solid Tumor,1,1,A16F,1,0,1,Female,1,Tumor,TCGA-BK-A26L-01A,10785,UCEC,71,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26002,Alive,TUMOR FREE,734,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,734,0,734,0,734,0,734,NA,older,32.46191136,level3,NA,NA,NA,NA,NA,NA
TCGA.BK.A4ZD.01A,TCGA-BK-A4ZD,TCGA.BK.A4ZD,2.018634174,8.874612561,TCGA.BK.A4ZD.01A.11R.A27V.07,0.8708463,0.8634452,-1.416811,-2.044057,0.04853494,UCEC,TCGA-BK-A4ZD,TCGA-BK-A4ZD-01A-11R-A27V-07,TCGA-BK-A4ZD-01A,TCGA-BK-A4ZD-01A-11R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-BK-A4ZD-01A,10786,UCEC,42,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15536,Alive,TUMOR FREE,506,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,506,0,506,0,506,0,506,NA,younger,53.44574504,level4,NA,NA,NA,NA,NA,YES
TCGA.BK.A56F.01A,TCGA-BK-A56F,TCGA.BK.A56F,4.430124667,9.817974936,TCGA.BK.A56F.01A.32R.A27V.07,2.936768,2.884707,0.02511323,0.02186518,0.7631825,UCEC,TCGA-BK-A56F,TCGA-BK-A56F-01A-32R-A27V-07,TCGA-BK-A56F-01A,TCGA-BK-A56F-01A-32R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-BK-A56F-01A,10787,UCEC,75,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27523,Alive,TUMOR FREE,401,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,401,0,401,0,401,0,401,NA,older,31.61579284,level3,NA,NA,NA,NA,NA,YES
TCGA.BK.A6W3.01A,TCGA-BK-A6W3,TCGA.BK.A6W3,8.008579887,8.148918856,TCGA.BK.A6W3.01A.12R.A34R.07,4.139511,3.847021,0.8093611,1.224607,1.190257,UCEC,TCGA-BK-A6W3,TCGA-BK-A6W3-01A-12R-A34R-07,TCGA-BK-A6W3-01A,TCGA-BK-A6W3-01A-12R-A34R-07,TP,Primary solid Tumor,1,1,A34R,1,0,1,Female,1,Tumor,TCGA-BK-A6W3-01A,10788,UCEC,34,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2013,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12590,Alive,TUMOR FREE,305,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,305,0,305,0,305,0,305,NA,younger,31.91222346,level3,NA,NA,NA,NA,NA,NO
TCGA.BK.A6W4.01A,TCGA-BK-A6W4,TCGA.BK.A6W4,4.470055236,8.719488078,TCGA.BK.A6W4.01A.12R.A34R.07,2.568466,2.285258,-0.2520464,-0.3464374,0.6560667,UCEC,TCGA-BK-A6W4,TCGA-BK-A6W4-01A-12R-A34R-07,TCGA-BK-A6W4-01A,TCGA-BK-A6W4-01A-12R-A34R-07,TP,Primary solid Tumor,1,1,A34R,1,0,1,Female,1,Tumor,TCGA-BK-A6W4-01A,10789,UCEC,62,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22766,Alive,TUMOR FREE,300,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,300,0,300,0,300,0,300,NA,younger,43.40946894,level4,NA,NA,NA,NA,NA,YES
TCGA.BS.A0T9.01A,TCGA-BS-A0T9,TCGA.BS.A0T9,5.113293477,9.197944653,TCGA.BS.A0T9.01A.11R.A12I.07,2.985075,2.786784,0.05268566,0.0701717,0.8097027,UCEC,TCGA-BS-A0T9,TCGA-BS-A0T9-01A-11R-A12I-07,TCGA-BS-A0T9-01A,TCGA-BS-A0T9-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-BS-A0T9-01A,10790,UCEC,39,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14253,Dead,WITH TUMOR,NA,1428,[Not Available],NA,NA,NA,634,Complete Remission/Response,NA,NA,1,1428,1,1428,NA,NA,1,634,NA,younger,40.03673095,level4,NA,NA,NA,NA,NA,NA
TCGA.BS.A0TA.01A,TCGA-BS-A0TA,TCGA.BS.A0TA,5.810147104,8.887515894,TCGA.BS.A0TA.01A.11R.A104.07,5.767825,5.753501,1.943176,2.852922,1.807275,UCEC,TCGA-BS-A0TA,TCGA-BS-A0TA-01A-11R-A104-07,TCGA-BS-A0TA-01A,TCGA-BS-A0TA-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0TA-01A,10791,UCEC,58,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21505,Dead,WITH TUMOR,NA,740,[Not Available],NA,NA,NA,394,Stable Disease,NA,NA,1,740,1,740,NA,NA,1,394,NA,younger,38.95429363,level4,NA,NA,NA,NA,NA,NA
TCGA.BS.A0TC.01A,TCGA-BS-A0TC,TCGA.BS.A0TC,6.488041501,10.36171579,TCGA.BS.A0TC.01A.11R.A104.07,2.51623,2.239426,-0.2827789,-0.3986736,0.5922055,UCEC,TCGA-BS-A0TC,TCGA-BS-A0TC-01A-11R-A104-07,TCGA-BS-A0TC-01A,TCGA-BS-A0TC-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0TC-01A,10792,UCEC,69,FEMALE,ASIAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25560,Alive,TUMOR FREE,2602,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2602,0,2602,0,2602,0,2602,NA,older,31.46836966,level3,NA,NA,NA,NA,NA,NA
TCGA.BS.A0TD.01A,TCGA-BS-A0TD,TCGA.BS.A0TD,5.278069107,9.166841635,TCGA.BS.A0TD.01A.11R.A104.07,2.456366,2.286034,-0.3180673,-0.4585377,0.5666957,UCEC,TCGA-BS-A0TD,TCGA-BS-A0TD-01A-11R-A104-07,TCGA-BS-A0TD-01A,TCGA-BS-A0TD-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0TD-01A,10793,UCEC,65,FEMALE,ASIAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23950,Alive,TUMOR FREE,2379,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2379,0,2379,0,2379,0,2379,NA,NA,35.3798127,level4,NA,NA,NA,NA,NA,NA
TCGA.BS.A0TE.01A,TCGA-BS-A0TE,TCGA.BS.A0TE,8.335812613,11.16697003,TCGA.BS.A0TE.01A.11R.A104.07,2.592206,2.451286,-0.2604459,-0.322697,0.6582701,UCEC,TCGA-BS-A0TE,TCGA-BS-A0TE-01A-11R-A104-07,TCGA-BS-A0TE-01A,TCGA-BS-A0TE-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0TE-01A,10794,UCEC,35,FEMALE,ASIAN,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12983,Dead,WITH TUMOR,NA,146,[Not Available],NA,NA,NA,58,Progressive Disease,NA,NA,1,146,1,146,NA,NA,1,58,NA,younger,32.24206349,level3,NA,NA,NA,NA,NA,NA
TCGA.BS.A0TG.01A,TCGA-BS-A0TG,TCGA.BS.A0TG,4.957048725,10.00532937,TCGA.BS.A0TG.01A.32R.A16W.07,3.667896,3.47219,0.5311063,0.7529929,1.013034,UCEC,TCGA-BS-A0TG,TCGA-BS-A0TG-01A-32R-A16W-07,TCGA-BS-A0TG-01A,TCGA-BS-A0TG-01A-32R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-BS-A0TG-01A,10795,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22043,Alive,WITH TUMOR,2371,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2371,0,2371,0,2371,0,2371,NA,younger,24.08822312,level1,NA,NA,NA,NA,NA,NA
TCGA.BS.A0TI.01A,TCGA-BS-A0TI,TCGA.BS.A0TI,5.635665992,9.171244439,TCGA.BS.A0TI.01A.11R.A104.07,3.606356,3.504387,0.4880231,0.6914526,1.01987,UCEC,TCGA-BS-A0TI,TCGA-BS-A0TI-01A-11R-A104-07,TCGA-BS-A0TI-01A,TCGA-BS-A0TI-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0TI-01A,10796,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23705,Alive,TUMOR FREE,1882,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1882,0,1882,0,1882,0,1882,NA,younger,22.20633069,level1,NA,NA,NA,NA,NA,NA
TCGA.BS.A0TJ.01A,TCGA-BS-A0TJ,TCGA.BS.A0TJ,5.07206832,9.048629992,TCGA.BS.A0TJ.01A.11R.A104.07,2.579859,2.494108,-0.2753201,-0.3350445,0.6975331,UCEC,TCGA-BS-A0TJ,TCGA-BS-A0TJ-01A-11R-A104-07,TCGA-BS-A0TJ-01A,TCGA-BS-A0TJ-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0TJ-01A,10797,UCEC,59,FEMALE,ASIAN,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21663,Alive,TUMOR FREE,2068,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2068,0,2068,0,2068,0,2068,NA,younger,38.08864266,level4,NA,NA,NA,NA,NA,NA
TCGA.BS.A0U5.01A,TCGA-BS-A0U5,TCGA.BS.A0U5,6.347063752,10.39023059,TCGA.BS.A0U5.01A.11R.A109.07,1.888261,1.684406,-0.7199952,-1.026642,0.4019784,UCEC,TCGA-BS-A0U5,TCGA-BS-A0U5-01A-11R-A109-07,TCGA-BS-A0U5-01A,TCGA-BS-A0U5-01A-11R-A109-07,TP,Primary solid Tumor,1,1,A109,1,0,1,Female,1,Tumor,TCGA-BS-A0U5-01A,10798,UCEC,76,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27945,Alive,TUMOR FREE,2935,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2935,0,2935,0,2935,0,2935,NA,older,21.67125803,level1,NA,NA,NA,NA,NA,NA
TCGA.BS.A0U7.01A,TCGA-BS-A0U7,TCGA.BS.A0U7,5.390260406,9.761272287,TCGA.BS.A0U7.01A.21R.A104.07,3.635117,3.54377,0.4808421,0.7202136,1.059916,UCEC,TCGA-BS-A0U7,TCGA-BS-A0U7-01A-21R-A104-07,TCGA-BS-A0U7-01A,TCGA-BS-A0U7-01A-21R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0U7-01A,10799,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23166,Dead,TUMOR FREE,NA,935,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,935,0,935,0,935,0,935,NA,younger,24.24242424,level1,NA,NA,NA,NA,NA,NA
TCGA.BS.A0U8.01A,TCGA-BS-A0U8,TCGA.BS.A0U8,3.998581028,8.155552947,TCGA.BS.A0U8.01A.11R.A104.07,2.311431,2.288383,-0.4406639,-0.6034723,0.5852,UCEC,TCGA-BS-A0U8,TCGA-BS-A0U8-01A-11R-A104-07,TCGA-BS-A0U8-01A,TCGA-BS-A0U8-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0U8-01A,10800,UCEC,55,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20402,Alive,TUMOR FREE,2963,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2963,0,2963,0,2963,0,2963,NA,younger,28.37370242,level2,NA,NA,NA,NA,NA,NA
TCGA.BS.A0U9.01B,TCGA-BS-A0U9,TCGA.BS.A0U9,7.116900165,9.390798727,TCGA.BS.A0U9.01B.21R.A10J.07,1.123236,1.240777,-1.220579,-1.791667,0.1423724,UCEC,TCGA-BS-A0U9,TCGA-BS-A0U9-01B-21R-A10J-07,TCGA-BS-A0U9-01B,TCGA-BS-A0U9-01B-21R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-BS-A0U9-01B,10801,UCEC,59,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IIA,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21580,Alive,TUMOR FREE,2825,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2825,0,2825,0,2825,0,2825,NA,younger,34.25605536,level3,NA,NA,NA,NA,NA,NA
TCGA.BS.A0UA.01A,TCGA-BS-A0UA,TCGA.BS.A0UA,5.247107958,10.64245166,TCGA.BS.A0UA.01A.11R.A118.07,3.568896,3.347233,0.4498256,0.6539929,1.016361,UCEC,TCGA-BS-A0UA,TCGA-BS-A0UA-01A-11R-A118-07,TCGA-BS-A0UA-01A,TCGA-BS-A0UA-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BS-A0UA-01A,10802,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24872,Alive,TUMOR FREE,3495,NA,[Not Available],Locoregional Disease,"Other, specify",endometrium,520,Complete Remission/Response,NA,NA,0,3495,0,3495,1,520,1,520,NA,older,27.70083102,level2,NA,NA,NA,NA,NA,NA
TCGA.BS.A0UF.01A,TCGA-BS-A0UF,TCGA.BS.A0UF,5.26514434,9.258047553,TCGA.BS.A0UF.01A.11R.A104.07,4.360091,4.209465,0.9832506,1.445188,1.293739,UCEC,TCGA-BS-A0UF,TCGA-BS-A0UF-01A-11R-A104-07,TCGA-BS-A0UF-01A,TCGA-BS-A0UF-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0UF-01A,10803,UCEC,65,FEMALE,ASIAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23771,Alive,TUMOR FREE,2611,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2611,0,2611,0,2611,0,2611,NA,NA,26.3778981,level2,NA,NA,NA,NA,NA,NA
TCGA.BS.A0UJ.01A,TCGA-BS-A0UJ,TCGA.BS.A0UJ,3.906657269,8.877923571,TCGA.BS.A0UJ.01A.12R.A104.07,3.562441,3.456068,0.4441905,0.6475374,0.9599041,UCEC,TCGA-BS-A0UJ,TCGA-BS-A0UJ-01A-12R-A104-07,TCGA-BS-A0UJ-01A,TCGA-BS-A0UJ-01A-12R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0UJ-01A,10804,UCEC,68,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25149,Alive,TUMOR FREE,2506,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2506,0,2506,0,2506,0,2506,NA,older,21.64412071,level1,NA,NA,NA,NA,NA,NA
TCGA.BS.A0UL.01A,TCGA-BS-A0UL,TCGA.BS.A0UL,5.756337271,9.049433667,TCGA.BS.A0UL.01A.11R.A109.07,3.895624,3.839673,0.6518259,0.980721,1.139932,UCEC,TCGA-BS-A0UL,TCGA-BS-A0UL-01A-11R-A109-07,TCGA-BS-A0UL-01A,TCGA-BS-A0UL-01A-11R-A109-07,TP,Primary solid Tumor,1,1,A109,1,0,1,Female,1,Tumor,TCGA-BS-A0UL-01A,10805,UCEC,54,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2004,Peri (6-12 months since last menstrual period),-19982,Alive,TUMOR FREE,2481,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2481,0,2481,0,2481,0,2481,NA,younger,39.44636678,level4,NA,NA,NA,NA,NA,NA
TCGA.BS.A0UM.01A,TCGA-BS-A0UM,TCGA.BS.A0UM,6.406392395,9.941410225,TCGA.BS.A0UM.01A.11R.A104.07,4.402357,4.184211,1.008228,1.487454,1.301787,UCEC,TCGA-BS-A0UM,TCGA-BS-A0UM-01A-11R-A104-07,TCGA-BS-A0UM-01A,TCGA-BS-A0UM-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0UM-01A,10806,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23400,Alive,WITH TUMOR,2644,NA,[Not Available],Metastatic,Brain,NA,1454,Complete Remission/Response,NA,NA,0,2644,0,2644,1,1454,1,1454,NA,younger,35.15625,level4,NA,NA,NA,NA,NA,NA
TCGA.BS.A0UT.01A,TCGA-BS-A0UT,TCGA.BS.A0UT,3.643227578,8.681706613,TCGA.BS.A0UT.01A.11R.A104.07,1.568939,1.491767,-0.9328432,-1.345964,0.3079201,UCEC,TCGA-BS-A0UT,TCGA-BS-A0UT-01A-11R-A104-07,TCGA-BS-A0UT-01A,TCGA-BS-A0UT-01A-11R-A104-07,TP,Primary solid Tumor,1,1,A104,1,0,1,Female,1,Tumor,TCGA-BS-A0UT-01A,10807,UCEC,62,FEMALE,ASIAN,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22775,Alive,TUMOR FREE,2212,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2212,0,2212,0,2212,0,2212,NA,younger,28.13365651,level2,NA,NA,NA,NA,NA,NA
TCGA.BS.A0UV.01A,TCGA-BS-A0UV,TCGA.BS.A0UV,3.749784551,8.201094911,TCGA.BS.A0UV.01A.11R.A16W.07,3.084546,3.133095,0.1012037,0.1696432,0.8307046,UCEC,TCGA-BS-A0UV,TCGA-BS-A0UV-01A-11R-A16W-07,TCGA-BS-A0UV-01A,TCGA-BS-A0UV-01A-11R-A16W-07,TP,Primary solid Tumor,1,1,A16W,1,0,1,Female,1,Tumor,TCGA-BS-A0UV-01A,10808,UCEC,55,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20266,Alive,TUMOR FREE,2228,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2228,0,2228,0,2228,0,2228,NA,younger,39.68253968,level4,NA,NA,NA,NA,NA,NA
TCGA.BS.A0V4.01A,TCGA-BS-A0V4,TCGA.BS.A0V4,7.638638637,8.852919585,TCGA.BS.A0V4.01A.11R.A14D.07,1.569662,1.746294,-0.9059452,-1.345241,0.2841505,UCEC,TCGA-BS-A0V4,TCGA-BS-A0V4-01A-11R-A14D-07,TCGA-BS-A0V4-01A,TCGA-BS-A0V4-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-BS-A0V4-01A,10809,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20777,Alive,TUMOR FREE,1810,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1810,0,1810,0,1810,0,1810,NA,younger,35.26170799,level4,NA,NA,NA,NA,NA,NA
TCGA.BS.A0V6.01A,TCGA-BS-A0V6,TCGA.BS.A0V6,6.829308509,9.734824291,TCGA.BS.A0V6.01A.11R.A118.07,2.928102,2.795088,0.01740741,0.01319873,0.7488288,UCEC,TCGA-BS-A0V6,TCGA-BS-A0V6-01A-11R-A118-07,TCGA-BS-A0V6-01A,TCGA-BS-A0V6-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BS-A0V6-01A,10810,UCEC,55,FEMALE,ASIAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20369,Alive,TUMOR FREE,2725,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2725,0,2725,0,2725,0,2725,NA,younger,33.67276563,level3,NA,NA,NA,NA,NA,NA
TCGA.BS.A0V7.01A,TCGA-BS-A0V7,TCGA.BS.A0V7,4.309059743,9.124483233,TCGA.BS.A0V7.01A.21R.A118.07,3.71839,3.849363,0.6039912,0.8034872,1.065188,UCEC,TCGA-BS-A0V7,TCGA-BS-A0V7-01A-21R-A118-07,TCGA-BS-A0V7-01A,TCGA-BS-A0V7-01A-21R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BS-A0V7-01A,10811,UCEC,48,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17810,Alive,TUMOR FREE,1934,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1934,0,1934,0,1934,0,1934,NA,younger,35.29411765,level4,NA,NA,NA,NA,NA,NA
TCGA.BS.A0V8.01A,TCGA-BS-A0V8,TCGA.BS.A0V8,3.32350156,7.376093859,TCGA.BS.A0V8.01A.11R.A118.07,2.717453,2.794756,-0.1155279,-0.1974501,0.7167596,UCEC,TCGA-BS-A0V8,TCGA-BS-A0V8-01A-11R-A118-07,TCGA-BS-A0V8-01A,TCGA-BS-A0V8-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-BS-A0V8-01A,10812,UCEC,68,FEMALE,NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24981,Alive,TUMOR FREE,2544,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2544,0,2544,0,2544,0,2544,NA,older,34.48415757,level3,NA,NA,NA,NA,NA,NA
TCGA.BS.A0VI.01A,TCGA-BS-A0VI,TCGA.BS.A0VI,4.632084374,7.100716417,TCGA.BS.A0VI.01A.11R.A14D.07,1.829753,1.613616,-0.7407394,-1.08515,0.3767619,UCEC,TCGA-BS-A0VI,TCGA-BS-A0VI-01A-11R-A14D-07,TCGA-BS-A0VI-01A,TCGA-BS-A0VI-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-BS-A0VI-01A,10813,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21198,Alive,TUMOR FREE,2646,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2646,0,2646,0,2646,0,2646,NA,younger,34.25044224,level3,NA,NA,NA,NA,NA,NA
TCGA.BS.A0WQ.01A,TCGA-BS-A0WQ,TCGA.BS.A0WQ,3.198410466,8.682274695,TCGA.BS.A0WQ.01A.21R.A109.07,1.510265,1.492215,-0.9753585,-1.404639,0.266972,UCEC,TCGA-BS-A0WQ,TCGA-BS-A0WQ-01A-21R-A109-07,TCGA-BS-A0WQ-01A,TCGA-BS-A0WQ-01A-21R-A109-07,TP,Primary solid Tumor,1,1,A109,1,0,1,Female,1,Tumor,TCGA-BS-A0WQ-01A,10814,UCEC,55,FEMALE,ASIAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20131,Alive,TUMOR FREE,2022,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2022,0,2022,0,2022,0,2022,NA,younger,36.328125,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A0ZN.01A,TCGA-D1-A0ZN,TCGA.D1.A0ZN,5.382261439,10.40370185,TCGA.D1.A0ZN.01A.11R.A118.07,2.676589,2.493326,-0.1750846,-0.2383144,0.688854,UCEC,TCGA-D1-A0ZN,TCGA-D1-A0ZN-01A-11R-A118-07,TCGA-D1-A0ZN-01A,TCGA-D1-A0ZN-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A0ZN-01A,10815,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Peri (6-12 months since last menstrual period),-22026,Alive,TUMOR FREE,512,NA,[Not Available],New Primary Tumor,"Other, specify",Breast left,448,Complete Remission/Response,NA,NA,0,512,0,512,0,512,1,448,NA,younger,29.05328798,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A0ZO.01A,TCGA-D1-A0ZO,TCGA.D1.A0ZO,5.768112155,10.23714992,TCGA.D1.A0ZO.01A.11R.A118.07,2.971799,2.824846,0.0114951,0.05689599,0.7842607,UCEC,TCGA-D1-A0ZO,TCGA-D1-A0ZO-01A-11R-A118-07,TCGA-D1-A0ZO-01A,TCGA-D1-A0ZO-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A0ZO-01A,10816,UCEC,75,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27482,Alive,TUMOR FREE,602,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,602,0,602,0,602,0,602,NA,older,40.4040404,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A0ZP.01A,TCGA-D1-A0ZP,TCGA.D1.A0ZP,3.816418487,9.009388018,TCGA.D1.A0ZP.01A.21R.A10J.07,1.785045,1.736387,-0.7886052,-1.129858,0.3740759,UCEC,TCGA-D1-A0ZP,TCGA-D1-A0ZP-01A-21R-A10J-07,TCGA-D1-A0ZP-01A,TCGA-D1-A0ZP-01A-21R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-D1-A0ZP-01A,10817,UCEC,59,FEMALE,WHITE,[Not Applicable],Stage IVA,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21581,Alive,TUMOR FREE,911,NA,[Not Available],Locoregional Disease,"Other, specify",Recurrent endometrial carcinoma in retriponeal lymphnodes,629,Complete Remission/Response,NA,NA,0,911,0,911,NA,NA,1,629,NA,younger,22.37567995,level1,NA,NA,NA,NA,NA,NA
TCGA.D1.A0ZQ.01A,TCGA-D1-A0ZQ,TCGA.D1.A0ZQ,2.881548086,11.12312812,TCGA.D1.A0ZQ.01A.11R.A118.07,1.958639,1.821716,-0.6572091,-0.9562643,0.4348472,UCEC,TCGA-D1-A0ZQ,TCGA-D1-A0ZQ-01A-11R-A118-07,TCGA-D1-A0ZQ-01A,TCGA-D1-A0ZQ-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A0ZQ-01A,10818,UCEC,90,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32873,Alive,TUMOR FREE,260,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,260,0,260,0,260,0,260,NA,older,28.72008325,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A0ZR.01A,TCGA-D1-A0ZR,TCGA.D1.A0ZR,4.007166892,10.75636541,TCGA.D1.A0ZR.01A.21R.A10J.07,1.4417,1.188995,-1.013224,-1.473203,0.2476112,UCEC,TCGA-D1-A0ZR,TCGA-D1-A0ZR-01A-21R-A10J-07,TCGA-D1-A0ZR-01A,TCGA-D1-A0ZR-01A-21R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-D1-A0ZR-01A,10819,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Indeterminate (neither Pre or Postmenopausal),-21157,Alive,TUMOR FREE,17,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,17,0,17,0,17,0,17,NA,younger,42.97520661,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A0ZS.01A,TCGA-D1-A0ZS,TCGA.D1.A0ZS,2.475835645,4.702699139,TCGA.D1.A0ZS.01A.11R.A118.07,0.979027,1.16906,-1.342173,-1.935876,0.06923019,UCEC,TCGA-D1-A0ZS,TCGA-D1-A0ZS-01A-11R-A118-07,TCGA-D1-A0ZS-01A,TCGA-D1-A0ZS-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A0ZS-01A,10820,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19821,Alive,TUMOR FREE,148,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,148,0,148,0,148,0,148,NA,younger,23.05175491,level1,NA,NA,NA,NA,NA,NA
TCGA.D1.A0ZU.01A,TCGA-D1-A0ZU,TCGA.D1.A0ZU,5.668763082,10.10617656,TCGA.D1.A0ZU.01A.11R.A10J.07,1.505137,1.26691,-0.9868512,-1.409766,0.2883774,UCEC,TCGA-D1-A0ZU,TCGA-D1-A0ZU-01A-11R-A10J-07,TCGA-D1-A0ZU-01A,TCGA-D1-A0ZU-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-D1-A0ZU-01A,10821,UCEC,34,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12458,Alive,TUMOR FREE,872,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,872,0,872,0,872,0,872,NA,younger,32.52595156,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A0ZV.01A,TCGA-D1-A0ZV,TCGA.D1.A0ZV,6.684814294,9.355989792,TCGA.D1.A0ZV.01A.11R.A10J.07,4.26695,4.10904,0.9622171,1.352047,1.216715,UCEC,TCGA-D1-A0ZV,TCGA-D1-A0ZV-01A-11R-A10J-07,TCGA-D1-A0ZV-01A,TCGA-D1-A0ZV-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-D1-A0ZV-01A,10822,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21374,Alive,TUMOR FREE,728,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,728,0,728,0,728,0,728,NA,younger,26.64359862,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A0ZZ.01A,TCGA-D1-A0ZZ,TCGA.D1.A0ZZ,3.558138943,8.528113466,TCGA.D1.A0ZZ.01A.11R.A10J.07,0.5731401,0.5022523,-1.63196,-2.341763,-0.03791706,UCEC,TCGA-D1-A0ZZ,TCGA-D1-A0ZZ-01A-11R-A10J-07,TCGA-D1-A0ZZ-01A,TCGA-D1-A0ZZ-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-D1-A0ZZ-01A,10823,UCEC,80,FEMALE,WHITE,[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29420,Alive,TUMOR FREE,686,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,686,0,686,0,686,0,686,NA,older,21.50446956,level1,NA,NA,NA,NA,NA,NA
TCGA.D1.A101.01A,TCGA-D1-A101,TCGA.D1.A101,5.9129977,7.963293698,TCGA.D1.A101.01A.12R.A10J.07,3.932544,3.962139,0.6694685,1.01764,1.152955,UCEC,TCGA-D1-A101,TCGA-D1-A101-01A-12R-A10J-07,TCGA-D1-A101-01A,TCGA-D1-A101-01A-12R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-D1-A101-01A,10824,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22078,Alive,TUMOR FREE,53,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,53,0,53,0,53,0,53,NA,younger,36.44444444,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A102.01A,TCGA-D1-A102,TCGA.D1.A102,4.605977663,9.716745272,TCGA.D1.A102.01A.11R.A10J.07,3.185182,3.092235,0.171382,0.2702788,0.8449966,UCEC,TCGA-D1-A102,TCGA-D1-A102-01A-11R-A10J-07,TCGA-D1-A102-01A,TCGA-D1-A102-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-D1-A102-01A,10825,UCEC,49,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Peri (6-12 months since last menstrual period),-17991,Alive,TUMOR FREE,135,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,135,0,135,0,135,0,135,NA,younger,38.50523924,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A103.01A,TCGA-D1-A103,TCGA.D1.A103,5.138942497,9.379939028,TCGA.D1.A103.01A.11R.A10J.07,3.127377,2.838798,0.1247257,0.2124739,0.8233697,UCEC,TCGA-D1-A103,TCGA-D1-A103-01A-11R-A10J-07,TCGA-D1-A103-01A,TCGA-D1-A103-01A-11R-A10J-07,TP,Primary solid Tumor,1,1,A10J,1,0,1,Female,1,Tumor,TCGA-D1-A103-01A,10826,UCEC,87,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31841,Alive,TUMOR FREE,669,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,669,0,669,0,669,0,669,NA,older,26.66666667,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A15V.01A,TCGA-D1-A15V,TCGA.D1.A15V,3.715405394,9.048230466,TCGA.D1.A15V.01A.11R.A118.07,2.214088,2.102241,-0.5234189,-0.7008153,0.5310717,UCEC,TCGA-D1-A15V,TCGA-D1-A15V-01A-11R-A118-07,TCGA-D1-A15V-01A,TCGA-D1-A15V-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A15V-01A,10827,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24886,Alive,TUMOR FREE,1201,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1201,0,1201,0,1201,0,1201,NA,older,26.953125,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A15W.01A,TCGA-D1-A15W,TCGA.D1.A15W,6.334274483,9.806151913,TCGA.D1.A15W.01A.11R.A118.07,2.912724,2.699269,0.009766906,-0.002179262,0.7582413,UCEC,TCGA-D1-A15W,TCGA-D1-A15W-01A-11R-A118-07,TCGA-D1-A15W-01A,TCGA-D1-A15W-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A15W-01A,10828,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21545,Alive,TUMOR FREE,915,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,915,0,915,0,915,0,915,NA,younger,46.28099174,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A15X.01A,TCGA-D1-A15X,TCGA.D1.A15X,8.768825858,3.68449669,TCGA.D1.A15X.01A.11R.A118.07,3.487068,3.295438,0.3283393,0.5721652,0.9694245,UCEC,TCGA-D1-A15X,TCGA-D1-A15X-01A-11R-A118-07,TCGA-D1-A15X-01A,TCGA-D1-A15X-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A15X-01A,10829,UCEC,45,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,High Grade,2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16532,Alive,TUMOR FREE,909,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,909,0,909,0,909,0,909,NA,younger,25.20920136,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A15Z.01A,TCGA-D1-A15Z,TCGA.D1.A15Z,3.417307475,10.42816887,TCGA.D1.A15Z.01A.11R.A118.07,1.55507,1.745298,-0.9160648,-1.359833,0.2682193,UCEC,TCGA-D1-A15Z,TCGA-D1-A15Z-01A-11R-A118-07,TCGA-D1-A15Z-01A,TCGA-D1-A15Z-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A15Z-01A,10830,UCEC,72,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26638,Dead,TUMOR FREE,NA,58,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,58,0,58,0,58,0,58,NA,older,48.828125,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A160.01A,TCGA-D1-A160,TCGA.D1.A160,4.431797051,9.939592729,TCGA.D1.A160.01A.11R.A118.07,3.36691,3.156962,0.2984027,0.4520069,0.9379748,UCEC,TCGA-D1-A160,TCGA-D1-A160-01A-11R-A118-07,TCGA-D1-A160-01A,TCGA-D1-A160-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A160-01A,10831,UCEC,70,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25673,Alive,TUMOR FREE,112,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,112,0,112,0,112,0,112,NA,older,41.2385073,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A161.01A,TCGA-D1-A161,TCGA.D1.A161,4.627160622,9.789065948,TCGA.D1.A161.01A.11R.A118.07,2.282443,2.108132,-0.4362709,-0.6324602,0.5540476,UCEC,TCGA-D1-A161,TCGA-D1-A161-01A-11R-A118-07,TCGA-D1-A161-01A,TCGA-D1-A161-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A161-01A,10832,UCEC,78,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28695,Alive,TUMOR FREE,892,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,892,0,892,0,892,0,892,NA,older,28.08433211,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A162.01A,TCGA-D1-A162,TCGA.D1.A162,4.808063466,9.454355875,TCGA.D1.A162.01A.11R.A118.07,2.26938,2.082926,-0.4290988,-0.6455237,0.5083792,UCEC,TCGA-D1-A162,TCGA-D1-A162-01A-11R-A118-07,TCGA-D1-A162-01A,TCGA-D1-A162-01A-11R-A118-07,TP,Primary solid Tumor,1,1,A118,1,0,1,Female,1,Tumor,TCGA-D1-A162-01A,10833,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25543,Alive,TUMOR FREE,1145,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1145,0,1145,0,1145,0,1145,NA,older,34.60207612,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A163.01A,TCGA-D1-A163,TCGA.D1.A163,4.989673493,9.530494076,TCGA.D1.A163.01A.11R.A12I.07,3.233942,3.033593,0.1853754,0.3190384,0.9215025,UCEC,TCGA-D1-A163,TCGA-D1-A163-01A-11R-A12I-07,TCGA-D1-A163-01A,TCGA-D1-A163-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A163-01A,10834,UCEC,50,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G2,2008,Peri (6-12 months since last menstrual period),-18604,Alive,TUMOR FREE,991,NA,[Not Available],Metastatic,"Other, specify",Paraaortic retroperitoneal lymphnode,223,Complete Remission/Response,NA,NA,0,991,0,991,1,223,1,223,NA,younger,38.16392983,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A165.01A,TCGA-D1-A165,TCGA.D1.A165,4.375285453,9.682411378,TCGA.D1.A165.01A.11R.A12I.07,1.681735,1.476176,-0.8479288,-1.233168,0.3263096,UCEC,TCGA-D1-A165,TCGA-D1-A165-01A-11R-A12I-07,TCGA-D1-A165-01A,TCGA-D1-A165-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A165-01A,10835,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23526,Alive,TUMOR FREE,20,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,20,0,20,0,20,0,20,NA,younger,26.55596594,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A167.01A,TCGA-D1-A167,TCGA.D1.A167,4.1229851,6.739798434,TCGA.D1.A167.01A.11R.A12I.07,1.380106,1.463272,-1.11397,-1.534797,0.2484841,UCEC,TCGA-D1-A167,TCGA-D1-A167-01A-11R-A12I-07,TCGA-D1-A167-01A,TCGA-D1-A167-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A167-01A,10836,UCEC,70,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25575,Alive,TUMOR FREE,478,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,478,0,478,0,478,0,478,NA,older,31.1634349,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A168.01A,TCGA-D1-A168,TCGA.D1.A168,4.125222171,11.58344642,TCGA.D1.A168.01A.31R.A12I.07,1.471143,1.554849,-0.9745983,-1.44376,0.2496406,UCEC,TCGA-D1-A168,TCGA-D1-A168-01A-31R-A12I-07,TCGA-D1-A168-01A,TCGA-D1-A168-01A-31R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A168-01A,10837,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24586,Alive,TUMOR FREE,1098,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1098,0,1098,0,1098,0,1098,NA,older,28.95900015,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A169.01A,TCGA-D1-A169,TCGA.D1.A169,5.082950117,10.39465481,TCGA.D1.A169.01A.11R.A12I.07,4.193995,3.991111,0.9011349,1.279091,1.182602,UCEC,TCGA-D1-A169,TCGA-D1-A169-01A-11R-A12I-07,TCGA-D1-A169-01A,TCGA-D1-A169-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A169-01A,10838,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IV,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23238,Alive,WITH TUMOR,1135,NA,[Not Available],Metastatic,"Other, specify",Bladder nodule,519,Complete Remission/Response,NA,NA,0,1135,0,1135,NA,NA,1,519,NA,younger,35.29411765,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A16B.01A,TCGA-D1-A16B,TCGA.D1.A16B,7.006854127,9.78077351,TCGA.D1.A16B.01A.11R.A12I.07,3.363067,3.295773,0.2947183,0.4481636,0.9478392,UCEC,TCGA-D1-A16B,TCGA-D1-A16B-01A-11R-A12I-07,TCGA-D1-A16B-01A,TCGA-D1-A16B-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16B-01A,10839,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23450,Alive,TUMOR FREE,1106,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1106,0,1106,0,1106,0,1106,NA,younger,34.01764171,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A16D.01A,TCGA-D1-A16D,TCGA.D1.A16D,7.251417295,9.5989782,TCGA.D1.A16D.01A.11R.A12I.07,3.348019,3.155672,0.3289318,0.4331159,0.8961807,UCEC,TCGA-D1-A16D,TCGA-D1-A16D-01A-11R-A12I-07,TCGA-D1-A16D-01A,TCGA-D1-A16D-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16D-01A,10840,UCEC,49,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2008,Peri (6-12 months since last menstrual period),-17933,Alive,TUMOR FREE,1141,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1141,0,1141,0,1141,0,1141,NA,younger,56.14217728,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A16E.01A,TCGA-D1-A16E,TCGA.D1.A16E,6.335439857,10.51724215,TCGA.D1.A16E.01A.22R.A12I.07,3.499992,3.450944,0.4397926,0.5850886,0.9483183,UCEC,TCGA-D1-A16E,TCGA-D1-A16E-01A-22R-A12I-07,TCGA-D1-A16E-01A,TCGA-D1-A16E-01A-22R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16E-01A,10841,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26859,Alive,TUMOR FREE,1119,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1119,0,1119,0,1119,0,1119,NA,older,25.29937595,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A16F.01A,TCGA-D1-A16F,TCGA.D1.A16F,5.460697752,10.25805591,TCGA.D1.A16F.01A.11R.A12I.07,3.048508,2.9144,0.1098414,0.1336052,0.8102956,UCEC,TCGA-D1-A16F,TCGA-D1-A16F-01A-11R-A12I-07,TCGA-D1-A16F-01A,TCGA-D1-A16F-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16F-01A,10842,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22242,Alive,TUMOR FREE,80,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,80,0,80,0,80,0,80,NA,younger,36.51263743,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A16G.01A,TCGA-D1-A16G,TCGA.D1.A16G,9.102272994,10.42100061,TCGA.D1.A16G.01A.31R.A12I.07,2.526323,2.239314,-0.2808187,-0.3885806,0.6021473,UCEC,TCGA-D1-A16G,TCGA-D1-A16G-01A-31R-A12I-07,TCGA-D1-A16G-01A,TCGA-D1-A16G-01A-31R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16G-01A,10843,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IV,Serous endometrial adenocarcinoma,High Grade,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27065,Dead,WITH TUMOR,NA,834,[Not Available],Locoregional Disease,"Other, specify",Lymph nodes,642,Complete Remission/Response,NA,NA,1,834,1,834,NA,NA,1,642,NA,older,25.05930703,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A16I.01A,TCGA-D1-A16I,TCGA.D1.A16I,3.723355341,7.832205812,TCGA.D1.A16I.01A.11R.A12I.07,2.911924,2.866531,0.005955689,-0.002979722,0.7846694,UCEC,TCGA-D1-A16I,TCGA-D1-A16I-01A-11R-A12I-07,TCGA-D1-A16I-01A,TCGA-D1-A16I-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16I-01A,10844,UCEC,62,FEMALE,WHITE,[Not Applicable],Stage IC,Serous endometrial adenocarcinoma,High Grade,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22836,Dead,TUMOR FREE,NA,350,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,350,0,350,0,350,0,350,NA,younger,31.61579284,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A16J.01A,TCGA-D1-A16J,TCGA.D1.A16J,5.249466985,10.823154,TCGA.D1.A16J.01A.11R.A12I.07,4.027996,3.734287,0.7522217,1.113093,1.145982,UCEC,TCGA-D1-A16J,TCGA-D1-A16J-01A-11R-A12I-07,TCGA-D1-A16J-01A,TCGA-D1-A16J-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16J-01A,10845,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22319,Alive,TUMOR FREE,910,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,910,0,910,0,910,0,910,NA,younger,42.93830096,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A16N.01A,TCGA-D1-A16N,TCGA.D1.A16N,4.577066532,10.54171234,TCGA.D1.A16N.01A.11R.A12I.07,2.737063,2.729308,-0.08968494,-0.1778403,0.6862625,UCEC,TCGA-D1-A16N,TCGA-D1-A16N-01A-11R-A12I-07,TCGA-D1-A16N-01A,TCGA-D1-A16N-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16N-01A,10846,UCEC,51,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009,Peri (6-12 months since last menstrual period),-18787,Alive,TUMOR FREE,945,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,945,0,945,0,945,0,945,NA,younger,37.04474506,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A16O.01A,TCGA-D1-A16O,TCGA.D1.A16O,5.239398886,11.2344806,TCGA.D1.A16O.01A.11R.A12I.07,1.830777,1.789516,-0.7434919,-1.084126,0.3987256,UCEC,TCGA-D1-A16O,TCGA-D1-A16O-01A-11R-A12I-07,TCGA-D1-A16O-01A,TCGA-D1-A16O-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16O-01A,10847,UCEC,44,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-16114,Alive,TUMOR FREE,1023,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1023,0,1023,0,1023,0,1023,NA,younger,35.71303526,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A16Q.01A,TCGA-D1-A16Q,TCGA.D1.A16Q,4.76575174,10.03698248,TCGA.D1.A16Q.01A.12R.A12I.07,3.601248,3.550574,0.4808887,0.6863445,1.027685,UCEC,TCGA-D1-A16Q,TCGA-D1-A16Q-01A-12R-A12I-07,TCGA-D1-A16Q-01A,TCGA-D1-A16Q-01A-12R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16Q-01A,10848,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19873,Alive,TUMOR FREE,324,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,324,0,324,0,324,0,324,NA,younger,39.54840454,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A16R.01A,TCGA-D1-A16R,TCGA.D1.A16R,4.837499684,10.20896143,TCGA.D1.A16R.01A.11R.A12I.07,3.510801,3.295423,0.3941437,0.5958978,0.9656748,UCEC,TCGA-D1-A16R,TCGA-D1-A16R-01A-11R-A12I-07,TCGA-D1-A16R-01A,TCGA-D1-A16R-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16R-01A,10849,UCEC,39,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Indeterminate (neither Pre or Postmenopausal),-14465,Alive,TUMOR FREE,21,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,21,0,21,0,21,0,21,NA,younger,41.5331672,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A16S.01A,TCGA-D1-A16S,TCGA.D1.A16S,5.312530683,8.903223555,TCGA.D1.A16S.01A.11R.A12I.07,1.688921,1.558349,-0.8366852,-1.225982,0.3436472,UCEC,TCGA-D1-A16S,TCGA-D1-A16S-01A-11R-A12I-07,TCGA-D1-A16S-01A,TCGA-D1-A16S-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16S-01A,10850,UCEC,70,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,High Grade,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25690,Alive,TUMOR FREE,568,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,568,0,568,0,568,0,568,NA,older,22.48132907,level1,NA,NA,NA,NA,NA,NA
TCGA.D1.A16V.01A,TCGA-D1-A16V,TCGA.D1.A16V,5.549580404,9.062241015,TCGA.D1.A16V.01A.11R.A12I.07,3.507377,3.252672,0.385313,0.5924739,0.9819587,UCEC,TCGA-D1-A16V,TCGA-D1-A16V-01A-11R-A12I-07,TCGA-D1-A16V-01A,TCGA-D1-A16V-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16V-01A,10851,UCEC,78,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28635,Dead,TUMOR FREE,NA,120,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,120,0,120,0,120,0,120,NA,older,35.08302984,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A16X.01A,TCGA-D1-A16X,TCGA.D1.A16X,5.178387909,9.505888738,TCGA.D1.A16X.01A.11R.A12I.07,4.509641,4.266332,1.096236,1.594738,1.325174,UCEC,TCGA-D1-A16X,TCGA-D1-A16X-01A-11R-A12I-07,TCGA-D1-A16X-01A,TCGA-D1-A16X-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16X-01A,10852,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19799,Alive,TUMOR FREE,111,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,111,0,111,0,111,0,111,NA,younger,39.453125,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A16Y.01A,TCGA-D1-A16Y,TCGA.D1.A16Y,2.479604658,9.931058029,TCGA.D1.A16Y.01A.31R.A12I.07,1.334553,1.087656,-1.10738,-1.58035,0.203278,UCEC,TCGA-D1-A16Y,TCGA-D1-A16Y-01A-31R-A12I-07,TCGA-D1-A16Y-01A,TCGA-D1-A16Y-01A-31R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A16Y-01A,10853,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20455,Alive,TUMOR FREE,532,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,532,0,532,0,532,0,532,NA,younger,35.7495069,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A174.01A,TCGA-D1-A174,TCGA.D1.A174,4.503228574,10.38974676,TCGA.D1.A174.01A.11R.A12I.07,4.70833,4.883322,1.214516,1.793427,1.434154,UCEC,TCGA-D1-A174,TCGA-D1-A174-01A-11R-A12I-07,TCGA-D1-A174-01A,TCGA-D1-A174-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A174-01A,10854,UCEC,51,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,Indeterminate (neither Pre or Postmenopausal),-18702,Alive,TUMOR FREE,594,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,594,0,594,0,594,0,594,NA,younger,26.37023814,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A175.01A,TCGA-D1-A175,TCGA.D1.A175,2.979122819,10.02035982,TCGA.D1.A175.01A.11R.A12I.07,1.794721,1.715655,-0.8278115,-1.120183,0.4140884,UCEC,TCGA-D1-A175,TCGA-D1-A175-01A-11R-A12I-07,TCGA-D1-A175-01A,TCGA-D1-A175-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A175-01A,10855,UCEC,48,FEMALE,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009,Indeterminate (neither Pre or Postmenopausal),-17802,Alive,TUMOR FREE,202,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,202,0,202,0,202,0,202,NA,younger,24.69040546,level1,NA,NA,NA,NA,NA,NA
TCGA.D1.A176.01A,TCGA-D1-A176,TCGA.D1.A176,5.771707699,10.08922344,TCGA.D1.A176.01A.11R.A12I.07,2.926442,2.767183,-0.004718097,0.01153847,0.7558404,UCEC,TCGA-D1-A176,TCGA-D1-A176-01A-11R-A12I-07,TCGA-D1-A176-01A,TCGA-D1-A176-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A176-01A,10856,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24521,Alive,TUMOR FREE,917,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,917,0,917,0,917,0,917,NA,older,33.705045,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A177.01A,TCGA-D1-A177,TCGA.D1.A177,3.707014628,9.659112323,TCGA.D1.A177.01A.21R.A12I.07,0.7433241,0.6107893,-1.536663,-2.171579,0.02290453,UCEC,TCGA-D1-A177,TCGA-D1-A177-01A-21R-A12I-07,TCGA-D1-A177-01A,TCGA-D1-A177-01A-21R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A177-01A,10857,UCEC,70,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25602,Alive,TUMOR FREE,548,NA,[Not Available],Locoregional Disease,"Other, specify",paraaortic lymph nodes,347,Complete Remission/Response,NA,NA,0,548,0,548,1,347,1,347,NA,older,22.93975069,level1,NA,NA,NA,NA,NA,NA
TCGA.D1.A179.01A,TCGA-D1-A179,TCGA.D1.A179,3.426995158,7.643338257,TCGA.D1.A179.01A.11R.A12I.07,1.703235,1.730237,-0.8218559,-1.211668,0.3416598,UCEC,TCGA-D1-A179,TCGA-D1-A179-01A-11R-A12I-07,TCGA-D1-A179-01A,TCGA-D1-A179-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A179-01A,10858,UCEC,76,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,High Grade,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28037,Dead,WITH TUMOR,NA,448,[Not Available],Metastatic,Lung,NA,427,Complete Remission/Response,NA,NA,1,448,1,448,1,427,1,427,NA,older,36.19875019,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A17A.01A,TCGA-D1-A17A,TCGA.D1.A17A,5.804672314,7.20075311,TCGA.D1.A17A.01A.11R.A12I.07,2.768612,2.691663,-0.1018397,-0.1462917,0.7307033,UCEC,TCGA-D1-A17A,TCGA-D1-A17A-01A-11R-A12I-07,TCGA-D1-A17A-01A,TCGA-D1-A17A-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17A-01A,10859,UCEC,59,FEMALE,WHITE,[Not Applicable],Stage IIA,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21560,Alive,TUMOR FREE,48,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,48,0,48,0,48,0,48,NA,younger,32.92871901,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A17B.01A,TCGA-D1-A17B,TCGA.D1.A17B,5.452655704,10.91106265,TCGA.D1.A17B.01A.22R.A12I.07,4.711668,4.701675,1.294124,1.796765,1.390692,UCEC,TCGA-D1-A17B,TCGA-D1-A17B-01A-22R-A12I-07,TCGA-D1-A17B-01A,TCGA-D1-A17B-01A-22R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17B-01A,10860,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25504,Alive,TUMOR FREE,213,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,213,0,213,0,213,0,213,NA,older,41.91434233,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A17C.01A,TCGA-D1-A17C,TCGA.D1.A17C,4.619580644,10.13539936,TCGA.D1.A17C.01A.11R.A12I.07,3.307851,3.03602,0.2728115,0.3929478,0.9061658,UCEC,TCGA-D1-A17C,TCGA-D1-A17C-01A-11R-A12I-07,TCGA-D1-A17C-01A,TCGA-D1-A17C-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17C-01A,10861,UCEC,78,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28571,Alive,TUMOR FREE,30,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,30,0,30,0,30,0,30,NA,older,31.24879441,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A17D.01A,TCGA-D1-A17D,TCGA.D1.A17D,3.952951788,9.810156813,TCGA.D1.A17D.01A.12R.A12I.07,3.506216,3.46486,0.4457335,0.5913128,0.9697489,UCEC,TCGA-D1-A17D,TCGA-D1-A17D-01A-12R-A12I-07,TCGA-D1-A17D-01A,TCGA-D1-A17D-01A-12R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17D-01A,10862,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21441,Alive,TUMOR FREE,926,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,926,0,926,0,926,0,926,NA,younger,28.30385016,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A17F.01A,TCGA-D1-A17F,TCGA.D1.A17F,5.67683533,10.68360825,TCGA.D1.A17F.01A.11R.A12I.07,3.932573,3.851895,0.7201775,1.01767,1.122248,UCEC,TCGA-D1-A17F,TCGA-D1-A17F-01A-11R-A12I-07,TCGA-D1-A17F-01A,TCGA-D1-A17F-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17F-01A,10863,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25116,Alive,TUMOR FREE,39,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,39,0,39,0,39,0,39,NA,older,31.64556962,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A17H.01A,TCGA-D1-A17H,TCGA.D1.A17H,5.454746534,9.337961389,TCGA.D1.A17H.01A.11R.A12I.07,3.426109,3.21814,0.3356066,0.511206,0.9463606,UCEC,TCGA-D1-A17H,TCGA-D1-A17H-01A-11R-A12I-07,TCGA-D1-A17H-01A,TCGA-D1-A17H-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17H-01A,10864,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22389,Alive,TUMOR FREE,852,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,852,0,852,0,852,0,852,NA,younger,34.42217362,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A17K.01A,TCGA-D1-A17K,TCGA.D1.A17K,5.436135551,8.463293617,TCGA.D1.A17K.01A.11R.A12I.07,2.244059,2.170458,-0.4671974,-0.6708438,0.529957,UCEC,TCGA-D1-A17K,TCGA-D1-A17K-01A-11R-A12I-07,TCGA-D1-A17K-01A,TCGA-D1-A17K-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17K-01A,10865,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27283,Alive,TUMOR FREE,854,NA,[Not Available],Locoregional Disease,"Other, specify","Vagina, apex",815,Complete Remission/Response,NA,NA,0,854,0,854,1,815,1,815,NA,older,37.42139578,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A17L.01A,TCGA-D1-A17L,TCGA.D1.A17L,5.161403157,9.631983565,TCGA.D1.A17L.01A.11R.A12I.07,3.983267,3.860439,0.7498558,1.068364,1.167924,UCEC,TCGA-D1-A17L,TCGA-D1-A17L-01A-11R-A12I-07,TCGA-D1-A17L-01A,TCGA-D1-A17L-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17L-01A,10866,UCEC,81,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29899,Alive,TUMOR FREE,802,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,802,0,802,0,802,0,802,NA,older,41.57652785,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A17M.01A,TCGA-D1-A17M,TCGA.D1.A17M,6.126820906,8.688313789,TCGA.D1.A17M.01A.21R.A12I.07,2.809082,2.58638,-0.09376207,-0.1058217,0.7324767,UCEC,TCGA-D1-A17M,TCGA-D1-A17M-01A-21R-A12I-07,TCGA-D1-A17M-01A,TCGA-D1-A17M-01A-21R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17M-01A,10867,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20685,Alive,TUMOR FREE,311,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,311,0,311,0,311,0,311,NA,younger,53.44574504,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A17N.01A,TCGA-D1-A17N,TCGA.D1.A17N,4.661510886,10.11062192,TCGA.D1.A17N.01A.11R.A12I.07,4.002237,4.010602,0.7633282,1.087334,1.140783,UCEC,TCGA-D1-A17N,TCGA-D1-A17N-01A-11R-A12I-07,TCGA-D1-A17N-01A,TCGA-D1-A17N-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17N-01A,10868,UCEC,46,FEMALE,[Not Available],[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009,Peri (6-12 months since last menstrual period),-17045,Alive,TUMOR FREE,46,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,46,0,46,0,46,0,46,NA,younger,48.62824793,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A17Q.01A,TCGA-D1-A17Q,TCGA.D1.A17Q,2.658713198,10.03854373,TCGA.D1.A17Q.01A.11R.A12I.07,1.719505,1.668378,-0.8407128,-1.195398,0.3487421,UCEC,TCGA-D1-A17Q,TCGA-D1-A17Q-01A-11R-A12I-07,TCGA-D1-A17Q-01A,TCGA-D1-A17Q-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17Q-01A,10869,UCEC,54,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009,Peri (6-12 months since last menstrual period),-20015,Alive,TUMOR FREE,54,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,54,0,54,0,54,0,54,NA,younger,23.80869017,level1,NA,NA,NA,NA,NA,NA
TCGA.D1.A17R.01A,TCGA-D1-A17R,TCGA.D1.A17R,6.179194748,9.700115287,TCGA.D1.A17R.01A.11R.A12I.07,2.147693,2.103273,-0.5027656,-0.7672102,0.467923,UCEC,TCGA-D1-A17R,TCGA-D1-A17R-01A-11R-A12I-07,TCGA-D1-A17R-01A,TCGA-D1-A17R-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17R-01A,10870,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-21382,Dead,TUMOR FREE,NA,339,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,339,0,339,0,339,0,339,NA,younger,46.28099174,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A17S.01A,TCGA-D1-A17S,TCGA.D1.A17S,4.486917044,10.53194487,TCGA.D1.A17S.01A.11R.A12I.07,2.442986,2.454811,-0.2924651,-0.4719173,0.5734539,UCEC,TCGA-D1-A17S,TCGA-D1-A17S-01A-11R-A12I-07,TCGA-D1-A17S-01A,TCGA-D1-A17S-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17S-01A,10871,UCEC,59,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21794,Alive,TUMOR FREE,739,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,739,0,739,0,739,0,739,NA,younger,42.578125,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A17T.01A,TCGA-D1-A17T,TCGA.D1.A17T,4.843250477,9.64936144,TCGA.D1.A17T.01A.11R.A12I.07,3.122906,3.010465,0.1519314,0.208003,0.8247421,UCEC,TCGA-D1-A17T,TCGA-D1-A17T-01A-11R-A12I-07,TCGA-D1-A17T-01A,TCGA-D1-A17T-01A-11R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17T-01A,10872,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24652,Alive,TUMOR FREE,71,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,71,0,71,0,71,0,71,NA,older,32.83097979,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A17U.01A,TCGA-D1-A17U,TCGA.D1.A17U,4.701595498,10.1654175,TCGA.D1.A17U.01A.21R.A12I.07,2.999759,2.93386,0.07313915,0.08485539,0.7950669,UCEC,TCGA-D1-A17U,TCGA-D1-A17U-01A-21R-A12I-07,TCGA-D1-A17U-01A,TCGA-D1-A17U-01A-21R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-D1-A17U-01A,10873,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19544,Alive,TUMOR FREE,697,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,697,0,697,0,697,0,697,NA,younger,30.82482993,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A1NS.01A,TCGA-D1-A1NS,TCGA.D1.A1NS,5.941483324,9.716335412,TCGA.D1.A1NS.01A.11R.A14D.07,2.508154,2.368368,-0.2471437,-0.4067493,0.5925799,UCEC,TCGA-D1-A1NS,TCGA-D1-A1NS-01A-11R-A14D-07,TCGA-D1-A1NS-01A,TCGA-D1-A1NS-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-D1-A1NS-01A,10874,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19638,Alive,TUMOR FREE,43,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,43,0,43,0,43,0,43,NA,younger,39.7677061,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A1NU.01A,TCGA-D1-A1NU,TCGA.D1.A1NU,4.006580018,8.386161277,TCGA.D1.A1NU.01A.11R.A14D.07,2.654748,2.579039,-0.2024453,-0.2601549,0.6907744,UCEC,TCGA-D1-A1NU,TCGA-D1-A1NU-01A-11R-A14D-07,TCGA-D1-A1NU-01A,TCGA-D1-A1NU-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-D1-A1NU-01A,10875,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27272,Alive,TUMOR FREE,402,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,402,0,402,0,402,0,402,NA,older,40.78768475,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A1NW.01A,TCGA-D1-A1NW,TCGA.D1.A1NW,4.580410195,9.132730655,TCGA.D1.A1NW.01A.11R.A14M.07,2.557333,2.428891,-0.2765462,-0.3575702,0.6301339,UCEC,TCGA-D1-A1NW,TCGA-D1-A1NW-01A-11R-A14M-07,TCGA-D1-A1NW-01A,TCGA-D1-A1NW-01A-11R-A14M-07,TP,Primary solid Tumor,1,1,A14M,1,0,1,Female,1,Tumor,TCGA-D1-A1NW-01A,10876,UCEC,72,FEMALE,WHITE,[Not Applicable],Stage IVB,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26556,Alive,TUMOR FREE,22,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,22,0,22,NA,NA,0,22,NA,older,38.28125,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A1NX.01A,TCGA-D1-A1NX,TCGA.D1.A1NX,5.263597007,8.308313413,TCGA.D1.A1NX.01A.11R.A16F.07,1.953809,1.919095,-0.6744748,-0.9610942,0.3946922,UCEC,TCGA-D1-A1NX,TCGA-D1-A1NX-01A-11R-A16F-07,TCGA-D1-A1NX-01A,TCGA-D1-A1NX-01A-11R-A16F-07,TP,Primary solid Tumor,1,1,A16F,1,0,1,Female,1,Tumor,TCGA-D1-A1NX-01A,10877,UCEC,66,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24441,Alive,WITH TUMOR,555,NA,[Not Available],Metastatic,"Other, specify",Supraclavicular lymphnodes,476,Complete Remission/Response,NA,NA,0,555,0,555,1,476,1,476,NA,older,34.41319568,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A1NY.01A,TCGA-D1-A1NY,TCGA.D1.A1NY,4.539418118,7.632912668,TCGA.D1.A1NY.01A.11R.A16F.07,2.05854,1.904369,-0.6137451,-0.8563629,0.4239752,UCEC,TCGA-D1-A1NY,TCGA-D1-A1NY-01A-11R-A16F-07,TCGA-D1-A1NY-01A,TCGA-D1-A1NY-01A-11R-A16F-07,TP,Primary solid Tumor,1,1,A16F,1,0,1,Female,1,Tumor,TCGA-D1-A1NY-01A,10878,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24683,Alive,TUMOR FREE,513,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,513,0,513,0,513,0,513,NA,older,34.36791383,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A1NZ.01A,TCGA-D1-A1NZ,TCGA.D1.A1NZ,5.41094587,10.30299684,TCGA.D1.A1NZ.01A.21R.A14D.07,3.26987,3.099118,0.1981918,0.3549671,0.8926677,UCEC,TCGA-D1-A1NZ,TCGA-D1-A1NZ-01A-21R-A14D-07,TCGA-D1-A1NZ-01A,TCGA-D1-A1NZ-01A-21R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-D1-A1NZ-01A,10879,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22027,Alive,TUMOR FREE,548,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,548,0,548,0,548,0,548,NA,younger,35.5998576,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A1O0.01A,TCGA-D1-A1O0,TCGA.D1.A1O0,3.866187538,9.32488209,TCGA.D1.A1O0.01A.11R.A17B.07,1.967923,1.828816,-0.649214,-0.9469806,0.4274478,UCEC,TCGA-D1-A1O0,TCGA-D1-A1O0-01A-11R-A17B-07,TCGA-D1-A1O0-01A,TCGA-D1-A1O0-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-D1-A1O0-01A,10880,UCEC,77,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28162,Alive,TUMOR FREE,63,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,63,0,63,0,63,0,63,NA,older,47.46642866,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A1O5.01A,TCGA-D1-A1O5,TCGA.D1.A1O5,5.550716562,8.906517132,TCGA.D1.A1O5.01A.11R.A14D.07,2.621833,2.607056,-0.176418,-0.2930701,0.6435701,UCEC,TCGA-D1-A1O5,TCGA-D1-A1O5-01A-11R-A14D-07,TCGA-D1-A1O5-01A,TCGA-D1-A1O5-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-D1-A1O5-01A,10881,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22580,Alive,TUMOR FREE,458,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,458,0,458,0,458,0,458,NA,younger,30.86300683,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A1O7.01A,TCGA-D1-A1O7,TCGA.D1.A1O7,6.156836271,9.69757509,TCGA.D1.A1O7.01A.11R.A14D.07,2.320837,2.149566,-0.414946,-0.5940658,0.5244366,UCEC,TCGA-D1-A1O7,TCGA-D1-A1O7-01A-11R-A14D-07,TCGA-D1-A1O7-01A,TCGA-D1-A1O7-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-D1-A1O7-01A,10882,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22037,Alive,TUMOR FREE,32,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,32,0,32,0,32,0,32,NA,younger,43.8276114,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A1O8.01A,TCGA-D1-A1O8,TCGA.D1.A1O8,1.544851633,3.785805727,TCGA.D1.A1O8.01A.11R.A14D.07,4.955906,4.935962,1.408244,2.041003,1.499535,UCEC,TCGA-D1-A1O8,TCGA-D1-A1O8-01A-11R-A14D-07,TCGA-D1-A1O8-01A,TCGA-D1-A1O8-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-D1-A1O8-01A,10883,UCEC,70,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25789,Dead,TUMOR FREE,NA,120,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,120,0,120,0,120,0,120,NA,older,31.22130395,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A2G0.01A,TCGA-D1-A2G0,TCGA.D1.A2G0,8.774958328,9.716097505,TCGA.D1.A2G0.01A.11R.A32Y.07,3.248052,3.282583,0.193866,0.3331484,0.9221088,UCEC,TCGA-D1-A2G0,TCGA-D1-A2G0-01A-11R-A32Y-07,TCGA-D1-A2G0-01A,TCGA-D1-A2G0-01A-11R-A32Y-07,TP,Primary solid Tumor,1,1,A32Y,1,0,1,Female,1,Tumor,TCGA-D1-A2G0-01A,10884,UCEC,70,FEMALE,WHITE,[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25573,Alive,TUMOR FREE,1484,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,1484,0,1484,NA,NA,0,1484,NA,older,24.96494648,level1,NA,NA,NA,NA,NA,NA
TCGA.D1.A2G5.01A,TCGA-D1-A2G5,TCGA.D1.A2G5,3.612842191,10.45670817,TCGA.D1.A2G5.01A.11R.A17B.07,1.414933,1.180269,-1.030384,-1.49997,0.2556196,UCEC,TCGA-D1-A2G5,TCGA-D1-A2G5-01A-11R-A17B-07,TCGA-D1-A2G5-01A,TCGA-D1-A2G5-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-D1-A2G5-01A,10885,UCEC,50,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18322,Alive,WITH TUMOR,1455,NA,[Not Available],Distant Metastasis,"Other, specify",omentum,1122,Complete Remission/Response,NA,NA,0,1455,0,1455,1,1122,1,1122,NA,younger,47.7797454,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A2G6.01A,TCGA-D1-A2G6,TCGA.D1.A2G6,4.436116839,7.667160343,TCGA.D1.A2G6.01A.11R.A17B.07,2.477872,2.357605,-0.2840408,-0.4370315,0.5800268,UCEC,TCGA-D1-A2G6,TCGA-D1-A2G6-01A-11R-A17B-07,TCGA-D1-A2G6-01A,TCGA-D1-A2G6-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-D1-A2G6-01A,10886,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19547,Dead,WITH TUMOR,NA,258,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,1,258,1,258,NA,NA,1,258,NA,younger,28.3446712,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A2G7.01A,TCGA-D1-A2G7,TCGA.D1.A2G7,3.417004055,8.129747989,TCGA.D1.A2G7.01A.21R.A180.07,1.29719,1.040101,-1.128985,-1.617713,0.1822664,UCEC,TCGA-D1-A2G7,TCGA-D1-A2G7-01A-21R-A180-07,TCGA-D1-A2G7-01A,TCGA-D1-A2G7-01A-21R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-D1-A2G7-01A,10887,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2007,Peri (6-12 months since last menstrual period),-23913,Dead,TUMOR FREE,NA,1793,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,1793,0,1793,0,1793,0,1793,NA,NA,49.4497323,level4,NA,NA,NA,NA,NA,NA
TCGA.D1.A3DA.01A,TCGA-D1-A3DA,TCGA.D1.A3DA,5.903103364,10.52262076,TCGA.D1.A3DA.01A.12R.A213.07,1.450004,1.401439,-0.9681294,-1.464899,0.2235661,UCEC,TCGA-D1-A3DA,TCGA-D1-A3DA-01A-12R-A213-07,TCGA-D1-A3DA-01A,TCGA-D1-A3DA-01A-12R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-D1-A3DA-01A,10888,UCEC,77,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28142,Alive,TUMOR FREE,483,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,483,0,483,0,483,0,483,NA,older,24.67105263,level1,NA,NA,NA,NA,NA,NA
TCGA.D1.A3DG.01A,TCGA-D1-A3DG,TCGA.D1.A3DG,2.399116393,9.176230507,TCGA.D1.A3DG.01A.11R.A19W.07,0.9871796,0.8964291,-1.302449,-1.927724,0.08639535,UCEC,TCGA-D1-A3DG,TCGA-D1-A3DG-01A-11R-A19W-07,TCGA-D1-A3DG-01A,TCGA-D1-A3DG-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-D1-A3DG-01A,10889,UCEC,81,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29771,Dead,TUMOR FREE,NA,130,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,1,130,0,130,NA,NA,0,130,NA,older,30.47052154,level3,NA,NA,NA,NA,NA,NA
TCGA.D1.A3DH.01A,TCGA-D1-A3DH,TCGA.D1.A3DH,2.602694412,7.829177262,TCGA.D1.A3DH.01A.11R.A19W.07,0.2003848,0.05839906,-1.882556,-2.714518,-0.2086229,UCEC,TCGA-D1-A3DH,TCGA-D1-A3DH-01A-11R-A19W-07,TCGA-D1-A3DH-01A,TCGA-D1-A3DH-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-D1-A3DH-01A,10890,UCEC,71,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25935,Alive,TUMOR FREE,573,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,573,0,573,0,573,0,573,NA,older,26.92743764,level2,NA,NA,NA,NA,NA,NA
TCGA.D1.A3JP.01A,TCGA-D1-A3JP,TCGA.D1.A3JP,9.390143155,9.531864877,TCGA.D1.A3JP.01A.31R.A22K.07,4.126284,4.058736,0.8424028,1.21138,1.214937,UCEC,TCGA-D1-A3JP,TCGA-D1-A3JP-01A-31R-A22K-07,TCGA-D1-A3JP-01A,TCGA-D1-A3JP-01A-31R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-D1-A3JP-01A,10891,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22538,Alive,TUMOR FREE,515,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,NA,NA,0,515,0,515,NA,NA,0,515,NA,younger,23.33768443,level1,NA,NA,NA,NA,NA,NO
TCGA.D1.A3JQ.01A,TCGA-D1-A3JQ,TCGA.D1.A3JQ,4.949324816,9.245949571,TCGA.D1.A3JQ.01A.11R.A22K.07,2.949061,2.819438,0.02304945,0.03415751,0.7604053,UCEC,TCGA-D1-A3JQ,TCGA-D1-A3JQ-01A-11R-A22K-07,TCGA-D1-A3JQ-01A,TCGA-D1-A3JQ-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-D1-A3JQ-01A,10892,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22297,Alive,TUMOR FREE,526,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,526,0,526,0,526,0,526,NA,younger,46.68029783,level4,NA,NA,NA,NA,NA,NO
TCGA.DF.A2KN.01A,TCGA-DF-A2KN,TCGA.DF.A2KN,5.49535939,9.942373748,TCGA.DF.A2KN.01A.11R.A180.07,4.381652,4.390066,1.010508,1.466749,1.302861,UCEC,TCGA-DF-A2KN,TCGA-DF-A2KN-01A-11R-A180-07,TCGA-DF-A2KN-01A,TCGA-DF-A2KN-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-DF-A2KN-01A,10893,UCEC,NA,FEMALE,[Not Evaluated],[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,67,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,67,0,67,0,67,0,67,NA,NA,33.32756233,level3,NA,NA,NA,NA,NA,NA
TCGA.DF.A2KR.01A,TCGA-DF-A2KR,TCGA.DF.A2KR,6.103124119,9.690553285,TCGA.DF.A2KR.01A.11R.A180.07,3.047405,2.88824,0.1087752,0.1325017,0.7872673,UCEC,TCGA-DF-A2KR,TCGA-DF-A2KR-01A-11R-A180-07,TCGA-DF-A2KR-01A,TCGA-DF-A2KR-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-DF-A2KR-01A,10894,UCEC,84,FEMALE,[Not Evaluated],[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31007,Alive,TUMOR FREE,2178,NA,[Not Available],New Primary Tumor,Lung,NA,2113,Complete Remission/Response,NA,NA,0,2178,0,2178,0,2178,1,2113,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.DF.A2KS.01A,TCGA-DF-A2KS,TCGA.DF.A2KS,5.379954142,11.04716984,TCGA.DF.A2KS.01A.11R.A18M.07,3.063778,3.100622,0.08692063,0.1488751,0.8486253,UCEC,TCGA-DF-A2KS,TCGA-DF-A2KS-01A-11R-A18M-07,TCGA-DF-A2KS-01A,TCGA-DF-A2KS-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-DF-A2KS-01A,10895,UCEC,69,FEMALE,[Not Evaluated],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25313,Alive,TUMOR FREE,3318,NA,[Not Available],New Primary Tumor,"Other, specify",colorectal,2277,Complete Remission/Response,NA,NA,0,3318,0,3318,0,3318,1,2277,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.DF.A2KU.01A,TCGA-DF-A2KU,TCGA.DF.A2KU,3.006675032,8.73699039,TCGA.DF.A2KU.01A.11R.A180.07,4.814276,4.806559,1.316963,1.899373,1.435674,UCEC,TCGA-DF-A2KU,TCGA-DF-A2KU-01A-11R-A180-07,TCGA-DF-A2KU-01A,TCGA-DF-A2KU-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-DF-A2KU-01A,10896,UCEC,NA,FEMALE,[Not Evaluated],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),NA,Alive,TUMOR FREE,3067,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,3067,0,3067,0,3067,0,3067,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.DF.A2KV.01A,TCGA-DF-A2KV,TCGA.DF.A2KV,5.209870517,9.372947746,TCGA.DF.A2KV.01A.11R.A180.07,3.363832,3.265653,0.3414356,0.4489285,0.8860038,UCEC,TCGA-DF-A2KV,TCGA-DF-A2KV-01A-11R-A180-07,TCGA-DF-A2KV-01A,TCGA-DF-A2KV-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-DF-A2KV-01A,10897,UCEC,55,FEMALE,[Not Evaluated],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20160,Alive,TUMOR FREE,2717,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,2717,0,2717,NA,NA,0,2717,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.DF.A2KY.01A,TCGA-DF-A2KY,TCGA.DF.A2KY,2.488257913,2.734525377,TCGA.DF.A2KY.01A.21R.A213.07,3.736723,3.692225,0.583011,0.8218194,1.039852,UCEC,TCGA-DF-A2KY,TCGA-DF-A2KY-01A-21R-A213-07,TCGA-DF-A2KY-01A,TCGA-DF-A2KY-01A-21R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-DF-A2KY-01A,10898,UCEC,49,FEMALE,[Not Evaluated],[Not Applicable],Stage IVA,Endometrioid endometrial adenocarcinoma,G3,NA,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18086,Alive,WITH TUMOR,332,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,332,0,332,NA,NA,0,332,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.DF.A2KZ.01A,TCGA-DF-A2KZ,TCGA.DF.A2KZ,4.765189943,8.250833703,TCGA.DF.A2KZ.01A.11R.A213.07,2.944109,2.945719,0.02232713,0.0292059,0.7828927,UCEC,TCGA-DF-A2KZ,TCGA-DF-A2KZ-01A-11R-A213-07,TCGA-DF-A2KZ-01A,TCGA-DF-A2KZ-01A-11R-A213-07,TP,Primary solid Tumor,1,1,A213,1,0,1,Female,1,Tumor,TCGA-DF-A2KZ-01A,10899,UCEC,87,FEMALE,[Not Evaluated],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31973,Alive,TUMOR FREE,826,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,826,0,826,NA,NA,0,826,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.DF.A2L0.01A,TCGA-DF-A2L0,TCGA.DF.A2L0,5.895549836,8.514015711,TCGA.DF.A2L0.01A.11R.A180.07,3.042389,3.329589,0.1349211,0.1274863,0.757574,UCEC,TCGA-DF-A2L0,TCGA-DF-A2L0-01A-11R-A180-07,TCGA-DF-A2L0-01A,TCGA-DF-A2L0-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-DF-A2L0-01A,10900,UCEC,60,FEMALE,[Not Evaluated],[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,NA,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22200,Dead,WITH TUMOR,NA,788,[Not Available],Distant Metastasis,"Other, specify",lymph nodes and retroperitoneal tissue,523,Complete Remission/Response,NA,NA,1,788,1,788,1,523,1,523,NA,younger,33.65929705,level3,NA,NA,NA,NA,NA,NA
TCGA.DI.A0WH.01A,TCGA-DI-A0WH,TCGA.DI.A0WH,3.727856098,7.438694865,TCGA.DI.A0WH.01A.12R.A12I.07,1.921134,1.890303,-0.7269181,-0.9937688,0.4445252,UCEC,TCGA-DI-A0WH,TCGA-DI-A0WH-01A-12R-A12I-07,TCGA-DI-A0WH-01A,TCGA-DI-A0WH-01A-12R-A12I-07,TP,Primary solid Tumor,1,1,A12I,1,0,1,Female,1,Tumor,TCGA-DI-A0WH-01A,10901,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,[Not Available],-23692,Alive,TUMOR FREE,496,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,496,0,496,0,496,0,496,NA,younger,35.75127802,level4,NA,NA,NA,NA,NA,NA
TCGA.DI.A1BU.01A,TCGA-DI-A1BU,TCGA.DI.A1BU,2.549693811,10.49739282,TCGA.DI.A1BU.01A.11R.A137.07,2.983667,3.070275,0.01136537,0.06876415,0.7964347,UCEC,TCGA-DI-A1BU,TCGA-DI-A1BU-01A-11R-A137-07,TCGA-DI-A1BU-01A,TCGA-DI-A1BU-01A-11R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-DI-A1BU-01A,10902,UCEC,55,FEMALE,WHITE,[Not Applicable],Stage IIB,Mixed serous and endometrioid,G3,2008,[Not Available],-20114,Alive,TUMOR FREE,1195,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1195,0,1195,0,1195,0,1195,NA,younger,31.80465784,level3,NA,NA,NA,NA,NA,NA
TCGA.DI.A1BY.01A,TCGA-DI-A1BY,TCGA.DI.A1BY,4.441059044,8.570380457,TCGA.DI.A1BY.01A.21R.A137.07,3.343389,3.305486,0.2684531,0.4284854,0.9078862,UCEC,TCGA-DI-A1BY,TCGA-DI-A1BY-01A-21R-A137-07,TCGA-DI-A1BY-01A,TCGA-DI-A1BY-01A-21R-A137-07,TP,Primary solid Tumor,1,1,A137,1,0,1,Female,1,Tumor,TCGA-DI-A1BY-01A,10903,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IIB,Endometrioid endometrial adenocarcinoma,G2,2008,[Not Available],-23113,Alive,TUMOR FREE,1114,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1114,0,1114,0,1114,0,1114,NA,younger,52.02913632,level4,NA,NA,NA,NA,NA,NA
TCGA.DI.A1NN.01A,TCGA-DI-A1NN,TCGA.DI.A1NN,3.877662632,7.606438175,TCGA.DI.A1NN.01A.11R.A16F.07,3.61508,3.574192,0.4952039,0.7001768,0.9846045,UCEC,TCGA-DI-A1NN,TCGA-DI-A1NN-01A-11R-A16F-07,TCGA-DI-A1NN-01A,TCGA-DI-A1NN-01A-11R-A16F-07,TP,Primary solid Tumor,1,1,A16F,1,0,1,Female,1,Tumor,TCGA-DI-A1NN-01A,10905,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23026,Alive,WITH TUMOR,1076,NA,[Not Available],Metastatic,"Other, specify",vagina,1023,Complete Remission/Response,NA,NA,0,1076,0,1076,1,1023,1,1023,NA,younger,23.72281065,level1,NA,NA,NA,NA,NA,NA
TCGA.DI.A1NO.01A,TCGA-DI-A1NO,TCGA.DI.A1NO,3.164685205,3.379577077,TCGA.DI.A1NO.01A.31R.A157.07,0.8084465,0.6847614,-1.471501,-2.106457,0.01472951,UCEC,TCGA-DI-A1NO,TCGA-DI-A1NO-01A-31R-A157-07,TCGA-DI-A1NO-01A,TCGA-DI-A1NO-01A-31R-A157-07,TP,Primary solid Tumor,1,1,A157,1,0,1,Female,1,Tumor,TCGA-DI-A1NO-01A,10906,UCEC,68,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24996,Dead,WITH TUMOR,NA,285,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,285,1,285,NA,NA,1,285,NA,older,44.27347946,level4,NA,NA,NA,NA,NA,NA
TCGA.DI.A2QT.01A,TCGA-DI-A2QT,TCGA.DI.A2QT,6.423277298,3.679874148,TCGA.DI.A2QT.01A.12R.A19W.07,1.600337,1.335216,-0.9077774,-1.314566,0.291625,UCEC,TCGA-DI-A2QT,TCGA-DI-A2QT-01A-12R-A19W-07,TCGA-DI-A2QT-01A,TCGA-DI-A2QT-01A-12R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-DI-A2QT-01A,10907,UCEC,51,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18835,Dead,WITH TUMOR,NA,377,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,1,377,1,377,NA,NA,1,377,NA,younger,25.47666009,level2,NA,NA,NA,NA,NA,NA
TCGA.DI.A2QU.01A,TCGA-DI-A2QU,TCGA.DI.A2QU,2.657991156,8.160412087,TCGA.DI.A2QU.01A.11R.A18M.07,2.086362,2.119496,-0.5515343,-0.8285415,0.4850026,UCEC,TCGA-DI-A2QU,TCGA-DI-A2QU-01A-11R-A18M-07,TCGA-DI-A2QU-01A,TCGA-DI-A2QU-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-DI-A2QU-01A,10908,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24488,Dead,WITH TUMOR,NA,946,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,1,946,1,946,NA,NA,1,946,NA,older,36.328125,level4,NA,NA,NA,NA,NA,NA
TCGA.DI.A2QY.01A,TCGA-DI-A2QY,TCGA.DI.A2QY,3.539196041,8.554765341,TCGA.DI.A2QY.01A.12R.A19W.07,0.9506283,0.8907485,-1.386962,-1.964275,0.1026031,UCEC,TCGA-DI-A2QY,TCGA-DI-A2QY-01A-12R-A19W-07,TCGA-DI-A2QY-01A,TCGA-DI-A2QY-01A-12R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-DI-A2QY-01A,10909,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IIB,Serous endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23398,Dead,TUMOR FREE,NA,3349,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,3349,0,3349,0,3349,0,3349,NA,younger,33.203125,level3,NA,NA,NA,NA,NA,NA
TCGA.E6.A1LX.01A,TCGA-E6-A1LX,TCGA.E6.A1LX,3.068297298,9.782141148,TCGA.E6.A1LX.01A.11R.A14D.07,1.773022,1.800083,-0.8319895,-1.141881,0.3871141,UCEC,TCGA-E6-A1LX,TCGA-E6-A1LX-01A-11R-A14D-07,TCGA-E6-A1LX-01A,TCGA-E6-A1LX-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-E6-A1LX-01A,10910,UCEC,40,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-14731,Alive,TUMOR FREE,711,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,711,0,711,0,711,0,711,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.E6.A1LZ.01A,TCGA-E6-A1LZ,TCGA.E6.A1LZ,6.300324125,8.433465911,TCGA.E6.A1LZ.01A.11R.A144.07,2.45024,2.404189,-0.3336269,-0.4646629,0.5825023,UCEC,TCGA-E6-A1LZ,TCGA-E6-A1LZ-01A-11R-A144-07,TCGA-E6-A1LZ-01A,TCGA-E6-A1LZ-01A-11R-A144-07,TP,Primary solid Tumor,1,1,A144,1,0,1,Female,1,Tumor,TCGA-E6-A1LZ-01A,10911,UCEC,76,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28054,Alive,TUMOR FREE,2406,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2406,0,2406,0,2406,0,2406,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.E6.A1M0.01A,TCGA-E6-A1M0,TCGA.E6.A1M0,3.254538819,5.767865084,TCGA.E6.A1M0.01A.11R.A144.07,2.153752,2.196769,-0.5766966,-0.761151,0.5059981,UCEC,TCGA-E6-A1M0,TCGA-E6-A1M0-01A-11R-A144-07,TCGA-E6-A1M0-01A,TCGA-E6-A1M0-01A-11R-A144-07,TP,Primary solid Tumor,1,1,A144,1,0,1,Female,1,Tumor,TCGA-E6-A1M0-01A,10912,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20629,Alive,TUMOR FREE,1793,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1793,0,1793,0,1793,0,1793,NA,younger,37.653587,level4,NA,NA,NA,NA,NA,NA
TCGA.E6.A2P8.01A,TCGA-E6-A2P8,TCGA.E6.A2P8,2.023255352,8.585927731,TCGA.E6.A2P8.01A.11R.A19W.07,3.810002,3.568179,0.6042524,0.8950986,1.091775,UCEC,TCGA-E6-A2P8,TCGA-E6-A2P8-01A-11R-A19W-07,TCGA-E6-A2P8-01A,TCGA-E6-A2P8-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-E6-A2P8-01A,10913,UCEC,53,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IV,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19448,Dead,WITH TUMOR,NA,72,[Not Available],Metastatic,Lung,NA,60,Progressive Disease,NA,NA,1,72,1,72,NA,NA,1,60,NA,younger,31.22945431,level3,NA,NA,NA,NA,NA,NA
TCGA.E6.A2P9.01A,TCGA-E6-A2P9,TCGA.E6.A2P9,2.583302447,10.48722706,TCGA.E6.A2P9.01A.11R.A19W.07,2.666824,2.631327,-0.2239679,-0.2480791,0.7227675,UCEC,TCGA-E6-A2P9,TCGA-E6-A2P9-01A-11R-A19W-07,TCGA-E6-A2P9-01A,TCGA-E6-A2P9-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-E6-A2P9-01A,10914,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24088,Alive,TUMOR FREE,1386,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1386,0,1386,0,1386,0,1386,NA,NA,41.76551171,level4,NA,NA,NA,NA,NA,NA
TCGA.E6.A8L9.01A,TCGA-E6-A8L9,TCGA.E6.A8L9,4.824172122,10.93307096,TCGA.E6.A8L9.01A.21R.A37O.07,2.872002,2.867888,-0.03442337,-0.04290141,0.7538785,UCEC,TCGA-E6-A8L9,TCGA-E6-A8L9-01A-21R-A37O-07,TCGA-E6-A8L9-01A,TCGA-E6-A8L9-01A-21R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-E6-A8L9-01A,10915,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22333,Alive,TUMOR FREE,1013,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1013,0,1013,0,1013,0,1013,NA,younger,29.7210791,level2,NA,NA,NA,NA,NA,YES
TCGA.EC.A1NJ.01A,TCGA-EC-A1NJ,TCGA.EC.A1NJ,7.277384757,9.853109485,TCGA.EC.A1NJ.01A.31R.A14D.07,3.834417,3.774032,0.5977731,0.9195139,1.126386,UCEC,TCGA-EC-A1NJ,TCGA-EC-A1NJ-01A-31R-A14D-07,TCGA-EC-A1NJ-01A,TCGA-EC-A1NJ-01A-31R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-EC-A1NJ-01A,10916,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27002,Alive,TUMOR FREE,488,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,488,0,488,0,488,0,488,NA,older,26.48553975,level2,NA,NA,NA,NA,NA,NA
TCGA.EC.A1QX.01A,TCGA-EC-A1QX,TCGA.EC.A1QX,6.648881339,7.806886463,TCGA.EC.A1QX.01A.31R.A16F.07,3.336937,3.2763,0.2726621,0.4220333,0.9211055,UCEC,TCGA-EC-A1QX,TCGA-EC-A1QX-01A-31R-A16F-07,TCGA-EC-A1QX-01A,TCGA-EC-A1QX-01A-31R-A16F-07,TP,Primary solid Tumor,1,1,A16F,1,0,1,Female,1,Tumor,TCGA-EC-A1QX-01A,10917,UCEC,71,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26259,Alive,TUMOR FREE,224,NA,[Not Available],NA,NA,NA,219,Progressive Disease,NA,NA,0,224,0,224,NA,NA,1,219,NA,older,34.72088268,level3,NA,NA,NA,NA,NA,NA
TCGA.EC.A24G.01A,TCGA-EC-A24G,TCGA.EC.A24G,4.878289855,10.31860721,TCGA.EC.A24G.01A.11R.A16F.07,3.013016,3.058427,0.0498778,0.09811269,0.7919765,UCEC,TCGA-EC-A24G,TCGA-EC-A24G-01A-11R-A16F-07,TCGA-EC-A24G-01A,TCGA-EC-A24G-01A-11R-A16F-07,TP,Primary solid Tumor,1,1,A16F,1,0,1,Female,1,Tumor,TCGA-EC-A24G-01A,10918,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20857,Alive,TUMOR FREE,511,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,511,0,511,0,511,0,511,NA,younger,42.45799854,level4,NA,NA,NA,NA,NA,NA
TCGA.EO.A1Y5.01A,TCGA-EO-A1Y5,TCGA.EO.A1Y5,3.021735349,7.001289129,TCGA.EO.A1Y5.01A.11R.A157.07,3.933862,3.981813,0.6830827,1.018959,1.113621,UCEC,TCGA-EO-A1Y5,TCGA-EO-A1Y5-01A-11R-A157-07,TCGA-EO-A1Y5-01A,TCGA-EO-A1Y5-01A-11R-A157-07,TP,Primary solid Tumor,1,1,A157,1,0,1,Female,1,Tumor,TCGA-EO-A1Y5-01A,10919,UCEC,63,FEMALE,[Not Available],[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23251,Alive,TUMOR FREE,332,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,332,0,332,0,332,0,332,NA,younger,30.47721924,level3,NA,NA,NA,NA,NA,NA
TCGA.EO.A1Y7.01A,TCGA-EO-A1Y7,TCGA.EO.A1Y7,3.895913311,9.527250223,TCGA.EO.A1Y7.01A.11R.A157.07,2.168839,2.031432,-0.5550348,-0.7460643,0.5156234,UCEC,TCGA-EO-A1Y7,TCGA-EO-A1Y7-01A-11R-A157-07,TCGA-EO-A1Y7-01A,TCGA-EO-A1Y7-01A-11R-A157-07,TP,Primary solid Tumor,1,1,A157,1,0,1,Female,1,Tumor,TCGA-EO-A1Y7-01A,10920,UCEC,65,FEMALE,[Not Available],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24085,Alive,WITH TUMOR,1495,NA,[Not Available],Distant Metastasis,Lung,NA,880,Progressive Disease,NA,NA,0,1495,0,1495,NA,NA,1,880,NA,NA,34.89439853,level3,NA,NA,NA,NA,NA,NA
TCGA.EO.A1Y8.01A,TCGA-EO-A1Y8,TCGA.EO.A1Y8,3.351778806,8.818590305,TCGA.EO.A1Y8.01A.11R.A157.07,1.224823,1.209007,-1.184248,-1.690081,0.1711545,UCEC,TCGA-EO-A1Y8,TCGA-EO-A1Y8-01A-11R-A157-07,TCGA-EO-A1Y8-01A,TCGA-EO-A1Y8-01A-11R-A157-07,TP,Primary solid Tumor,1,1,A157,1,0,1,Female,1,Tumor,TCGA-EO-A1Y8-01A,10921,UCEC,87,FEMALE,[Not Available],[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31971,Alive,TUMOR FREE,1147,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1147,0,1147,0,1147,0,1147,NA,older,27.20960781,level2,NA,NA,NA,NA,NA,NA
TCGA.EO.A22R.01A,TCGA-EO-A22R,TCGA.EO.A22R,2.862771663,10.26316342,TCGA.EO.A22R.01A.11R.A18M.07,2.614224,2.524898,-0.202649,-0.3006788,0.6496629,UCEC,TCGA-EO-A22R,TCGA-EO-A22R-01A-11R-A18M-07,TCGA-EO-A22R-01A,TCGA-EO-A22R-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-EO-A22R-01A,10922,UCEC,56,FEMALE,[Not Available],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20604,Alive,TUMOR FREE,1878,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1878,0,1878,0,1878,0,1878,NA,younger,31.17913832,level3,NA,NA,NA,NA,NA,NA
TCGA.EO.A22S.01A,TCGA-EO-A22S,TCGA.EO.A22S,3.141874402,9.272835761,TCGA.EO.A22S.01A.11R.A18M.07,1.031531,1.050007,-1.321897,-1.883372,0.1249701,UCEC,TCGA-EO-A22S,TCGA-EO-A22S-01A-11R-A18M-07,TCGA-EO-A22S-01A,TCGA-EO-A22S-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-EO-A22S-01A,10923,UCEC,58,FEMALE,[Not Available],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21328,Alive,TUMOR FREE,1872,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1872,0,1872,0,1872,0,1872,NA,younger,34.51676529,level3,NA,NA,NA,NA,NA,NA
TCGA.EO.A22T.01A,TCGA-EO-A22T,TCGA.EO.A22T,4.019898156,9.616607676,TCGA.EO.A22T.01A.21R.A18M.07,3.257772,3.000997,0.2177364,0.3428683,0.9047371,UCEC,TCGA-EO-A22T,TCGA-EO-A22T-01A-21R-A18M-07,TCGA-EO-A22T-01A,TCGA-EO-A22T-01A-21R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-EO-A22T-01A,10924,UCEC,56,FEMALE,ASIAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20608,Alive,TUMOR FREE,2035,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2035,0,2035,0,2035,0,2035,NA,younger,22.93975069,level1,NA,NA,NA,NA,NA,NA
TCGA.EO.A22U.01A,TCGA-EO-A22U,TCGA.EO.A22U,4.059424503,10.15924065,TCGA.EO.A22U.01A.11R.A180.07,2.183717,2.1524,-0.5592222,-0.7311865,0.5460331,UCEC,TCGA-EO-A22U,TCGA-EO-A22U-01A-11R-A180-07,TCGA-EO-A22U-01A,TCGA-EO-A22U-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-EO-A22U-01A,10925,UCEC,83,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30557,Alive,TUMOR FREE,1407,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1407,0,1407,0,1407,0,1407,NA,older,26.22222222,level2,NA,NA,NA,NA,NA,NA
TCGA.EO.A22X.01A,TCGA-EO-A22X,TCGA.EO.A22X,3.919340082,6.512647243,TCGA.EO.A22X.01A.11R.A180.07,3.110164,3.085778,0.1521776,0.195261,0.8164566,UCEC,TCGA-EO-A22X,TCGA-EO-A22X-01A-11R-A180-07,TCGA-EO-A22X-01A,TCGA-EO-A22X-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-EO-A22X-01A,10926,UCEC,36,FEMALE,[Not Available],[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2008,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-13245,Alive,TUMOR FREE,1752,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1752,0,1752,0,1752,0,1752,NA,younger,24.23822715,level1,NA,NA,NA,NA,NA,NA
TCGA.EO.A22Y.01A,TCGA-EO-A22Y,TCGA.EO.A22Y,4.346623649,8.571244483,TCGA.EO.A22Y.01A.11R.A180.07,1.736138,1.653448,-0.8009273,-1.178765,0.3476413,UCEC,TCGA-EO-A22Y,TCGA-EO-A22Y-01A-11R-A180-07,TCGA-EO-A22Y-01A,TCGA-EO-A22Y-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-EO-A22Y-01A,10927,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25127,Alive,TUMOR FREE,1567,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1567,0,1567,0,1567,0,1567,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.EO.A2CG.01A,TCGA-EO-A2CG,TCGA.EO.A2CG,2.967022075,8.477565305,TCGA.EO.A2CG.01A.12R.A180.07,1.833122,1.892661,-0.7494325,-1.081781,0.4088946,UCEC,TCGA-EO-A2CG,TCGA-EO-A2CG-01A-12R-A180-07,TCGA-EO-A2CG-01A,TCGA-EO-A2CG-01A-12R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-EO-A2CG-01A,10928,UCEC,69,FEMALE,ASIAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25279,Alive,TUMOR FREE,1564,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1564,0,1564,0,1564,0,1564,NA,older,29.43213296,level2,NA,NA,NA,NA,NA,NA
TCGA.EO.A2CH.01A,TCGA-EO-A2CH,TCGA.EO.A2CH,4.012261774,10.41967445,TCGA.EO.A2CH.01A.11R.A180.07,2.012588,1.672836,-0.6303261,-0.9023152,0.4004872,UCEC,TCGA-EO-A2CH,TCGA-EO-A2CH-01A-11R-A180-07,TCGA-EO-A2CH-01A,TCGA-EO-A2CH-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-EO-A2CH-01A,10929,UCEC,73,FEMALE,[Not Available],[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26966,Dead,WITH TUMOR,NA,590,[Not Available],Metastatic,Liver,NA,304,Progressive Disease,NA,NA,1,590,1,590,NA,NA,1,304,NA,older,28.56648199,level2,NA,NA,NA,NA,NA,NA
TCGA.EO.A3AS.01A,TCGA-EO-A3AS,TCGA.EO.A3AS,5.558374791,8.021113233,TCGA.EO.A3AS.01A.11R.A19W.07,2.55181,2.284929,-0.244179,-0.363093,0.613271,UCEC,TCGA-EO-A3AS,TCGA-EO-A3AS-01A-11R-A19W-07,TCGA-EO-A3AS-01A,TCGA-EO-A3AS-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-EO-A3AS-01A,10930,UCEC,86,FEMALE,[Not Available],[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31450,Alive,TUMOR FREE,1046,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1046,0,1046,0,1046,0,1046,NA,older,26.84066824,level2,NA,NA,NA,NA,NA,NA
TCGA.EO.A3AU.01A,TCGA-EO-A3AU,TCGA.EO.A3AU,7.641791659,7.908902953,TCGA.EO.A3AU.01A.21R.A19W.07,2.872021,2.593716,-0.06583947,-0.04288256,0.7743653,UCEC,TCGA-EO-A3AU,TCGA-EO-A3AU-01A-21R-A19W-07,TCGA-EO-A3AU-01A,TCGA-EO-A3AU-01A-21R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-EO-A3AU-01A,10931,UCEC,72,FEMALE,[Not Available],[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26406,Alive,TUMOR FREE,1543,NA,[Not Available],New Primary Tumor,Lung,NA,1178,Complete Remission/Response,NA,NA,0,1543,0,1543,0,1543,1,1178,NA,older,34.66666667,level3,NA,NA,NA,NA,NA,NA
TCGA.EO.A3AV.01A,TCGA-EO-A3AV,TCGA.EO.A3AV,8.131049237,11.59256916,TCGA.EO.A3AV.01A.12R.A19W.07,4.23329,4.171812,0.8915921,1.318387,1.227272,UCEC,TCGA-EO-A3AV,TCGA-EO-A3AV-01A-12R-A19W-07,TCGA-EO-A3AV-01A,TCGA-EO-A3AV-01A-12R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-EO-A3AV-01A,10932,UCEC,51,FEMALE,[Not Available],[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2010,Peri (6-12 months since last menstrual period),-18713,Alive,TUMOR FREE,1069,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1069,0,1069,0,1069,0,1069,NA,younger,18.02595738,level1,NA,NA,NA,NA,NA,NA
TCGA.EO.A3AY.01A,TCGA-EO-A3AY,TCGA.EO.A3AY,5.951729987,8.167674045,TCGA.EO.A3AY.01A.12R.A19W.07,3.514115,3.694405,0.3988696,0.5992121,0.9441227,UCEC,TCGA-EO-A3AY,TCGA-EO-A3AY-01A-12R-A19W-07,TCGA-EO-A3AY-01A,TCGA-EO-A3AY-01A-12R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-EO-A3AY-01A,10933,UCEC,58,FEMALE,[Not Available],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21291,Alive,WITH TUMOR,1158,NA,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal Vault,1163,Complete Remission/Response,NA,NA,0,1158,0,1158,1,1163,1,1163,NA,younger,28.25698989,level2,NA,NA,NA,NA,NA,NA
TCGA.EO.A3AZ.01A,TCGA-EO-A3AZ,TCGA.EO.A3AZ,2.916266435,1.910041845,TCGA.EO.A3AZ.01A.12R.A19W.07,4.838098,5.021873,1.326712,1.923195,1.449788,UCEC,TCGA-EO-A3AZ,TCGA-EO-A3AZ-01A-12R-A19W-07,TCGA-EO-A3AZ-01A,TCGA-EO-A3AZ-01A-12R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-EO-A3AZ-01A,10934,UCEC,80,FEMALE,[Not Available],[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29234,Alive,TUMOR FREE,826,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,826,0,826,0,826,0,826,NA,older,39.79591837,level4,NA,NA,NA,NA,NA,NA
TCGA.EO.A3B0.01A,TCGA-EO-A3B0,TCGA.EO.A3B0,2.974217245,9.241802057,TCGA.EO.A3B0.01A.12R.A19W.07,3.121413,3.054273,0.1381763,0.2065096,0.8555671,UCEC,TCGA-EO-A3B0,TCGA-EO-A3B0-01A-12R-A19W-07,TCGA-EO-A3B0-01A,TCGA-EO-A3B0-01A-12R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-EO-A3B0-01A,10935,UCEC,43,FEMALE,ASIAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2011,Indeterminate (neither Pre or Postmenopausal),-15954,Alive,TUMOR FREE,1412,NA,[Not Available],NA,NA,NA,NA,[Discrepancy],NA,NA,0,1412,0,1412,NA,NA,0,1412,NA,younger,22.93975069,level1,NA,NA,NA,NA,NA,NA
TCGA.EO.A3B1.01A,TCGA-EO-A3B1,TCGA.EO.A3B1,1.99714786,8.922266246,TCGA.EO.A3B1.01A.12R.A19W.07,3.347872,3.012987,0.2990582,0.4329692,0.9451061,UCEC,TCGA-EO-A3B1,TCGA-EO-A3B1-01A-12R-A19W-07,TCGA-EO-A3B1-01A,TCGA-EO-A3B1-01A-12R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-EO-A3B1-01A,10936,UCEC,63,FEMALE,[Not Available],[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23162,Alive,TUMOR FREE,820,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,820,0,820,0,820,0,820,NA,younger,32.1799308,level3,NA,NA,NA,NA,NA,NA
TCGA.EO.A3KU.01A,TCGA-EO-A3KU,TCGA.EO.A3KU,3.704041955,8.644130276,TCGA.EO.A3KU.01A.11R.A22K.07,1.85093,1.820923,-0.7553986,-1.063973,0.3780354,UCEC,TCGA-EO-A3KU,TCGA-EO-A3KU-01A-11R-A22K-07,TCGA-EO-A3KU-01A,TCGA-EO-A3KU-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-EO-A3KU-01A,10937,UCEC,68,FEMALE,[Not Available],[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25116,Alive,TUMOR FREE,677,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,677,0,677,0,677,0,677,NA,older,24.4646016,level1,NA,NA,NA,NA,NA,NA
TCGA.EO.A3KW.01A,TCGA-EO-A3KW,TCGA.EO.A3KW,5.15233758,6.030249991,TCGA.EO.A3KW.01A.11R.A22K.07,3.46128,3.394751,0.3708824,0.546377,0.9220486,UCEC,TCGA-EO-A3KW,TCGA-EO-A3KW-01A-11R-A22K-07,TCGA-EO-A3KW-01A,TCGA-EO-A3KW-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-EO-A3KW-01A,10938,UCEC,72,FEMALE,[Not Available],[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26492,Alive,TUMOR FREE,497,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,497,0,497,0,497,0,497,NA,older,26.48553975,level2,NA,NA,NA,NA,NA,NA
TCGA.EO.A3KX.01A,TCGA-EO-A3KX,TCGA.EO.A3KX,4.428122286,10.90967561,TCGA.EO.A3KX.01A.11R.A22K.07,1.837439,1.962688,-0.7959834,-1.077464,0.4299861,UCEC,TCGA-EO-A3KX,TCGA-EO-A3KX-01A-11R-A22K-07,TCGA-EO-A3KX-01A,TCGA-EO-A3KX-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-EO-A3KX-01A,10939,UCEC,80,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29260,Alive,TUMOR FREE,1170,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1170,0,1170,0,1170,0,1170,NA,older,20.9274673,level1,NA,NA,NA,NA,NA,NA
TCGA.EO.A3L0.01A,TCGA-EO-A3L0,TCGA.EO.A3L0,5.064663017,9.192201564,TCGA.EO.A3L0.01A.11R.A22K.07,1.857174,1.648949,-0.7519791,-1.057729,0.3798415,UCEC,TCGA-EO-A3L0,TCGA-EO-A3L0-01A-11R-A22K-07,TCGA-EO-A3L0-01A,TCGA-EO-A3L0-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-EO-A3L0-01A,10940,UCEC,76,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28003,Alive,TUMOR FREE,1554,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1554,0,1554,0,1554,0,1554,NA,older,43.51093707,level4,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GC.01A,TCGA-EY-A1GC,TCGA.EY.A1GC,2.145990696,8.61396995,TCGA.EY.A1GC.01A.11R.A13S.07,4.917624,4.764765,1.384041,2.002721,1.455643,UCEC,TCGA-EY-A1GC,TCGA-EY-A1GC-01A-11R-A13S-07,TCGA-EY-A1GC-01A,TCGA-EY-A1GC-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GC-01A,10943,UCEC,62,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22656,Alive,TUMOR FREE,1647,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1647,0,1647,0,1647,0,1647,NA,younger,34.42217362,level3,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GD.01A,TCGA-EY-A1GD,TCGA.EY.A1GD,3.401946737,9.490275597,TCGA.EY.A1GD.01A.11R.A13S.07,2.605594,2.363169,-0.2335654,-0.3093094,0.6615523,UCEC,TCGA-EY-A1GD,TCGA-EY-A1GD-01A-11R-A13S-07,TCGA-EY-A1GD-01A,TCGA-EY-A1GD-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GD-01A,10944,UCEC,51,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-18638,Alive,TUMOR FREE,1639,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1639,0,1639,0,1639,0,1639,NA,younger,32.04998174,level3,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GE.01A,TCGA-EY-A1GE,TCGA.EY.A1GE,7.337570326,10.1298465,TCGA.EY.A1GE.01A.11R.A13S.07,3.987157,3.845787,0.7453936,1.072253,1.170395,UCEC,TCGA-EY-A1GE,TCGA-EY-A1GE-01A-11R-A13S-07,TCGA-EY-A1GE-01A,TCGA-EY-A1GE-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GE-01A,10945,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24667,Alive,TUMOR FREE,741,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,741,0,741,0,741,0,741,NA,older,37.8328742,level4,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GF.01A,TCGA-EY-A1GF,TCGA.EY.A1GF,4.98864893,10.82186118,TCGA.EY.A1GF.01A.11R.A13S.07,3.204923,2.990266,0.1453281,0.2900202,0.9112424,UCEC,TCGA-EY-A1GF,TCGA-EY-A1GF-01A-11R-A13S-07,TCGA-EY-A1GF-01A,TCGA-EY-A1GF-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GF-01A,10946,UCEC,75,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27450,Alive,TUMOR FREE,826,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,826,0,826,0,826,0,826,NA,older,26.07897153,level2,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GH.01A,TCGA-EY-A1GH,TCGA.EY.A1GH,6.305724943,9.815285135,TCGA.EY.A1GH.01A.11R.A13S.07,3.08621,3.013414,0.1249621,0.1713067,0.8209222,UCEC,TCGA-EY-A1GH,TCGA-EY-A1GH-01A-11R-A13S-07,TCGA-EY-A1GH-01A,TCGA-EY-A1GH-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GH-01A,10947,UCEC,70,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25802,Alive,TUMOR FREE,710,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,710,0,710,0,710,0,710,NA,older,40.48442907,level4,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GI.01A,TCGA-EY-A1GI,TCGA.EY.A1GI,4.313697266,9.697941623,TCGA.EY.A1GI.01A.11R.A13S.07,3.444434,3.114762,0.3319159,0.5295306,0.9688118,UCEC,TCGA-EY-A1GI,TCGA-EY-A1GI-01A-11R-A13S-07,TCGA-EY-A1GI-01A,TCGA-EY-A1GI-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GI-01A,10948,UCEC,52,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-19117,Alive,TUMOR FREE,710,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,710,0,710,0,710,0,710,NA,younger,25.34435262,level2,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GK.01A,TCGA-EY-A1GK,TCGA.EY.A1GK,4.488853484,10.12067586,TCGA.EY.A1GK.01A.11R.A13S.07,4.166334,4.173549,0.823491,1.251431,1.260263,UCEC,TCGA-EY-A1GK,TCGA-EY-A1GK-01A-11R-A13S-07,TCGA-EY-A1GK-01A,TCGA-EY-A1GK-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GK-01A,10950,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27127,Alive,TUMOR FREE,693,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,693,0,693,0,693,0,693,NA,older,41.015625,level4,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GL.01A,TCGA-EY-A1GL,TCGA.EY.A1GL,7.027474782,7.558657954,TCGA.EY.A1GL.01A.11R.A13S.07,2.170835,1.740787,-0.5341839,-0.7440681,0.4993896,UCEC,TCGA-EY-A1GL,TCGA-EY-A1GL-01A-11R-A13S-07,TCGA-EY-A1GL-01A,TCGA-EY-A1GL-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GL-01A,10951,UCEC,51,FEMALE,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18761,Alive,TUMOR FREE,1014,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1014,0,1014,0,1014,0,1014,NA,younger,24.39105884,level1,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GM.01A,TCGA-EY-A1GM,TCGA.EY.A1GM,4.074153434,8.364949013,TCGA.EY.A1GM.01A.12R.A14D.07,0.8707974,0.7942355,-1.42623,-2.044106,0.04472444,UCEC,TCGA-EY-A1GM,TCGA-EY-A1GM-01A-12R-A14D-07,TCGA-EY-A1GM-01A,TCGA-EY-A1GM-01A-12R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-EY-A1GM-01A,10952,UCEC,60,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22010,Dead,WITH TUMOR,NA,995,[Not Available],Locoregional Recurrence,NA,NA,791,Complete Remission/Response,NA,NA,1,995,1,995,1,791,1,791,NA,younger,28.80441397,level2,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GO.01A,TCGA-EY-A1GO,TCGA.EY.A1GO,2.510911298,8.413682928,TCGA.EY.A1GO.01A.11R.A14D.07,0.1317212,-0.1679101,-1.958808,-2.783182,-0.2007491,UCEC,TCGA-EY-A1GO,TCGA-EY-A1GO-01A-11R-A14D-07,TCGA-EY-A1GO-01A,TCGA-EY-A1GO-01A-11R-A14D-07,TP,Primary solid Tumor,1,1,A14D,1,0,1,Female,1,Tumor,TCGA-EY-A1GO-01A,10953,UCEC,65,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23853,Alive,WITH TUMOR,586,NA,[Not Available],Metastatic,Lung,NA,517,Complete Remission/Response,NA,NA,0,586,0,586,1,517,1,517,NA,NA,31.22945431,level3,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GP.01A,TCGA-EY-A1GP,TCGA.EY.A1GP,6.316976574,9.010589645,TCGA.EY.A1GP.01A.11R.A13S.07,3.232405,3.259845,0.1978729,0.317502,0.9173995,UCEC,TCGA-EY-A1GP,TCGA-EY-A1GP-01A-11R-A13S-07,TCGA-EY-A1GP-01A,TCGA-EY-A1GP-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GP-01A,10954,UCEC,54,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20011,Alive,TUMOR FREE,573,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,573,0,573,0,573,0,573,NA,younger,28.84153181,level2,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GQ.01A,TCGA-EY-A1GQ,TCGA.EY.A1GQ,3.612090384,9.296461554,TCGA.EY.A1GQ.01A.21R.A13S.07,2.630653,2.457869,-0.183051,-0.2842503,0.6754505,UCEC,TCGA-EY-A1GQ,TCGA-EY-A1GQ-01A-21R-A13S-07,TCGA-EY-A1GQ-01A,TCGA-EY-A1GQ-01A-21R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GQ-01A,10955,UCEC,76,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27905,Alive,WITH TUMOR,544,NA,[Not Available],Metastatic,"Other, specify","R external iliac node, presacral peritoneal implant, ascitic fluid",334,Complete Remission/Response,NA,NA,0,544,0,544,1,334,1,334,NA,older,29.75206612,level2,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GR.01A,TCGA-EY-A1GR,TCGA.EY.A1GR,3.976752963,9.353700362,TCGA.EY.A1GR.01A.11R.A13S.07,3.948653,4.064413,0.7856481,1.03375,1.104096,UCEC,TCGA-EY-A1GR,TCGA-EY-A1GR-01A-11R-A13S-07,TCGA-EY-A1GR-01A,TCGA-EY-A1GR-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GR-01A,10956,UCEC,67,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24784,Alive,TUMOR FREE,536,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,536,0,536,0,536,0,536,NA,older,34.15977961,level3,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GS.01A,TCGA-EY-A1GS,TCGA.EY.A1GS,5.118838255,8.237604017,TCGA.EY.A1GS.01A.11R.A13S.07,2.763753,2.598944,-0.06422126,-0.1511505,0.6545721,UCEC,TCGA-EY-A1GS,TCGA-EY-A1GS-01A-11R-A13S-07,TCGA-EY-A1GS-01A,TCGA-EY-A1GS-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GS-01A,10957,UCEC,71,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26012,Dead,WITH TUMOR,NA,670,[Not Available],NA,NA,NA,NA,Stable Disease,NA,NA,1,670,1,670,NA,NA,1,670,NA,older,23.91883029,level1,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GT.01A,TCGA-EY-A1GT,TCGA.EY.A1GT,2.941866272,9.858445554,TCGA.EY.A1GT.01A.11R.A13S.07,1.941714,1.856649,-0.6654141,-0.9731897,0.4033717,UCEC,TCGA-EY-A1GT,TCGA-EY-A1GT-01A-11R-A13S-07,TCGA-EY-A1GT-01A,TCGA-EY-A1GT-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GT-01A,10958,UCEC,68,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25151,Alive,TUMOR FREE,490,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,490,0,490,0,490,0,490,NA,older,24.8015873,level1,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GU.01A,TCGA-EY-A1GU,TCGA.EY.A1GU,5.340866952,9.96598929,TCGA.EY.A1GU.01A.11R.A13S.07,3.151029,2.968573,0.1788749,0.2361259,0.8279727,UCEC,TCGA-EY-A1GU,TCGA-EY-A1GU-01A-11R-A13S-07,TCGA-EY-A1GU-01A,TCGA-EY-A1GU-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GU-01A,10959,UCEC,66,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24304,Dead,TUMOR FREE,NA,997,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,997,0,997,0,997,0,997,NA,older,35.15625,level4,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GV.01A,TCGA-EY-A1GV,TCGA.EY.A1GV,4.172363999,6.087684872,TCGA.EY.A1GV.01A.11R.A13S.07,2.997843,3.049334,0.07802346,0.08293961,0.8119876,UCEC,TCGA-EY-A1GV,TCGA-EY-A1GV-01A-11R-A13S-07,TCGA-EY-A1GV-01A,TCGA-EY-A1GV-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GV-01A,10960,UCEC,75,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Mixed serous and endometrioid,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27581,Alive,TUMOR FREE,481,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,481,0,481,0,481,0,481,NA,older,29.0174472,level2,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GW.01A,TCGA-EY-A1GW,TCGA.EY.A1GW,5.878427873,10.31190732,TCGA.EY.A1GW.01A.22R.A13S.07,2.271594,2.275035,-0.436186,-0.6433093,0.5610484,UCEC,TCGA-EY-A1GW,TCGA-EY-A1GW-01A-22R-A13S-07,TCGA-EY-A1GW-01A,TCGA-EY-A1GW-01A-22R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GW-01A,10961,UCEC,73,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26979,Dead,WITH TUMOR,NA,337,[Not Available],Metastatic,Liver,NA,190,Progressive Disease,NA,NA,1,337,1,337,NA,NA,1,190,NA,older,36.48484303,level4,NA,NA,NA,NA,NA,NA
TCGA.EY.A1GX.01A,TCGA-EY-A1GX,TCGA.EY.A1GX,3.254609159,11.52281199,TCGA.EY.A1GX.01A.12R.A13S.07,0.1228693,-0.07334859,-1.934767,-2.792034,-0.2000652,UCEC,TCGA-EY-A1GX,TCGA-EY-A1GX-01A-12R-A13S-07,TCGA-EY-A1GX-01A,TCGA-EY-A1GX-01A-12R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1GX-01A,10962,UCEC,76,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27962,Dead,TUMOR FREE,NA,1127,[Not Available],Locoregional Recurrence,"Other, specify",pelvic mass,743,Complete Remission/Response,NA,NA,1,1127,0,1127,1,743,1,743,NA,older,26.953125,level2,NA,NA,NA,NA,NA,NA
TCGA.EY.A1H0.01A,TCGA-EY-A1H0,TCGA.EY.A1H0,4.528450829,10.51725985,TCGA.EY.A1H0.01A.11R.A13S.07,1.443575,1.421189,-1.035544,-1.471329,0.2635027,UCEC,TCGA-EY-A1H0,TCGA-EY-A1H0-01A-11R-A13S-07,TCGA-EY-A1H0-01A,TCGA-EY-A1H0-01A-11R-A13S-07,TP,Primary solid Tumor,1,1,A13S,1,0,1,Female,1,Tumor,TCGA-EY-A1H0-01A,10963,UCEC,57,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20937,Alive,WITH TUMOR,588,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,NA,NA,0,588,0,588,NA,NA,0,588,NA,younger,33.87406376,level3,NA,NA,NA,NA,NA,NA
TCGA.EY.A210.01A,TCGA-EY-A210,TCGA.EY.A210,4.497663456,8.440296127,TCGA.EY.A210.01A.11R.A157.07,4.007525,4.099352,0.7503893,1.092622,1.139444,UCEC,TCGA-EY-A210,TCGA-EY-A210-01A-11R-A157-07,TCGA-EY-A210-01A,TCGA-EY-A210-01A-11R-A157-07,TP,Primary solid Tumor,1,1,A157,1,0,1,Female,1,Tumor,TCGA-EY-A210-01A,10964,UCEC,82,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Mixed serous and endometrioid,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30095,Alive,TUMOR FREE,383,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,383,0,383,0,383,0,383,NA,older,26.2226847,level2,NA,NA,NA,NA,NA,NA
TCGA.EY.A212.01A,TCGA-EY-A212,TCGA.EY.A212,4.810134443,8.990654522,TCGA.EY.A212.01A.11R.A14M.07,1.299677,1.135937,-1.129049,-1.615226,0.1767994,UCEC,TCGA-EY-A212,TCGA-EY-A212-01A-11R-A14M-07,TCGA-EY-A212-01A,TCGA-EY-A212-01A-11R-A14M-07,TP,Primary solid Tumor,1,1,A14M,1,0,1,Female,1,Tumor,TCGA-EY-A212-01A,10965,UCEC,83,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30680,Dead,WITH TUMOR,NA,310,[Not Available],NA,NA,NA,NA,Partial Remission/Response,NA,NA,1,310,1,310,NA,NA,1,310,NA,older,32.03987184,level3,NA,NA,NA,NA,NA,NA
TCGA.EY.A214.01A,TCGA-EY-A214,TCGA.EY.A214,6.771645704,8.884425864,TCGA.EY.A214.01A.12R.A157.07,3.143141,3.221649,0.1585959,0.2282374,0.8574188,UCEC,TCGA-EY-A214,TCGA-EY-A214-01A-12R-A157-07,TCGA-EY-A214-01A,TCGA-EY-A214-01A-12R-A157-07,TP,Primary solid Tumor,1,1,A157,1,0,1,Female,1,Tumor,TCGA-EY-A214-01A,10966,UCEC,66,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24136,Alive,TUMOR FREE,438,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,438,0,438,0,438,0,438,NA,older,34.52708907,level3,NA,NA,NA,NA,NA,NA
TCGA.EY.A215.01A,TCGA-EY-A215,TCGA.EY.A215,5.926929322,7.669612247,TCGA.EY.A215.01A.11R.A14M.07,2.009604,2.026786,-0.6805924,-0.905299,0.5248861,UCEC,TCGA-EY-A215,TCGA-EY-A215-01A-11R-A14M-07,TCGA-EY-A215-01A,TCGA-EY-A215-01A-11R-A14M-07,TP,Primary solid Tumor,1,1,A14M,1,0,1,Female,1,Tumor,TCGA-EY-A215-01A,10967,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22076,Alive,TUMOR FREE,574,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,574,0,574,0,574,0,574,NA,younger,17.36111111,level1,NA,NA,NA,NA,NA,NA
TCGA.EY.A2OM.01A,TCGA-EY-A2OM,TCGA.EY.A2OM,6.11314237,8.147467187,TCGA.EY.A2OM.01A.11R.A18M.07,1.846159,2.052874,-0.6969123,-1.068745,0.3523221,UCEC,TCGA-EY-A2OM,TCGA-EY-A2OM-01A-11R-A18M-07,TCGA-EY-A2OM-01A,TCGA-EY-A2OM-01A-11R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-EY-A2OM-01A,10968,UCEC,55,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20398,Alive,TUMOR FREE,694,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,694,0,694,0,694,0,694,NA,younger,47.61080332,level4,NA,NA,NA,NA,NA,NA
TCGA.EY.A2ON.01A,TCGA-EY-A2ON,TCGA.EY.A2ON,5.160178003,6.241502727,TCGA.EY.A2ON.01A.21R.A18M.07,2.5108,2.333946,-0.2357659,-0.4041031,0.5751633,UCEC,TCGA-EY-A2ON,TCGA-EY-A2ON-01A-21R-A18M-07,TCGA-EY-A2ON-01A,TCGA-EY-A2ON-01A-21R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-EY-A2ON-01A,10969,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22624,Dead,WITH TUMOR,NA,610,[Not Available],NA,NA,NA,226,Progressive Disease,NA,NA,1,610,1,610,NA,NA,1,226,NA,younger,36.73094582,level4,NA,NA,NA,NA,NA,NA
TCGA.EY.A2OO.01A,TCGA-EY-A2OO,TCGA.EY.A2OO,5.980073298,9.031858316,TCGA.EY.A2OO.01A.11R.A19W.07,0.8911723,0.8128855,-1.367509,-2.023731,0.02763125,UCEC,TCGA-EY-A2OO,TCGA-EY-A2OO-01A-11R-A19W-07,TCGA-EY-A2OO-01A,TCGA-EY-A2OO-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-EY-A2OO-01A,10970,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20797,Alive,TUMOR FREE,1392,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1392,0,1392,0,1392,0,1392,NA,younger,25.79591837,level2,NA,NA,NA,NA,NA,NA
TCGA.EY.A2OP.01A,TCGA-EY-A2OP,TCGA.EY.A2OP,5.619650701,9.122771062,TCGA.EY.A2OP.01A.11R.A19W.07,1.203959,0.8674616,-1.198346,-1.710944,0.1507498,UCEC,TCGA-EY-A2OP,TCGA-EY-A2OP-01A-11R-A19W-07,TCGA-EY-A2OP-01A,TCGA-EY-A2OP-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-EY-A2OP-01A,10971,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23090,Alive,TUMOR FREE,944,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,944,0,944,0,944,0,944,NA,younger,25.33333333,level2,NA,NA,NA,NA,NA,NA
TCGA.EY.A2OQ.01A,TCGA-EY-A2OQ,TCGA.EY.A2OQ,2.830579853,7.46504392,TCGA.EY.A2OQ.01A.11R.A19W.07,2.148683,2.202469,-0.5360446,-0.7662207,0.4713874,UCEC,TCGA-EY-A2OQ,TCGA-EY-A2OQ-01A-11R-A19W-07,TCGA-EY-A2OQ-01A,TCGA-EY-A2OQ-01A-11R-A19W-07,TP,Primary solid Tumor,1,1,A19W,1,0,1,Female,1,Tumor,TCGA-EY-A2OQ-01A,10972,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22309,Alive,TUMOR FREE,885,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,885,0,885,0,885,0,885,NA,younger,32.88241415,level3,NA,NA,NA,NA,NA,NA
TCGA.EY.A3L3.01A,TCGA-EY-A3L3,TCGA.EY.A3L3,1.964620426,8.742723741,TCGA.EY.A3L3.01A.11R.A22K.07,0.9268289,0.7654985,-1.431146,-1.988074,0.1007757,UCEC,TCGA-EY-A3L3,TCGA-EY-A3L3-01A-11R-A22K-07,TCGA-EY-A3L3-01A,TCGA-EY-A3L3-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-EY-A3L3-01A,10973,UCEC,82,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30138,Alive,TUMOR FREE,832,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,832,0,832,0,832,0,832,NA,older,35.49245785,level4,NA,NA,NA,NA,NA,NA
TCGA.EY.A3QX.01A,TCGA-EY-A3QX,TCGA.EY.A3QX,6.696258172,10.4824248,TCGA.EY.A3QX.01A.11R.A22K.07,2.885027,2.811714,-0.02075845,-0.02987647,0.7600266,UCEC,TCGA-EY-A3QX,TCGA-EY-A3QX-01A-11R-A22K-07,TCGA-EY-A3QX-01A,TCGA-EY-A3QX-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-EY-A3QX-01A,10974,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23663,Dead,WITH TUMOR,NA,989,[Not Available],Locoregional Recurrence,"Other, specify",Peritoneum,896,Complete Remission/Response,NA,NA,1,989,1,989,NA,NA,1,896,NA,younger,22.32142857,level1,NA,NA,NA,NA,NA,NA
TCGA.EY.A4KR.01A,TCGA-EY-A4KR,TCGA.EY.A4KR,3.405897084,7.53088228,TCGA.EY.A4KR.01A.11R.A27V.07,4.188138,4.188489,0.8777631,1.273235,1.203062,UCEC,TCGA-EY-A4KR,TCGA-EY-A4KR-01A-11R-A27V-07,TCGA-EY-A4KR-01A,TCGA-EY-A4KR-01A-11R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-EY-A4KR-01A,10975,UCEC,56,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20669,Dead,WITH TUMOR,NA,346,[Not Available],NA,NA,NA,NA,Progressive Disease,NA,NA,1,346,1,346,NA,NA,1,346,NA,younger,42.38548483,level4,NA,NA,NA,NA,NA,NO
TCGA.EY.A547.01A,TCGA-EY-A547,TCGA.EY.A547,2.016104036,8.530488273,TCGA.EY.A547.01A.11R.A27V.07,1.274225,1.325167,-1.098023,-1.640678,0.1714186,UCEC,TCGA-EY-A547,TCGA-EY-A547-01A-11R-A27V-07,TCGA-EY-A547-01A,TCGA-EY-A547-01A-11R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-EY-A547-01A,10976,UCEC,75,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27686,Alive,TUMOR FREE,545,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,545,0,545,0,545,0,545,NA,older,39.19291624,level4,NA,NA,NA,NA,NA,YES
TCGA.EY.A548.01A,TCGA-EY-A548,TCGA.EY.A548,3.216392779,9.033951526,TCGA.EY.A548.01A.11R.A27V.07,3.076031,2.925321,0.1113726,0.1611277,0.8009656,UCEC,TCGA-EY-A548,TCGA-EY-A548-01A-11R-A27V-07,TCGA-EY-A548-01A,TCGA-EY-A548-01A-11R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-EY-A548-01A,10977,UCEC,83,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30544,Alive,TUMOR FREE,430,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,430,0,430,0,430,0,430,NA,older,27.18163009,level2,NA,NA,NA,NA,NA,NO
TCGA.EY.A549.01A,TCGA-EY-A549,TCGA.EY.A549,6.271139903,10.28614187,TCGA.EY.A549.01A.11R.A27V.07,2.71705,2.520985,-0.1537183,-0.1978533,0.6984792,UCEC,TCGA-EY-A549,TCGA-EY-A549-01A-11R-A27V-07,TCGA-EY-A549-01A,TCGA-EY-A549-01A-11R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-EY-A549-01A,10978,UCEC,78,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28570,Alive,TUMOR FREE,605,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,605,0,605,0,605,0,605,NA,older,27.18089991,level2,NA,NA,NA,NA,NA,NO
TCGA.EY.A54A.01A,TCGA-EY-A54A,TCGA.EY.A54A,5.516116031,7.752092915,TCGA.EY.A54A.01A.11R.A27V.07,3.519359,3.441898,0.4415986,0.6044556,0.9590116,UCEC,TCGA-EY-A54A,TCGA-EY-A54A-01A-11R-A27V-07,TCGA-EY-A54A-01A,TCGA-EY-A54A-01A-11R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-EY-A54A-01A,10979,UCEC,67,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24822,Alive,TUMOR FREE,447,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,447,0,447,0,447,0,447,NA,older,27.00513097,level2,NA,NA,NA,NA,NA,YES
TCGA.EY.A5W2.01A,TCGA-EY-A5W2,TCGA.EY.A5W2,4.698457426,7.935624753,TCGA.EY.A5W2.01A.11R.A31O.07,2.027421,2.051335,-0.6622249,-0.8874822,0.4556881,UCEC,TCGA-EY-A5W2,TCGA-EY-A5W2-01A-11R-A31O-07,TCGA-EY-A5W2-01A,TCGA-EY-A5W2-01A-11R-A31O-07,TP,Primary solid Tumor,1,1,A31O,1,0,1,Female,1,Tumor,TCGA-EY-A5W2-01A,10980,UCEC,72,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26498,Alive,TUMOR FREE,516,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,516,0,516,0,516,0,516,NA,older,32.02036958,level3,NA,NA,NA,NA,NA,NO
TCGA.EY.A72D.01A,TCGA-EY-A72D,TCGA.EY.A72D,2.867856938,8.013914427,TCGA.EY.A72D.01A.12R.A34R.07,1.565539,1.399734,-0.9362261,-1.349364,0.2959566,UCEC,TCGA-EY-A72D,TCGA-EY-A72D-01A-12R-A34R-07,TCGA-EY-A72D-01A,TCGA-EY-A72D-01A-12R-A34R-07,TP,Primary solid Tumor,1,1,A34R,1,0,1,Female,1,Tumor,TCGA-EY-A72D-01A,10981,UCEC,87,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31818,Alive,TUMOR FREE,179,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,179,0,179,0,179,0,179,NA,older,40.39018442,level4,NA,NA,NA,NA,NA,NO
TCGA.F2.6879.01A,TCGA-F2-6879,TCGA.F2.6879,8.61574365,11.45293616,TCGA.F2.6879.01A.11R.2156.07,2.073257,1.933908,-0.5864845,-0.8416463,0.4366377,PAAD,TCGA-F2-6879,TCGA-F2-6879-01A-11R-2156-07,TCGA-F2-6879-01A,TCGA-F2-6879-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-F2-6879-01A,7545,PAAD,57,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2009,[Not Available],-20984,Dead,WITH TUMOR,NA,334,NA,Distant Metastasis,NA,NA,183,Complete Remission/Response,NA,NA,1,334,1,334,1,183,1,183,NA,younger,NA,NA,NA,NA,2000,4,NA,NO
TCGA.F2.6880.01A,TCGA-F2-6880,TCGA.F2.6880,6.88719624,11.91553584,TCGA.F2.6880.01A.11R.2156.07,0.9495377,1.04919,-1.368611,-1.965365,0.06806657,PAAD,TCGA-F2-6880,TCGA-F2-6880-01A-11R-2156-07,TCGA-F2-6880-01A,TCGA-F2-6880-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-F2-6880-01A,7546,PAAD,70,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2009,[Not Available],-25809,Alive,TUMOR FREE,295,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,295,0,295,0,295,0,295,NA,older,NA,NA,NA,15,1984,3,NA,YES
TCGA.F2.7273.01A,TCGA-F2-7273,TCGA.F2.7273,9.963776099,10.86897685,TCGA.F2.7273.01A.11R.2156.07,3.778019,3.641889,0.6205953,0.8631158,1.076627,PAAD,TCGA-F2-7273,TCGA-F2-7273-01A-11R-2156-07,TCGA-F2-7273-01A,TCGA-F2-7273-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-F2-7273-01A,7547,PAAD,54,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-20071,Dead,WITH TUMOR,NA,592,Pancreatic Cancer,Distant Metastasis,Liver,NA,256,Progressive Disease,NA,NA,1,592,1,592,NA,NA,1,256,NA,younger,NA,NA,NA,NA,NA,3,NA,NO
TCGA.F2.7276.01A,TCGA-F2-7276,TCGA.F2.7276,8.78587418,9.733510263,TCGA.F2.7276.01A.11R.2156.07,3.632212,3.491726,0.4961536,0.7173084,1.039338,PAAD,TCGA-F2-7276,TCGA-F2-7276-01A-11R-2156-07,TCGA-F2-7276-01A,TCGA-F2-7276-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-F2-7276-01A,7548,PAAD,64,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-23713,Dead,WITH TUMOR,NA,216,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,216,1,216,NA,NA,1,216,NA,younger,NA,NA,NA,NA,NA,1,NA,YES
TCGA.F2.A44G.01A,TCGA-F2-A44G,TCGA.F2.A44G,4.679587066,11.18730258,TCGA.F2.A44G.01A.11R.A26U.07,3.125356,3.157424,0.1442422,0.2104524,0.830164,PAAD,TCGA-F2-A44G,TCGA-F2-A44G-01A-11R-A26U-07,TCGA-F2-A44G-01A,TCGA-F2-A44G-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-F2-A44G-01A,7549,PAAD,79,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-29150,Dead,WITH TUMOR,NA,233,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",malignant ascites,214,Complete Remission/Response,NA,NA,1,233,1,233,1,214,1,214,NA,older,NA,NA,NA,NA,NA,2,NA,NO
TCGA.F2.A44H.01A,TCGA-F2-A44H,TCGA.F2.A44H,5.053167826,10.60115793,TCGA.F2.A44H.01A.11R.A26U.07,4.029,4.064047,0.7898273,1.114097,1.147,PAAD,TCGA-F2-A44H,TCGA-F2-A44H-01A-11R-A26U-07,TCGA-F2-A44H-01A,TCGA-F2-A44H-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-F2-A44H-01A,7550,PAAD,65,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-24007,Alive,TUMOR FREE,586,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,586,0,586,0,586,0,586,NA,NA,NA,NA,NA,NA,NA,1,NA,YES
TCGA.F2.A7TX.01A,TCGA-F2-A7TX,TCGA.F2.A7TX,5.942214206,10.27257147,TCGA.F2.A7TX.01A.33R.A38C.07,3.487832,3.3594,0.3749417,0.5729286,0.9681241,PAAD,TCGA-F2-A7TX,TCGA-F2-A7TX-01A-33R-A38C-07,TCGA-F2-A7TX-01A,TCGA-F2-A7TX-01A-33R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-F2-A7TX-01A,7551,PAAD,77,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-28239,Dead,WITH TUMOR,NA,95,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,95,1,95,NA,NA,1,95,NA,older,NA,NA,NA,NA,1958,3,NA,YES
TCGA.F2.A8YN.01A,TCGA-F2-A8YN,TCGA.F2.A8YN,7.241497007,11.98553601,TCGA.F2.A8YN.01A.11R.A37L.07,3.322418,3.29322,0.3173266,0.407515,0.8627917,PAAD,TCGA-F2-A8YN,TCGA-F2-A8YN-01A-11R-A37L-07,TCGA-F2-A8YN-01A,TCGA-F2-A8YN-01A-11R-A37L-07,TP,Primary solid Tumor,1,1,A37L,1,0,1,Pancreas,1,Tumor,TCGA-F2-A8YN-01A,7552,PAAD,76,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-28047,Alive,WITH TUMOR,517,NA,NA,NA,NA,NA,NA,Progressive Disease,NA,NA,0,517,0,517,NA,NA,0,517,NA,older,NA,NA,NA,60,1983,3,NA,YES
TCGA.FB.A4P5.01A,TCGA-FB-A4P5,TCGA.FB.A4P5,7.594720218,9.777293129,TCGA.FB.A4P5.01A.11R.A26U.07,5.061386,5.134336,1.457177,2.146483,1.574322,PAAD,TCGA-FB-A4P5,TCGA-FB-A4P5-01A-11R-A26U-07,TCGA-FB-A4P5-01A,TCGA-FB-A4P5-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-FB-A4P5-01A,7553,PAAD,69,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-25412,Dead,WITH TUMOR,NA,179,NA,NA,NA,NA,NA,[Unknown],NA,NA,1,179,1,179,NA,NA,1,179,NA,older,NA,NA,NA,40,2008,4,1968,NO
TCGA.FB.A4P6.01A,TCGA-FB-A4P6,TCGA.FB.A4P6,11.41496001,10.56794657,TCGA.FB.A4P6.01A.12R.A26U.07,3.980575,3.959028,0.7278794,1.065672,1.166347,PAAD,TCGA-FB-A4P6,TCGA-FB-A4P6-01A-12R-A26U-07,TCGA-FB-A4P6-01A,TCGA-FB-A4P6-01A-12R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-FB-A4P6-01A,7554,PAAD,54,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2012,[Not Available],-19904,Alive,TUMOR FREE,767,NA,NA,Locoregional Recurrence,NA,NA,620,Complete Remission/Response,NA,NA,0,767,0,767,1,620,1,620,NA,younger,NA,NA,NA,25,2012,4,1987,NO
TCGA.FB.A545.01A,TCGA-FB-A545,TCGA.FB.A545,4.403819877,10.11206152,TCGA.FB.A545.01A.11R.A26U.07,1.175215,1.18977,-1.230449,-1.739688,0.1672117,PAAD,TCGA-FB-A545,TCGA-FB-A545-01A-11R-A26U-07,TCGA-FB-A545-01A,TCGA-FB-A545-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-FB-A545-01A,7555,PAAD,72,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26635,Dead,TUMOR FREE,NA,732,Pancreatic Cancer,Distant Metastasis,Liver,NA,378,Complete Remission/Response,NA,NA,1,732,1,732,1,378,1,378,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.FB.A5VM.01A,TCGA-FB-A5VM,TCGA.FB.A5VM,6.248512066,10.92601425,TCGA.FB.A5VM.01A.11R.A32O.07,4.456945,4.385662,1.099096,1.542042,1.308075,PAAD,TCGA-FB-A5VM,TCGA-FB-A5VM-01A-11R-A32O-07,TCGA-FB-A5VM-01A,TCGA-FB-A5VM-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-FB-A5VM-01A,7556,PAAD,74,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-27362,Dead,WITH TUMOR,NA,498,Pancreatic Cancer,Distant Metastasis,Liver,NA,177,Progressive Disease,NA,NA,1,498,1,498,NA,NA,1,177,NA,older,NA,NA,NA,24,2000,4,1953,YES
TCGA.FB.A78T.01A,TCGA-FB-A78T,TCGA.FB.A78T,8.534781432,11.13929553,TCGA.FB.A78T.01A.12R.A32O.07,3.924548,3.962799,0.7393949,1.009644,1.107326,PAAD,TCGA-FB-A78T,TCGA-FB-A78T-01A-12R-A32O-07,TCGA-FB-A78T-01A,TCGA-FB-A78T-01A-12R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-FB-A78T-01A,7557,PAAD,71,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-26179,Dead,NA,NA,375,Pancreatic Cancer,NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,375,1,375,0,375,0,375,NA,older,NA,NA,NA,2,2000,4,1980,NO
TCGA.FB.A7DR.01A,TCGA-FB-A7DR,TCGA.FB.A7DR,6.898353486,12.21924416,TCGA.FB.A7DR.01A.21R.A33R.07,4.061267,3.962537,0.825219,1.146363,1.163936,PAAD,TCGA-FB-A7DR,TCGA-FB-A7DR-01A-21R-A33R-07,TCGA-FB-A7DR-01A,TCGA-FB-A7DR-01A-21R-A33R-07,TP,Primary solid Tumor,1,1,A33R,1,0,1,Pancreas,1,Tumor,TCGA-FB-A7DR-01A,7558,PAAD,48,MALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Colloid (mucinous non-cystic) Carcinoma,G2,2012,[Not Available],-17649,Dead,TUMOR FREE,NA,353,Pancreatic Cancer,NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,353,1,353,0,353,0,353,NA,younger,NA,NA,NA,20,NA,2,1993,NO
TCGA.FB.AAPP.01A,TCGA-FB-AAPP,TCGA.FB.AAPP,4.444885681,10.27004999,TCGA.FB.AAPP.01A.12R.A41B.07,-0.05592313,-0.1723654,-2.06928,-2.970826,-0.261747,PAAD,TCGA-FB-AAPP,TCGA-FB-AAPP-01A-12R-A41B-07,TCGA-FB-AAPP-01A,TCGA-FB-AAPP-01A-12R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAPP-01A,7559,PAAD,71,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2009,[Not Available],-26239,Dead,WITH TUMOR,NA,485,Pancreatic Cancer,Distant Metastasis,Lung,NA,150,Progressive Disease,NA,NA,1,485,1,485,NA,NA,1,150,NA,older,NA,NA,NA,NA,1974,3,NA,NO
TCGA.FB.AAPQ.01A,TCGA-FB-AAPQ,TCGA.FB.AAPQ,7.532784481,12.53155691,TCGA.FB.AAPQ.01A.11R.A41B.07,2.003064,1.683325,-0.6288239,-0.911839,0.4134875,PAAD,TCGA-FB-AAPQ,TCGA-FB-AAPQ-01A-11R-A41B-07,TCGA-FB-AAPQ-01A,TCGA-FB-AAPQ-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAPQ-01A,7560,PAAD,65,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-24078,Dead,NA,NA,1130,NA,NA,NA,NA,NA,Progressive Disease,NA,NA,1,1130,NA,1130,NA,NA,0,1130,NA,NA,NA,NA,NA,25,2008,4,1983,YES
TCGA.FB.AAPS.01A,TCGA-FB-AAPS,TCGA.FB.AAPS,4.00929342,9.18393555,TCGA.FB.AAPS.01A.12R.A39D.07,4.162076,4.201019,0.8735651,1.247173,1.222732,PAAD,TCGA-FB-AAPS,TCGA-FB-AAPS-01A-12R-A39D-07,TCGA-FB-AAPS-01A,TCGA-FB-AAPS-01A-12R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAPS-01A,7561,PAAD,62,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-22981,Alive,NA,228,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,228,0,228,NA,NA,0,228,NA,younger,NA,NA,NA,10,1970,3,1960,NO
TCGA.FB.AAPU.01A,TCGA-FB-AAPU,TCGA.FB.AAPU,9.174496305,12.15159058,TCGA.FB.AAPU.01A.31R.A41B.07,1.650062,1.64331,-0.8853947,-1.264841,0.3558117,PAAD,TCGA-FB-AAPU,TCGA-FB-AAPU-01A-31R-A41B-07,TCGA-FB-AAPU-01A,TCGA-FB-AAPU-01A-31R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAPU-01A,7562,PAAD,41,FEMALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-15129,Dead,WITH TUMOR,NA,381,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,381,1,381,NA,NA,1,381,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.FB.AAPY.01A,TCGA-FB-AAPY,TCGA.FB.AAPY,8.097273679,11.11049636,TCGA.FB.AAPY.01A.11R.A41B.07,4.261816,4.012514,0.9420201,1.346913,1.238709,PAAD,TCGA-FB-AAPY,TCGA-FB-AAPY-01A-11R-A41B-07,TCGA-FB-AAPY-01A,TCGA-FB-AAPY-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAPY-01A,7563,PAAD,71,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2007,[Not Available],-26085,Dead,TUMOR FREE,NA,1059,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,1059,0,1059,0,1059,0,1059,NA,older,NA,NA,NA,25,1985,3,1960,YES
TCGA.FB.AAPZ.01A,TCGA-FB-AAPZ,TCGA.FB.AAPZ,8.002477504,10.79763721,TCGA.FB.AAPZ.01A.11R.A41B.07,3.688344,3.512859,0.5481878,0.7734412,1.05713,PAAD,TCGA-FB-AAPZ,TCGA-FB-AAPZ-01A-11R-A41B-07,TCGA-FB-AAPZ-01A,TCGA-FB-AAPZ-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAPZ-01A,7564,PAAD,54,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2008,[Not Available],-19847,Alive,TUMOR FREE,716,NA,NA,Distant Metastasis,"Other, specify",Adrenal and right buttock,716,Complete Remission/Response,NA,NA,0,716,0,716,1,716,1,716,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.FB.AAQ0.01A,TCGA-FB-AAQ0,TCGA.FB.AAQ0,8.919938896,11.62298982,TCGA.FB.AAQ0.01A.31R.A41B.07,1.256266,1.137597,-1.154731,-1.658638,0.1834673,PAAD,TCGA-FB-AAQ0,TCGA-FB-AAQ0-01A-31R-A41B-07,TCGA-FB-AAQ0-01A,TCGA-FB-AAQ0-01A-31R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAQ0-01A,7565,PAAD,68,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-24988,Dead,TUMOR FREE,NA,473,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,473,0,473,0,473,0,473,NA,older,NA,NA,NA,NA,NA,1,NA,YES
TCGA.FB.AAQ1.01A,TCGA-FB-AAQ1,TCGA.FB.AAQ1,8.380469723,9.611790219,TCGA.FB.AAQ1.01A.12R.A41B.07,3.195508,3.193665,0.2357557,0.2806049,0.83436,PAAD,TCGA-FB-AAQ1,TCGA-FB-AAQ1-01A-12R-A41B-07,TCGA-FB-AAQ1-01A,TCGA-FB-AAQ1-01A-12R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAQ1-01A,7566,PAAD,49,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-18172,Dead,WITH TUMOR,NA,123,NA,NA,NA,NA,NA,Stable Disease,NA,NA,1,123,1,123,NA,NA,1,123,NA,younger,NA,NA,NA,NA,2005,4,NA,NO
TCGA.FB.AAQ2.01A,TCGA-FB-AAQ2,TCGA.FB.AAQ2,5.363076437,8.403033334,TCGA.FB.AAQ2.01A.31R.A41B.07,2.02565,1.929521,-0.6199932,-0.8892534,0.4707259,PAAD,TCGA-FB-AAQ2,TCGA-FB-AAQ2-01A-31R-A41B-07,TCGA-FB-AAQ2-01A,TCGA-FB-AAQ2-01A-31R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAQ2-01A,7567,PAAD,81,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-29585,Dead,WITH TUMOR,NA,153,NA,Distant Metastasis,Liver,NA,92,Partial Remission/Response,NA,NA,1,153,1,153,NA,NA,1,92,NA,older,NA,NA,NA,NA,NA,1,NA,YES
TCGA.FB.AAQ3.01A,TCGA-FB-AAQ3,TCGA.FB.AAQ3,8.695245694,11.05688153,TCGA.FB.AAQ3.01A.11R.A41B.07,3.110827,3.03116,0.1368553,0.1959235,0.82165,PAAD,TCGA-FB-AAQ3,TCGA-FB-AAQ3-01A-11R-A41B-07,TCGA-FB-AAQ3-01A,TCGA-FB-AAQ3-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAQ3-01A,7568,PAAD,65,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-23953,Dead,TUMOR FREE,NA,31,Surgical Complications,NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,31,0,31,0,31,0,31,NA,NA,NA,NA,NA,NA,NA,1,NA,NO
TCGA.FB.AAQ6.01A,TCGA-FB-AAQ6,TCGA.FB.AAQ6,7.361961314,10.8214312,TCGA.FB.AAQ6.01A.11R.A41B.07,1.812692,1.642745,-0.7678279,-1.102211,0.3567008,PAAD,TCGA-FB-AAQ6,TCGA-FB-AAQ6-01A-11R-A41B-07,TCGA-FB-AAQ6-01A,TCGA-FB-AAQ6-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-FB-AAQ6-01A,7569,PAAD,85,MALE,WHITE,Stage IA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-31319,Dead,WITH TUMOR,NA,244,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,NA,213,Progressive Disease,NA,NA,1,244,1,244,NA,NA,1,213,NA,older,NA,NA,NA,NA,1952,3,NA,NO
TCGA.FI.A2CX.01A,TCGA-FI-A2CX,TCGA.FI.A2CX,1.544851633,2.492846728,TCGA.FI.A2CX.01A.11R.A17B.07,7.190826,7.160088,2.981811,4.275923,2.284537,UCEC,TCGA-FI-A2CX,TCGA-FI-A2CX-01A-11R-A17B-07,TCGA-FI-A2CX-01A,TCGA-FI-A2CX-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2CX-01A,10982,UCEC,82,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30224,Alive,TUMOR FREE,2031,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2031,0,2031,0,2031,0,2031,NA,older,21.64412071,level1,NA,NA,NA,NA,NA,NA
TCGA.FI.A2CY.01A,TCGA-FI-A2CY,TCGA.FI.A2CY,5.353628653,4.694568106,TCGA.FI.A2CY.01A.11R.A17B.07,4.470898,4.321313,1.090628,1.555995,1.279963,UCEC,TCGA-FI-A2CY,TCGA-FI-A2CY-01A-11R-A17B-07,TCGA-FI-A2CY-01A,TCGA-FI-A2CY-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2CY-01A,10983,UCEC,60,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Mixed serous and endometrioid,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22098,Alive,TUMOR FREE,2080,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2080,0,2080,0,2080,0,2080,NA,younger,47.56242568,level4,NA,NA,NA,NA,NA,NA
TCGA.FI.A2D0.01A,TCGA-FI-A2D0,TCGA.FI.A2D0,5.396137493,6.017225243,TCGA.FI.A2D0.01A.11R.A17B.07,2.047566,1.994936,-0.6295069,-0.8673375,0.4813751,UCEC,TCGA-FI-A2D0,TCGA-FI-A2D0-01A-11R-A17B-07,TCGA-FI-A2D0-01A,TCGA-FI-A2D0-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2D0-01A,10984,UCEC,55,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2008,Peri (6-12 months since last menstrual period),-20393,Alive,TUMOR FREE,1213,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1213,0,1213,0,1213,0,1213,NA,younger,54.07787214,level4,NA,NA,NA,NA,NA,NA
TCGA.FI.A2D2.01A,TCGA-FI-A2D2,TCGA.FI.A2D2,6.618261468,8.920006922,TCGA.FI.A2D2.01A.11R.A17B.07,2.705459,2.755905,-0.1133129,-0.2094447,0.6651507,UCEC,TCGA-FI-A2D2,TCGA-FI-A2D2-01A-11R-A17B-07,TCGA-FI-A2D2-01A,TCGA-FI-A2D2-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2D2-01A,10985,UCEC,66,FEMALE,WHITE,[Not Applicable],Stage IB,Mixed serous and endometrioid,G3,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24260,Dead,WITH TUMOR,NA,2352,[Not Available],Locoregional Recurrence,Lung,Liver,1917,Complete Remission/Response,NA,NA,1,2352,1,2352,1,1917,1,1917,NA,older,58.81519274,level4,NA,NA,NA,NA,NA,NA
TCGA.FI.A2D4.01A,TCGA-FI-A2D4,TCGA.FI.A2D4,3.301512971,9.269767164,TCGA.FI.A2D4.01A.12R.A17B.07,1.724112,1.691835,-0.8050244,-1.190792,0.338764,UCEC,TCGA-FI-A2D4,TCGA-FI-A2D4-01A-12R-A17B-07,TCGA-FI-A2D4-01A,TCGA-FI-A2D4-01A-12R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2D4-01A,10986,UCEC,44,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2009,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16163,Dead,WITH TUMOR,NA,243,[Not Available],NA,NA,NA,NA,Partial Remission/Response,NA,NA,1,243,1,243,NA,NA,1,243,NA,younger,42.15439046,level4,NA,NA,NA,NA,NA,NA
TCGA.FI.A2D5.01A,TCGA-FI-A2D5,TCGA.FI.A2D5,3.904336036,10.42432006,TCGA.FI.A2D5.01A.11R.A17B.07,2.887743,2.769169,-0.02388136,-0.02716054,0.7292078,UCEC,TCGA-FI-A2D5,TCGA-FI-A2D5-01A-11R-A17B-07,TCGA-FI-A2D5-01A,TCGA-FI-A2D5-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2D5-01A,10987,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20666,Dead,WITH TUMOR,NA,421,[Not Available],Metastatic,"Other, specify",vaginal cuff,280,Partial Remission/Response,NA,NA,1,421,1,421,NA,NA,1,280,NA,younger,35.9375,level4,NA,NA,NA,NA,NA,NA
TCGA.FI.A2D6.01A,TCGA-FI-A2D6,TCGA.FI.A2D6,2.554167617,2.429787073,TCGA.FI.A2D6.01A.11R.A17B.07,3.858516,3.908242,0.6452558,0.9436126,1.10164,UCEC,TCGA-FI-A2D6,TCGA-FI-A2D6-01A-11R-A17B-07,TCGA-FI-A2D6-01A,TCGA-FI-A2D6-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2D6-01A,10988,UCEC,74,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27060,Dead,TUMOR FREE,NA,767,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,767,0,767,0,767,0,767,NA,older,34.89439853,level3,NA,NA,NA,NA,NA,NA
TCGA.FI.A2EU.01A,TCGA-FI-A2EU,TCGA.FI.A2EU,3.116000207,6.021310884,TCGA.FI.A2EU.01A.11R.A17B.07,1.18011,1.013264,-1.249812,-1.734793,0.1725746,UCEC,TCGA-FI-A2EU,TCGA-FI-A2EU-01A-11R-A17B-07,TCGA-FI-A2EU-01A,TCGA-FI-A2EU-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2EU-01A,10989,UCEC,68,FEMALE,[Not Available],[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24837,Alive,TUMOR FREE,2941,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2941,0,2941,0,2941,0,2941,NA,older,32.95068027,level3,NA,NA,NA,NA,NA,NA
TCGA.FI.A2EW.01A,TCGA-FI-A2EW,TCGA.FI.A2EW,4.339019744,7.561857465,TCGA.FI.A2EW.01A.11R.A17B.07,1.955252,1.895223,-0.651138,-0.9596513,0.4593746,UCEC,TCGA-FI-A2EW,TCGA-FI-A2EW-01A-11R-A17B-07,TCGA-FI-A2EW-01A,TCGA-FI-A2EW-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2EW-01A,10990,UCEC,71,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIB,Serous endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26267,Alive,WITH TUMOR,1795,NA,[Not Available],Metastatic,Liver,NA,1169,Complete Remission/Response,NA,NA,0,1795,0,1795,1,1169,1,1169,NA,older,32.421875,level3,NA,NA,NA,NA,NA,NA
TCGA.FI.A2EX.01A,TCGA-FI-A2EX,TCGA.FI.A2EX,6.428754232,6.306590357,TCGA.FI.A2EX.01A.11R.A17B.07,2.268905,2.090589,-0.4558046,-0.6459979,0.519317,UCEC,TCGA-FI-A2EX,TCGA-FI-A2EX-01A-11R-A17B-07,TCGA-FI-A2EX-01A,TCGA-FI-A2EX-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2EX-01A,10991,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21489,Alive,WITH TUMOR,284,NA,[Not Available],Metastatic,NA,NA,213,Complete Remission/Response,NA,NA,0,284,0,284,1,213,1,213,NA,younger,37.52740766,level4,NA,NA,NA,NA,NA,NA
TCGA.FI.A2EY.01A,TCGA-FI-A2EY,TCGA.FI.A2EY,5.906890596,6.686500527,TCGA.FI.A2EY.01A.12R.A18M.07,0.7968178,0.6770883,-1.424878,-2.118085,0.01284098,UCEC,TCGA-FI-A2EY,TCGA-FI-A2EY-01A-12R-A18M-07,TCGA-FI-A2EY-01A,TCGA-FI-A2EY-01A-12R-A18M-07,TP,Primary solid Tumor,1,1,A18M,1,0,1,Female,1,Tumor,TCGA-FI-A2EY-01A,10992,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23042,Dead,TUMOR FREE,NA,880,[Not Available],New Primary Tumor,Lung,NA,577,Complete Remission/Response,NA,NA,1,880,0,880,0,880,1,577,NA,younger,28.66612918,level2,NA,NA,NA,NA,NA,NA
TCGA.FI.A2F4.01A,TCGA-FI-A2F4,TCGA.FI.A2F4,5.5190735,9.734749187,TCGA.FI.A2F4.01A.11R.A17B.07,3.975697,3.592292,0.7187713,1.060794,1.117706,UCEC,TCGA-FI-A2F4,TCGA-FI-A2F4-01A-11R-A17B-07,TCGA-FI-A2F4-01A,TCGA-FI-A2F4-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2F4-01A,10993,UCEC,64,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23621,Alive,TUMOR FREE,2230,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2230,0,2230,0,2230,0,2230,NA,younger,27.18089991,level2,NA,NA,NA,NA,NA,NA
TCGA.FI.A2F8.01A,TCGA-FI-A2F8,TCGA.FI.A2F8,5.681613981,9.791044609,TCGA.FI.A2F8.01A.12R.A17B.07,2.63492,2.648457,-0.2015661,-0.2799828,0.6753262,UCEC,TCGA-FI-A2F8,TCGA-FI-A2F8-01A-12R-A17B-07,TCGA-FI-A2F8-01A,TCGA-FI-A2F8-01A-12R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2F8-01A,10994,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23649,Alive,WITH TUMOR,933,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,933,0,933,0,933,0,933,NA,younger,33.07828528,level3,NA,NA,NA,NA,NA,NA
TCGA.FI.A2F9.01A,TCGA-FI-A2F9,TCGA.FI.A2F9,2.393205379,4.967234491,TCGA.FI.A2F9.01A.11R.A17B.07,0.9651373,1.020309,-1.327374,-1.949766,0.09093803,UCEC,TCGA-FI-A2F9,TCGA-FI-A2F9-01A-11R-A17B-07,TCGA-FI-A2F9-01A,TCGA-FI-A2F9-01A-11R-A17B-07,TP,Primary solid Tumor,1,1,A17B,1,0,1,Female,1,Tumor,TCGA-FI-A2F9-01A,10995,UCEC,79,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28886,Alive,TUMOR FREE,1803,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1803,0,1803,0,1803,0,1803,NA,older,32.32653061,level3,NA,NA,NA,NA,NA,NA
TCGA.FI.A3PV.01A,TCGA-FI-A3PV,TCGA.FI.A3PV,3.293664762,9.762920146,TCGA.FI.A3PV.01A.11R.A22K.07,0.9862734,0.8481419,-1.363338,-1.92863,0.09529852,UCEC,TCGA-FI-A3PV,TCGA-FI-A3PV-01A-11R-A22K-07,TCGA-FI-A3PV-01A,TCGA-FI-A3PV-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-FI-A3PV-01A,10996,UCEC,68,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,High Grade,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24898,Dead,WITH TUMOR,NA,1249,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,1,1249,1,1249,NA,NA,1,1249,NA,older,34.68093539,level3,NA,NA,NA,NA,NA,NA
TCGA.FI.A3PX.01A,TCGA-FI-A3PX,TCGA.FI.A3PX,4.309547293,9.703599088,TCGA.FI.A3PX.01A.11R.A22K.07,1.272945,1.247983,-1.149266,-1.641959,0.2117693,UCEC,TCGA-FI-A3PX,TCGA-FI-A3PX-01A-11R-A22K-07,TCGA-FI-A3PX-01A,TCGA-FI-A3PX-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-FI-A3PX-01A,10997,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,High Grade,2008,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21063,Alive,TUMOR FREE,2384,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2384,0,2384,0,2384,0,2384,NA,younger,31.14186851,level3,NA,NA,NA,NA,NA,NA
TCGA.H5.A2HR.01A,TCGA-H5-A2HR,TCGA.H5.A2HR,4.404753288,5.686074659,TCGA.H5.A2HR.01A.11R.A180.07,2.938218,3.074053,0.05701097,0.02331512,0.7325637,UCEC,TCGA-H5-A2HR,TCGA-H5-A2HR-01A-11R-A180-07,TCGA-H5-A2HR-01A,TCGA-H5-A2HR-01A-11R-A180-07,TP,Primary solid Tumor,1,1,A180,1,0,1,Female,1,Tumor,TCGA-H5-A2HR-01A,10998,UCEC,71,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25986,Alive,TUMOR FREE,53,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,53,0,53,NA,NA,0,53,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.H6.8124.01A,TCGA-H6-8124,TCGA.H6.8124,4.482848283,9.33998358,TCGA.H6.8124.01A.11R.2404.07,2.13917,2.055271,-0.5523587,-0.7757333,0.4955169,PAAD,TCGA-H6-8124,TCGA-H6-8124-01A-11R-2404-07,TCGA-H6-8124-01A,TCGA-H6-8124-01A-11R-2404-07,TP,Primary solid Tumor,1,1,2404,1,0,1,Pancreas,1,Tumor,TCGA-H6-8124-01A,7577,PAAD,56,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-20741,Alive,WITH TUMOR,392,NA,NA,Distant Metastasis,Liver,NA,259,Complete Remission/Response,NA,NA,0,392,0,392,1,259,1,259,NA,younger,NA,NA,NA,3.5,1976,3,1969,NO
TCGA.H6.A45N.01A,TCGA-H6-A45N,TCGA.H6.A45N,7.992960989,10.58946389,TCGA.H6.A45N.01A.11R.A26U.07,4.19259,4.06011,0.8679957,1.277687,1.244924,PAAD,TCGA-H6-A45N,TCGA-H6-A45N-01A-11R-A26U-07,TCGA-H6-A45N-01A,TCGA-H6-A45N-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-H6-A45N-01A,7578,PAAD,88,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2012,[Not Available],-32475,Dead,WITH TUMOR,NA,421,Pancreatic Cancer,Locoregional Recurrence,Tumor Bed,NA,363,Progressive Disease,NA,NA,1,421,1,421,NA,NA,1,363,NA,older,NA,NA,NA,1,NA,3,NA,NO
TCGA.H8.A6C1.01A,TCGA-H8-A6C1,TCGA.H8.A6C1,11.26406722,11.8517061,TCGA.H8.A6C1.01A.11R.A32O.07,3.843044,3.654198,0.6727459,0.9281413,1.0978,PAAD,TCGA-H8-A6C1,TCGA-H8-A6C1-01A-11R-A32O-07,TCGA-H8-A6C1-01A,TCGA-H8-A6C1-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-H8-A6C1-01A,7579,PAAD,53,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2012,[Not Available],-19677,Alive,WITH TUMOR,671,NA,NA,Distant Metastasis,Liver,NA,455,[Discrepancy],NA,NA,0,671,0,671,NA,NA,1,455,NA,younger,NA,NA,NA,30,2012,4,1982,NO
TCGA.HV.A5A3.01A,TCGA-HV-A5A3,TCGA.HV.A5A3,5.468228138,12.26382962,TCGA.HV.A5A3.01A.11R.A26U.07,2.309604,2.158418,-0.4317872,-0.6052991,0.5410518,PAAD,TCGA-HV-A5A3,TCGA-HV-A5A3-01A-11R-A26U-07,TCGA-HV-A5A3-01A,TCGA-HV-A5A3-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-HV-A5A3-01A,7580,PAAD,50,MALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-18475,Dead,TUMOR FREE,NA,128,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,128,0,128,0,128,0,128,NA,younger,NA,NA,NA,NA,2002,NA,NA,NO
TCGA.HV.A5A4.01A,TCGA-HV-A5A4,TCGA.HV.A5A4,7.656911043,10.7867352,TCGA.HV.A5A4.01A.11R.A26U.07,3.321792,3.256805,0.2685417,0.4068887,0.8973651,PAAD,TCGA-HV-A5A4,TCGA-HV-A5A4-01A-11R-A26U-07,TCGA-HV-A5A4-01A,TCGA-HV-A5A4-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-HV-A5A4-01A,7581,PAAD,72,FEMALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26311,Alive,NA,232,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,232,0,232,0,232,0,232,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.HV.A5A5.01A,TCGA-HV-A5A5,TCGA.HV.A5A5,10.53437098,11.03541772,TCGA.HV.A5A5.01A.11R.A26U.07,3.881714,3.77228,0.6568544,0.9668107,1.126555,PAAD,TCGA-HV-A5A5,TCGA-HV-A5A5-01A-11R-A26U-07,TCGA-HV-A5A5-01A,TCGA-HV-A5A5-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-HV-A5A5-01A,7582,PAAD,61,FEMALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-22329,Alive,NA,289,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,289,0,289,0,289,0,289,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.HV.A5A6.01A,TCGA-HV-A5A6,TCGA.HV.A5A6,3.936647361,10.23267275,TCGA.HV.A5A6.01A.11R.A26U.07,2.357717,2.341171,-0.4043768,-0.5571859,0.5654784,PAAD,TCGA-HV-A5A6,TCGA-HV-A5A6-01A-11R-A26U-07,TCGA-HV-A5A6-01A,TCGA-HV-A5A6-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-HV-A5A6-01A,7583,PAAD,65,FEMALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2001,[Not Available],-24025,Dead,WITH TUMOR,NA,2036,Other malignancy,Distant Metastasis,Lung,NA,1511,Complete Remission/Response,NA,NA,1,2036,0,2036,1,1511,1,1511,NA,NA,NA,NA,NA,NA,NA,1,NA,NO
TCGA.HV.A7OL.01A,TCGA-HV-A7OL,TCGA.HV.A7OL,7.139715053,12.38462728,TCGA.HV.A7OL.01A.11R.A33R.07,5.275858,5.389349,1.657042,2.360954,1.599791,PAAD,TCGA-HV-A7OL,TCGA-HV-A7OL-01A-11R-A33R-07,TCGA-HV-A7OL-01A,TCGA-HV-A7OL-01A-11R-A33R-07,TP,Primary solid Tumor,1,1,A33R,1,0,1,Pancreas,1,Tumor,TCGA-HV-A7OL-01A,7584,PAAD,70,MALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-25768,Alive,NA,252,NA,NA,Distant Metastasis,Non-regional / Distant Lymph Nodes,NA,123,Stable Disease,NA,NA,0,252,0,252,NA,NA,1,123,NA,older,NA,NA,NA,NA,NA,1,NA,YES
TCGA.HV.A7OP.01A,TCGA-HV-A7OP,TCGA.HV.A7OP,2.00773372,9.86341041,TCGA.HV.A7OP.01A.11R.A33R.07,2.521465,2.186051,-0.2378126,-0.3934386,0.5679412,PAAD,TCGA-HV-A7OP,TCGA-HV-A7OP-01A-11R-A33R-07,TCGA-HV-A7OP-01A,TCGA-HV-A7OP-01A-11R-A33R-07,TP,Primary solid Tumor,1,1,A33R,1,0,1,Pancreas,1,Tumor,TCGA-HV-A7OP-01A,7585,PAAD,72,MALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,GX,2012,[Not Available],-26322,Alive,NA,978,NA,NA,Distant Metastasis,Liver,NA,342,[Discrepancy],NA,NA,0,978,0,978,NA,NA,1,342,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.HV.AA8V.01A,TCGA-HV-AA8V,TCGA.HV.AA8V,6.845828731,10.60215137,TCGA.HV.AA8V.01A.11R.A41B.07,3.242795,2.976794,0.2614515,0.3278915,0.8645669,PAAD,TCGA-HV-AA8V,TCGA-HV-AA8V-01A-11R-A41B-07,TCGA-HV-AA8V-01A,TCGA-HV-AA8V-01A-11R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-HV-AA8V-01A,7586,PAAD,50,MALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-18357,Alive,NA,920,NA,NA,Distant Metastasis,"Other, specify",bone,526,[Discrepancy],NA,NA,0,920,0,920,NA,NA,1,526,NA,younger,NA,NA,NA,60,NA,4,NA,NO
TCGA.HV.AA8X.01A,TCGA-HV-AA8X,TCGA.HV.AA8X,7.616284172,12.84613285,TCGA.HV.AA8X.01A.11R.A39D.07,1.632204,1.354732,-0.8924699,-1.282699,0.2786203,PAAD,TCGA-HV-AA8X,TCGA-HV-AA8X-01A-11R-A39D-07,TCGA-HV-AA8X-01A,TCGA-HV-AA8X-01A-11R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-HV-AA8X-01A,7587,PAAD,75,FEMALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-27662,Dead,WITH TUMOR,NA,532,NA,Distant Metastasis,"Other, specify",Omentum,375,[Discrepancy],NA,NA,1,532,1,532,NA,NA,1,375,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.HZ.7289.01A,TCGA-HZ-7289,TCGA.HZ.7289,8.489880065,13.22944222,TCGA.HZ.7289.01A.11R.2156.07,-0.03634572,-0.1240002,-2.071523,-2.951249,-0.2689867,PAAD,TCGA-HZ-7289,TCGA-HZ-7289-01A-11R-2156-07,TCGA-HZ-7289-01A,TCGA-HZ-7289-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-HZ-7289-01A,7588,PAAD,77,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2010,[Not Available],-28174,Dead,WITH TUMOR,NA,661,Pancreatic Cancer,Distant Metastasis,Liver,NA,228,[Unknown],NA,NA,1,661,1,661,NA,NA,1,228,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.7918.01A,TCGA-HZ-7918,TCGA.HZ.7918,5.980087011,10.85206128,TCGA.HZ.7918.01A.11R.2156.07,4.31595,4.056778,0.9521789,1.401047,1.281812,PAAD,TCGA-HZ-7918,TCGA-HZ-7918-01A-11R-2156-07,TCGA-HZ-7918-01A,TCGA-HZ-7918-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-HZ-7918-01A,7589,PAAD,72,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-26573,Alive,WITH TUMOR,969,NA,NA,Distant Metastasis,Liver,NA,542,Complete Remission/Response,NA,NA,0,969,0,969,1,542,1,542,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.7919.01A,TCGA-HZ-7919,TCGA.HZ.7919,8.894654087,10.89773959,TCGA.HZ.7919.01A.11R.2156.07,2.782023,2.742649,-0.1152407,-0.1328807,0.7238945,PAAD,TCGA-HZ-7919,TCGA-HZ-7919-01A-11R-2156-07,TCGA-HZ-7919-01A,TCGA-HZ-7919-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-HZ-7919-01A,7590,PAAD,52,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-19064,Dead,WITH TUMOR,NA,593,Pancreatic Cancer,NA,NA,NA,NA,[Unknown],NA,NA,1,593,1,593,NA,NA,1,593,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.7920.01A,TCGA-HZ-7920,TCGA.HZ.7920,8.982146527,8.532597491,TCGA.HZ.7920.01A.11R.2204.07,3.482322,3.579405,0.3911503,0.5674187,0.991886,PAAD,TCGA-HZ-7920,TCGA-HZ-7920-01A-11R-2204-07,TCGA-HZ-7920-01A,TCGA-HZ-7920-01A-11R-2204-07,TP,Primary solid Tumor,1,1,2204,1,0,1,Pancreas,1,Tumor,TCGA-HZ-7920-01A,7591,PAAD,71,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-26167,Dead,TUMOR FREE,NA,236,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,236,0,236,0,236,0,236,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.7922.01A,TCGA-HZ-7922,TCGA.HZ.7922,5.463148324,10.5142505,TCGA.HZ.7922.01A.11R.2156.07,2.819442,2.660391,-0.06989674,-0.09546146,0.7395463,PAAD,TCGA-HZ-7922,TCGA-HZ-7922-01A-11R-2156-07,TCGA-HZ-7922-01A,TCGA-HZ-7922-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-HZ-7922-01A,7592,PAAD,61,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-22413,Alive,NA,4,NA,NA,NA,NA,NA,NA,[Not Applicable],NA,NA,0,4,0,4,NA,NA,0,4,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.7923.01A,TCGA-HZ-7923,TCGA.HZ.7923,11.89989311,9.815296828,TCGA.HZ.7923.01A.12R.2156.07,4.056767,3.975621,0.8067367,1.141863,1.209674,PAAD,TCGA-HZ-7923,TCGA-HZ-7923-01A-12R-2156-07,TCGA-HZ-7923-01A,TCGA-HZ-7923-01A-12R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-HZ-7923-01A,7593,PAAD,65,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-23760,Alive,TUMOR FREE,314,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,314,0,314,0,314,0,314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.7924.01A,TCGA-HZ-7924,TCGA.HZ.7924,12.26654939,11.29130886,TCGA.HZ.7924.01A.11R.2156.07,2.70736,2.542578,-0.1474992,-0.2075433,0.7311029,PAAD,TCGA-HZ-7924,TCGA-HZ-7924-01A-11R-2156-07,TCGA-HZ-7924-01A,TCGA-HZ-7924-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-HZ-7924-01A,7594,PAAD,60,FEMALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-22090,Alive,WITH TUMOR,840,NA,NA,Distant Metastasis,NA,Liver,831,Complete Remission/Response,NA,NA,0,840,0,840,1,831,1,831,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.7925.01A,TCGA-HZ-7925,TCGA.HZ.7925,8.465509267,10.60844889,TCGA.HZ.7925.01A.11R.2156.07,2.660462,2.495832,-0.1580408,-0.2544414,0.6608958,PAAD,TCGA-HZ-7925,TCGA-HZ-7925-01A-11R-2156-07,TCGA-HZ-7925-01A,TCGA-HZ-7925-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-HZ-7925-01A,7595,PAAD,66,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-24150,Dead,WITH TUMOR,NA,614,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",Regional LNs,364,Complete Remission/Response,NA,NA,1,614,1,614,1,364,1,364,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.7926.01A,TCGA-HZ-7926,TCGA.HZ.7926,12.21898091,11.86795822,TCGA.HZ.7926.01A.11R.2156.07,2.653932,2.576803,-0.1906596,-0.2609713,0.7071148,PAAD,TCGA-HZ-7926,TCGA-HZ-7926-01A-11R-2156-07,TCGA-HZ-7926-01A,TCGA-HZ-7926-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-HZ-7926-01A,7596,PAAD,57,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-21024,Dead,WITH TUMOR,NA,518,Pancreatic Cancer,Distant Metastasis,Lung,NA,340,Progressive Disease,NA,NA,1,518,1,518,NA,NA,1,340,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.8001.01A,TCGA-HZ-8001,TCGA.HZ.8001,7.329778403,9.467833755,TCGA.HZ.8001.01A.11R.2204.07,3.878545,3.850677,0.6755121,0.9636418,1.134995,PAAD,TCGA-HZ-8001,TCGA-HZ-8001-01A-11R-2204-07,TCGA-HZ-8001-01A,TCGA-HZ-8001-01A-11R-2204-07,TP,Primary solid Tumor,1,1,2204,1,0,1,Pancreas,1,Tumor,TCGA-HZ-8001-01A,7597,PAAD,69,MALE,WHITE,Stage III,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-25227,Alive,TUMOR FREE,706,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,706,0,706,0,706,0,706,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.8002.01A,TCGA-HZ-8002,TCGA.HZ.8002,8.118245505,9.816017238,TCGA.HZ.8002.01A.11R.2204.07,3.367645,3.237317,0.3113114,0.4527414,0.9523054,PAAD,TCGA-HZ-8002,TCGA-HZ-8002-01A-11R-2204-07,TCGA-HZ-8002-01A,TCGA-HZ-8002-01A-11R-2204-07,TP,Primary solid Tumor,1,1,2204,1,0,1,Pancreas,1,Tumor,TCGA-HZ-8002-01A,7598,PAAD,61,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-22433,Dead,WITH TUMOR,NA,366,NA,NA,NA,NA,NA,[Unknown],NA,NA,1,366,1,366,NA,NA,1,366,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.8003.01A,TCGA-HZ-8003,TCGA.HZ.8003,7.138660904,11.04802361,TCGA.HZ.8003.01A.21R.2204.07,3.923095,3.82429,0.6850204,1.008192,1.146824,PAAD,TCGA-HZ-8003,TCGA-HZ-8003-01A-21R-2204-07,TCGA-HZ-8003-01A,TCGA-HZ-8003-01A-21R-2204-07,TP,Primary solid Tumor,1,1,2204,1,0,1,Pancreas,1,Tumor,TCGA-HZ-8003-01A,7599,PAAD,65,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-23868,Dead,WITH TUMOR,NA,596,Pancreatic Cancer,NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,596,1,596,NA,NA,1,596,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.8005.01A,TCGA-HZ-8005,TCGA.HZ.8005,3.175859887,7.212579066,TCGA.HZ.8005.01A.11R.2204.07,2.826015,2.685676,-0.06623107,-0.08888846,0.6705818,PAAD,TCGA-HZ-8005,TCGA-HZ-8005-01A-11R-2204-07,TCGA-HZ-8005-01A,TCGA-HZ-8005-01A-11R-2204-07,TP,Primary solid Tumor,1,1,2204,1,0,1,Pancreas,1,Tumor,TCGA-HZ-8005-01A,7600,PAAD,81,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-29674,Dead,WITH TUMOR,NA,120,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,120,1,120,NA,NA,1,120,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.8315.01A,TCGA-HZ-8315,TCGA.HZ.8315,7.9138887,10.64533419,TCGA.HZ.8315.01A.11R.2404.07,4.271882,4.015663,0.8886257,1.356979,1.279576,PAAD,TCGA-HZ-8315,TCGA-HZ-8315-01A-11R-2404-07,TCGA-HZ-8315-01A,TCGA-HZ-8315-01A-11R-2404-07,TP,Primary solid Tumor,1,1,2404,1,0,1,Pancreas,1,Tumor,TCGA-HZ-8315-01A,7601,PAAD,54,FEMALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-19839,Dead,WITH TUMOR,NA,299,Pancreatic Cancer,NA,NA,NA,NA,[Unknown],NA,NA,1,299,1,299,NA,NA,1,299,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.8317.01A,TCGA-HZ-8317,TCGA.HZ.8317,10.42493258,11.16737424,TCGA.HZ.8317.01A.11R.2404.07,3.06323,2.988935,0.07429036,0.1483272,0.8370419,PAAD,TCGA-HZ-8317,TCGA-HZ-8317-01A-11R-2404-07,TCGA-HZ-8317-01A,TCGA-HZ-8317-01A-11R-2404-07,TP,Primary solid Tumor,1,1,2404,1,0,1,Pancreas,1,Tumor,TCGA-HZ-8317-01A,7602,PAAD,69,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2012,[Not Available],-25214,Dead,WITH TUMOR,NA,378,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,378,1,378,NA,NA,1,378,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.8519.01A,TCGA-HZ-8519,TCGA.HZ.8519,7.753243496,9.745670963,TCGA.HZ.8519.01A.11R.2404.07,4.192422,4.189904,0.8423946,1.277519,1.268985,PAAD,TCGA-HZ-8519,TCGA-HZ-8519-01A-11R-2404-07,TCGA-HZ-8519-01A,TCGA-HZ-8519-01A-11R-2404-07,TP,Primary solid Tumor,1,1,2404,1,0,1,Pancreas,1,Tumor,TCGA-HZ-8519-01A,7603,PAAD,73,MALE,WHITE,Stage IA,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2012,[Not Available],-26947,Alive,TUMOR FREE,454,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,454,0,454,0,454,0,454,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.8636.01A,TCGA-HZ-8636,TCGA.HZ.8636,7.38623327,10.38996469,TCGA.HZ.8636.01A.21R.2404.07,4.124759,3.895737,0.8086375,1.209856,1.224586,PAAD,TCGA-HZ-8636,TCGA-HZ-8636-01A-21R-2404-07,TCGA-HZ-8636-01A,TCGA-HZ-8636-01A-21R-2404-07,TP,Primary solid Tumor,1,1,2404,1,0,1,Pancreas,1,Tumor,TCGA-HZ-8636-01A,7604,PAAD,58,FEMALE,WHITE,Stage IV,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-21501,Dead,WITH TUMOR,NA,545,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,545,1,545,NA,NA,1,545,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.8637.01A,TCGA-HZ-8637,TCGA.HZ.8637,7.702179613,10.8550086,TCGA.HZ.8637.01A.11R.2404.07,5.748967,5.553608,1.915258,2.834064,1.803279,PAAD,TCGA-HZ-8637,TCGA-HZ-8637-01A-11R-2404-07,TCGA-HZ-8637-01A,TCGA-HZ-8637-01A-11R-2404-07,TP,Primary solid Tumor,1,1,2404,1,0,1,Pancreas,1,Tumor,TCGA-HZ-8637-01A,7605,PAAD,76,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-27929,Dead,TUMOR FREE,NA,517,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,517,0,517,0,517,0,517,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.8638.01A,TCGA-HZ-8638,TCGA.HZ.8638,11.86533891,11.09938069,TCGA.HZ.8638.01A.11R.2404.07,3.537181,3.455604,0.3415457,0.6222776,1.040834,PAAD,TCGA-HZ-8638,TCGA-HZ-8638-01A-11R-2404-07,TCGA-HZ-8638-01A,TCGA-HZ-8638-01A-11R-2404-07,TP,Primary solid Tumor,1,1,2404,1,0,1,Pancreas,1,Tumor,TCGA-HZ-8638-01A,7606,PAAD,84,FEMALE,WHITE,Stage IA,[Not Applicable],Pancreas-Colloid (mucinous non-cystic) Carcinoma,GX,2012,[Not Available],-30821,Dead,TUMOR FREE,NA,151,Surgical Complications,NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,151,0,151,0,151,0,151,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.A49G.01A,TCGA-HZ-A49G,TCGA.HZ.A49G,7.398786438,10.90224697,TCGA.HZ.A49G.01A.11R.A26U.07,4.520484,4.58578,1.119878,1.605581,1.349108,PAAD,TCGA-HZ-A49G,TCGA-HZ-A49G-01A-11R-A26U-07,TCGA-HZ-A49G-01A,TCGA-HZ-A49G-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A49G-01A,7607,PAAD,58,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-21491,Alive,WITH TUMOR,660,NA,NA,NA,NA,NA,NA,Progressive Disease,NA,NA,0,660,0,660,NA,NA,0,660,NA,younger,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.A49H.01A,TCGA-HZ-A49H,TCGA.HZ.A49H,9.114780845,11.49613475,TCGA.HZ.A49H.01A.11R.A26U.07,4.525881,4.42859,1.081212,1.610978,1.376953,PAAD,TCGA-HZ-A49H,TCGA-HZ-A49H-01A-11R-A26U-07,TCGA-HZ-A49H-01A,TCGA-HZ-A49H-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A49H-01A,7608,PAAD,68,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-24891,Alive,TUMOR FREE,491,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,491,0,491,0,491,0,491,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.A49I.01A,TCGA-HZ-A49I,TCGA.HZ.A49I,7.071258547,11.04753294,TCGA.HZ.A49I.01A.12R.A26U.07,4.193547,4.095069,0.9010192,1.278643,1.242035,PAAD,TCGA-HZ-A49I,TCGA-HZ-A49I-01A-12R-A26U-07,TCGA-HZ-A49I-01A,TCGA-HZ-A49I-01A-12R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A49I-01A,7609,PAAD,77,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-28454,Dead,WITH TUMOR,NA,308,Pancreatic Cancer,NA,NA,NA,NA,Progressive Disease,NA,NA,1,308,1,308,NA,NA,1,308,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.A4BH.01A,TCGA-HZ-A4BH,TCGA.HZ.A4BH,6.386009035,9.840537192,TCGA.HZ.A4BH.01A.11R.A26U.07,4.180905,4.059025,0.8385179,1.266002,1.249269,PAAD,TCGA-HZ-A4BH,TCGA-HZ-A4BH-01A-11R-A26U-07,TCGA-HZ-A4BH-01A,TCGA-HZ-A4BH-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A4BH-01A,7610,PAAD,75,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-27637,Alive,WITH TUMOR,194,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,194,0,194,NA,NA,0,194,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.A4BK.01A,TCGA-HZ-A4BK,TCGA.HZ.A4BK,10.62715994,11.27968022,TCGA.HZ.A4BK.01A.11R.A26U.07,4.161062,4.071789,0.8540365,1.246159,1.226895,PAAD,TCGA-HZ-A4BK,TCGA-HZ-A4BK-01A-11R-A26U-07,TCGA-HZ-A4BK-01A,TCGA-HZ-A4BK-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A4BK-01A,7611,PAAD,72,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2012,[Not Available],-26503,Alive,WITH TUMOR,657,NA,NA,NA,NA,NA,NA,Progressive Disease,NA,NA,0,657,0,657,NA,NA,0,657,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.HZ.A77O.01A,TCGA-HZ-A77O,TCGA.HZ.A77O,4.990296878,10.54205487,TCGA.HZ.A77O.01A.11R.A33R.07,3.789565,3.7753,0.6359659,0.8746623,1.036825,PAAD,TCGA-HZ-A77O,TCGA-HZ-A77O-01A-11R-A33R-07,TCGA-HZ-A77O-01A,TCGA-HZ-A77O-01A-11R-A33R-07,TP,Primary solid Tumor,1,1,A33R,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A77O-01A,7612,PAAD,77,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-28434,Dead,WITH TUMOR,NA,160,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,NA,98,Complete Remission/Response,NA,NA,1,160,1,160,1,98,1,98,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.HZ.A77P.01A,TCGA-HZ-A77P,TCGA.HZ.A77P,8.791761987,10.42836017,TCGA.HZ.A77P.01A.11R.A33R.07,4.33725,4.258609,1.020525,1.422347,1.268447,PAAD,TCGA-HZ-A77P,TCGA-HZ-A77P-01A-11R-A33R-07,TCGA-HZ-A77P-01A,TCGA-HZ-A77P-01A-11R-A33R-07,TP,Primary solid Tumor,1,1,A33R,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A77P-01A,7613,PAAD,77,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G1,2013,[Not Available],-28403,Alive,TUMOR FREE,330,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,330,0,330,0,330,0,330,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.HZ.A77Q.01A,TCGA-HZ-A77Q,TCGA.HZ.A77Q,5.520129908,11.30794645,TCGA.HZ.A77Q.01A.11R.A36G.07,5.137919,5.161433,1.585226,2.223016,1.571413,PAAD,TCGA-HZ-A77Q,TCGA-HZ-A77Q-01A-11R-A36G-07,TCGA-HZ-A77Q-01A,TCGA-HZ-A77Q-01A-11R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A77Q-01A,7614,PAAD,55,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2013,[Not Available],-20366,Alive,TUMOR FREE,33,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,33,0,33,NA,NA,0,33,NA,younger,NA,NA,NA,15,NA,2,1983,YES
TCGA.HZ.A8P0.01A,TCGA-HZ-A8P0,TCGA.HZ.A8P0,8.443308269,9.53342513,TCGA.HZ.A8P0.01A.11R.A36G.07,3.477728,3.461089,0.4207602,0.5628246,0.9656395,PAAD,TCGA-HZ-A8P0,TCGA-HZ-A8P0-01A-11R-A36G-07,TCGA-HZ-A8P0-01A,TCGA-HZ-A8P0-01A-11R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A8P0-01A,7615,PAAD,76,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-27850,Alive,TUMOR FREE,0,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,0,0,0,NA,NA,0,0,NA,older,NA,NA,NA,20,1988,3,1968,NO
TCGA.HZ.A8P1.01A,TCGA-HZ-A8P1,TCGA.HZ.A8P1,9.982109439,11.933023,TCGA.HZ.A8P1.01A.11R.A37L.07,2.776293,2.737378,-0.08289341,-0.1386098,0.7235852,PAAD,TCGA-HZ-A8P1,TCGA-HZ-A8P1-01A-11R-A37L-07,TCGA-HZ-A8P1-01A,TCGA-HZ-A8P1-01A-11R-A37L-07,TP,Primary solid Tumor,1,1,A37L,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A8P1-01A,7616,PAAD,81,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-29631,Alive,TUMOR FREE,7,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,7,0,7,NA,NA,0,7,NA,older,NA,NA,NA,15,1967,3,1952,NO
TCGA.HZ.A9TJ.01A,TCGA-HZ-A9TJ,TCGA.HZ.A9TJ,5.350567966,10.94638728,TCGA.HZ.A9TJ.01A.11R.A41I.07,2.391502,2.288659,-0.3722311,-0.5234016,0.5696207,PAAD,TCGA-HZ-A9TJ,TCGA-HZ-A9TJ-01A-11R-A41I-07,TCGA-HZ-A9TJ-01A,TCGA-HZ-A9TJ-01A-11R-A41I-07,TP,Primary solid Tumor,1,1,A41I,1,0,1,Pancreas,1,Tumor,TCGA-HZ-A9TJ-01A,7617,PAAD,70,MALE,WHITE,Stage IV,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2013,[Not Available],-25849,Alive,WITH TUMOR,603,NA,NA,Distant Metastasis,Peritoneal Surfaces,NA,555,[Unknown],NA,NA,0,603,0,603,NA,NA,1,555,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.IB.7644.01A,TCGA-IB-7644,TCGA.IB.7644,8.304647931,11.14194746,TCGA.IB.7644.01A.11R.2156.07,2.363949,2.25082,-0.3941494,-0.5509543,0.5731073,PAAD,TCGA-IB-7644,TCGA-IB-7644-01A-11R-2156-07,TCGA-IB-7644-01A,TCGA-IB-7644-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7644-01A,7618,PAAD,65,FEMALE,WHITE,Stage IV,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-24043,Dead,WITH TUMOR,NA,394,Pancreatic Cancer,Distant Metastasis,"Other, specify","Omentum, Peritoneal surface, Non regional Lymph nodes",306,Progressive Disease,NA,NA,1,394,1,394,NA,NA,1,306,NA,NA,NA,NA,NA,30,NA,2,1981,YES
TCGA.IB.7645.01A,TCGA-IB-7645,TCGA.IB.7645,8.094183277,10.60748752,TCGA.IB.7645.01A.22R.2204.07,4.099289,3.986448,0.8164298,1.184386,1.208438,PAAD,TCGA-IB-7645,TCGA-IB-7645-01A-22R-2204-07,TCGA-IB-7645-01A,TCGA-IB-7645-01A-22R-2204-07,TP,Primary solid Tumor,1,1,2204,1,0,1,Pancreas,1,Tumor,TCGA-IB-7645-01A,7619,PAAD,44,FEMALE,[Unknown],Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2007,[Not Available],-16126,Dead,WITH TUMOR,NA,1502,Pancreatic Cancer,Distant Metastasis,Liver,NA,984,Progressive Disease,NA,NA,1,1502,1,1502,NA,NA,1,984,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.7646.01A,TCGA-IB-7646,TCGA.IB.7646,4.227741076,10.06954375,TCGA.IB.7646.01A.11R.2156.07,3.09797,2.898523,0.1362817,0.1830668,0.784779,PAAD,TCGA-IB-7646,TCGA-IB-7646-01A-11R-2156-07,TCGA-IB-7646-01A,TCGA-IB-7646-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7646-01A,7620,PAAD,60,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2007,[Not Available],-22148,Dead,WITH TUMOR,NA,145,Pancreatic Cancer,Locoregional Recurrence,Liver,NA,132,Progressive Disease,NA,NA,1,145,1,145,NA,NA,1,132,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.7649.01A,TCGA-IB-7649,TCGA.IB.7649,9.941427676,10.34859538,TCGA.IB.7649.01A.11R.2156.07,3.666903,3.538266,0.5210696,0.7519994,1.051146,PAAD,TCGA-IB-7649,TCGA-IB-7649-01A-11R-2156-07,TCGA-IB-7649-01A,TCGA-IB-7649-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7649-01A,7622,PAAD,73,FEMALE,[Unknown],Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2007,[Not Available],-26773,Dead,NA,NA,467,NA,Distant Metastasis,Liver,NA,282,Partial Remission/Response,NA,NA,1,467,NA,467,NA,NA,1,282,NA,older,NA,NA,NA,57,NA,2,1951,NO
TCGA.IB.7651.01A,TCGA-IB-7651,TCGA.IB.7651,8.274000685,10.50983437,TCGA.IB.7651.01A.11R.2156.07,3.639958,3.536222,0.4954597,0.7250543,1.004024,PAAD,TCGA-IB-7651,TCGA-IB-7651-01A-11R-2156-07,TCGA-IB-7651-01A,TCGA-IB-7651-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7651-01A,7623,PAAD,64,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2009,[Not Available],-23580,Dead,WITH TUMOR,NA,603,Pancreatic Cancer,Locoregional Recurrence,NA,NA,492,Complete Remission/Response,NA,NA,1,603,1,603,1,492,1,492,NA,younger,NA,NA,NA,20,NA,2,1989,YES
TCGA.IB.7652.01A,TCGA-IB-7652,TCGA.IB.7652,7.402423744,11.43098562,TCGA.IB.7652.01A.11R.2156.07,3.191426,3.284884,0.2342554,0.2765224,0.8352915,PAAD,TCGA-IB-7652,TCGA-IB-7652-01A-11R-2156-07,TCGA-IB-7652-01A,TCGA-IB-7652-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7652-01A,7624,PAAD,49,FEMALE,ASIAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-18129,Alive,TUMOR FREE,1116,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1116,0,1116,0,1116,0,1116,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.7654.01A,TCGA-IB-7654,TCGA.IB.7654,7.718162951,11.51075922,TCGA.IB.7654.01A.11R.2156.07,2.186152,2.108903,-0.5040159,-0.7287512,0.4835755,PAAD,TCGA-IB-7654,TCGA-IB-7654-01A-11R-2156-07,TCGA-IB-7654-01A,TCGA-IB-7654-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7654-01A,7625,PAAD,80,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-29292,Dead,WITH TUMOR,NA,476,Other malignancy,NA,NA,NA,NA,Progressive Disease,NA,NA,1,476,0,476,NA,NA,1,476,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.7885.01A,TCGA-IB-7885,TCGA.IB.7885,8.390745059,10.25830691,TCGA.IB.7885.01A.11R.2156.07,3.345107,3.432638,0.302751,0.4302034,0.9247791,PAAD,TCGA-IB-7885,TCGA-IB-7885-01A-11R-2156-07,TCGA-IB-7885-01A,TCGA-IB-7885-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7885-01A,7626,PAAD,78,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-28554,Alive,TUMOR FREE,1257,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1257,0,1257,0,1257,0,1257,NA,older,NA,NA,NA,20,1980,3,1960,NO
TCGA.IB.7886.01A,TCGA-IB-7886,TCGA.IB.7886,8.187653943,10.57023521,TCGA.IB.7886.01A.11R.2156.07,3.054524,2.92887,0.0965006,0.1396205,0.8007381,PAAD,TCGA-IB-7886,TCGA-IB-7886-01A-11R-2156-07,TCGA-IB-7886-01A,TCGA-IB-7886-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7886-01A,7627,PAAD,80,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2010,[Not Available],-29319,Dead,TUMOR FREE,NA,123,"Other, non-malignant disease",NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,123,0,123,0,123,0,123,NA,older,NA,NA,NA,35,NA,2,1975,NO
TCGA.IB.7887.01A,TCGA-IB-7887,TCGA.IB.7887,8.293540621,9.844749696,TCGA.IB.7887.01A.11R.2156.07,2.450648,2.343784,-0.3269045,-0.4642554,0.5895932,PAAD,TCGA-IB-7887,TCGA-IB-7887-01A-11R-2156-07,TCGA-IB-7887-01A,TCGA-IB-7887-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7887-01A,7628,PAAD,62,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2009,[Not Available],-22990,Dead,NA,NA,110,Pancreatic Cancer,NA,NA,NA,NA,[Unknown],NA,NA,1,110,1,110,NA,NA,0,110,NA,younger,NA,NA,NA,20,NA,2,NA,NO
TCGA.IB.7888.01A,TCGA-IB-7888,TCGA.IB.7888,9.646682904,10.42871609,TCGA.IB.7888.01A.11R.2156.07,3.898342,3.827797,0.6937392,0.9834388,1.139678,PAAD,TCGA-IB-7888,TCGA-IB-7888-01A-11R-2156-07,TCGA-IB-7888-01A,TCGA-IB-7888-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7888-01A,7629,PAAD,66,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-24117,Dead,WITH TUMOR,NA,1332,Pancreatic Cancer,Distant Metastasis,"Other, specify",Retroperitoneum,427,Stable Disease,NA,NA,1,1332,1,1332,NA,NA,1,427,NA,older,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.IB.7889.01A,TCGA-IB-7889,TCGA.IB.7889,5.666631629,11.19510764,TCGA.IB.7889.01A.11R.2156.07,3.681589,3.585314,0.5255144,0.766686,1.051424,PAAD,TCGA-IB-7889,TCGA-IB-7889-01A-11R-2156-07,TCGA-IB-7889-01A,TCGA-IB-7889-01A-11R-2156-07,TP,Primary solid Tumor,1,1,2156,1,0,1,Pancreas,1,Tumor,TCGA-IB-7889-01A,7630,PAAD,85,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-31393,Dead,WITH TUMOR,NA,481,Pancreatic Cancer,Locoregional Recurrence,NA,NA,352,Progressive Disease,NA,NA,1,481,1,481,NA,NA,1,352,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.7890.01A,TCGA-IB-7890,TCGA.IB.7890,6.501878575,9.262900556,TCGA.IB.7890.01A.12R.2204.07,2.439754,2.551146,-0.2813582,-0.4751492,0.5590112,PAAD,TCGA-IB-7890,TCGA-IB-7890-01A-12R-2204-07,TCGA-IB-7890-01A,TCGA-IB-7890-01A-12R-2204-07,TP,Primary solid Tumor,1,1,2204,1,0,1,Pancreas,1,Tumor,TCGA-IB-7890-01A,7631,PAAD,73,MALE,[Unknown],Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2008,[Not Available],-26747,Dead,WITH TUMOR,NA,598,Pancreatic Cancer,Distant Metastasis,Liver,NA,519,Progressive Disease,NA,NA,1,598,1,598,NA,NA,1,519,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.7891.01A,TCGA-IB-7891,TCGA.IB.7891,7.140512829,11.06340856,TCGA.IB.7891.01A.11R.2204.07,3.794012,3.749517,0.5939763,0.8791086,1.092594,PAAD,TCGA-IB-7891,TCGA-IB-7891-01A-11R-2204-07,TCGA-IB-7891-01A,TCGA-IB-7891-01A-11R-2204-07,TP,Primary solid Tumor,1,1,2204,1,0,1,Pancreas,1,Tumor,TCGA-IB-7891-01A,7632,PAAD,49,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-18202,Dead,WITH TUMOR,NA,913,Pancreatic Cancer,Distant Metastasis,"Other, specify",Lung and Liver,525,Complete Remission/Response,NA,NA,1,913,1,913,1,525,1,525,NA,younger,NA,NA,NA,29,2009,4,1980,NO
TCGA.IB.7893.01A,TCGA-IB-7893,TCGA.IB.7893,6.169233544,8.491139587,TCGA.IB.7893.01A.11R.2204.07,2.457018,2.373144,-0.3037946,-0.4578853,0.5784759,PAAD,TCGA-IB-7893,TCGA-IB-7893-01A-11R-2204-07,TCGA-IB-7893-01A,TCGA-IB-7893-01A-11R-2204-07,TP,Primary solid Tumor,1,1,2204,1,0,1,Pancreas,1,Tumor,TCGA-IB-7893-01A,7633,PAAD,64,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2009,[Not Available],-23703,Dead,WITH TUMOR,NA,117,Pancreatic Cancer,Distant Metastasis,Peritoneal Surfaces,NA,80,Progressive Disease,NA,NA,1,117,1,117,NA,NA,1,80,NA,younger,NA,NA,NA,NA,1979,3,NA,YES
TCGA.IB.7897.01A,TCGA-IB-7897,TCGA.IB.7897,7.962757222,8.366623837,TCGA.IB.7897.01A.21R.2204.07,3.798762,3.686572,0.5897177,0.8838591,1.125659,PAAD,TCGA-IB-7897,TCGA-IB-7897-01A-21R-2204-07,TCGA-IB-7897-01A,TCGA-IB-7897-01A-21R-2204-07,TP,Primary solid Tumor,1,1,2204,1,0,1,Pancreas,1,Tumor,TCGA-IB-7897-01A,7634,PAAD,53,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2008,[Not Available],-19718,Dead,WITH TUMOR,NA,486,Pancreatic Cancer,Locoregional Recurrence|Distant Metastasis,Liver,NA,397,Progressive Disease,NA,NA,1,486,1,486,NA,NA,1,397,NA,younger,NA,NA,NA,NA,1981,5,NA,NO
TCGA.IB.8126.01A,TCGA-IB-8126,TCGA.IB.8126,7.896949921,10.65773824,TCGA.IB.8126.01A.11R.2404.07,4.687266,4.725032,1.168854,1.772363,1.466595,PAAD,TCGA-IB-8126,TCGA-IB-8126-01A-11R-2404-07,TCGA-IB-8126-01A,TCGA-IB-8126-01A-11R-2404-07,TP,Primary solid Tumor,1,1,2404,1,0,1,Pancreas,1,Tumor,TCGA-IB-8126-01A,7635,PAAD,79,FEMALE,WHITE,Stage III,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-29213,Alive,WITH TUMOR,462,NA,NA,Distant Metastasis,Lung,NA,83,Partial Remission/Response,NA,NA,0,462,0,462,NA,NA,1,83,NA,older,NA,NA,NA,4,1961,3,1957,YES
TCGA.IB.8127.01A,TCGA-IB-8127,TCGA.IB.8127,6.977657723,11.05139929,TCGA.IB.8127.01A.11R.2404.07,4.214533,4.066659,0.8627907,1.29963,1.260755,PAAD,TCGA-IB-8127,TCGA-IB-8127-01A-11R-2404-07,TCGA-IB-8127-01A,TCGA-IB-8127-01A-11R-2404-07,TP,Primary solid Tumor,1,1,2404,1,0,1,Pancreas,1,Tumor,TCGA-IB-8127-01A,7636,PAAD,59,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-21676,Alive,WITH TUMOR,522,NA,NA,Locoregional Recurrence|Distant Metastasis,"Other, specify",Tumor Bed and Liver,486,Complete Remission/Response,NA,NA,0,522,0,522,1,486,1,486,NA,younger,NA,NA,NA,40,2011,4,1971,NO
TCGA.IB.A5SO.01A,TCGA-IB-A5SO,TCGA.IB.A5SO,6.259553088,10.83349892,TCGA.IB.A5SO.01A.11R.A32O.07,4.634365,4.518724,1.215873,1.719462,1.394514,PAAD,TCGA-IB-A5SO,TCGA-IB-A5SO-01A-11R-A32O-07,TCGA-IB-A5SO-01A,TCGA-IB-A5SO-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-IB-A5SO-01A,7637,PAAD,71,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-26129,Dead,WITH TUMOR,NA,365,Pancreatic Cancer,Locoregional Recurrence,Peritoneal Surfaces,NA,276,Progressive Disease,NA,NA,1,365,1,365,NA,NA,1,276,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.A5SP.01A,TCGA-IB-A5SP,TCGA.IB.A5SP,7.943470121,11.63888838,TCGA.IB.A5SP.01A.11R.A32O.07,3.290966,3.094849,0.2857978,0.3760631,0.8794305,PAAD,TCGA-IB-A5SP,TCGA-IB-A5SP-01A-11R-A32O-07,TCGA-IB-A5SP-01A,TCGA-IB-A5SP-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-IB-A5SP-01A,7638,PAAD,77,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2011,[Not Available],-28317,Alive,WITH TUMOR,482,NA,NA,Locoregional Recurrence,"Other, specify",Superior Mesenteric Artery,300,[Unknown],NA,NA,0,482,0,482,NA,NA,1,300,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.A5SQ.01A,TCGA-IB-A5SQ,TCGA.IB.A5SQ,6.487942908,9.514441859,TCGA.IB.A5SQ.01A.11R.A32O.07,4.328482,4.166541,1.002329,1.413579,1.272905,PAAD,TCGA-IB-A5SQ,TCGA-IB-A5SQ-01A-11R-A32O-07,TCGA-IB-A5SQ-01A,TCGA-IB-A5SQ-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-IB-A5SQ-01A,7639,PAAD,56,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-20760,Dead,WITH TUMOR,NA,219,NA,Distant Metastasis,Lung,NA,197,Complete Remission/Response,NA,NA,1,219,1,219,1,197,1,197,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.A5SS.01A,TCGA-IB-A5SS,TCGA.IB.A5SS,4.809918579,9.738622614,TCGA.IB.A5SS.01A.11R.A32O.07,4.006975,4.095663,0.8036228,1.092072,1.115882,PAAD,TCGA-IB-A5SS,TCGA-IB-A5SS-01A-11R-A32O-07,TCGA-IB-A5SS-01A,TCGA-IB-A5SS-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-IB-A5SS-01A,7640,PAAD,64,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-23431,Dead,WITH TUMOR,NA,460,Pancreatic Cancer,Distant Metastasis,Liver,NA,66,Complete Remission/Response,NA,NA,1,460,1,460,1,66,1,66,NA,younger,NA,NA,NA,20,NA,2,1991,YES
TCGA.IB.A5ST.01A,TCGA-IB-A5ST,TCGA.IB.A5ST,6.630984926,11.10645171,TCGA.IB.A5ST.01A.11R.A32O.07,5.233602,5.253159,1.637249,2.318699,1.608924,PAAD,TCGA-IB-A5ST,TCGA-IB-A5ST-01A-11R-A32O-07,TCGA-IB-A5ST-01A,TCGA-IB-A5ST-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-IB-A5ST-01A,7641,PAAD,64,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-23672,Alive,TUMOR FREE,635,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,635,0,635,0,635,0,635,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.A6UF.01A,TCGA-IB-A6UF,TCGA.IB.A6UF,5.198832,10.19704464,TCGA.IB.A6UF.01A.23R.A33R.07,3.093154,3.151863,0.175026,0.1782511,0.80268,PAAD,TCGA-IB-A6UF,TCGA-IB-A6UF-01A-23R-A33R-07,TCGA-IB-A6UF-01A,TCGA-IB-A6UF-01A-23R-A33R-07,TP,Primary solid Tumor,1,1,A33R,1,0,1,Pancreas,1,Tumor,TCGA-IB-A6UF-01A,7642,PAAD,63,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-23152,Alive,WITH TUMOR,666,NA,NA,Distant Metastasis,Liver,NA,593,Partial Remission/Response,NA,NA,0,666,0,666,NA,NA,1,593,NA,younger,NA,NA,NA,40,NA,2,1973,YES
TCGA.IB.A6UG.01A,TCGA-IB-A6UG,TCGA.IB.A6UG,6.153248008,10.63312238,TCGA.IB.A6UG.01A.32R.A33R.07,3.92267,3.865134,0.6974332,1.007767,1.141051,PAAD,TCGA-IB-A6UG,TCGA-IB-A6UG-01A-32R-A33R-07,TCGA-IB-A6UG-01A,TCGA-IB-A6UG-01A-32R-A33R-07,TP,Primary solid Tumor,1,1,A33R,1,0,1,Pancreas,1,Tumor,TCGA-IB-A6UG-01A,7643,PAAD,65,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-23751,Dead,WITH TUMOR,NA,41,"Other, non-malignant disease",NA,NA,NA,NA,Partial Remission/Response,NA,NA,1,41,0,41,NA,NA,1,41,NA,NA,NA,NA,NA,33.75,NA,2,1968,NO
TCGA.IB.A7LX.01A,TCGA-IB-A7LX,TCGA.IB.A7LX,6.428221131,11.10679846,TCGA.IB.A7LX.01A.12R.A36G.07,2.989152,2.805378,0.05552356,0.07424925,0.7996134,PAAD,TCGA-IB-A7LX,TCGA-IB-A7LX-01A-12R-A36G-07,TCGA-IB-A7LX-01A,TCGA-IB-A7LX-01A-12R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-IB-A7LX-01A,7644,PAAD,57,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-20898,Dead,WITH TUMOR,NA,250,Pancreatic Cancer,Distant Metastasis,Liver,NA,7,Progressive Disease,NA,NA,1,250,1,250,NA,NA,1,7,NA,younger,NA,NA,NA,NA,NA,4,NA,NO
TCGA.IB.A7M4.01A,TCGA-IB-A7M4,TCGA.IB.A7M4,5.663327539,11.13278888,TCGA.IB.A7M4.01A.11R.A36G.07,4.078804,4.171865,0.7978409,1.163901,1.187231,PAAD,TCGA-IB-A7M4,TCGA-IB-A7M4-01A-11R-A36G-07,TCGA-IB-A7M4-01A,TCGA-IB-A7M4-01A-11R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-IB-A7M4-01A,7645,PAAD,81,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-29792,Alive,TUMOR FREE,483,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,483,0,483,0,483,0,483,NA,older,NA,NA,NA,52,2008,4,1956,NO
TCGA.IB.AAUM.01A,TCGA-IB-AAUM,TCGA.IB.AAUM,8.594369396,11.35940367,TCGA.IB.AAUM.01A.11R.A37L.07,4.171715,3.995294,0.8686659,1.256812,1.243649,PAAD,TCGA-IB-AAUM,TCGA-IB-AAUM-01A-11R-A37L-07,TCGA-IB-AAUM-01A,TCGA-IB-AAUM-01A-11R-A37L-07,TP,Primary solid Tumor,1,1,A37L,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUM-01A,7646,PAAD,76,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-28013,Alive,WITH TUMOR,8,NA,NA,NA,NA,NA,NA,Partial Remission/Response,NA,NA,0,8,0,8,NA,NA,0,8,NA,older,NA,NA,NA,NA,NA,1,NA,YES
TCGA.IB.AAUN.01A,TCGA-IB-AAUN,TCGA.IB.AAUN,6.37190904,11.13122677,TCGA.IB.AAUN.01A.12R.A38C.07,2.269741,2.084204,-0.4705011,-0.6451624,0.5155294,PAAD,TCGA-IB-AAUN,TCGA-IB-AAUN-01A-12R-A38C-07,TCGA-IB-AAUN-01A,TCGA-IB-AAUN-01A-12R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUN-01A,7647,PAAD,74,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-27128,Dead,NA,NA,144,NA,Locoregional Recurrence,"Other, specify",NA,131,Complete Remission/Response,NA,NA,1,144,NA,144,1,131,1,131,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.AAUO.01A,TCGA-IB-AAUO,TCGA.IB.AAUO,6.797181628,9.147670482,TCGA.IB.AAUO.01A.12R.A38C.07,2.597578,2.440461,-0.2182198,-0.3173257,0.6397058,PAAD,TCGA-IB-AAUO,TCGA-IB-AAUO-01A-12R-A38C-07,TCGA-IB-AAUO-01A,TCGA-IB-AAUO-01A-12R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUO-01A,7648,PAAD,64,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-23622,Dead,WITH TUMOR,NA,239,NA,Distant Metastasis,Liver,NA,74,Partial Remission/Response,NA,NA,1,239,1,239,NA,NA,1,74,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.IB.AAUP.01A,TCGA-IB-AAUP,TCGA.IB.AAUP,7.563142873,9.064457161,TCGA.IB.AAUP.01A.11R.A37L.07,5.746638,5.775917,1.961913,2.831735,1.811731,PAAD,TCGA-IB-AAUP,TCGA-IB-AAUP-01A-11R-A37L-07,TCGA-IB-AAUP-01A,TCGA-IB-AAUP-01A-11R-A37L-07,TP,Primary solid Tumor,1,1,A37L,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUP-01A,7649,PAAD,68,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-24864,Alive,TUMOR FREE,431,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,431,0,431,0,431,0,431,NA,older,NA,NA,NA,NA,1984,3,NA,YES
TCGA.IB.AAUQ.01A,TCGA-IB-AAUQ,TCGA.IB.AAUQ,8.574362678,9.772827551,TCGA.IB.AAUQ.01A.22R.A41I.07,2.880927,2.870094,-0.007091763,-0.0339764,0.7380479,PAAD,TCGA-IB-AAUQ,TCGA-IB-AAUQ-01A-22R-A41I-07,TCGA-IB-AAUQ-01A,TCGA-IB-AAUQ-01A-22R-A41I-07,TP,Primary solid Tumor,1,1,A41I,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUQ-01A,7650,PAAD,50,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-18315,Dead,WITH TUMOR,NA,183,Pancreatic Cancer,Distant Metastasis,Non-regional / Distant Lymph Nodes,NA,107,Partial Remission/Response,NA,NA,1,183,1,183,NA,NA,1,107,NA,younger,NA,NA,NA,69,2001,4,1978,NO
TCGA.IB.AAUR.01A,TCGA-IB-AAUR,TCGA.IB.AAUR,7.471528906,10.1959504,TCGA.IB.AAUR.01A.21R.A38C.07,4.575,4.563969,1.147253,1.660096,1.399753,PAAD,TCGA-IB-AAUR,TCGA-IB-AAUR-01A-21R-A38C-07,TCGA-IB-AAUR-01A,TCGA-IB-AAUR-01A-21R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUR-01A,7651,PAAD,67,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-24576,Alive,WITH TUMOR,338,NA,NA,Locoregional Recurrence,Tumor Bed,NA,318,Partial Remission/Response,NA,NA,0,338,0,338,NA,NA,1,318,NA,older,NA,NA,NA,NA,1989,3,NA,YES
TCGA.IB.AAUS.01A,TCGA-IB-AAUS,TCGA.IB.AAUS,7.479004152,9.39186651,TCGA.IB.AAUS.01A.12R.A38C.07,4.414703,4.477275,1.086734,1.4998,1.301526,PAAD,TCGA-IB-AAUS,TCGA-IB-AAUS-01A-12R-A38C-07,TCGA-IB-AAUS-01A,TCGA-IB-AAUS-01A-12R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUS-01A,7652,PAAD,84,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-30684,Alive,WITH TUMOR,225,NA,NA,NA,NA,NA,NA,[Not Applicable],NA,NA,0,225,0,225,NA,NA,0,225,NA,older,NA,NA,NA,40,2013,4,1948,YES
TCGA.IB.AAUT.01A,TCGA-IB-AAUT,TCGA.IB.AAUT,10.0617627,10.76027085,TCGA.IB.AAUT.01A.11R.A37L.07,5.1533,4.940332,1.552144,2.238397,1.573347,PAAD,TCGA-IB-AAUT,TCGA-IB-AAUT-01A-11R-A37L-07,TCGA-IB-AAUT-01A,TCGA-IB-AAUT-01A-11R-A37L-07,TP,Primary solid Tumor,1,1,A37L,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUT-01A,7653,PAAD,65,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Colloid (mucinous non-cystic) Carcinoma,G1,2013,[Not Available],-23801,Alive,TUMOR FREE,287,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,287,0,287,0,287,0,287,NA,NA,NA,NA,NA,15,2003,4,1988,YES
TCGA.IB.AAUU.01A,TCGA-IB-AAUU,TCGA.IB.AAUU,7.642752106,11.90569913,TCGA.IB.AAUU.01A.11R.A37L.07,4.05101,4.000095,0.8160514,1.136107,1.166557,PAAD,TCGA-IB-AAUU,TCGA-IB-AAUU-01A-11R-A37L-07,TCGA-IB-AAUU-01A,TCGA-IB-AAUU-01A-11R-A37L-07,TP,Primary solid Tumor,1,1,A37L,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUU-01A,7654,PAAD,35,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-13127,Alive,TUMOR FREE,245,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,245,0,245,0,245,0,245,NA,younger,NA,NA,NA,15,2013,4,NA,NO
TCGA.IB.AAUV.01A,TCGA-IB-AAUV,TCGA.IB.AAUV,6.789990019,7.84235663,TCGA.IB.AAUV.01A.11R.A38C.07,3.849278,3.757069,0.6528474,0.9343745,1.121158,PAAD,TCGA-IB-AAUV,TCGA-IB-AAUV-01A-11R-A38C-07,TCGA-IB-AAUV-01A,TCGA-IB-AAUV-01A-11R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUV-01A,7655,PAAD,49,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-18059,Alive,TUMOR FREE,404,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,404,0,404,0,404,0,404,NA,younger,NA,NA,NA,50,NA,2,1980,NO
TCGA.IB.AAUW.01A,TCGA-IB-AAUW,TCGA.IB.AAUW,10.75827319,11.05291442,TCGA.IB.AAUW.01A.12R.A38C.07,3.062976,2.943384,0.08992949,0.148073,0.8419611,PAAD,TCGA-IB-AAUW,TCGA-IB-AAUW-01A-12R-A38C-07,TCGA-IB-AAUW-01A,TCGA-IB-AAUW-01A-12R-A38C-07,TP,Primary solid Tumor,1,1,A38C,1,0,1,Pancreas,1,Tumor,TCGA-IB-AAUW-01A,7656,PAAD,63,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-23306,Dead,WITH TUMOR,NA,230,NA,Locoregional Recurrence,Tumor Bed,NA,185,Complete Remission/Response,NA,NA,1,230,1,230,1,185,1,185,NA,younger,NA,NA,NA,NA,NA,1,NA,YES
TCGA.JU.AAVI.01A,TCGA-JU-AAVI,TCGA.JU.AAVI,4.877508689,4.34663074,TCGA.JU.AAVI.01A.11R.A40A.07,3.290425,3.253246,0.2085853,0.3755214,0.926494,UCEC,TCGA-JU-AAVI,TCGA-JU-AAVI-01A-11R-A40A-07,TCGA-JU-AAVI-01A,TCGA-JU-AAVI-01A-11R-A40A-07,TP,Primary solid Tumor,1,1,A40A,1,0,1,Female,1,Tumor,TCGA-JU-AAVI-01A,10999,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22289,Dead,WITH TUMOR,NA,540,[Not Available],Distant Metastasis,"Other, specify",Porta Hepatis,505,Complete Remission/Response,NA,NA,1,540,1,540,1,505,1,505,NA,younger,53.77777778,level4,NA,NA,NA,NA,NA,NO
TCGA.K6.A3WQ.01A,TCGA-K6-A3WQ,TCGA.K6.A3WQ,6.420777123,9.352376741,TCGA.K6.A3WQ.01A.11R.A22K.07,1.973514,2.037403,-0.6530773,-0.9413894,0.4083143,UCEC,TCGA-K6-A3WQ,TCGA-K6-A3WQ-01A-11R-A22K-07,TCGA-K6-A3WQ-01A,TCGA-K6-A3WQ-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-K6-A3WQ-01A,11000,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22092,Dead,WITH TUMOR,NA,427,[Not Available],Locoregional Recurrence,"Other, specify",uterine,351,[Not Available],NA,NA,1,427,1,427,NA,NA,1,351,NA,younger,33.85657125,level3,NA,NA,NA,NA,NA,NA
TCGA.KJ.A3U4.01A,TCGA-KJ-A3U4,TCGA.KJ.A3U4,9.435597343,6.218796664,TCGA.KJ.A3U4.01A.11R.A22K.07,3.532715,3.319385,0.407796,0.6178117,0.9907317,UCEC,TCGA-KJ-A3U4,TCGA-KJ-A3U4-01A-11R-A22K-07,TCGA-KJ-A3U4-01A,TCGA-KJ-A3U4-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-KJ-A3U4-01A,11001,UCEC,55,FEMALE,WHITE,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G1,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20392,Alive,TUMOR FREE,1095,NA,[Not Available],Locoregional Recurrence,"Other, specify",abdominal,306,[Discrepancy],NA,NA,0,1095,0,1095,NA,NA,1,306,NA,younger,35.26170799,level4,NA,NA,NA,NA,NA,NA
TCGA.KP.A3VZ.01A,TCGA-KP-A3VZ,TCGA.KP.A3VZ,3.936185627,4.642586059,TCGA.KP.A3VZ.01A.11R.A22K.07,1.254074,1.216574,-1.151004,-1.660829,0.193885,UCEC,TCGA-KP-A3VZ,TCGA-KP-A3VZ-01A-11R-A22K-07,TCGA-KP-A3VZ-01A,TCGA-KP-A3VZ-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-KP-A3VZ-01A,11002,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IV,Serous endometrial adenocarcinoma,High Grade,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25366,Alive,WITH TUMOR,722,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,722,0,722,NA,NA,0,722,NA,older,20.70081674,level1,NA,NA,NA,NA,NA,NA
TCGA.KP.A3W0.01A,TCGA-KP-A3W0,TCGA.KP.A3W0,3.508682179,5.370893118,TCGA.KP.A3W0.01A.21R.A22K.07,3.669248,3.581125,0.5352939,0.7543451,1.019539,UCEC,TCGA-KP-A3W0,TCGA-KP-A3W0-01A-21R-A22K-07,TCGA-KP-A3W0-01A,TCGA-KP-A3W0-01A-21R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-KP-A3W0-01A,11003,UCEC,72,FEMALE,[Not Evaluated],[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26378,Alive,TUMOR FREE,404,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,404,0,404,0,404,0,404,NA,older,35.81771071,level4,NA,NA,NA,NA,NA,NO
TCGA.KP.A3W1.01A,TCGA-KP-A3W1,TCGA.KP.A3W1,5.874270734,2.949665657,TCGA.KP.A3W1.01A.11R.A22K.07,4.951144,4.851498,1.396495,2.036241,1.497358,UCEC,TCGA-KP-A3W1,TCGA-KP-A3W1-01A-11R-A22K-07,TCGA-KP-A3W1-01A,TCGA-KP-A3W1-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-KP-A3W1-01A,11004,UCEC,76,FEMALE,[Not Evaluated],[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27902,Alive,TUMOR FREE,288,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,288,0,288,0,288,0,288,NA,older,22.83737024,level1,NA,NA,NA,NA,NA,NO
TCGA.KP.A3W3.01A,TCGA-KP-A3W3,TCGA.KP.A3W3,4.92931286,9.28476165,TCGA.KP.A3W3.01A.11R.A22K.07,3.589811,3.564793,0.4650046,0.6749079,0.9751128,UCEC,TCGA-KP-A3W3,TCGA-KP-A3W3-01A-11R-A22K-07,TCGA-KP-A3W3-01A,TCGA-KP-A3W3-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-KP-A3W3-01A,11005,UCEC,72,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26310,Alive,WITH TUMOR,794,NA,[Not Available],Distant Metastasis,Liver,NA,661,Complete Remission/Response,NA,NA,0,794,0,794,1,661,1,661,NA,older,46.84711481,level4,NA,NA,NA,NA,NA,NO
TCGA.KP.A3W4.01A,TCGA-KP-A3W4,TCGA.KP.A3W4,4.719900776,7.909083028,TCGA.KP.A3W4.01A.11R.A22K.07,2.958049,2.89993,0.01440067,0.04314598,0.7988963,UCEC,TCGA-KP-A3W4,TCGA-KP-A3W4-01A-11R-A22K-07,TCGA-KP-A3W4-01A,TCGA-KP-A3W4-01A-11R-A22K-07,TP,Primary solid Tumor,1,1,A22K,1,0,1,Female,1,Tumor,TCGA-KP-A3W4-01A,11006,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23200,Dead,WITH TUMOR,NA,554,[Not Available],Distant Metastasis,Liver,NA,321,Partial Remission/Response,NA,NA,1,554,1,554,NA,NA,1,321,NA,younger,26.75321258,level2,NA,NA,NA,NA,NA,NO
TCGA.L1.A7W4.01A,TCGA-L1-A7W4,TCGA.L1.A7W4,4.446084155,8.607533756,TCGA.L1.A7W4.01A.12R.A36G.07,2.335085,2.137229,-0.3705952,-0.5798178,0.5675667,PAAD,TCGA-L1-A7W4,TCGA-L1-A7W4-01A-12R-A36G-07,TCGA-L1-A7W4-01A,TCGA-L1-A7W4-01A-12R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-L1-A7W4-01A,7657,PAAD,48,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-17821,Dead,WITH TUMOR,NA,278,Pancreatic Cancer,Distant Metastasis,Liver,NA,129,Progressive Disease,NA,NA,1,278,1,278,NA,NA,1,129,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.LB.A7SX.01A,TCGA-LB-A7SX,TCGA.LB.A7SX,7.956463283,11.3962462,TCGA.LB.A7SX.01A.11R.A33R.07,3.321505,3.19502,0.281613,0.4066022,0.9162761,PAAD,TCGA-LB-A7SX,TCGA-LB-A7SX-01A-11R-A33R-07,TCGA-LB-A7SX-01A,TCGA-LB-A7SX-01A-11R-A33R-07,TP,Primary solid Tumor,1,1,A33R,1,0,1,Pancreas,1,Tumor,TCGA-LB-A7SX-01A,7658,PAAD,74,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-27295,Dead,NA,NA,393,"Other, non-malignant disease",NA,NA,NA,NA,Stable Disease,NA,NA,1,393,0,393,NA,NA,0,393,NA,older,NA,NA,NA,40,NA,2,1952,NO
TCGA.LB.A8F3.01A,TCGA-LB-A8F3,TCGA.LB.A8F3,3.660460904,11.5253593,TCGA.LB.A8F3.01A.11R.A36G.07,2.653221,2.63464,-0.1488623,-0.2616819,0.6415938,PAAD,TCGA-LB-A8F3,TCGA-LB-A8F3-01A-11R-A36G-07,TCGA-LB-A8F3-01A,TCGA-LB-A8F3-01A-11R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-LB-A8F3-01A,7659,PAAD,64,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-23624,Alive,TUMOR FREE,379,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,379,0,379,NA,NA,0,379,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.LB.A9Q5.01A,TCGA-LB-A9Q5,TCGA.LB.A9Q5,7.314696526,11.03070851,TCGA.LB.A9Q5.01A.11R.A39D.07,3.701741,3.776498,0.5812239,0.7868382,1.038621,PAAD,TCGA-LB-A9Q5,TCGA-LB-A9Q5-01A-11R-A39D-07,TCGA-LB-A9Q5-01A,TCGA-LB-A9Q5-01A-11R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-LB-A9Q5-01A,7660,PAAD,63,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-23218,Dead,WITH TUMOR,NA,313,Pancreatic Cancer,Locoregional Recurrence,"Other, specify",omentum,290,[Unknown],NA,NA,1,313,1,313,NA,NA,1,290,NA,younger,NA,NA,NA,0.3,1973,3,1971,NO
TCGA.M8.A5N4.01A,TCGA-M8-A5N4,TCGA.M8.A5N4,6.279279988,10.96877478,TCGA.M8.A5N4.01A.11R.A26U.07,3.740302,3.650479,0.5866076,0.8253986,1.029297,PAAD,TCGA-M8-A5N4,TCGA-M8-A5N4-01A-11R-A26U-07,TCGA-M8-A5N4-01A,TCGA-M8-A5N4-01A-11R-A26U-07,TP,Primary solid Tumor,1,1,A26U,1,0,1,Pancreas,1,Tumor,TCGA-M8-A5N4-01A,7661,PAAD,48,FEMALE,[Not Evaluated],Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,NA,[Not Available],-17628,Alive,WITH TUMOR,584,NA,NA,Locoregional Recurrence,"Other, specify",retroperitoneal recurrence around the supramesenteric artery and vein and some para aortic nodes,416,Partial Remission/Response,NA,NA,0,584,0,584,NA,NA,1,416,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.OE.A75W.01A,TCGA-OE-A75W,TCGA.OE.A75W,7.124576284,10.7851827,TCGA.OE.A75W.01A.12R.A32O.07,4.095887,4.104543,0.8144857,1.180984,1.170693,PAAD,TCGA-OE-A75W,TCGA-OE-A75W-01A-12R-A32O-07,TCGA-OE-A75W-01A,TCGA-OE-A75W-01A-12R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-OE-A75W-01A,7662,PAAD,75,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-27684,Dead,NA,NA,267,NA,Distant Metastasis,Liver,NA,146,Progressive Disease,NA,NA,1,267,NA,267,NA,NA,1,146,NA,older,NA,NA,NA,30,1976,3,1956,YES
TCGA.PG.A5BC.01A,TCGA-PG-A5BC,TCGA.PG.A5BC,3.300050489,9.699284406,TCGA.PG.A5BC.01A.12R.A27V.07,1.565291,1.244683,-0.9546008,-1.349612,0.3124583,UCEC,TCGA-PG-A5BC,TCGA-PG-A5BC-01A-12R-A27V-07,TCGA-PG-A5BC-01A,TCGA-PG-A5BC-01A-12R-A27V-07,TP,Primary solid Tumor,1,1,A27V,1,0,1,Female,1,Tumor,TCGA-PG-A5BC-01A,11007,UCEC,72,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436,Alive,TUMOR FREE,707,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,707,0,707,0,707,0,707,NA,older,32.7449283,level3,NA,NA,NA,NA,NA,NA
TCGA.PG.A6IB.01A,TCGA-PG-A6IB,TCGA.PG.A6IB,2.126576457,9.824040659,TCGA.PG.A6IB.01A.21R.A31O.07,3.708322,3.711524,0.5189861,0.7934189,1.082078,UCEC,TCGA-PG-A6IB,TCGA-PG-A6IB-01A-21R-A31O-07,TCGA-PG-A6IB-01A,TCGA-PG-A6IB-01A-21R-A31O-07,TP,Primary solid Tumor,1,1,A31O,1,0,1,Female,1,Tumor,TCGA-PG-A6IB-01A,11008,UCEC,68,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24969,Alive,TUMOR FREE,648,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,648,0,648,0,648,0,648,NA,older,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.PG.A7D5.01A,TCGA-PG-A7D5,TCGA.PG.A7D5,4.824324897,10.96288878,TCGA.PG.A7D5.01A.11R.A34R.07,1.801784,1.659179,-0.8354781,-1.113119,0.4035737,UCEC,TCGA-PG-A7D5,TCGA-PG-A7D5-01A-11R-A34R-07,TCGA-PG-A7D5-01A,TCGA-PG-A7D5-01A-11R-A34R-07,TP,Primary solid Tumor,1,1,A34R,1,0,1,Female,1,Tumor,TCGA-PG-A7D5-01A,11009,UCEC,62,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23006,Alive,TUMOR FREE,1177,NA,[Not Available],NA,NA,NA,NA,Stable Disease,NA,NA,0,1177,0,1177,NA,NA,0,1177,NA,younger,31.64556962,level3,NA,NA,NA,NA,NA,YES
TCGA.PG.A914.01A,TCGA-PG-A914,TCGA.PG.A914,3.18705509,7.371654691,TCGA.PG.A914.01A.11R.A37O.07,2.447625,2.542969,-0.3212096,-0.4672779,0.579544,UCEC,TCGA-PG-A914,TCGA-PG-A914-01A-11R-A37O-07,TCGA-PG-A914-01A,TCGA-PG-A914-01A-11R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-PG-A914-01A,11010,UCEC,73,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26992,Alive,TUMOR FREE,687,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,687,0,687,0,687,0,687,NA,older,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.PG.A915.01A,TCGA-PG-A915,TCGA.PG.A915,4.522055749,7.992643821,TCGA.PG.A915.01A.11R.A37O.07,1.092829,0.8401303,-1.273534,-1.822074,0.1138658,UCEC,TCGA-PG-A915,TCGA-PG-A915-01A-11R-A37O-07,TCGA-PG-A915-01A,TCGA-PG-A915-01A-11R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-PG-A915-01A,11011,UCEC,60,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22119,Alive,TUMOR FREE,249,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,249,0,249,0,249,0,249,NA,younger,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.PG.A916.01A,TCGA-PG-A916,TCGA.PG.A916,6.464173236,9.917330305,TCGA.PG.A916.01A.11R.A37O.07,1.991875,1.724411,-0.6452449,-0.9230279,0.4276272,UCEC,TCGA-PG-A916,TCGA-PG-A916-01A-11R-A37O-07,TCGA-PG-A916-01A,TCGA-PG-A916-01A-11R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-PG-A916-01A,11012,UCEC,70,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617,Alive,TUMOR FREE,522,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,522,0,522,0,522,0,522,NA,older,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.PG.A917.01A,TCGA-PG-A917,TCGA.PG.A917,4.746753463,8.562501933,TCGA.PG.A917.01A.31R.A37O.07,3.587331,3.467957,0.4435599,0.6724278,0.9760165,UCEC,TCGA-PG-A917,TCGA-PG-A917-01A-31R-A37O-07,TCGA-PG-A917-01A,TCGA-PG-A917-01A-31R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-PG-A917-01A,11013,UCEC,74,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27104,Alive,TUMOR FREE,212,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,212,0,212,0,212,0,212,NA,older,NA,NA,NA,NA,NA,NA,NA,NO
TCGA.PZ.A5RE.01A,TCGA-PZ-A5RE,TCGA.PZ.A5RE,6.767668039,12.32564838,TCGA.PZ.A5RE.01A.11R.A32O.07,4.31418,4.262459,1.033566,1.399276,1.229989,PAAD,TCGA-PZ-A5RE,TCGA-PZ-A5RE-01A-11R-A32O-07,TCGA-PZ-A5RE-01A,TCGA-PZ-A5RE-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-PZ-A5RE-01A,7663,PAAD,44,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2012,[Not Available],-16255,Dead,WITH TUMOR,NA,470,Pancreatic Cancer,Distant Metastasis,Liver,NA,393,[Unknown],NA,NA,1,470,1,470,NA,NA,1,393,NA,younger,NA,NA,NA,NA,NA,3,NA,NA
TCGA.Q3.A5QY.01A,TCGA-Q3-A5QY,TCGA.Q3.A5QY,4.161202441,8.506156807,TCGA.Q3.A5QY.01A.12R.A32O.07,6.183027,6.226423,2.284713,3.268124,1.962114,PAAD,TCGA-Q3-A5QY,TCGA-Q3-A5QY-01A-12R-A32O-07,TCGA-Q3-A5QY-01A,TCGA-Q3-A5QY-01A-12R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-Q3-A5QY-01A,7664,PAAD,58,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-21277,Alive,NA,416,NA,NA,NA,NA,NA,NA,[Discrepancy],NA,NA,0,416,0,416,NA,NA,0,416,NA,younger,NA,NA,NA,NA,NA,1,NA,YES
TCGA.Q3.AA2A.01A,TCGA-Q3-AA2A,TCGA.Q3.AA2A,7.663287685,10.98292942,TCGA.Q3.AA2A.01A.11R.A37L.07,3.712007,3.675122,0.5892238,0.7971034,1.024388,PAAD,TCGA-Q3-AA2A,TCGA-Q3-AA2A-01A-11R-A37L-07,TCGA-Q3-AA2A-01A,TCGA-Q3-AA2A-01A-11R-A37L-07,TP,Primary solid Tumor,1,1,A37L,1,0,1,Pancreas,1,Tumor,TCGA-Q3-AA2A-01A,7665,PAAD,64,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-23685,Alive,TUMOR FREE,95,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,95,0,95,NA,NA,0,95,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.QF.A5YS.01A,TCGA-QF-A5YS,TCGA.QF.A5YS,6.076935282,9.201415774,TCGA.QF.A5YS.01A.11R.A31O.07,1.849537,1.656893,-0.7746197,-1.065366,0.3742236,UCEC,TCGA-QF-A5YS,TCGA-QF-A5YS-01A-11R-A31O-07,TCGA-QF-A5YS-01A,TCGA-QF-A5YS-01A-11R-A31O-07,TP,Primary solid Tumor,1,1,A31O,1,0,1,Female,1,Tumor,TCGA-QF-A5YS-01A,11014,UCEC,57,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Mixed serous and endometrioid,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20841,Alive,TUMOR FREE,689,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,689,0,689,0,689,0,689,NA,younger,30.10211858,level3,NA,NA,NA,NA,NA,YES
TCGA.QF.A5YT.01A,TCGA-QF-A5YT,TCGA.QF.A5YT,4.272904069,9.521698579,TCGA.QF.A5YT.01A.11R.A31O.07,0.4082983,0.1566995,-1.778508,-2.506605,-0.1248227,UCEC,TCGA-QF-A5YT,TCGA-QF-A5YT-01A-11R-A31O-07,TCGA-QF-A5YT-01A,TCGA-QF-A5YT-01A-11R-A31O-07,TP,Primary solid Tumor,1,1,A31O,1,0,1,Female,1,Tumor,TCGA-QF-A5YT-01A,11015,UCEC,57,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G1,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20981,Alive,TUMOR FREE,1215,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1215,0,1215,0,1215,0,1215,NA,younger,50.51903114,level4,NA,NA,NA,NA,NA,NO
TCGA.QS.A5YQ.01A,TCGA-QS-A5YQ,TCGA.QS.A5YQ,4.36903368,9.819947538,TCGA.QS.A5YQ.01A.11R.A31O.07,2.59843,2.550149,-0.2548585,-0.3164727,0.6765106,UCEC,TCGA-QS-A5YQ,TCGA-QS-A5YQ-01A-11R-A31O-07,TCGA-QS-A5YQ-01A,TCGA-QS-A5YQ-01A-11R-A31O-07,TP,Primary solid Tumor,1,1,A31O,1,0,1,Female,1,Tumor,TCGA-QS-A5YQ-01A,11016,UCEC,55,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20425,Alive,TUMOR FREE,759,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,759,0,759,0,759,0,759,NA,younger,32.421875,level3,NA,NA,NA,NA,NA,NO
TCGA.QS.A5YR.01A,TCGA-QS-A5YR,TCGA.QS.A5YR,6.371097057,9.425234789,TCGA.QS.A5YR.01A.31R.A31O.07,2.589675,2.514709,-0.2231115,-0.3252285,0.6610167,UCEC,TCGA-QS-A5YR,TCGA-QS-A5YR-01A-31R-A31O-07,TCGA-QS-A5YR-01A,TCGA-QS-A5YR-01A-31R-A31O-07,TP,Primary solid Tumor,1,1,A31O,1,0,1,Female,1,Tumor,TCGA-QS-A5YR-01A,11017,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22372,Alive,WITH TUMOR,719,NA,[Not Available],NA,NA,NA,NA,Stable Disease,NA,NA,0,719,0,719,NA,NA,0,719,NA,younger,35.430839,level4,NA,NA,NA,NA,NA,YES
TCGA.QS.A744.01A,TCGA-QS-A744,TCGA.QS.A744,3.328319482,7.73336112,TCGA.QS.A744.01A.11R.A34R.07,0.603934,0.1994264,-1.604566,-2.310969,-0.01167941,UCEC,TCGA-QS-A744,TCGA-QS-A744-01A-11R-A34R-07,TCGA-QS-A744-01A,TCGA-QS-A744-01A-11R-A34R-07,TP,Primary solid Tumor,1,1,A34R,1,0,1,Female,1,Tumor,TCGA-QS-A744-01A,11018,UCEC,86,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G2,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31520,Alive,TUMOR FREE,451,NA,[Not Available],NA,NA,NA,NA,[Not Applicable],NA,NA,0,451,0,451,NA,NA,0,451,NA,older,28.60476495,level2,NA,NA,NA,NA,NA,NO
TCGA.QS.A8F1.01A,TCGA-QS-A8F1,TCGA.QS.A8F1,3.961493684,6.650826297,TCGA.QS.A8F1.01A.21R.A37O.07,1.472285,1.470439,-0.9625086,-1.442618,0.2480861,UCEC,TCGA-QS-A8F1,TCGA-QS-A8F1-01A-21R-A37O-07,TCGA-QS-A8F1-01A,TCGA-QS-A8F1-01A-21R-A37O-07,TP,Primary solid Tumor,1,1,A37O,1,0,1,Female,1,Tumor,TCGA-QS-A8F1-01A,11019,UCEC,85,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31386,Dead,WITH TUMOR,NA,135,[Not Available],NA,NA,NA,NA,Progressive Disease,NA,NA,1,135,1,135,NA,NA,1,135,NA,older,26.57312925,level2,NA,NA,NA,NA,NA,NO
TCGA.RB.A7B8.01A,TCGA-RB-A7B8,TCGA.RB.A7B8,7.932734442,9.816098862,TCGA.RB.A7B8.01A.12R.A33R.07,4.53034,4.54344,1.146411,1.615437,1.340377,PAAD,TCGA-RB-A7B8,TCGA-RB-A7B8-01A-12R-A33R-07,TCGA-RB-A7B8-01A,TCGA-RB-A7B8-01A-12R-A33R-07,TP,Primary solid Tumor,1,1,A33R,1,0,1,Pancreas,1,Tumor,TCGA-RB-A7B8-01A,7666,PAAD,81,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2013,[Not Available],-29585,Dead,TUMOR FREE,NA,466,Pancreatic Cancer,Locoregional Recurrence,NA,NA,449,Complete Remission/Response,NA,NA,1,466,1,466,1,449,1,449,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.RB.AA9M.01A,TCGA-RB-AA9M,TCGA.RB.AA9M,8.739659115,10.12562011,TCGA.RB.AA9M.01A.11R.A39D.07,2.609366,2.503619,-0.2187658,-0.3055377,0.6709115,PAAD,TCGA-RB-AA9M,TCGA-RB-AA9M-01A-11R-A39D-07,TCGA-RB-AA9M-01A,TCGA-RB-AA9M-01A-11R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-RB-AA9M-01A,7667,PAAD,43,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-15807,Alive,WITH TUMOR,286,NA,NA,Distant Metastasis,Liver,NA,258,Progressive Disease,NA,NA,0,286,0,286,NA,NA,1,258,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.RL.AAAS.01A,TCGA-RL-AAAS,TCGA.RL.AAAS,7.679733429,10.30620983,TCGA.RL.AAAS.01A.32R.A39D.07,4.343404,4.17717,0.983765,1.428501,1.288701,PAAD,TCGA-RL-AAAS,TCGA-RL-AAAS-01A-32R-A39D-07,TCGA-RL-AAAS-01A,TCGA-RL-AAAS-01A-32R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-RL-AAAS-01A,7668,PAAD,60,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-22126,Alive,TUMOR FREE,9,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,9,0,9,0,9,0,9,NA,younger,NA,NA,NA,NA,NA,2,NA,YES
TCGA.S4.A8RM.01A,TCGA-S4-A8RM,TCGA.S4.A8RM,9.814257202,11.69924709,TCGA.S4.A8RM.01A.11R.A37L.07,3.586631,3.520371,0.4641196,0.6717273,1.028754,PAAD,TCGA-S4-A8RM,TCGA-S4-A8RM-01A-11R-A37L-07,TCGA-S4-A8RM-01A,TCGA-S4-A8RM-01A-11R-A37L-07,TP,Primary solid Tumor,1,1,A37L,1,0,1,Pancreas,1,Tumor,TCGA-S4-A8RM-01A,7669,PAAD,67,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2013,[Not Available],-24589,Alive,TUMOR FREE,737,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,737,0,737,0,737,0,737,NA,older,NA,NA,NA,25,1991,3,1966,YES
TCGA.S4.A8RO.01A,TCGA-S4-A8RO,TCGA.S4.A8RO,8.194589433,10.42009707,TCGA.S4.A8RO.01A.12R.A37L.07,3.668595,3.538763,0.5494458,0.7536917,1.018325,PAAD,TCGA-S4-A8RO,TCGA-S4-A8RO-01A-12R-A37L-07,TCGA-S4-A8RO-01A,TCGA-S4-A8RO-01A-12R-A37L-07,TP,Primary solid Tumor,1,1,A37L,1,0,1,Pancreas,1,Tumor,TCGA-S4-A8RO-01A,7670,PAAD,75,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-27645,Alive,WITH TUMOR,525,NA,NA,Distant Metastasis,Lung,NA,291,Complete Remission/Response,NA,NA,0,525,0,525,1,291,1,291,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.S4.A8RP.01A,TCGA-S4-A8RP,TCGA.S4.A8RP,8.231278791,11.1443141,TCGA.S4.A8RP.01A.11R.A36G.07,4.210511,4.077368,0.9169822,1.295608,1.217961,PAAD,TCGA-S4-A8RP,TCGA-S4-A8RP-01A-11R-A36G-07,TCGA-S4-A8RP-01A,TCGA-S4-A8RP-01A-11R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-S4-A8RP-01A,7671,PAAD,77,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2010,[Not Available],-28353,Dead,NA,NA,702,NA,NA,NA,NA,NA,[Unknown],NA,NA,1,702,NA,702,NA,NA,0,702,NA,older,NA,NA,NA,26,1982,3,NA,NO
TCGA.SJ.A6ZI.01A,TCGA-SJ-A6ZI,TCGA.SJ.A6ZI,6.701230209,9.769365131,TCGA.SJ.A6ZI.01A.12R.A34R.07,4.436993,4.280516,1.031145,1.522089,1.337205,UCEC,TCGA-SJ-A6ZI,TCGA-SJ-A6ZI-01A-12R-A34R-07,TCGA-SJ-A6ZI-01A,TCGA-SJ-A6ZI-01A-12R-A34R-07,TP,Primary solid Tumor,1,1,A34R,1,0,1,Female,1,Tumor,TCGA-SJ-A6ZI-01A,11020,UCEC,64,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2013,[Unknown],-23653,Alive,TUMOR FREE,631,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,631,0,631,0,631,0,631,NA,younger,213.4986226,level4,NA,NA,NA,NA,NA,NO
TCGA.SJ.A6ZJ.01A,TCGA-SJ-A6ZJ,TCGA.SJ.A6ZJ,3.807839174,10.3004212,TCGA.SJ.A6ZJ.01A.12R.A34R.07,2.49811,2.39401,-0.2841052,-0.416793,0.5935983,UCEC,TCGA-SJ-A6ZJ,TCGA-SJ-A6ZJ-01A-12R-A34R-07,TCGA-SJ-A6ZJ-01A,TCGA-SJ-A6ZJ-01A-12R-A34R-07,TP,Primary solid Tumor,1,1,A34R,1,0,1,Female,1,Tumor,TCGA-SJ-A6ZJ-01A,11021,UCEC,61,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2012,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22597,Alive,TUMOR FREE,556,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,556,0,556,0,556,0,556,NA,younger,46.76870748,level4,NA,NA,NA,NA,NA,NO
TCGA.SL.A6J9.01A,TCGA-SL-A6J9,TCGA.SL.A6J9,5.153229764,5.786789754,TCGA.SL.A6J9.01A.11R.A31O.07,3.705967,3.561406,0.5171668,0.7910639,1.047806,UCEC,TCGA-SL-A6J9,TCGA-SL-A6J9-01A-11R-A31O-07,TCGA-SL-A6J9-01A,TCGA-SL-A6J9-01A-11R-A31O-07,TP,Primary solid Tumor,1,1,A31O,1,0,1,Female,1,Tumor,TCGA-SL-A6J9-01A,11022,UCEC,73,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26701,Alive,NA,2,NA,[Not Available],NA,NA,NA,NA,[Unknown],NA,NA,0,2,0,2,NA,NA,0,2,NA,older,31.55365915,level3,NA,NA,NA,NA,NA,NO
TCGA.SL.A6JA.01A,TCGA-SL-A6JA,TCGA.SL.A6JA,6.604326383,10.23433845,TCGA.SL.A6JA.01A.11R.A31O.07,0.07671707,-0.2592191,-2.000481,-2.838186,-0.2289473,UCEC,TCGA-SL-A6JA,TCGA-SL-A6JA-01A-11R-A31O-07,TCGA-SL-A6JA-01A,TCGA-SL-A6JA-01A-11R-A31O-07,TP,Primary solid Tumor,1,1,A31O,1,0,1,Female,1,Tumor,TCGA-SL-A6JA-01A,11023,UCEC,77,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2013,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-28401,Alive,TUMOR FREE,7,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,7,0,7,0,7,0,7,NA,older,46.2547958,level4,NA,NA,NA,NA,NA,NO
TCGA.US.A774.01A,TCGA-US-A774,TCGA.US.A774,9.812177306,10.95484334,TCGA.US.A774.01A.21R.A32O.07,4.5085,4.342529,1.119452,1.593597,1.339761,PAAD,TCGA-US-A774,TCGA-US-A774-01A-21R-A32O-07,TCGA-US-A774-01A,TCGA-US-A774-01A-21R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-US-A774-01A,7672,PAAD,76,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-27957,Dead,WITH TUMOR,NA,695,Pancreatic Cancer,Distant Metastasis,Liver,NA,366,Progressive Disease,NA,NA,1,695,1,695,NA,NA,1,366,NA,older,NA,NA,NA,4.65,1992,3,1955,NO
TCGA.US.A776.01A,TCGA-US-A776,TCGA.US.A776,6.229270664,11.78753123,TCGA.US.A776.01A.13R.A33R.07,1.678559,1.538716,-0.870098,-1.236344,0.3600649,PAAD,TCGA-US-A776,TCGA-US-A776-01A-13R-A33R-07,TCGA-US-A776-01A,TCGA-US-A776-01A-13R-A33R-07,TP,Primary solid Tumor,1,1,A33R,1,0,1,Pancreas,1,Tumor,TCGA-US-A776-01A,7673,PAAD,61,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Colloid (mucinous non-cystic) Carcinoma,G2,2011,[Not Available],-22283,Alive,TUMOR FREE,1216,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1216,0,1216,0,1216,0,1216,NA,younger,NA,NA,NA,NA,NA,1,NA,YES
TCGA.US.A779.01A,TCGA-US-A779,TCGA.US.A779,8.242026037,11.55490057,TCGA.US.A779.01A.11R.A32O.07,2.227514,2.070923,-0.4421679,-0.6873894,0.5181792,PAAD,TCGA-US-A779,TCGA-US-A779-01A-11R-A32O-07,TCGA-US-A779-01A,TCGA-US-A779-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-US-A779-01A,7674,PAAD,54,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2011,[Not Available],-20051,Dead,WITH TUMOR,NA,511,Pancreatic Cancer,NA,NA,NA,NA,[Not Available],NA,NA,1,511,1,511,NA,NA,1,511,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.US.A77E.01A,TCGA-US-A77E,TCGA.US.A77E,7.283903257,11.92583998,TCGA.US.A77E.01A.11R.A32O.07,2.694602,2.629416,-0.132228,-0.2203011,0.6729714,PAAD,TCGA-US-A77E,TCGA-US-A77E-01A-11R-A32O-07,TCGA-US-A77E-01A,TCGA-US-A77E-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-US-A77E-01A,7675,PAAD,73,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2012,[Not Available],-26745,Dead,WITH TUMOR,NA,430,Pancreatic Cancer,Distant Metastasis,Liver,NA,166,[Not Available],NA,NA,1,430,1,430,NA,NA,1,166,NA,older,NA,NA,NA,NA,1987,3,NA,NO
TCGA.US.A77G.01A,TCGA-US-A77G,TCGA.US.A77G,7.358554505,11.59474914,TCGA.US.A77G.01A.11R.A32O.07,2.604672,2.338674,-0.2038931,-0.3102313,0.6536432,PAAD,TCGA-US-A77G,TCGA-US-A77G-01A-11R-A32O-07,TCGA-US-A77G-01A,TCGA-US-A77G-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-US-A77G-01A,7676,PAAD,64,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-23443,Dead,TUMOR FREE,NA,12,Surgical Complications,NA,NA,NA,NA,[Not Available],NA,NA,1,12,0,12,NA,NA,0,12,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.US.A77J.01A,TCGA-US-A77J,TCGA.US.A77J,9.209248644,9.86001457,TCGA.US.A77J.01A.11R.A32O.07,5.603818,5.645541,1.881805,2.688915,1.738167,PAAD,TCGA-US-A77J,TCGA-US-A77J-01A-11R-A32O-07,TCGA-US-A77J-01A,TCGA-US-A77J-01A-11R-A32O-07,TP,Primary solid Tumor,1,1,A32O,1,0,1,Pancreas,1,Tumor,TCGA-US-A77J-01A,7677,PAAD,81,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2010,[Not Available],-29904,Dead,WITH TUMOR,NA,568,Pancreatic Cancer,NA,NA,NA,NA,[Not Available],NA,NA,1,568,1,568,NA,NA,1,568,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.XD.AAUG.01A,TCGA-XD-AAUG,TCGA.XD.AAUG,7.955766132,9.031411739,TCGA.XD.AAUG.01A.61R.A41B.07,3.313995,3.153689,0.2985417,0.3990922,0.9102292,PAAD,TCGA-XD-AAUG,TCGA-XD-AAUG-01A-61R-A41B-07,TCGA-XD-AAUG-01A,TCGA-XD-AAUG-01A-61R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-XD-AAUG-01A,7678,PAAD,66,FEMALE,WHITE,Stage IV,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-24291,Alive,TUMOR FREE,420,NA,NA,NA,NA,NA,NA,[Discrepancy],NA,NA,0,420,0,420,NA,NA,0,420,NA,older,NA,NA,NA,NA,NA,1,NA,NA
TCGA.XD.AAUH.01A,TCGA-XD-AAUH,TCGA.XD.AAUH,6.908404631,9.821987581,TCGA.XD.AAUH.01A.42R.A41B.07,4.236282,4.025643,0.9134625,1.321379,1.270028,PAAD,TCGA-XD-AAUH,TCGA-XD-AAUH-01A-42R-A41B-07,TCGA-XD-AAUH-01A,TCGA-XD-AAUH-01A-42R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-XD-AAUH-01A,7679,PAAD,57,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-20858,Alive,NA,395,NA,NA,New Primary Tumor,"Other, specify",Left shoulder,87,[Unknown],NA,NA,0,395,0,395,NA,NA,1,87,NA,younger,NA,NA,NA,NA,NA,1,NA,NO
TCGA.XD.AAUI.01A,TCGA-XD-AAUI,TCGA.XD.AAUI,7.838283698,11.10434321,TCGA.XD.AAUI.01A.42R.A41B.07,3.480257,3.350887,0.4059379,0.5653541,0.9878983,PAAD,TCGA-XD-AAUI,TCGA-XD-AAUI-01A-42R-A41B-07,TCGA-XD-AAUI-01A,TCGA-XD-AAUI-01A-42R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-XD-AAUI-01A,7680,PAAD,50,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-18607,Dead,WITH TUMOR,NA,366,Pancreatic Cancer,Distant Metastasis,Liver,NA,175,Progressive Disease,NA,NA,1,366,1,366,NA,NA,1,175,NA,younger,NA,NA,NA,NA,NA,2,1979,YES
TCGA.XD.AAUL.01A,TCGA-XD-AAUL,TCGA.XD.AAUL,7.194274234,11.44136728,TCGA.XD.AAUL.01A.21R.A39D.07,3.145105,3.025106,0.1975583,0.2302017,0.8186531,PAAD,TCGA-XD-AAUL,TCGA-XD-AAUL-01A-21R-A39D-07,TCGA-XD-AAUL-01A,TCGA-XD-AAUL-01A-21R-A39D-07,TP,Primary solid Tumor,1,1,A39D,1,0,1,Pancreas,1,Tumor,TCGA-XD-AAUL-01A,7681,PAAD,56,MALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-20607,Alive,TUMOR FREE,498,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,498,0,498,0,498,0,498,NA,younger,NA,NA,NA,30,NA,2,1984,NO
TCGA.XN.A8T3.01A,TCGA-XN-A8T3,TCGA.XN.A8T3,6.86942728,9.204632274,TCGA.XN.A8T3.01A.11R.A36G.07,4.103173,4.036876,0.8435913,1.18827,1.162761,PAAD,TCGA-XN-A8T3,TCGA-XN-A8T3-01A-11R-A36G-07,TCGA-XN-A8T3-01A,TCGA-XN-A8T3-01A-11R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-XN-A8T3-01A,7682,PAAD,67,MALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-24810,Alive,WITH TUMOR,951,NA,NA,NA,NA,NA,NA,Progressive Disease,NA,NA,0,951,0,951,NA,NA,0,951,NA,older,NA,NA,NA,NA,1981,5,NA,NO
TCGA.XN.A8T5.01A,TCGA-XN-A8T5,TCGA.XN.A8T5,8.575263161,9.559357969,TCGA.XN.A8T5.01A.12R.A36G.07,4.971399,4.932296,1.437207,2.056496,1.533521,PAAD,TCGA-XN-A8T5,TCGA-XN-A8T5-01A-12R-A36G-07,TCGA-XN-A8T5-01A,TCGA-XN-A8T5-01A-12R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-XN-A8T5-01A,7683,PAAD,53,FEMALE,WHITE,Stage IB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G2,2012,[Not Available],-19707,Alive,WITH TUMOR,720,NA,NA,Distant Metastasis,Liver,NA,242,Progressive Disease,NA,NA,0,720,0,720,NA,NA,1,242,NA,younger,NA,NA,NA,15.2,NA,2,1974,YES
TCGA.YB.A89D.01A,TCGA-YB-A89D,TCGA.YB.A89D,8.198950817,10.96979661,TCGA.YB.A89D.01A.12R.A36G.07,4.452384,4.375773,1.097417,1.53748,1.298875,PAAD,TCGA-YB-A89D,TCGA-YB-A89D-01A-12R-A36G-07,TCGA-YB-A89D-01A,TCGA-YB-A89D-01A-12R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-YB-A89D-01A,7684,PAAD,59,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-21792,Alive,TUMOR FREE,350,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,350,0,350,0,350,0,350,NA,younger,NA,NA,NA,NA,NA,1,NA,YES
TCGA.YH.A8SY.01A,TCGA-YH-A8SY,TCGA.YH.A8SY,6.415484891,11.3836017,TCGA.YH.A8SY.01A.11R.A37L.07,3.467908,3.333596,0.4013748,0.5530046,0.9464864,PAAD,TCGA-YH-A8SY,TCGA-YH-A8SY-01A-11R-A37L-07,TCGA-YH-A8SY-01A,TCGA-YH-A8SY-01A-11R-A37L-07,TP,Primary solid Tumor,1,1,A37L,1,0,1,Pancreas,1,Tumor,TCGA-YH-A8SY-01A,7685,PAAD,73,FEMALE,WHITE,[Discrepancy],[Not Applicable],[Discrepancy],G2,2011,[Not Available],-26859,Alive,NA,388,NA,NA,NA,NA,NA,NA,[Unknown],NA,NA,0,388,0,388,NA,NA,0,388,NA,older,NA,NA,NA,NA,NA,1,NA,NO
TCGA.YY.A8LH.01A,TCGA-YY-A8LH,TCGA.YY.A8LH,7.94493456,12.15981143,TCGA.YY.A8LH.01A.11R.A36G.07,2.65715,2.567156,-0.1788176,-0.2577533,0.6984071,PAAD,TCGA-YY-A8LH,TCGA-YY-A8LH-01A-11R-A36G-07,TCGA-YY-A8LH-01A,TCGA-YY-A8LH-01A-11R-A36G-07,TP,Primary solid Tumor,1,1,A36G,1,0,1,Pancreas,1,Tumor,TCGA-YY-A8LH-01A,7686,PAAD,61,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2009,[Not Available],-22376,Alive,TUMOR FREE,2016,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2016,0,2016,0,2016,0,2016,NA,younger,NA,NA,NA,46,NA,2,1963,NO
TCGA.Z5.AAPL.01A,TCGA-Z5-AAPL,TCGA.Z5.AAPL,4.44648122,9.344946084,TCGA.Z5.AAPL.01A.12R.A41B.07,5.521169,5.536357,1.795172,2.606266,1.730064,PAAD,TCGA-Z5-AAPL,TCGA-Z5-AAPL-01A-12R-A41B-07,TCGA-Z5-AAPL-01A,TCGA-Z5-AAPL-01A-12R-A41B-07,TP,Primary solid Tumor,1,1,A41B,1,0,1,Pancreas,1,Tumor,TCGA-Z5-AAPL-01A,7687,PAAD,74,FEMALE,WHITE,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G1,2013,[Not Available],-27152,Alive,TUMOR FREE,467,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,467,0,467,0,467,0,467,NA,older,NA,NA,NA,NA,NA,1,NA,NA
TCGA.AJ.A2QL.11A,TCGA-AJ-A2QL,TCGA.AJ.A2QL,4.397753275,9.276244626,TCGA.AJ.A2QL.11A.11R.A18M.07,1.88312,1.700305,-0.6781186,-1.031783,0.38991,UCEC,TCGA-AJ-A2QL,TCGA-AJ-A2QL-11A-11R-A18M-07,TCGA-AJ-A2QL-11A,TCGA-AJ-A2QL-11A-11R-A18M-07,NT,Solid Tissue Normal,1,1,A18M,1,0,1,Female,1,Normal,TCGA-AJ-A2QL-11A,10529,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22057,Alive,TUMOR FREE,602,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,602,0,602,0,602,0,602,NA,younger,42.15439046,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3NC.11A,TCGA-AJ-A3NC,TCGA.AJ.A3NC,4.222750474,3.893303958,TCGA.AJ.A3NC.11A.11R.A22K.07,2.692813,2.470207,-0.1495761,-0.22209,0.6882502,UCEC,TCGA-AJ-A3NC,TCGA-AJ-A3NC-11A-11R-A22K-07,TCGA-AJ-A3NC-11A,TCGA-AJ-A3NC-11A-11R-A22K-07,NT,Solid Tissue Normal,1,1,A22K,1,0,1,Female,1,Normal,TCGA-AJ-A3NC-11A,10545,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23353,Alive,TUMOR FREE,1125,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1125,0,1125,0,1125,0,1125,NA,younger,38.9739229,level4,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3NE.11A,TCGA-AJ-A3NE,TCGA.AJ.A3NE,4.716694645,7.824691491,TCGA.AJ.A3NE.11A.11R.A22K.07,2.929254,2.722356,-0.002464216,0.0143505,0.7855094,UCEC,TCGA-AJ-A3NE,TCGA-AJ-A3NE-11A-11R-A22K-07,TCGA-AJ-A3NE-11A,TCGA-AJ-A3NE-11A-11R-A22K-07,NT,Solid Tissue Normal,1,1,A22K,1,0,1,Female,1,Normal,TCGA-AJ-A3NE-11A,10546,UCEC,46,FEMALE,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16957,Alive,TUMOR FREE,628,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,628,0,628,0,628,0,628,NA,younger,31.25,level3,NA,NA,NA,NA,NA,NA
TCGA.AJ.A3NH.11A,TCGA-AJ-A3NH,TCGA.AJ.A3NH,4.759715116,9.081360934,TCGA.AJ.A3NH.11A.11R.A22K.07,2.069864,1.926359,-0.585366,-0.8450389,0.4643567,UCEC,TCGA-AJ-A3NH,TCGA-AJ-A3NH-11A-11R-A22K-07,TCGA-AJ-A3NH-11A,TCGA-AJ-A3NH-11A-11R-A22K-07,NT,Solid Tissue Normal,1,1,A22K,1,0,1,Female,1,Normal,TCGA-AJ-A3NH-11A,10549,UCEC,90,FEMALE,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32871,Dead,TUMOR FREE,NA,310,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,310,0,310,0,310,0,310,NA,older,24.76756592,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A05Y.11A,TCGA-AX-A05Y,TCGA.AX.A05Y,4.739842703,5.252616238,TCGA.AX.A05Y.11A.11R.A27V.07,2.83184,2.638782,-0.060871,-0.08306284,0.7500727,UCEC,TCGA-AX-A05Y,TCGA-AX-A05Y-11A-11R-A27V-07,TCGA-AX-A05Y-11A,TCGA-AX-A05Y-11A-11R-A27V-07,NT,Solid Tissue Normal,1,1,A27V,1,0,1,Female,1,Normal,TCGA-AX-A05Y-11A,10612,UCEC,57,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20904,Alive,TUMOR FREE,2684,NA,[Not Available],NA,NA,NA,194,Complete Remission/Response,NA,NA,0,2684,0,2684,1,194,1,194,NA,younger,33.38655828,level3,NA,NA,NA,NA,NA,NA
TCGA.AX.A0IZ.11A,TCGA-AX-A0IZ,TCGA.AX.A0IZ,4.129925903,3.358100828,TCGA.AX.A0IZ.11A.11R.A27V.07,2.250219,2.118961,-0.4574977,-0.6646839,0.5127225,UCEC,TCGA-AX-A0IZ,TCGA-AX-A0IZ-11A-11R-A27V-07,TCGA-AX-A0IZ-11A,TCGA-AX-A0IZ-11A-11R-A27V-07,NT,Solid Tissue Normal,1,1,A27V,1,0,1,Female,1,Normal,TCGA-AX-A0IZ-11A,10627,UCEC,53,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19364,Alive,TUMOR FREE,1333,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1333,0,1333,0,1333,0,1333,NA,younger,23.4375,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A0J0.11A,TCGA-AX-A0J0,TCGA.AX.A0J0,3.943208709,6.84446098,TCGA.AX.A0J0.11A.11R.A27V.07,2.749773,2.542653,-0.1408701,-0.1651307,0.7129731,UCEC,TCGA-AX-A0J0,TCGA-AX-A0J0-11A-11R-A27V-07,TCGA-AX-A0J0-11A,TCGA-AX-A0J0-11A-11R-A27V-07,NT,Solid Tissue Normal,1,1,A27V,1,0,1,Female,1,Normal,TCGA-AX-A0J0-11A,10628,UCEC,47,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2006,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-17466,Alive,TUMOR FREE,1220,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1220,0,1220,0,1220,0,1220,NA,younger,19.94805977,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CF.11A,TCGA-AX-A1CF,TCGA.AX.A1CF,5.074989157,8.14602781,TCGA.AX.A1CF.11A.11R.A137.07,2.862383,2.648235,-0.01171234,-0.05252027,0.7228819,UCEC,TCGA-AX-A1CF,TCGA-AX-A1CF-11A-11R-A137-07,TCGA-AX-A1CF-11A,TCGA-AX-A1CF-11A-11R-A137-07,NT,Solid Tissue Normal,1,1,A137,1,0,1,Female,1,Normal,TCGA-AX-A1CF-11A,10638,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2004,[Not Available],-25300,Alive,WITH TUMOR,2337,NA,[Not Available],NA,NA,NA,875,Progressive Disease,NA,NA,0,2337,0,2337,NA,NA,1,875,NA,older,35.11111111,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CI.11A,TCGA-AX-A1CI,TCGA.AX.A1CI,4.868789901,9.263584466,TCGA.AX.A1CI.11A.11R.A137.07,2.459963,2.33022,-0.3087398,-0.4549405,0.5895977,UCEC,TCGA-AX-A1CI,TCGA-AX-A1CI-11A-11R-A137-07,TCGA-AX-A1CI-11A,TCGA-AX-A1CI-11A-11R-A137-07,NT,Solid Tissue Normal,1,1,A137,1,0,1,Female,1,Normal,TCGA-AX-A1CI-11A,10639,UCEC,61,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2004,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22582,Alive,TUMOR FREE,2600,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,2600,0,2600,NA,NA,0,2600,NA,younger,27.51338489,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A1CK.11A,TCGA-AX-A1CK,TCGA.AX.A1CK,5.842865101,8.736986847,TCGA.AX.A1CK.11A.11R.A137.07,3.720201,3.536135,0.5736606,0.8052982,1.007246,UCEC,TCGA-AX-A1CK,TCGA-AX-A1CK-11A-11R-A137-07,TCGA-AX-A1CK-11A,TCGA-AX-A1CK-11A-11R-A137-07,NT,Solid Tissue Normal,1,1,A137,1,0,1,Female,1,Normal,TCGA-AX-A1CK-11A,10641,UCEC,58,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21200,Alive,WITH TUMOR,2441,NA,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,0,2441,0,2441,NA,NA,0,2441,NA,younger,27.09925101,level2,NA,NA,NA,NA,NA,NA
TCGA.AX.A2HA.11A,TCGA-AX-A2HA,TCGA.AX.A2HA,4.862915373,7.318719429,TCGA.AX.A2HA.11A.11R.A18M.07,3.766958,3.590775,0.5756345,0.8520547,1.049939,UCEC,TCGA-AX-A2HA,TCGA-AX-A2HA-11A-11R-A18M-07,TCGA-AX-A2HA-11A,TCGA-AX-A2HA-11A-11R-A18M-07,NT,Solid Tissue Normal,1,1,A18M,1,0,1,Female,1,Normal,TCGA-AX-A2HA-11A,10650,UCEC,35,FEMALE,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2005,[Not Available],-13142,Alive,TUMOR FREE,2475,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,2475,0,2475,0,2475,0,2475,NA,younger,21.51385851,level1,NA,NA,NA,NA,NA,NA
TCGA.AX.A2HC.11A,TCGA-AX-A2HC,TCGA.AX.A2HC,3.480135843,5.040739038,TCGA.AX.A2HC.11A.11R.A32Y.07,2.992741,2.705134,0.03497636,0.07783822,0.7990541,UCEC,TCGA-AX-A2HC,TCGA-AX-A2HC-11A-11R-A32Y-07,TCGA-AX-A2HC-11A,TCGA-AX-A2HC-11A-11R-A32Y-07,NT,Solid Tissue Normal,1,1,A32Y,1,0,1,Female,1,Normal,TCGA-AX-A2HC-11A,10651,UCEC,53,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2006,[Not Available],-19485,Alive,WITH TUMOR,1044,NA,[Not Available],Metastatic,"Other, specify",Abdomen,756,Complete Remission/Response,NA,NA,0,1044,0,1044,1,756,1,756,NA,younger,47.26806602,level4,NA,NA,NA,NA,NA,NA
TCGA.AX.A2HD.11A,TCGA-AX-A2HD,TCGA.AX.A2HD,4.182708186,5.440527032,TCGA.AX.A2HD.11A.11R.A32Y.07,3.067374,3.02691,0.1196768,0.1524704,0.8043921,UCEC,TCGA-AX-A2HD,TCGA-AX-A2HD-11A-11R-A32Y-07,TCGA-AX-A2HD-11A,TCGA-AX-A2HD-11A-11R-A32Y-07,NT,Solid Tissue Normal,1,1,A32Y,1,0,1,Female,1,Normal,TCGA-AX-A2HD-11A,10652,UCEC,69,FEMALE,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2008,[Not Available],-25499,Alive,WITH TUMOR,1414,NA,[Not Available],NA,NA,NA,NA,Partial Remission/Response,NA,NA,0,1414,0,1414,NA,NA,0,1414,NA,older,22.9719382,level1,NA,NA,NA,NA,NA,NA
TCGA.BG.A2AD.11A,TCGA-BG-A2AD,TCGA.BG.A2AD,4.121454776,4.832201406,TCGA.BG.A2AD.11A.11R.A16F.07,3.221874,2.998829,0.2374081,0.3069711,0.8682559,UCEC,TCGA-BG-A2AD,TCGA-BG-A2AD-11A-11R-A16F-07,TCGA-BG-A2AD-11A,TCGA-BG-A2AD-11A-11R-A16F-07,NT,Solid Tissue Normal,1,1,A16F,1,0,1,Female,1,Normal,TCGA-BG-A2AD-11A,10773,UCEC,63,FEMALE,WHITE,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23064,Alive,TUMOR FREE,609,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,609,0,609,0,609,0,609,NA,younger,31.25,level3,NA,NA,NA,NA,NA,NA
TCGA.BG.A3EW.11A,TCGA-BG-A3EW,TCGA.BG.A3EW,5.328545685,4.237089472,TCGA.BG.A3EW.11A.22R.A22K.07,2.499009,2.287272,-0.2804742,-0.4158944,0.6234654,UCEC,TCGA-BG-A3EW,TCGA-BG-A3EW-11A-22R-A22K-07,TCGA-BG-A3EW-11A,TCGA-BG-A3EW-11A-22R-A22K-07,NT,Solid Tissue Normal,1,1,A22K,1,0,1,Female,1,Normal,TCGA-BG-A3EW-11A,10776,UCEC,62,FEMALE,WHITE,[Not Applicable],Stage III,Endometrioid endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22705,Alive,TUMOR FREE,344,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,344,0,344,0,344,0,344,NA,younger,45.72506895,level4,NA,NA,NA,NA,NA,NA
TCGA.BG.A3PP.11A,TCGA-BG-A3PP,TCGA.BG.A3PP,5.234344197,1.584962501,TCGA.BG.A3PP.11A.11R.A22K.07,1.43431,1.441771,-1.02845,-1.480594,0.2676144,UCEC,TCGA-BG-A3PP,TCGA-BG-A3PP-11A-11R-A22K-07,TCGA-BG-A3PP-11A,TCGA-BG-A3PP-11A-11R-A22K-07,NT,Solid Tissue Normal,1,1,A22K,1,0,1,Female,1,Normal,TCGA-BG-A3PP-11A,10777,UCEC,82,FEMALE,WHITE,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2011,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30227,Alive,WITH TUMOR,681,NA,[Not Available],Locoregional Recurrence,"Other, specify",Vagina apex,665,Progressive Disease,NA,NA,0,681,0,681,NA,NA,1,665,NA,older,NA,NA,NA,NA,NA,NA,NA,NA
TCGA.BK.A0CB.11A,TCGA-BK-A0CB,TCGA.BK.A0CB,3.389924329,2.600183078,TCGA.BK.A0CB.11A.33R.A104.07,2.528534,2.413707,-0.2617944,-0.3863689,0.669445,UCEC,TCGA-BK-A0CB,TCGA-BK-A0CB-11A-33R-A104-07,TCGA-BK-A0CB-11A,TCGA-BK-A0CB-11A-33R-A104-07,NT,Solid Tissue Normal,1,1,A104,1,0,1,Female,1,Normal,TCGA-BK-A0CB-11A,10780,UCEC,60,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G2,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21930,Alive,TUMOR FREE,1092,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1092,0,1092,0,1092,0,1092,NA,younger,46.80384551,level4,NA,NA,NA,NA,NA,NA
TCGA.BK.A13C.11A,TCGA-BK-A13C,TCGA.BK.A13C,4.123933689,2.351057246,TCGA.BK.A13C.11A.11R.A118.07,2.63463,2.519577,-0.1729389,-0.2802734,0.6647908,UCEC,TCGA-BK-A13C,TCGA-BK-A13C-11A-11R-A118-07,TCGA-BK-A13C-11A,TCGA-BK-A13C-11A-11R-A118-07,NT,Solid Tissue Normal,1,1,A118,1,0,1,Female,1,Normal,TCGA-BK-A13C-11A,10784,UCEC,47,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010,Peri (6-12 months since last menstrual period),-17317,Alive,TUMOR FREE,760,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,760,0,760,0,760,0,760,NA,younger,33.74945565,level3,NA,NA,NA,NA,NA,NA
TCGA.BK.A4ZD.11A,TCGA-BK-A4ZD,TCGA.BK.A4ZD,3.404208304,6.561703412,TCGA.BK.A4ZD.11A.12R.A27V.07,2.191572,2.09274,-0.500524,-0.7233313,0.5309639,UCEC,TCGA-BK-A4ZD,TCGA-BK-A4ZD-11A-12R-A27V-07,TCGA-BK-A4ZD-11A,TCGA-BK-A4ZD-11A-12R-A27V-07,NT,Solid Tissue Normal,1,1,A27V,1,0,1,Female,1,Normal,TCGA-BK-A4ZD-11A,10786,UCEC,42,FEMALE,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15536,Alive,TUMOR FREE,506,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,506,0,506,0,506,0,506,NA,younger,53.44574504,level4,NA,NA,NA,NA,NA,YES
TCGA.DI.A2QU.11A,TCGA-DI-A2QU,TCGA.DI.A2QU,3.093291486,4.325428926,TCGA.DI.A2QU.11A.11R.A18M.07,1.281759,1.118253,-1.118473,-1.633144,0.1881951,UCEC,TCGA-DI-A2QU,TCGA-DI-A2QU-11A-11R-A18M-07,TCGA-DI-A2QU-11A,TCGA-DI-A2QU-11A-11R-A18M-07,NT,Solid Tissue Normal,1,1,A18M,1,0,1,Female,1,Normal,TCGA-DI-A2QU-11A,10908,UCEC,67,FEMALE,WHITE,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24488,Dead,WITH TUMOR,NA,946,[Not Available],NA,NA,NA,NA,[Not Available],NA,NA,1,946,1,946,NA,NA,1,946,NA,older,36.328125,level4,NA,NA,NA,NA,NA,NA
TCGA.DI.A2QY.11A,TCGA-DI-A2QY,TCGA.DI.A2QY,5.108177332,9.614089573,TCGA.DI.A2QY.11A.11R.A19W.07,2.91504,2.680954,-0.01679636,0.000136744,0.7645325,UCEC,TCGA-DI-A2QY,TCGA-DI-A2QY-11A-11R-A19W-07,TCGA-DI-A2QY-11A,TCGA-DI-A2QY-11A-11R-A19W-07,NT,Solid Tissue Normal,1,1,A19W,1,0,1,Female,1,Normal,TCGA-DI-A2QY-11A,10909,UCEC,64,FEMALE,WHITE,[Not Applicable],Stage IIB,Serous endometrial adenocarcinoma,G3,2003,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23398,Dead,TUMOR FREE,NA,3349,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,3349,0,3349,0,3349,0,3349,NA,younger,33.203125,level3,NA,NA,NA,NA,NA,NA
TCGA.E6.A1M0.11A,TCGA-E6-A1M0,TCGA.E6.A1M0,8.262561788,1.584431192,TCGA.E6.A1M0.11A.11R.A144.07,0.3211364,0.1360831,-1.789065,-2.593767,-0.1357778,UCEC,TCGA-E6-A1M0,TCGA-E6-A1M0-11A-11R-A144-07,TCGA-E6-A1M0-11A,TCGA-E6-A1M0-11A-11R-A144-07,NT,Solid Tissue Normal,1,1,A144,1,0,1,Female,1,Normal,TCGA-E6-A1M0-11A,10912,UCEC,56,FEMALE,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G3,2010,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20629,Alive,TUMOR FREE,1793,NA,[Not Available],NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,1793,0,1793,0,1793,0,1793,NA,younger,37.653587,level4,NA,NA,NA,NA,NA,NA
TCGA.H6.8124.11A,TCGA-H6-8124,TCGA.H6.8124,6.052515885,10.22208243,TCGA.H6.8124.11A.01R.2404.07,4.943891,4.747268,1.389743,2.028988,1.495245,PAAD,TCGA-H6-8124,TCGA-H6-8124-11A-01R-2404-07,TCGA-H6-8124-11A,TCGA-H6-8124-11A-01R-2404-07,NT,Solid Tissue Normal,1,1,2404,1,0,1,Pancreas,1,Normal,TCGA-H6-8124-11A,7577,PAAD,56,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G3,2011,[Not Available],-20741,Alive,WITH TUMOR,392,NA,NA,Distant Metastasis,Liver,NA,259,Complete Remission/Response,NA,NA,0,392,0,392,1,259,1,259,NA,younger,NA,NA,NA,3.5,1976,3,1969,NO
TCGA.H6.A45N.11A,TCGA-H6-A45N,TCGA.H6.A45N,2.31019468,2.647498721,TCGA.H6.A45N.11A.12R.A26U.07,6.365865,6.455021,2.380078,3.450961,2.049458,PAAD,TCGA-H6-A45N,TCGA-H6-A45N-11A-12R-A26U-07,TCGA-H6-A45N-11A,TCGA-H6-A45N-11A-12R-A26U-07,NT,Solid Tissue Normal,1,1,A26U,1,0,1,Pancreas,1,Normal,TCGA-H6-A45N-11A,7578,PAAD,88,FEMALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma-Other Subtype,G3,2012,[Not Available],-32475,Dead,WITH TUMOR,NA,421,Pancreatic Cancer,Locoregional Recurrence,Tumor Bed,NA,363,Progressive Disease,NA,NA,1,421,1,421,NA,NA,1,363,NA,older,NA,NA,NA,1,NA,3,NA,NO
TCGA.HV.A5A3.11A,TCGA-HV-A5A3,TCGA.HV.A5A3,5.55398095,10.70074314,TCGA.HV.A5A3.11A.11R.A26U.07,4.405424,4.206228,1.028938,1.490521,1.282197,PAAD,TCGA-HV-A5A3,TCGA-HV-A5A3-11A-11R-A26U-07,TCGA-HV-A5A3-11A,TCGA-HV-A5A3-11A-11R-A26U-07,NT,Solid Tissue Normal,1,1,A26U,1,0,1,Pancreas,1,Normal,TCGA-HV-A5A3-11A,7580,PAAD,50,MALE,ASIAN,Stage IIA,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2012,[Not Available],-18475,Dead,TUMOR FREE,NA,128,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,1,128,0,128,0,128,0,128,NA,younger,NA,NA,NA,NA,2002,NA,NA,NO
TCGA.YB.A89D.11A,TCGA-YB-A89D,TCGA.YB.A89D,7.176462407,10.38993243,TCGA.YB.A89D.11A.11R.A36G.07,5.270744,5.223472,1.708304,2.355841,1.573541,PAAD,TCGA-YB-A89D,TCGA-YB-A89D-11A-11R-A36G-07,TCGA-YB-A89D-11A,TCGA-YB-A89D-11A-11R-A36G-07,NT,Solid Tissue Normal,1,1,A36G,1,0,1,Pancreas,1,Normal,TCGA-YB-A89D-11A,7684,PAAD,59,MALE,WHITE,Stage IIB,[Not Applicable],Pancreas-Adenocarcinoma Ductal Type,G2,2013,[Not Available],-21792,Alive,TUMOR FREE,350,NA,NA,NA,NA,NA,NA,Complete Remission/Response,NA,NA,0,350,0,350,0,350,0,350,NA,younger,NA,NA,NA,NA,NA,1,NA,YES
